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Abstract 
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, typically leads to death within 3-5 
years of symptom onset. Understanding what causes ALS has been a challenge, but more research in this 
area, enhanced by advanced technology like high-throughput next generation sequencing, is paving the way 
for better information and direction. The volume of data generated by genetics researchers has dramatically 
increased, largely because of increased opportunities for collaboration. ALSoD, a widely used online genetics 
database for collating, analysing and integrating ALS data, has been updated with analytics tools and is able 
to portray the data graphically to users. Mutations and other gene variants have been mapped to genomic 
coordinates, and the inclusion of dbSNP ids has been implemented to facilitate the integration of data from 
numerous public sources. To increase the usability and functionality of ALSoD, population frequency of each 
variant found in the 1000 Genome Project and Exome Variation Server (EVS) databases is displayed. To 
contribute to a better understanding of the pathogenesis of ALS, links to information on animal models are 
also available. Furthermore, ALSoD can now be viewed on mobile devices and for Android platforms a mobile 
app is also available. 
 
  
 - 3 - 
 
Table Of Contents 
Abstract ................................................................................................................................................... 2 
Table Of Contents ................................................................................................................................... 3 
Table of Figures .................................................................................................................................... 10 
Table of Tables ..................................................................................................................................... 16 
Table of Equations ................................................................................................................................ 16 
Document Information ........................................................................................................................... 16 
Acknowledgements ............................................................................................................................... 17 
Chapter 1 INTRODUCTION AND BACKGROUND .............................................................................. 19 
1.1 Health is wealth ........................................................................................................................... 19 
1.2 Diseases and Disorders .............................................................................................................. 19 
1.3 Motor Neuron Disease................................................................................................................. 19 
1.4 Amyotrophic Lateral Sclerosis ..................................................................................................... 20 
1.5 Clinical representation of ALS ..................................................................................................... 20 
1.6 Diagnosis ..................................................................................................................................... 21 
1.7 Prevention and Cure .................................................................................................................... 21 
1.8 Clinical Trials ............................................................................................................................... 22 
1.9 Palliative care / Equipment .......................................................................................................... 22 
1.10 Epistasis .................................................................................................................................... 22 
1.11 Epigenetics ................................................................................................................................ 23 
1.12 Epidemiology ............................................................................................................................. 23 
1.13 Neuroimaging ............................................................................................................................ 23 
1.14 In Vivo and in Vitro Models ........................................................................................................ 23 
1.15 Genetics of Amyotrophic Lateral Sclerosis ............................................................................... 24 
1.16 Environmental causes ............................................................................................................... 25 
1.17 How credible are these reported genes? .................................................................................. 25 
1.18 Origin of ALS-linked loci ............................................................................................................ 26 
1.19 Databases ................................................................................................................................. 52 
1.19.1 Data .................................................................................................................................... 52 
1.19.2 Evolution of Database ......................................................................................................... 53 
 - 4 - 
1.19.3 Relational model: review..................................................................................................... 53 
1.19.4 Database Management Systems ....................................................................................... 53 
1.19.5 Examples of Databases ...................................................................................................... 53 
1.20 Genetics database ..................................................................................................................... 53 
1.20.1 History of Genetics Databases ........................................................................................... 53 
1.20.2 Non-locus specific mutation databases .............................................................................. 54 
1.20.3 ALS-specific mutation databases ....................................................................................... 58 
1.21 Collection ................................................................................................................................... 59 
1.21.1 Data mining, Text mining and Web mining ......................................................................... 59 
1.21.2 External Databases ............................................................................................................ 59 
1.21.3 The need for a Single Resource ......................................................................................... 60 
1.22 Integration .................................................................................................................................. 60 
1.22.1 What is needed in ALS ....................................................................................................... 60 
1.22.2 Curators/Contributors ......................................................................................................... 61 
1.22.3 Google API ......................................................................................................................... 61 
1.22.4 Animal Models .................................................................................................................... 61 
1.23 Analysis ..................................................................................................................................... 61 
1.23.1 Genome Wide Association Study (GWAS) ......................................................................... 62 
1.23.2 On-the-fly Meta Analysis..................................................................................................... 62 
1.23.3 Predicting gene interactions ............................................................................................... 62 
1.24 Smartphone Development ......................................................................................................... 63 
1.24.1 Mobile Websites ................................................................................................................. 64 
1.24.2 Apps .................................................................................................................................... 64 
1.24.3 Advantages of a mobile website over an app ..................................................................... 66 
1.24.4 Advantages of an app over a mobile website ..................................................................... 67 
1.25 The Project ................................................................................................................................ 68 
1.25.1 Problem Statement ............................................................................................................. 68 
1.25.2 Research Questions ........................................................................................................... 68 
1.25.3 Overall aim .......................................................................................................................... 69 
1.25.4 Objectives ........................................................................................................................... 69 
Chapter 2 Publication 1 - ALSoD: A User-Friendly Online Bioinformatics Tool for Amyotrophic Lateral Sclerosis 
Genetics [521] ....................................................................................................................................... 70 
 - 5 - 
Chapter 3 Publication 2 - Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and 
ALSGene databases [486] .................................................................................................................... 78 
Chapter 4 Publication 3 - Credibility Analysis of Putative Disease-Causing Genes Using Bioinformatics[522]
 .............................................................................................................................................................. 91 
Chapter 5 Publication 4 - Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral 
Sclerosis Online Genetics Data [523] ................................................................................................... 98 
Chapter 6 METHODS ......................................................................................................................... 109 
6.1 Research questions with an overview of proposed methods .................................................... 109 
6.2 Keeping up with genetic discoveries in amyotrophic lateral sclerosis: ...................................... 110 
6.2.1 Data Submission ................................................................................................................. 110 
6.2.2 Submit mutation data .......................................................................................................... 111 
6.2.3 Submit new gene ................................................................................................................ 118 
6.2.4 Submit patient data ............................................................................................................. 120 
6.2.5 Submit replicated mutation data ......................................................................................... 126 
6.2.6 Submission process into ALSoD ........................................................................................ 127 
6.2.7 Search terms on search engines ........................................................................................ 129 
6.2.8 Contributors and Collaborators ........................................................................................... 130 
6.2.9 Unique Identifiers ................................................................................................................ 130 
6.2.10 Graphical display of phenotypic data ................................................................................ 130 
6.2.11 Mapping variants on Google Earth ................................................................................... 131 
6.2.12 Meta-analysis and on-the-fly analysis of association data ............................................... 131 
6.2.13 Instruction Manual on updating database ......................................................................... 131 
6.2.14 Updating Database ........................................................................................................... 131 
6.3 ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis Genetics .. 135 
6.3.1 Funding and Sponsorship ................................................................................................... 135 
6.3.2 Programming ...................................................................................................................... 140 
6.3.3 Web Design ........................................................................................................................ 143 
6.3.3.2 MasterPage ..................................................................................................................... 150 
6.3.3.3 Homepage ....................................................................................................................... 160 
6.3.4 On-the-fly Meta-Analysis of Genome Wide Association Studies in ALS ............................ 173 
6.3.5 Collaborations ..................................................................................................................... 187 
6.3.6 Embedded bioinformatics tools .......................................................................................... 187 
 - 6 - 
6.3.7 Imported bioinformatics data .............................................................................................. 188 
6.3.8 Population Frequency from 1000genome and EVS ........................................................... 191 
6.3.9 Animal Models .................................................................................................................... 194 
6.3.10 Integrated Bioinformatics links .......................................................................................... 197 
6.3.11 Borrowed Diagrams .......................................................................................................... 201 
6.3.12 Feedback .......................................................................................................................... 205 
6.3.13 Tracking Visitors ............................................................................................................... 206 
6.3.14 ChangeLog ....................................................................................................................... 207 
6.3.15 Search keyword(s) externally or internally ........................................................................ 208 
6.4 Credibility analysis of putative disease-causing genes using bioinformatics ............................ 209 
6.4.1 Data collection .................................................................................................................... 209 
6.4.2 Pathogenicity analysis using bioinformatic tools ................................................................ 209 
6.4.3 Data extraction from publications ....................................................................................... 230 
6.4.4 Automated gene ranking ..................................................................................................... 231 
6.4.5 Validation of the method ..................................................................................................... 244 
6.4.6 User interface ..................................................................................................................... 247 
6.4.7 Statistical methods .............................................................................................................. 247 
6.5 Development of a smartphone app for a genetics website, ALSoD .......................................... 248 
6.5.1 Searched online for direction .............................................................................................. 248 
6.5.2 Choosing between a mobile website or an app .................................................................. 248 
6.5.3 Optimization of webpage .................................................................................................... 248 
6.5.4 Design heuristics ................................................................................................................ 249 
6.5.5 Mobile Device Detection ..................................................................................................... 249 
6.5.6 User Interface redirection ................................................................................................... 251 
6.5.7 Compact version of website................................................................................................ 251 
6.5.8 Choosing to develop an app ............................................................................................... 251 
6.5.9 Using WebView to open a website ..................................................................................... 252 
6.5.10 Testing .............................................................................................................................. 252 
6.5.11 App submission ................................................................................................................ 254 
6.5.12 Creating awareness .......................................................................................................... 254 
6.5.13 Feedback from app users ................................................................................................. 255 
6.5.14 Analysis of visits ............................................................................................................... 255 
 - 7 - 
Chapter 7 RESULTS ........................................................................................................................... 256 
7.1 Keeping up with genetic discoveries in amyotrophic lateral sclerosis: ...................................... 256 
7.1.1 Data Submission ................................................................................................................. 256 
7.1.2 Database Schema .............................................................................................................. 258 
7.1.3 Search terms on search engines ........................................................................................ 258 
7.1.4 Contributors and Collaborators ........................................................................................... 260 
7.1.5 Unique Identifiers ................................................................................................................ 261 
7.1.6 Graphical display of phenotypic data .................................................................................. 261 
7.1.7 Mapping variants on Google Earth ..................................................................................... 262 
7.1.8 Meta-analysis and on-the-fly analysis of association data ................................................. 263 
7.2 ALSoD: A user-friendly online bioinformatics tool for Amyotrophic Lateral Sclerosis Genetics 264 
7.2.1 Funding and Sponsorship ................................................................................................... 264 
7.2.2 Programming ...................................................................................................................... 264 
7.2.3 Web Design ........................................................................................................................ 264 
7.2.4 On-the-fly Meta-Analysis of Genome Wide Association Studies in ALS ............................ 274 
7.2.5 Collaborations and Embedded Tools ................................................................................. 276 
7.2.6 Integrated Bioinformatics Links .......................................................................................... 277 
7.2.7 Feedback ............................................................................................................................ 278 
7.2.8 Tracking Visitors ................................................................................................................. 278 
7.2.9 ChangeLog ......................................................................................................................... 281 
7.2.10 Search keyword(s) externally or internally ........................................................................ 281 
7.3 Credibility analysis of putative disease-causing genes using bioinformatics ............................ 284 
7.3.1 Data collection .................................................................................................................... 284 
7.3.2 Pathogenicity analysis using bioinformatics tools .............................................................. 284 
7.3.3 Data extraction from publications ....................................................................................... 285 
7.3.4 Automated gene ranking ..................................................................................................... 285 
7.3.5 Validation of the method ..................................................................................................... 297 
7.3.6 User interface ..................................................................................................................... 297 
7.3.7 Statistical methods .............................................................................................................. 297 
7.4 Development of a smartphone app for a genetics website, ALSoD .......................................... 298 
7.4.1 Searched online for direction .............................................................................................. 298 
7.4.2 Choosing between a mobile website or an app .................................................................. 298 
 - 8 - 
7.4.3 Optimization of Webpages.................................................................................................. 298 
7.4.4 Design Heuristics ................................................................................................................ 299 
7.4.5 Mobile Device Detection ..................................................................................................... 299 
7.4.6 Requesting Responses ....................................................................................................... 299 
7.4.7 App Development ............................................................................................................... 299 
7.4.8 Creating Awareness ........................................................................................................... 299 
7.4.9 Feedback From App Users ................................................................................................. 300 
7.4.10 Analysis of Visits ............................................................................................................... 300 
7.4.11 Analysis to date (January 2014) ....................................................................................... 304 
Chapter 8 DISCUSSION AND FUTURE WORK ................................................................................ 307 
8.1 Bioinformatics exploration of ALS genetics ............................................................................... 307 
8.2 ALSoD versus Others ................................................................................................................ 308 
8.2.1 Daily Updates ..................................................................................................................... 309 
8.2.2 Data submission ................................................................................................................. 310 
8.2.3 Missing genetic data ........................................................................................................... 310 
8.2.4 Global representation ......................................................................................................... 310 
8.2.5 Popularity of database ........................................................................................................ 310 
8.3 Limitations of Genetic Databases .............................................................................................. 311 
8.3.1 Continued Funding ............................................................................................................. 311 
8.3.2 Duplication of Efforts ........................................................................................................... 311 
8.3.3 Limited resources ............................................................................................................... 311 
8.3.4 Political boundaries on data sharing policies...................................................................... 311 
8.4 Limitations of the ALS Online Database.................................................................................... 311 
8.4.1 Storage ............................................................................................................................... 311 
8.4.2 Funding ............................................................................................................................... 312 
8.4.3 Browser Incompatibility ....................................................................................................... 312 
8.4.4 Upgraded versions of third-party applications .................................................................... 312 
8.5 Concluded Research Questions ................................................................................................ 313 
8.6 Extra Development .................................................................................................................... 314 
8.6.1 Development of mobile computing applications ................................................................. 314 
8.6.2 Expansion of phenotypic inclusion criteria to include frontotemporal dementia ................. 314 
8.6.3 Suggestions from feedback ................................................................................................ 314 
 - 9 - 
8.7 Future of ALSoD ........................................................................................................................ 315 
8.7.1 Collaborations ..................................................................................................................... 315 
8.7.2 Larger Datasets .................................................................................................................. 316 
8.7.3 Graphical displays .............................................................................................................. 316 
8.7.4 Analysis............................................................................................................................... 317 
8.7.5 Development ....................................................................................................................... 317 
Chapter 9 CONCLUSIONS ................................................................................................................. 318 
9.1 Summary for Chapter 3 ............................................................................................................. 318 
9.2 Summary for Chapter 4 ............................................................................................................. 318 
9.3 Summary for Chapter 5 ............................................................................................................. 320 
9.4 Summary for Chapter 6 ............................................................................................................. 321 
9.5 Conclusion ................................................................................................................................. 321 
References .......................................................................................................................................... 324 
Appendix 1 – Data Submission Flowchart .......................................................................................... 346 
Appendix 2 – Genome Wide Association Study Flowchart ................................................................. 347 
Appendix 3 – Visitors’ Statistics .......................................................................................................... 348 
Appendix 4 – Embedding Google Earth Flowchart ............................................................................. 349 
Appendix 5 – Flowchart for integrating Animal model into ALSoD ..................................................... 350 
Appendix 6 - Data extraction from publications .................................................................................. 351 
Appendix 7 – Population Frequency script ......................................................................................... 359 
Appendix 8 - Data extraction from publications .................................................................................. 362 
Appendix 9 – Population Frequency script using python .................................................................... 363 
Appendix 10 - Process of installing and executing Eclipse application .............................................. 365 
Appendix 11 – SurveyMonkey screenshot.......................................................................................... 390 
Appendix 12 – Script for Blog ............................................................................................................. 391 
Appendix 13 – Masterpage Websitemap ............................................................................................ 397 
Appendix 14 – Tracking visitors script ................................................................................................ 408 
Appendix 15 – Inserting association text files into SQL Server .......................................................... 412 
Appendix 16 – ALTER TABLE for inserting ID and population column .............................................. 414 
Appendix 17 – Codes for creating scientific hyperlinks section .......................................................... 415 
Appendix 18 - Claustalw and Jalview codes ....................................................................................... 431 
Appendix 19 – GeneMANIA ................................................................................................................ 435 
 - 10 - 
Appendix 20 – Google Earth API ........................................................................................................ 437 
Appendix 21 – Python Script for Population Frequency ..................................................................... 441 
Appendix 22 – Perl Scripts to transpose, break, replace and join columns of a sequence ................ 444 
Appendix 23 – SQL Script for testing and verifying ranking system ................................................... 456 
Appendix 24 – Columns/Field list in each SQL table .......................................................................... 458 
Appendix 25 – T-SQL scripts in each SQL view ................................................................................. 480 
Appendix 26 – Disk Usage by Table in ALSoD .................................................................................. 494 
Appendix 27 – Label visibility on credibility analysis webpage ........................................................... 496 
Appendix 28 – User interface ASP.NET code .................................................................................... 498 
Appendix 29 – MainActivity.Java for Android app .............................................................................. 499 
Appendix 30 – Possible graphs of 31 combinations for 5 populations ............................................... 500 
Appendix 31 – UCSC Genome Browser ............................................................................................. 504 
Appendix 32 – UCSC Track for chromosome 9 .................................................................................. 554 
Appendix 33 – Codes for searching SNP ids on GWAS page............................................................ 558 
Appendix 34 – Credibility analysis of genes on SPSS and spreadsheet ............................................ 559 
Appendix 35 – Populating Animal model table using T-SQL .............................................................. 560 
Appendix 36 – GWAS method for 5 Populations ................................................................................ 563 
Appendix 37 – Updating database using T-SQL ................................................................................ 573 
Appendix 38 – Process of generating all possible mutations ............................................................. 627 
Appendix 39 – Sample of letter sent to ALS Experts .......................................................................... 644 
Appendix 40 – Database Schema ...................................................................................................... 645 
Appendix 41 – List of Files .................................................................................................................. 646 
Appendix 42 - Recaptcha .................................................................................................................... 661 
Appendix 43 – Errors .......................................................................................................................... 664 
Appendix 44 – Gantt Chart of Project ................................................................................................. 669 
Appendix 45 – Glossary ...................................................................................................................... 670 
Appendix 46 - Acronyms ..................................................................................................................... 675 
Appendix 47 - Resources .................................................................................................................... 676 
 
Table of Figures 
Figure 1: Mobile Marketing Statistics adapted from Netmarketshare webpage ................................................. 64 
 - 11 - 
Figure 2: Logging in section .............................................................................................................................. 110 
Figure 3: Protected page after log in ................................................................................................................. 111 
Figure 4: Confirmation page ............................................................................................................................. 111 
Figure 5: Mutation table on SQL Server ........................................................................................................... 112 
Figure 6: Gene submission page 1 ................................................................................................................... 112 
Figure 7: Gene submission page 2 ................................................................................................................... 113 
Figure 8: Gene submission page 3 ................................................................................................................... 114 
Figure 9: Gene submission page 4 ................................................................................................................... 115 
Figure 10: Gene submission page 5 ................................................................................................................. 116 
Figure 11: Gene submission page 6 ................................................................................................................. 117 
Figure 12: Gene submission page 7 ................................................................................................................. 118 
Figure 13: Gene table on SQL server ............................................................................................................... 119 
Figure 14: Gene submission page on ALSoD .................................................................................................. 120 
Figure 15: Patient table in SQL server .............................................................................................................. 121 
Figure 16: Patient submission page 1 ............................................................................................................... 122 
Figure 17: Patient submission page 2 ............................................................................................................... 123 
Figure 18: Patient submission page 3 ............................................................................................................... 124 
Figure 19: Patient submission page 4 ............................................................................................................... 125 
Figure 20: Patient submission page 5 ............................................................................................................... 126 
Figure 21: Replicated mutation table on SQL server ........................................................................................ 127 
Figure 22: Replicated mutation submission page ............................................................................................. 128 
Figure 23: Database Schema ........................................................................................................................... 129 
Figure 24: WGN-ALS logo ................................................................................................................................ 135 
Figure 25: ENCALS logo ................................................................................................................................... 135 
Figure 26: ALSA logo ........................................................................................................................................ 136 
Figure 27: MNDA logo ....................................................................................................................................... 136 
Figure 28: Clickable image using ImageMap control ........................................................................................ 136 
Figure 29: Opening the Paint application .......................................................................................................... 137 
Figure 30: Using <asp:RectangleHotSpot> control .......................................................................................... 138 
Figure 31: Full code for mapping image ........................................................................................................... 138 
Figure 32: Clickable image showing gene overview of MAPT .......................................................................... 139 
Figure 33: Using <asp:RectangleHotSpot>  for logos ...................................................................................... 139 
 - 12 - 
Figure 34: Calling Microsoft .NET framework ................................................................................................... 140 
Figure 35: Microsoft SQL Server 2008 startup page ........................................................................................ 141 
Figure 36: Microsoft SQL Server 2008 application ........................................................................................... 141 
Figure 37: Using Python to map population frequency ..................................................................................... 142 
Figure 38: WayBackMachine showing ALSoD homepage timeline .................................................................. 144 
Figure 39: Home page 2007-2008 .................................................................................................................... 145 
Figure 40: Home page 2009 ............................................................................................................................. 146 
Figure 41: Home page 2010 ............................................................................................................................. 147 
Figure 42: Home page 2011 ............................................................................................................................. 148 
Figure 43: Home page 2012 ............................................................................................................................. 149 
Figure 44: Home page 2013 ............................................................................................................................. 150 
Figure 45: Masterpage structure ....................................................................................................................... 151 
Figure 46: Masterpage Header ......................................................................................................................... 151 
Figure 47: Masterpage Footer .......................................................................................................................... 152 
Figure 48: Masterpage Top section .................................................................................................................. 152 
Figure 49: Masterpage Left section .................................................................................................................. 155 
Figure 50: Chromosomal overview of chr 9 ...................................................................................................... 156 
Figure 51: Flowchart for monitoring visitors ...................................................................................................... 157 
Figure 52: Analysis menu.................................................................................................................................. 162 
Figure 53: Detailed Analysis submenu ............................................................................................................. 162 
Figure 54: Interaction submenu ........................................................................................................................ 163 
Figure 55: Side by side comparison submenu .................................................................................................. 164 
Figure 56: Pathogenicity prediction submenu ................................................................................................... 164 
Figure 57: Credibility score analysis submenu ................................................................................................. 165 
Figure 58: Summary menu ............................................................................................................................... 166 
Figure 59: GWAS menu .................................................................................................................................... 167 
Figure 60: Customizing UCSC tracks process 1 .............................................................................................. 168 
Figure 61: Customizing UCSC tracks process 2 .............................................................................................. 169 
Figure 62: Customizing UCSC tracks process 3 .............................................................................................. 169 
Figure 63: News menu ...................................................................................................................................... 170 
Figure 64: Data menu ....................................................................................................................................... 171 
Figure 65: Contributors menu ........................................................................................................................... 171 
 - 13 - 
Figure 66: Feedback menu ............................................................................................................................... 172 
Figure 67: GWAS flowchart .............................................................................................................................. 174 
Figure 68: GWAS text file stored on SQL database ......................................................................................... 175 
Figure 69: Genome Wide Association Study webpage .................................................................................... 177 
Figure 70: Whole Genome analysis .................................................................................................................. 177 
Figure 71: GWA_NOKEY table ......................................................................................................................... 178 
Figure 72: Downloading java software .............................................................................................................. 180 
Figure 73: Haploview interface ......................................................................................................................... 181 
Figure 74 : UCSC genome browser track configuration ................................................................................... 185 
Figure 75 : Flowchart of Google Earth .............................................................................................................. 188 
Figure 76: Navigating to Python application on desktop ................................................................................... 192 
Figure 77: Screenshot of executing python ...................................................................................................... 192 
Figure 78: Result of running Python script ........................................................................................................ 193 
Figure 79: Screenshot of reformatting Python output in spreadsheet .............................................................. 193 
Figure 80: Accessing data from MGI website ................................................................................................... 195 
Figure 81: Screenshot on the process of creating Animal model table ............................................................ 196 
Figure 82: Chromosomal overview of all ALS-related genes............................................................................ 202 
Figure 83: SOD1 subpsec score created in 2008 by Amy Butler ..................................................................... 203 
Figure 84: ALS-FTD relationship created in 2013 by Ashley Jones ................................................................. 204 
Figure 85: Search externally and internally ...................................................................................................... 208 
Figure 86: Overview of credibility analysis method ........................................................................................... 209 
Figure 87: Generating all possible gene mutation process 1............................................................................ 210 
Figure 88: Generating all possible gene mutation process 2............................................................................ 211 
Figure 89: Generating all possible gene mutation process 3............................................................................ 212 
Figure 90: Generating all possible gene mutation process 4............................................................................ 213 
Figure 91: Generating all possible gene mutation process 5............................................................................ 214 
Figure 92: Pathogenicity prediction in PANTHER process 1 ............................................................................ 215 
Figure 93: Pathogenicity prediction PANTHER process 2 ................................................................................ 216 
Figure 94: Pathogenicity prediction in PANTHER process 3 ............................................................................ 217 
Figure 95: Pathogenicity prediction in PANTHER process 4 ............................................................................ 217 
Figure 96: Pathogenicity prediction in SIFT process 1 ..................................................................................... 218 
Figure 97: Pathogenicity prediction in SIFT process 2 ..................................................................................... 219 
 - 14 - 
Figure 98: Pathogenicity prediction in SIFT process 3 ..................................................................................... 220 
Figure 99: Pathogenicity prediction in SIFT process 4 ..................................................................................... 221 
Figure 100: Pathogenicity prediction in PolyPhen process 1 ........................................................................... 222 
Figure 101: Pathogenicity prediction in PolyPhen process 2 ........................................................................... 223 
Figure 102: Pathogenicity prediction in PolyPhen process 3 ........................................................................... 224 
Figure 103: Pathogenicity prediction in PolyPhen process 4 ........................................................................... 225 
Figure 104: Storing data from generated analyses into database tables process 1 ........................................ 226 
Figure 105: Storing data from generated analyses into database tables process 2 ........................................ 227 
Figure 106: Storing data from generated analyses into database tables process 3 ........................................ 228 
Figure 107: Storing data from generated analyses into database tables process 4 ........................................ 229 
Figure 108: Flowchart of pathogenicity prediction query .................................................................................. 229 
Figure 109: Criteria for Credibility score analysis ............................................................................................. 232 
Figure 110: Number of affected patients in ALSoD .......................................................................................... 234 
Figure 111: Number of mutations per gene ...................................................................................................... 235 
Figure 112: Number of cases recorded ............................................................................................................ 236 
Figure 113: Number of predicted pathogenic mutations by rank ...................................................................... 237 
Figure 114: Number of controls recorded ......................................................................................................... 238 
Figure 115: Number of mutations in same codon by rank ................................................................................ 239 
Figure 116: Number of patients with family history FALS ................................................................................. 239 
Figure 117: Number of ptients with SALS ......................................................................................................... 240 
Figure 118: Number of times mutation is replicated ......................................................................................... 241 
Figure 119: Number of unique countries on genes ........................................................................................... 242 
Figure 120: Survey displayed on webpage ....................................................................................................... 245 
Figure 121: Forced ranking output .................................................................................................................... 246 
Figure 122: Non-forced ranking ........................................................................................................................ 247 
Figure 123: A method for redirecting to the appropriate view ........................................................................... 250 
Figure 124: Overview of mobile website development ..................................................................................... 250 
Figure 125: Mobile view of website optimize .................................................................................................... 253 
Figure 126: ALSoD Google play account showing number of downloads as at June 2013 ............................. 254 
Figure 127: Desktop view creating awareness using a Facebook and marquee ............................................. 255 
Figure 128: Submit new gene ........................................................................................................................... 256 
Figure 129: Submit mutation data ..................................................................................................................... 257 
 - 15 - 
Figure 130: Submit patient data ........................................................................................................................ 257 
Figure 131: Submit replicated mutation data .................................................................................................... 258 
Figure 132: Screenshot of search terms on pubmed ........................................................................................ 259 
Figure 133: Screenshot of search terms on Google Scholar ............................................................................ 259 
Figure 134: Latest News webpage ................................................................................................................... 260 
Figure 135: Gene Overview page ..................................................................................................................... 262 
Figure 136: Mapping variants on Google Earth ................................................................................................ 263 
Figure 137: Sitemap of ALSoD ......................................................................................................................... 265 
Figure 138: Interaction result using GeneMANIA ............................................................................................. 266 
Figure 139: Side by side comparison result between FUS and TDP43 ........................................................... 267 
Figure 140: Detailed analysis of a selected gene ............................................................................................. 268 
Figure 141: Summary report of genetic data .................................................................................................... 269 
Figure 142: Displaying GWA result of 5 populations on Whole Genome ......................................................... 270 
Figure 143: Displaying output of querying database for a single SNP ............................................................. 272 
Figure 144: UCSC Genome Browser on chromosome 9 .................................................................................. 273 
Figure 145: GWAS by Fogh 2013 ..................................................................................................................... 273 
Figure 146: Multiple Alignment on SOD1.......................................................................................................... 277 
Figure 147: Social media accounts of ALSoD .................................................................................................. 278 
Figure 148: Visitors' statistics ............................................................................................................................ 279 
Figure 149: Graph of Visitors' statistics ............................................................................................................ 279 
Figure 150: Google Analytics display ................................................................................................................ 280 
Figure 151: Search output using Google search engine interface for external search .................................... 282 
Figure 152: Search output using Google search engine interface for internal search ..................................... 283 
Figure 153: Query result of predicted pathogenic FALS genes mutations ....................................................... 284 
Figure 154: Number of affected patients........................................................................................................... 286 
Figure 155: Number of mutations per gene ...................................................................................................... 287 
Figure 156: Number of cases recorded ............................................................................................................ 288 
Figure 157: Number of predicted pathogenic mutations by rank ...................................................................... 289 
Figure 158: Number of controls recorded ......................................................................................................... 290 
Figure 159: Number of mutations in the same codon by rank .......................................................................... 291 
Figure 160: Number of patients with family history ........................................................................................... 292 
Figure 161: Number of patients with no family history ...................................................................................... 293 
 - 16 - 
Figure 162: Number of times a mutation is replicated ...................................................................................... 294 
Figure 163: Number of unique countries on genes ........................................................................................... 295 
Figure 164: Number of publications .................................................................................................................. 296 
Figure 165: Reliability Analysis using Cronbach's alpha .................................................................................. 298 
Figure 166: Visits on ALSoD for 17 months on devices ................................................................................... 304 
Figure 167: First 10 Countries accessing database ......................................................................................... 305 
Figure 168: First 10 Pageviews ........................................................................................................................ 306 
 
 
Table of Tables 
Table 1 : Origin of ALS-linked loci as at March 2014 .......................................................................................... 26 
Table 2: Non-locus specific mutation databases ................................................................................................ 54 
Table 3: ALS-specific mutation databases.......................................................................................................... 58 
Table 4: Comparison between mobile website and app ..................................................................................... 65 
Table 5: GWAS of 5 populations ....................................................................................................................... 181 
Table 6: Comparison of website visits between the pre-mobile and post-mobile development. ...................... 300 
Table 7: Referral traffic from search engines from August 2012 to June 2013 ................................................ 303 
Table 8: First 10 Browser and OS used to access ALSoD from August 2012 to January 2014 ...................... 305 
 
Table of Equations 
Equation 1 : Combination formula ..................................................................................................................... 179 
Equation 2: Fisher's method ............................................................................................................................. 184 
 
Document Information 
Number of Pages: 680 
Word count (with appendices and references): 112974 
Word count (without appendices and references): 54066 
File size: 71.7 MB  
 - 17 - 
Acknowledgements 
At long last, I can say “thank God for grace”. I appreciate the Almighty God for strength, sound health and the 
ability to end a long-awaited degree. 
My profound gratitude goes to my unique Supervisor, Professor Ammar Al-Chalabi. I could not have done this 
without you nurturing and equipping me with all the necessary skills required for completing my programme 
despite your very busy schedule. Your fatherly support is incomparable and I sincerely appreciate all your 
efforts. 
To my second supervisor, Dr John Powell, I am grateful for your immense support. You never turn me away 
even at your busy times. My impromptu turn-up at your office and your sincere comments, suggestions and 
praises have carried me through. 
Thanks to Dr Nigel Leigh and Dr Radunivoc for bringing to life the ALS database idea in 1999. You gave me 
the raw materials to work on. To Dr Richard Wroe and Dr Amy Butler (who helped to proofread my thesis) who 
initially developed the website, you set the ball rolling for me and I cannot thank you enough. 
I have been blessed with a wonderful team of colleagues: Dr Aleksy Shatunov, Dr Ashley Jones, Dr William 
Spatoveri, Dr Kuang Lin, Dr Conrad Iyiegbe, Dr Petra Petrouli, Dr Isabella Fogh, Michele Benigni and Simon 
Topp. Working with you all has exposed me to the benefits of working in a team. Thanks for all your help. 
My family and friends have been very supportive during my period of study by asking about the progress of my 
programme and remembering me in prayers for he grace to carry on. Motivators worth mentioning are from my 
Aunts: Dr (Mrs) Adedayo, Dr (Mrs) Amao-Kehinde, Mrs Keshinro, Mrs Durojaiye, Ms Adesioye, Mrs Pat 
Babatunde and my uncle Mr Lekan Babatunde. Thank you very much and God bless you for your love. To 
TBBC family and UCU Alumni Family and Friends, I really appreciate your prayers and support. 
To my late mum, Mrs A.B. Babatunde who experienced some of the times I had to write my M.Sc. exams 
while I was pregnant and helped to take care of her grand children - may your gentle soul rest in peace. I can 
never forget your love and care. To my dad, Mr E.O. Babatunde, who sacrificed his comfort to set my feet on 
the pathway to achieving greater height in life, I say a very big thank you. You shall reap the fruit of your 
labour over every of your children. My brother and sisters (Mr Babade Babatunde, Mrs Bisola Apata, Dr 
Bosede Omodara and Dr Bimbola Babatude), I love you all. My sisters-in-law and brothers-in-law (Mrs Ese 
Ndu, Mrs Folake Babade-Babatunde, Mr Ejiro Abel, Mr Edesiri Abel, Dr Niran Omodara, Mr Adewale Apata), 
you are a blessing to me. To my numerous cousins home and abroad (The Babatundes, The Durojaiyes, The 
 - 18 - 
Adedayos and The Adesolas), I really appreciate you. To all members of True Believers Baptist Church UK, I 
sincerely appreciate your prayers and fellowship. 
So many times I am asked how I am able to combine studentship with motherhood. My secret is my ever-
loving, supportive, understanding, helpful and incomparable husband who gives me all the physical, emotional 
and spiritual support needed. What could I have done without you, my love, my partner, my backbone and 
soulmate. God bless and keep you. To my lovely damsels (Rebecca, Rachel, Ruth and Rhoda), mummy loves 
you very much. You are my crown. Thanks for being supportive in your own little ways. 
 - 19 - 
Chapter 1 INTRODUCTION AND BACKGROUND 
1.1 Health is wealth 
“Health is wealth” is a common phrase often used in my growing-up days by friends and family especially 
when an action taken by an individual could affect his/her health but I never bothered searching for the origin 
of this statement until now. I only just realised that the exact quote is, “The greatest wealth is health” by a 
Roman Poet, Publius Vergilius Maro (from 70BC – 19BC commonly known as Virgil or Vergil) [1]. Every 
pregnant mother longs for a healthy baby at birth and every ill person yearns for a sound health. Any medical 
condition (either a disorder or disease) no matter how insignificant could rob an individual of his/her 
happiness. In the western world, studies have confirmed that population is growing older rapidly and a 
persistent drop in mortality is reported due to improved medical knowledge and services. Despite the 
breakthrough, increase in chronic diseases is experienced in many countries [2-4]. 
1.2 Diseases and Disorders 
A disorder is a functional abnormality or disturbance while a disease is an abnormal condition affecting the 
body of an organism [5]. Searching through literature, I discovered there is a never-ending long list of diseases 
in the world today.  Some are linked to genes and others are not, some are complex and others are not, some 
are curable and others are not, some are contagious and others are not. A chromosomal disorder in 
chromosome 21 is associated with patients with the Down’s syndrome [6-8] while a non-genetic disease like 
Poliomyelitis threatened the health of children in the past but thanks to Dr Salk who created a vaccine to 
conquer Polio [9, 10]. A study conducted on chronic diseases selected 8 diseases for analysis –diabetes, 
heart disease, peripheral arterial disease, stroke, lung disease, joint diseases, back problems and cancer [3]. 
This is just a tip of the iceberg. Even OMIM which is a catalogue of Human genes and genetic disorders is 
only restricted to a list of diseases that are gene-related [11]. Geneticists have made significant advancement 
in discovering genetic root of diseases like Huntington’s disease, Breast cancer, Alzheimer’s disease while 
more research work is still being carried out on complex diseases like schizophrenia, bipolar disorder, and 
diabetes [12].  
 
1.3 Motor Neuron Disease 
Motor Neuron Disease (MND) is a neurological disorder affecting motor neurons, which control voluntary 
muscle movements. Forms of MND include Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS), Spinal 
 - 20 - 
Muscular Atrophy (SMA), Progressive Muscular Atrophy (PMA), Primary Lateral Sclerosis (PLS), 
Frontotemporal Dementia (FTD) and progressive bulbar palsy [13-15].  
 
1.4 Amyotrophic Lateral Sclerosis 
Amyotrophic Lateral Sclerosis (ALS) also known as Charcot disease [16] or Lou Gehrig’s disease [17] or 
sometimes MND (Motor Neuron Disease) [18] , is a complex and fatal progressive neurodegenerative disease 
which kills patients within 2-5 years after diagnosis [19-22] and is a syndrome resulting in death from 
respiratory failure [18, 23]. ALS is known as Lou Gehrig’s disease in the United Stated with association to a 
famous baseball player who died at the age of 37 years (2 years after he missed a game) due to this 
neurodegenerative disease [17, 24]. 
ALS is largely sporadic but with a minor proportion of familial cases which rarely exceeds 5% of all cases of 
ALS occur across population based studies[25]. ALS is the most common form of adult onset motor neuron 
degeneration, and affects adults in their mid-life [26, 27]. The causes of ALS are gradually being discovered 
but there is no known cure. Although there are other treatment strategies, the only effective drug treatment is 
riluzole, which helps prolong survival by about 3-6 months after 18 months treatment [28]. Non-invasive 
ventilation extends survival and improves quality of life [29].  
1.5 Clinical representation of ALS 
ALS affects motor nerve cells in the brain and the spinal cord resulting in muscle weakness and atrophy [16], 
leading to death through diaphragmatic paralysis. It involves both upper motor neurons (UMN) and lower 
motor neurons (LMN). UMN signs include hyperreflexia (overactive or over responsive reflexes), extensor 
plantar response (also known as Babinski response), increased muscle tone, and weakness. LMN signs 
include weakness, muscle wasting, hyporeflexia (below normal or absent reflexes), muscle cramps, and 
fasciculation (muscle twitch). Initial presentation varies. Affected individuals typically present with either 
asymmetric focal weakness of the extremities (stumbling or poor handgrip) or bulbar findings (dysarthria, 
dysphagia). Other findings may include muscle fasciculation, muscle cramps, and labile affect leading to 
involuntary emotional expression. Regardless of initial symptoms, atrophy and weakness eventually affect 
other muscles [30, 31].  
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1.6 Diagnosis 
ALS is the most common form of adult onset motor neuron degeneration, and affects adults in their mid-life 
[26, 27]. Death from respiratory failure usually occurs within 3-5 years [19-22]. The occurrence and death rate 
of ALS have increased slightly over the past 50 years [32]. 
Because there is no diagnostic test, ALS poses a challenge to clinicians on how to diagnose the disease and 
the main guideline for the diagnosis and management of the disease is regularly updated [33, 34]. Even 
though early diagnosis is highly desired by clinicians, some diseases like Multiple Sclerosis, Pick’s disease, 
Polymyositis, Myokymia etc can mimic ALS [33, 34].  In 1994, diagnosis criteria for ALS were proposed by the 
World Federation of Neurology. These are called the El Escorial criteria and were later revised in 2000 [35, 
36]. Although largely helpful, the El Escorial criteria have been criticized for making recruitment to clinical trials 
difficult. In 2006, the Awaji algorithm was introduced to increase the eligibility of patients for clinical trials [37]. 
In recent times, the involvement of cognitive dysfunction in some ALS patients redirected researchers in 
finding a relationship between ALS and FrontoTemporal Dementia (FTD) (one form later localized to 
Chromosome 9) [38]. The diagnosis of FTD was based on the revised Neary criteria which were designed to 
improve clinical recognition of the disease [39, 40]. 
1.7 Prevention and Cure 
“Prevention is better than cure” is an old adage commonly used and accepted as the truth but in the case of a 
complex disease like ALS, there is neither prevention nor a cure available. Studies are being carried out 
worldwide to determine ways of preventing ALS by observing possible patterns in the Age of onset of patients, 
duration of disease and site of onset in patient data which are curated into ALSoD.  
There is no known cure available for the treatment of the disease but the use of Rilozule drug has some 
evidence of extending the survival of patients and improves their life quality [29, 41-43]. 
An announcement in November 2007 sparked a rush in treating ALS patients with lithium but was disproved in 
December 2008 from analysis directly carried out on patients [44-47]. Studies confirmed that Lithium did not 
demonstrate any valuable effect. It rather raised concerns on the reduced acceptability of lithium and its safety 
in ALS [48, 49]. 
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1.8 Clinical Trials 
A subcommittee of the MND Research Group of the World Federation of Neurology formed the Consortium on 
Clinical Trials in ALS in 1994 and then in 1998. The only approved treatment for ALS to date –as previously 
mentioned - which has gone through patient testing is Rilozule (Rilutek). Although this drug is not a cure, it 
extends the survival of patients. Further development is regularly carried out on potential drugs and 
compounds in various clinics across the globe for pharmacologic evaluation. Some of the drugs tested and/or 
being tested are Talampanel, Coenzyme Q10, Tamoxifen, Ceftriaxone, ONO-2506, AEOL 10150, 
Arimoclomol, Celastrol, Copaxone, IGF-1–viral delivery, Memantine, IGF-1 polypeptide, NAALADase 
inhibitors, scriptaid, Minocycline, Sodium Phenylbutyrate, Nimesulide, Thalidomide and Trehalose [50-54]. 
1.9 Palliative care / Equipment 
The challenging nature of ALS makes it difficult for the physician to explain the diagnosis and prognosis of the 
disease to a patient thereby leaving patients uncertain about the diagnosis which often leads to more 
confusion when patients try to collect information from different sources [55, 56]. Palliative care as defined by 
the World Health Organization “is the active total care of patients whose disease is not responsive to curative 
treatment” which is aimed at “the best quality of life for patients and their families” [57]. Palliative care in ALS 
could increase survival if properly managed [55].  
Quality of Life is “The extent to which hopes and ambitions are matched by experience”. Various equipment 
enhance the life quality of patients [33, 34, 58-60] which include percutaneous endoscopic gastrostomy (PEG), 
non-invasive ventilation (NIV), tracheostomy ventilation (TV), sniff nasal pressure (SNP), non-invasive 
positive-pressure ventilation (NIPPV) and invasive mechanical ventilation (IMV). 
The ALS Functional Rating Scale (ALSFRS) was introduced as a rating instrument for measuring the 
degeneration of muscles in patients and this scale was later revised (ALSFRS-R) incorporating additional 
assessments and the necessity for respiratory support [61, 62].  
1.10 Epistasis 
The complexity of ALS genetics combines various challenging factors like epistasis making the disease 
complicated to study. The process by which genes interact to affect phenotypes and masking the presence of 
each other or combine to create a new attribute is known as Epistasis [63-65]. The occurrence of gene–gene 
interactions has been hypothesized to be at the foundation of many diseases common to humans even though 
current GWAS studies largely overlook its function [66, 67]. 
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1.11 Epigenetics 
Epigenetics is the process of modifying the DNA externally thereby affecting how cells interpret genes and not 
necessarily changing the DNA sequence. Because this study of heritable alterations in gene role occurs 
independently of changes to primary DNA sequence, it is proposed in a study that epigenetically silencing 
genes essential for the function of motor neuron could trigger Sporadic ALS. However, SOD1 and VEGF 
genes which were thought to be implicated in SALS do not have unusual methylation levels [68, 69] 
1.12 Epidemiology 
Epidemiology is the study of the pattern of a disease in different populations [70]. A study has pointed out that 
Italian Soccer professionals have a high risk of developing ALS [71-73]. A cluster of ALS patients who served 
in the military and veterans of the first Gulf war were also identified [74-76]. Together these evidences 
suggested that environment acting on genetic load is a likely critical contributor to ALS risk [77-80]. Examples 
of environmental factors affecting ALS include dietary, oxidative stress, occupation, head injuries, sports, 
pesticides, heavy metals and lifestyles [68, 69, 81]. 
1.13 Neuroimaging 
Magnetic resonance imaging (MRI) uses strong magnetic fields and radio waves to produce detailed images 
of the inside of the body [82]. Most researchers support the use of MRI scan which it is thought could provide 
a substitute marker of ALS to help in detection of early stage disease and observe advancement and 
treatment reaction [83]. Studies have been carried out using neuroimaging to detect the characteristics of 
brain functions and structure by comparing the brain images of patients with ALS with healthy controls. It was 
discovered that the grey and white matter change in ALS and ALS-FTD patients [84-86]. 
1.14 In Vivo and in Vitro Models 
There are more ALS publications in animal models and cellular models than in human models. The study of 
ALS toxicity in animal and cellular models aids in the investigation of pathological biomarkers for ALS. Mus 
Musculus (mice), rats (Rattus norvegicus), fruit flies (Drosophila melanogaster), zebrafish (Danio rerio), dog 
(Canis familiaris), pig (Sus scrofa), frog (Xenopus Laevi) etc. have been used mainly in SOD1, TDP-43 and 
FUS candidate gene studies [87, 88]. Tissues from cerebellum, spinal cord, brain tissues, blood etc have been 
examined to better understand the disease [89, 90]. 
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1.15 Genetics of Amyotrophic Lateral Sclerosis 
It is thought that the initial cases of ALS were defined in 1848 by Aran and in 1853 by Cruveilhier. But the first 
formal publication was written in 1874 describing a case of a female affected by an unknown disease in 1865 
by the French physician, also regarded as the godfather of MND, Jean-Martin Charcot who lived from 1825 to 
1893. Until the 1950s when the pedigrees of a family history was reported by Kurland and Mulder, ALS was 
not thought to have a familial component. A linkage study in 1991 suggested a familial ALS locus on 
chromosome 21, later identified to be the SOD1 gene. Eleven mutations were identified in 13 families [18, 23, 
91]. 
About 5% of people with ALS have a family history of the disease. About 20% of such people harbour a 
mutation in the SOD1 gene and a further 5% have mutations of TARDBP, and FUS [92-94]. Genes with strong 
but less robust evidence for being involved in familial ALS include NEFH, ANG, OPTN and DAO [95-98]. 
Genes for atypical forms of ALS, such as young onset, or slowly progressive ALS include ALS2, implicated in 
a recessive form of juvenile onset, mainly upper motor neuron disease, SETX, responsible for young onset, 
slowly progressive mainly lower motor neuron degeneration, and VAPB, responsible for various phenotypes of 
motor neuron disease, some similar to classical ALS, others largely lower motor neuron diseases. 
Variants of all familial ALS genes are also found in sporadic ALS and account for about 10-15% of such cases. 
A recent meta-analysis of three twin studies has shown sporadic ALS has a heritability of about 0.61 (0.38, 
0.78) confirming the validity of searching for genes associated with sporadic ALS[99]. A study suggests that 
the classification of genes as either sporadic or familial is artificial. Due to demographic drifts and family size, 
penetrance calculation leads to a false reclassification of a proportion of familial cases as sporadic [100]. 
There are two classical methods for the identification of such genes. The first is the candidate gene 
association study in which a gene considered to be relevant to ALS pathogenesis is tested for association of 
specific genetic variants with disease. The second is the genome-wide association study (GWAS) in which 
hundreds of thousands of gene variants are tested for association with ALS without prior hypothesis in a 
manner analogous to a genome-wide linkage study. Candidate gene studies have only yielded a few 
replicable genetic associations [101]. Examples of genes identified with this approach are SOD1, TARDBP 
(coding for TDP43), FUS, ANG, NEFH, VEGF, ELP3, DPP6, ITPR2, UNC13A and ATXN2. 
Larger volumes of data are derived from rapidly increasing throughput from more individuals sequenced in a 
population with more sequenced genetic markers per individual with greater depth and accuracy [102]. Next-
generation sequencing technology enables cheaply-produced massively sequenced data compared to the 
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conventional methods of sequencing [103] [104]. The detection of disease-specific biomarkers will make a way 
for the development of early diagnostic measures and substitute markers to monitor disease evolution and 
examine drug worthiness in clinical trials [105] [106]. It is becoming more difficult to keep abreast with this 
growing quantity of studies and enormous data regularly generated in ALS genetics research. A collaboration 
between ALS database teams working together to collate ALS results could help to keep researchers updated 
on current findings.  
At least 15 fALS loci, under various modes of inheritance, have been identified by linkage studies, and 
pathogenic mutations have been described in 11 genes, SOD1, NEFH, ALS2, DCTN1, VAPB, SETX, ANG, 
TARDBP, FUS, OPTN and DAO, in fALS [107, 108].  
Rare genes have a greater biological effect on patients but less impact on the disease due to the sample size 
whereas, common genes have a greater impact in terms of the numbers affected but with less biological effect 
on individual patients [109]. 
1.16 Environmental causes 
Amyotrophic Lateral Sclerosis was observed in the Chamorro people of Guam with additional features similar 
to Parkinson’s disease. The Chamorro tribe of Guam were afflicted with a neurodegenerative disease known 
as ALS-PDC. The major cause of this disease was associated with their diet of flying fox. Cycad seeds which 
are from neurotoxic plants are consumed by flying foxes causing ALS-PDC in the population. There is a 
biological amplification of the toxin in the fox tissues as they accumulate high levels so that people who eat 
them are then exposed to very high toxin levels. 
Other suggested causes are chick pea and the custom of eating brains of dead ancestors. The β-N-
Oxalylamino-l-alanine (BOAA) non-protein amino acid present in chickling peas [lathyrus sativus] causes 
neurolathyrism when eaten in excess and the toxins are concentrated in the brain tissues of patients [110, 
111]. 
1.17 How credible are these reported genes? 
The term ‘credibility’ was first used in a publication referring to how probable an association exists following a 
gathering of evidences. Pragmatic research and widely-agreed development are required to create a genetic 
model which combines biological and epidemiological evidences. The three Venice criteria used to determine 
how credible a gene is associated with a disease are: Amount of evidence (the larger the studies the better), 
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Replication (consistent replication across different populations) and Protection from bias (the less the 
prejudice in the studies the better) [112].  
The discovery of many genes is helping researchers build a bigger picture of the pathogenic process involved 
and the connection between ALS and FTD helps to construct a better understanding for generating a 
treatment for ALS in the future [113]. What will be very useful in ALS studies is an analytical tool giving 
direction to new researchers in the field of ALS and encouraging current researchers to submit published and 
unpublished data for in-depth automated analysis of genetic data on a wider scope. 
1.18 Origin of ALS-linked loci 
There are over 20 ALS-linked loci, tens more linked to other motor neuron diseases (such as hereditary 
spastic paraparesis and distal spinal muscular atrophies) and several linked to related neurodegenerative 
diseases such as frontotemporal dementia which can affect the cognitive function of patients with ALS [14, 28, 
113]. 
Table 1 : Origin of ALS-linked loci as at March 2014 
Locus Gene Gene name Chromosome Mutations Patients Publications 
ALS 1 SOD1 
Cu/Zn superoxide 
dismutase 1, soluble 
(amyotrophic lateral 
sclerosis 1 (adult)) 
21q22.11 177 374 125 
ALS 2 ALS2 
amyotrophic lateral 
sclerosis 2 (juvenile) 
homolog (human). Alsin 
2q33.2 23 10 16 
ALS 3 ALS3 Unknown 18q21  0  0  1 
ALS 4 SETX Senataxin 9q34.13 7 64 3 
ALS 5 SPG11 
spastic paraplegia 11 
(autosomal recessive) 
15q14 12 27 2 
ALS 6 FUS 
fusion (involved in 
t(12;16) in malignant 
16p11.2 77 96 25 
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liposarcoma) 
ALS 7 ALS7 Unknown 20p13  0  0  1 
ALS 8 VAPB 
Vesicle-associated 
membrane protein-
associated protein B 
20q13.33 2 19 6 
ALS 9 ANG Angiogenin 14q11.1 29 31 22 
ALS 10 TARDBP 
TAR DNA binding 
protein 
1p36.22 50 91 29 
ALS 11 FIG4 
FIG4 homolog, SAC1 
lipid phosphatase 
domain containing (S. 
cerevisiae) 
6q21 10 9 1 
ALS 12 OPTN optineurin 10p13 37 19 9 
ALS 13 ATXN2 ataxin 2 12q23-q24.1 1 10 3 
ALS 14 VCP 
valosin-containing 
protein 
9p13 7 9 2 
ALS 15 UBQLN2 ubiquilin 2 Xp11.21 6 40 4 
ALS 16 SIGMAR1 
sigma non-opioid 
intracellular receptor 1 
9p13 1 0 1 
ALS 17 CHMP2B 
chromatin modifying protein 
3p11.2  2  0  3 
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2B 
ALS 18 PFN1 profilin 1 17p13.3 4 5 7 





2q33.3-q34 2 6 1 
ALS 20 HNRNPA1 
heterogeneous nuclear 
ribonucleoprotein A1 
12q13.1 1  0  1 
ALS-
FTD 1 




chromosome 9 open 
reading frame 72 
9p21.2 1 76 70 
ALS UNC13A 
unc-13 homolog A (C. 
elegans) 
19p13.12 0 0 6 
ALS DAO D-amino-acid oxidase 12q24 2 2 2 







11 10 10 
ALS PRPH peripherin 12q12 0 0 2 
ALS SQSTM1 sequestosome 1 5q35 16 14 2 
ALS TAF15 
TAF15 RNA 
polymerase II, TATA 
box binding protein 
17q11.1-
q11.2 
7 4 1 
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(TBP)-associated 
factor, 68kDa 
ALS SPAST Spastin 2p24 0 0 3 
ALS ELP3 
elongation protein 3 
homolog (S. cerevisiae) 
8p21.1 0 0 1 
ALS SPAST Spastin 2p24 0 0 3 
ALS ELP3 
elongation protein 3 
homolog (S. cerevisiae) 
8p21.1 0 0 1 
 
1.18.1.1 ALS1/SOD1 [147450] 
Cu/Zn superoxide dismutase gene is associated with autosomal dominant form having 23 exons on 
chromosome 21q22.1 consisting of 154 amino acids with 160 mutations reported so far. 
In 1991, Siddique mapped Autosomal dominant forms to chromosome21q21 [114] . 
In 1993, Rosen described eleven disease-associated mutations (Gly37Arg, Leu38Val, Gly41Ser, Gly41Asp, 
His43Arg, Gly85Arg, Gly93Cys, Gly93Ala, Glu100Gly, Leu106Val, Ile113Thr) in 13 different FALS families 
[91]. Aoki and Ogasawara found an exon 2 novel point mutation His46Arg in two unrelated Japanese families 
[115]. Deng detected an exon 1 mutation Ala4Val and exon 5 mutations (Ile144Phe, Val148Gly) [116]. 
In 1994, Aoki found a novel H46R mutation in 2 FALS Japanese families [117]. Elshafey identified a new 
missense point mutation (Gly93Arg) in exon 4 in a family [118]. Esteban found two novel mutations in exon 4 
(Gly93Asp, Ile112Thr) and a new intron 3 polymorphism (34basepair A to C) in FALS patients but not in 169 
sporadic ALS patients nor in 100 normal controls [119]. Hirano identified a heterozygous mutation (Val7Glu) in 
2 members of a Japanese family[120]. Jones reported a new missense mutation (Asp101Asn) in exon 4 of a 
sporadic 53 year old ALS patient of Asian origin after screening a cohort of 46 sporadic and 10 familial ALS 
patients [121]. Jones again detected a novel Glu21Lys mutation and a previously detected Ile113Thr in three 
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other patients [122]. Kostrzewa recognized an exon 4 mutation (Arg115Gly) in a FALS family which was not 
detected in 90 controls nor in 212 normal individuals [123]. Nakano discovered an exon 1 novel missense 
mutation (Ala4Thr) in 2 FALS patients from one Japanese family after studying 17 SALS patients and 9 FALS 
patients [124]. Pramatarova found a two base pair deletion (L126delTT) in a FALS patient [125]. Rainero 
discovered a Gly41Ser mutation in exon 2 from 8 patients in an Italian pedigree comprising 75 members 
distributed in five generations [126]. Siddique identified 14 previously found mutations (A4V, A4T, G37R, 
G41D, H43R, G85R, G93A, E100G, L106V, I113T, L144F, V148G) and two new mutations, V14M and L84V. 
Mutation A4V is the most frequent one which occurred in 14 out of 29 FALS families [127]. Suthers reported a 
mutation Ile113Thr [128]. Takahashi also identified a previously reported A4T mutation in an autopsied patient 
with FALS [129]. Tsuda investigated the effects of a Gly41Ser mutation found in a FALS pedigree [130].  
In 1995, Andersen found an exon 4 homozygous Asp90Ala mutation in 14 patients (from 4 unrelated ALS 
families and 4 sporadic ALS patients) from Sweden and Finland [131]. Aoki reported a new point mutation 
Leu84Val in exon 4 in a Japanese FALS patient but not observed in the 57 normal Japanese control subjects 
[132]. Deng identified 15 different mutations (Ala4Val, Ala4Thr, Val14Met, Gly37Arg, Gly41Asp, His43Arg, 
His46Arg, Leu84Val, Gly85Arg, Gly93Ala, Glu100Gly, Leu106Val, Ile113Thr, Leu144Phe, Val148Gly) in 37 
FALS families out of a total of 222 families screened [133]. Enayat detected 2 novel mutations (in exon 2- 
His48Glu, exon 5- Asp125His) and four formerly detected mutations (exon 4-Ile112Thr, Ile113Thr, Gly93Arg, 
exon 5-Ile149Thr) in UK families [134]. Ikeda identified a novel Val148Ile mutation in exon 5 [135]. Ikeda again 
detected an exon 4 novel Ile104Phe mutation in affected members of three generations of Japanese kindred 
[136]. Orrell reported Gly93Arg mutation and Ile133Thr mutation in another publication [137, 138].  
Pramatarova examined 114 unrelated affected individuals and 67 controls identifying previously reported 
mutations (Ala4Val, Gly37Arg, Gly93Cys, Ile113Thr, Leu144Phe) and two novel mutations (Ile149Thr, 
Asn139Lys) in a total of 15 families [139]. Sapp found 3 mutations (Leu144Ser, Ala145Thr and intron 4 T-G 
10bp before exon 5) [140]. Sjalander identified a heterozygous and homozygous missense mutation Asp90Ala 
(D90A) in exon 4 from Swedish and Finnish populations [141]. Yulug detected E100G, I113T and a new 
mutation Asp101Gly [142]. 
In 1996, Abe reported 4 missense mutations (His46Arg, Leu84Val, Ile104Phe, Val148Ile) in 5 Japanese 
families [143]. Andersen described 36 patients (6 SALS cases and 30 FALS cases from nine families) 
characterized by a distinct phenotype associated with homozygosity for an Asp90Ala mutation [144]. Hosler 
identified 3 novel mutations (Gly93Val, Asp124Val, Glu133) and 2 variants (Ser59Ser, Ala140Ala) [145]. Ince 
described an autopsy case with the mutation E100G (exon 4) [146]. Kostrzewa revealed an exon 5 mutation 
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Ile151Thr in FALS [147]. Morita discovered a novel two-base (TGC to TTT) mutation Cys6Phe in a Japanese 
family [148]. Orrell examined a sporadic patient originally from Pakistan with a previously identified Asp101Asn 
mutation [149]. Siddique discovered the E100K mutation [150]. 
In 1997, Andersen found 5 different mutations (Ala4Val-Central Sweden, Val14Gly-Central Sweden, 
Asp76Tyr-Denmark, homozygous Asp90Ala-Finland and Sweden, heterozygous Asp90ala-Northern Finland 
and Gly127insTGGG-Denmark) [151]. Bereznai found a novel mutation L8Q in an Austrian family [152]. 
Cudkowicz screened 290 families detecting 18 mutations (Ala4Val, Ile113Thr, Glu100Gly, Leu38Val, 
Gly93Ala, Gly37Arg, Gly41Asp, Gly93Cys, Gly41Ser, His43Arg, Leu106Val, Val148Gly, Gly93Asp, Ile112Thr, 
Leu144Ser, Ala145Thr, Intron Phe-Leu-Gln, Glu133) in 68 families [153]. Jackson analyzed 155 cases 
identifying previously reported mutations (Asp90Ala, Ile113Thr) and a novel mutation (Val118Lys ) in exon 4 in 
a single SALS patient [154]. Kawamata found a novel Gly16Ser mutation in a SALS patient with young onset 
[155]. Kawata identified a missense mutation (Gly93Ser) in exon 4 of a 48-year-old Japanese man with familial 
amyotrophic lateral sclerosis (FALS) [156]. Kikugawa performed mutational analyses of the SOD1 gene of 23 
patients (three familial cases and 20 sporadic cases) with ALS from the Kii Peninsula and its vicinity and 
identified the same missense mutation ( Ile113Thr) in exon 4 as a heterozygous state [157]. Maeda found 
mutation N86S in a FALS patient [158]. Orrell discovered a novel Gly108Val mutation identified in a family 
manifesting ALS in 3 generations [159]. He also found a novel heterozygous mutation in exon 3 (Gly72Ser) in 
a family with 2 individuals affected by ALS [159]. Orrell again investigated 71 families identifying 10 previously 
reported mutations(His48Gln, Gly93Arg, Gly93Val, Glu100Gly, Asp101Gly, Asp101Asn, Gl108Val, Ile113Thr, 
Asp125His, Ile149Thr) and a novel insertion (132insTT)[160]. Shaw P. reported E100G (in 1 FALS case), 
I113T (in 1 FALS and 1 SALS), and an exon 5 in a SALS (3’UTR 816-819 deletion) [161]. Shaw C. detected 
appoint mutation His48Glu in a patient with rapidly progressive FALS [162].Watanabe discovered a novel 
missense point mutation S134N in a FALS patient [163]. Zu found 2 new mutations L126Z and intronic 
mutation from A-G in intron 4, 11 bp has been opened by removing the loop forming one entire side upstream 
in 2 unrelated patients [164].  
In 1998, Boukaftane screened affected individuals from 70 unrelated FALS kindreds and identified 10 
mutations, 6 of which are novel (Glu21Gly, Leu38Arg, Glu49Lys, Leu84Phe, Leu67Arg, intron4del30bp) [165]. 
Hayward detected a homozygous Asn86Ser mutation in a juvenile onset FALS case [166]. Morita found a 
novel Asp90Val mutation in a Japanese family with ALS [167]. Nakanishi obtained blood samples from FALS 
cases detecting G37R, A4S, H46R, I149T [168]. Shaw  discovered 8 of 38 patients with FALS and 5 of 175 
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patients with SALS had missense mutations with 2 novel mutations (L84F, G72S) identified [169]. Cudkowicz 
examined 11 subjects with A4V mutation as a replicated study [170].  
In 1999, Aguirre studied 23 patients from 11 ALS families and 69 SALS patients of Belgian origin identifying 3 
different mutations (L38V, D90A and G93C) in seven families [171]. Ceroni examined 13 family members and 
6 of 10 unrelated patients with sporadic cases in Italy and discovered that all familial ALS patients and one of 
the six sporadic patients carry the same L84F missense point mutation in exon 4 of the SOD1 gene [172]. 
Kohno identified a novel missense mutation (Cys6Gly) in exon 1 in a Japanese woman and her family [173]. 
Orrell studied 17 families from the UK identifying 12 different mutations (H48Q, G72S, G93R, G93V, E100G, 
D101N, D101G, G108V, I113T, D125H, I149T – and also an insertion mutation – 132insTT) [174]. Penco 
reported a new missense mutation (Gly12Arg) in exon 1 in a 67-year-old patient with familial ALS (FALS) 
[175]. 
In 2000, Cervenakova reported that a D101N mutation in exon 4 of the SOD1 gene was identified in a 
PMA/ALS patient and in one of her three unaffected children [176]. Shimizu found a novel V118L mutation in a 
sporadic ALS patient [177]. Slominsky discovered a missense point mutation Asp90Ala in two patients and a 
novel intronic point mutation IVS3 + 35A>C in two typical sporadic ALS patients [178]. Weber studied 8 
patients with homozygous D90A mutation, compared the results with those examined from 12 SALS and 11 
healthy controls [179]. Winter found the D90A mutation in Germany [180].   
In 2001, Gellera found mutations in 5 of 34 unrelated FALS and in 2 of 44 SALS patients in an Italian 
population with 2 FALS cases having A4V, 1 FALS case of with L84F. One FALS patient carried new G12R 
substitution in exon 1, one FALS patient with a F45C substitution in exon 2, 1 SALS patients carried the 
homozygous D90A, 1 SALS patient had the heterozygous I113T mutation and 1 SALS patient with an A95T 
amino acid substitution [181]. Hand described a French amyotrophic lateral sclerosis (ALS) family with two 
distinct mutations (heterozygous for the D90A mutation and also carry a single copy of a novel SOD1 
mutation, D96N) [182]. Kato identified a homozygous Leu126Ser mutation in a Japanese family [183]. Mase 
investigated a large family of Istro-Rumanian origin in 18 cases throughout 6 generations discovering a 
Leu144Phe mutation [184]. Murakami identified a novel missense mutation Leu126Ser [185]. Takehisa also 
claimed to have discovered 2 Japanese families with a novel mutation TTG to TCG missense heterozygous 
mutation in the exon 5 causing substitution of leucine for serine at codon 126 (Leu126Ser) [186]. 
In 2002, Alexander discovered an H80A mutation in a patient with genetically proven sporadic ALS [187]. 
Garcia-Redondo found G37R in exon 2, N65S in exon 3 and I112M in exon 4 in Spanish patients with 
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sporadic or familial ALS [188]. Iwai examined the G93S mutation in Japanese population [189]. Jonsson 
analyzed D90A heterozygotes from recessive and dominant ALS pedigrees [190]. Naini reported a familial 
amyotrophic lateral sclerosis (FALS) patient presenting a late-onset disease associated with a missense 
mutation (Ala140Gly) in exon 5 [191]. Segovia-Silvestre found a  D76V amino acid change on a large family 
with 15 affected individuals spanning five generations [192].   
In 2003, Aksoy reported an exon 1 mutation A4T in a large kindred of FALS [193] while Andersen found 16 
novel exonic mutations (L8V, F20C, Q22L, H48R, T54R,S59I, V87A, T88DTAD, A89T, V97M, 
S105delSL,V118L, D124G, G141X, G147R, I151S) [194]. Ferrera examined the first Italian FALS comprising 
of 7 affected members in 6 generation pedigree with a Leu144Phe mutation [195]. Kim observed a novel 
mutation Gly10Val in a Korean family [196]. Mayeux discovered a new mutation N19S in 2 SALS patients after 
examining 331 SALS cases though it was also found in 1 healthy control [197]. Rezania presented three 
members of a pedigree with familial amyotrophic lateral sclerosis (FALS) who have a  rare mutation in exon 4 
of Ala89Val [198].  
In 2004, Niemann found R115G mutation in 4 FALS patients in a German population [199]. Nogales-Gadea 
discovered an exon 5 mutation N139H in a Spanish family [200]. Ohi analyzed a Japanese family carrying the 
His46Arg mutation [201]. Sato identified 2 novel mutations (Asp101His and Gly141Glu in exons 4 and 5 
respectively) [202]. Shi identified an Insertion mutation of exon 2 in an ALS family in Chongqing, China [203]. 
Tan described a patient with FALS having a novel missense mutation (Asp101Tyr) in exon 4 [204].  
In 2005, Antonyuk examined the His46Arg mutation in familial ALS [205]. Battistini studied 264 Italian patients 
(with 225 SALS and 39 FALS) identifying G12R, G41S, L114F, D90A, S59S, IVS3: + 34 A-->C, IVS3 + 62 T--
>C mutations [206]. Sato examined 29 patients with ALS and 4 carriers having previously detected Ala4Ser, 
Ala4Thr, Ala4Val, Val14Gly, Gly37Arg, Gly41Asp, His46Arg, Asp76Tyr, Asn86Ser, Ala89Val, Asp101His, 
Ser105Leu, Ile113Thr, Ile113Phe, Gly114Ala, Arg115Gly, Leu1262bp del, Leu126Ser, Gly127insTGGG, 
Ser134Asn, Gly141Glu, Leu144Phe, Ala4Val, Asp76Tyr, Ile113Thr [207]. Zhang found a novel mutation 
Glu133Val in FALS patients in China [208]. 
In 2006, Andersen discovered novel N139D, G147D mutations amongst other previously detected SOD1 
mutations [209]. Corrado found a new mutation K136X and replicated mutations N65S and A95T in Italian 
patients [210]. Fong reported a large multigenerational Chinese FALS kindred with I149T mutation [211]. 
Gamez carried out a mutational analysis and identified 5 out of 30 FALS and 4 out of 94 SALS patients with 
Gly37Arg (G37R), Asp76Val (D76V), Ser105Leu (S105L), Ile112Met (I112M) and Asn139His (N139H) 
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mutations [212].  Li Xiaoguang found a heterozygous mutation, GAA to GTA, causing the substitution of valine 
for glutamic acid at codon 133 (Glu133Val) in exon 5 in five out of 16 individuals from one Chinese family 
[213]. Regal conducted further research on 20 patients with G93C mutation [214]. Stewart analyzed a 71 year 
old woman revealing a novel mutation G72C [215]. 
In 2007, Beck found a new heterozygous N86K mutation in a patient with an inherited ALS [216]. Holmoy 
reported the first case of FALS caused by H46R in a patient of Pakistani descent [217]. Kim H.Y.  identified 
Phe20Cys (F20C) mutation in a Korean family [218]. Kim W. revealed Val10Gly, IVS4+15_16insA, 
IVS4+42delG and IVS4+59_60insT variants [219]. Naini identified a novel Asp109Tyr mutation in exon 4 
(D109Y) in a sporadic ALS woman [220].  
In 2008, Broom examined the homozygous 50bpdel mutation [221]. Cao studied the structure of G85R variant 
in familial ALS [221]. Corti found a new heterozygous mutation Q22R in codon 22 [222]. Eisen discovered 6 
missense mutations (A4V, G72C, D76Y, D90A, C111Y, I113T) in 13 patients of both FALS and SALS cases 
[223]. Suzuki described a 39 year old Japanese woman with FALS identifying  a missense exon 4 mutation 
(Gly93Ser) [224].Takahashi conducted an analysis of 35 patients with sporadic ALS and 238 controls 
revealing a previously known SOD1 mutation, S134N [225]. 
In 2009, Syriani identified E22G sequence change in 3 affected ALS patients [226]. Winkler studied 2 
mutations His46Arg (H46R) and His48Gln (H48Q) claimed to be pathogenic [227]. Zinman found a 
homozygous novel 6bp deletion in exon 2 (delG27/P28) after examining 12 members of a Canadian ALS 
family of Filipino origin [228]. 
In 2010, Battistini found a severe familial ALS with a novel exon 4 mutation (L106F) [229]. Felbecker reported 
four ALS pedigrees from Finland, France, Germany and Sweden with either the D90A or E100K SOD1 
mutations [230]. Georgoulopoulou found a new mutation D11Y in a sporadic ALS patient [231]. Giannini first 
described two, apparently sporadic, Italian ALS patients heterozygous for the D90A mutation [232]. Holmøy 
described a SALS patient with a novel G127R mutation at position 382 [233]. Kobayashi discovered a 
Japanese FALS patient with Gly72Ser mutation in SOD1 gene [234]. Laaksovirta analysed 405 ALS patients 
with 497 controls from a sample of 442 ALS patients and 521 controls after filtering data for quality control; 
and discovered rs13048019 with a p-value of 2·58×10(-8) in chromosome 21q22 [235]. Millecamps screened a 
cohort of 162 families enrolled in France and 500 controls identifying 31 pathogenic missense mutations found 
in 36 patients (20 SOD1 - E21G, G37R, L38R, G41S (2 patients), H46D, P66R, D83G, L84F, L84V, N86S, 
G93C, G93A, G93D, G93V, V118L, N139D, G147D (2 patients) and I151T , 1 ANG, 1 VAPB, 7 TARDBP and 
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7 FUS) [236]. Origone found a novel Gly147Ser mutation in an Italian sporadic ALS [237]. Rabe analyzed 217 
families from Germany (n = 213), Austria (n = 2) and Switzerland (n = 2) discovering previously detected 
mutations Q22L, L38V, H46R, L84F, N86D, D90A, G93A, E100K, I104F, I113T, R115G, L144F, V148G, I149T 
and I151T [238]. Ricci reported a novel exon 1 G10R mutation in an examined 68 year old female with FALS 
[239]. Synofzik presented a G93A mutation from a large German pedigree [240]. Takazawa found a new 
G85S mutation in exon 4 [241]. Tsai screened a cohort of 15 index patients of Taiwanese Han Chinese 
descent with adult-onset FALS identifying 7 different mutations in 8 patients, including 3 in SOD1 (G85R, 
T137R, and G138E), 2 in exon 15 of FUS and 2 in exon 6 of TARDBP [242]. Van Es screened a total of 451 
sporadic and 55 familial patients detecting a novel mutation I99V, a homozygous D90A mutation identified in 
SALS and one FALS patient had a heterozygous D90A mutation [28]. Visani found a novel variant T137A 
mutation in two members of an Italian family [243]. 
In 2011, Baek found a novel A4F mutation in FALS in 6 family members [244]. Brotherton found Cys6Ser 
mutation [245]. Conforti reported a G61R mutation in a sporadic ALS patient [246]. Del Grande described a 
novel L67P mutation located in exon 3 [247]. Hermann reported a heterozygous I113F mutation in FALS [248]. 
Vela examined the N19S mutation in a family with 4 ALS patients [249]. Visani found T137A mutation in an 
Italian family[243]. Zhao identified two previously reported mutations Cys6Phe and Leu84Phe in two Chinese 
families [250].  
In 2012, Berdynski replicated a study of G41S mutation in a large Polish family [251]. Brown found Val95Ala*, 
His121Leu, Asp126ThrfsX24, Gly142Ala amongst other replicated variants previously found [252]. Hu 
identified a novel frameshift mutation in a Chinese family on positions 29-35 converting Val-Lys-Val-Trp-Gly-
Ser-Ile to Asp-Glu-Gly-Val-Gly-Lys-His [253]. Keckarević found a novel P66S mutation in exon 3 [254]. 
Origone analyzed the novel Gly147Ser mutation in a sporadic ALS Italian patient. [255]. Piaceri found a single 
SOD1 mutation (Asp109Tyr) and 3 TARDBP mutations in 5 SALS patients from 61 Italian ALS patients [256]. 
In 2013, Diard-Detoeuf found a novel heterozygous I18del variant [257]. Dangoumau discovered a novel 
heterozygous V31A variant in a Bulgarian man [258]. Nakamura conducted an autopsy on a SALS case with 
the replicated I113T mutation previously discovered [259]. Naruse studied a Japanese family reporting a novel 
A4D mutation [260]. Klein identified a novel Phe64Leu mutation [261] while Wang found a novel C7W 
mutation in a FALS pedigree [262]. Cui reported a new mutation S134T in a female ALS Chinese patient [263]. 
Trojsi found in an Italian kindred the replicated Ile149Thr mutation [264]. Kuzma-Kozakiewicz found a 
recurrent K3E mutation found in Polish and Japanese ALS patients [265]. 
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1.18.1.2 ALS2 
Alsin gene is a causative gene for a juvenile autosomal recessive form of motor neuron diseases (MNDs) 
having 33 introns and 34 exons on chromosome 2q33.2 consisting of 1657 amino acids with 23 mutations 
reported so far. Losing ALS2 function results in numerous recessive motor neuron diseases [266]. 
Refsum, Ben Hamida and Gragg originally described the ALS2 gene when patients with hereditary motor 
system diseases were studied [267-270]. 
In 1992 and 1994, Hentati applied linkage analysis to a large Tunisian family suggesting that the ALS2 locus 
lies in the 8cM segment flanked by D2S155 and D2S115 [271, 272]. 
In 1998, Hosler confirmed the previously reported linkage of the chromosome 2q33-35 region while analyzing 
additional markers [273]. 
In 2001, Hadano and Yang first linked the recessive form of juvenile ALS type 3 to chromosome 2q33-35 and 
subsequently also linked juvenile-onset PLS (JPLS) to 2q33 reporting two deletion mutations (A46fsx50 which 
is 138delA and L623fs×646 which is 1867-1868delCT) in two Saudi families (North African and Middle Eastern 
origin) [274, 275]. 
In 2002, Eymard-Pierre reported that Alsin mutations are responsible for a primitive, retrograde degeneration 
of the upper motor neurons of the pyramidal tracts, leading to a clinical continuum from infantile (IAHSP) to 
juvenile forms with (ALS2) or without (JPLS) lower motor-neuron involvement. Four alsin mutations (3742delA, 
1471delGTTTCCCCCA, 2660del AT, 1130delAT) were discovered in four families that lead to abnormal short 
and long ALS2 transcripts and truncated alsin proteins suggesting that IAHSP is allelic to juvenile ALS and 
JPLS [276].  
In 2003, Al-Chalabi’s results showed that variants of the ALS2 gene are not a common cause of a 
predominantly young onset, upper motor neuron disease phenotype of sporadic ALS, nor are they associated 
with a more-typical phenotype. Twenty-one variants including 5 exonic,13 intronic and 3 non-SNPs (ivs1–
57(T)11–13 , ivs2+62 t>c , ivs3–10(T)9–10 , 1102g>a V368M , ivs6+49 c>g , ivs10–62 c>t, ivs11–39 c>a, 
2466g>a V822V, ivs13–142 t>a,  ivs13–132 t>c, 2796c>t S932S, ivs16–30_–26del, ivs19+40 c>t, ivs20–75 
a>g, 3885g>a A1295A, ivs25–76 t>c, 4015c>t L1339L, ivs26–64 g>a, ivs29+7 g>a, ivs30–69 t>a, ivs34+29 
t>c ) were found in 12 individuals [277]. Devon has revealed that ALS2 mutations are much more common 
than previously supposed due to the subsequent discovery of further ALS2 mutations within multiple different 
populations and a novel homozygous C3115T variant (R998X) was discovered in a Jewish family [278]. Gros-
 - 37 - 
Louis reported the identification of a novel ALS2 mutation in a large consanguineous Pakistani kindred with 
infantile onset autosomal recessive complicated HSP [279]. Hand screened 95 unrelated familial, 95 unrelated 
sporadic, and 11 early-onset ALS patients detecting 23 novel sequence variants; however, none is disease-
associated [280]. Nagano screened 3 Japanese patients finding no deletion mutation suggesting that deletion 
mutations in ALS2 gene detected in ALS2 patients seem to be uncommon in Japanese patients [281]. 
In 2005, Kress presented an ALS2 Turkish male patient with a novel homozygous deletion in exon 4 identified 
as 553delA [282]. 
In 2006, Panzeri described the first homozygous missense which falls within the RCC1 domain in ALS2, 
c.1619 G >A which is p.G540E mutation identified in a patient [283]. Eymard-Pierre reported a novel ALS2 
missense homozygous G669A mutation in patients from a consanguineous Turkish family affected by IAHSP, 
and demonstrated the instability of this ALS2 mutant protein [284]. 
In 2008, Verschuuren-Bemelmans recognized 10 homozygous variants. Nine were previously described and a 
nonsense mutation c.2143C4T  in exon 10 of the ALS2 gene in two siblings with infantile-onset ascending 
spastic paralysis which predicted chain termination at amino-acid position 715 of the gene product ALSIN 
(p.Gln715X) was discovered [285]. 
In 2009, Shirakawa also reported heterozygous ALS2 mutations (V1189WfsX19, G1172EfsX29) in Japanese 
siblings [286]. 
In 2011, Mintchev reported a new homozygous splice-site frameshift mutation c.2980-2A>G (p.993fsX7) on 
intron 17 thereby causing a loss of exon 18 in a Cyprus family [287]. 
1.18.1.3 ALS4 - SETX 
Senataxin gene is associated with autosomal dominant juvenile form of ALS having 24 exons on chromosome 
9q34.13 consisting of 2677 amino acids with 7 mutations reported so far. It was suggested that juvenile-onset 
sporadic ALS and hereditary motor neuropathy patients with syndromes of ataxia and motor neuron disease 
should be examined for SETX mutations [288]. 
In 1998, Chance first linked ALS4 locus to markers from chromosome 9q34 after studying 11-generation 
pedigree with autosomal dominant, juvenile-onset motor-systems disease [289]. 
In 2004, Chen detected 3 missense mutations (L389S, T3I, R1236H) in a Maryland and Belgian family when 
19 genes were tested within the ALS4 interval on 9q34 [290]. 
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In 2009, Zhao screened 45 SALS and 200 controls identifying a novel variation Thr118Ile in a 42 year old 
SALS Chinese patient [291]. 
In 2011, Hirano detected c.4660T > G transversion mutations  in two relatives of a patient [288]. 
1.18.1.4 ALS5 - SPG11 
Spatacsin gene is associated with autosomal recessive juvenile ALS having 40 exons on chromosome 15q14 
consisting of 2330 amino acids with 12 mutations reported so far. 
In 2010, Orlacchio analysed patients of 25 unrelated pedigrees identifying 12 mutations (Gln40X, Trp89X, 
Met245Valfs, Arg1992X, Leu733X, Ile870Valfs, Arg1026fs, Val1468Leufs, IVS30 + 1 G > A, Tyr1990X, 
Val2053Met, Val2344Cysfs) [292]. 
In 2012, Daoud discovered a novel deletion variant,  c.5199delA in exon 30 using exome sequencing [293] 
1.18.1.5 ALS6 - FUS 
Fusion gene is associated with autosomal dominant form having 15 exons on chromosome 16p11.2 consisting 
of 347 amino acids with 65 mutations reported so far. 
In 2003, Abalkhail identified a putative locus on chromosome 16q12.1-q12.2 after carrying out a preliminary 
genome screen, using a U.K. resource of families lacking SOD1 mutations [294]. Ruddy identified two large 
European families with ALS disease were demonstrated only across regions of chromosome 16 [295]. Sapp 
performed a genetic linkage screen in 16 pedigrees with FALS and identified novel ALS loci on chromosomes 
16 and 20 [296]. 
In 2009, Belzil screened the entire gene in a cohort of 200 patients with ALS identifying 3 different mutations 
(S57delTCT, R521C, R521H) in 4 different patients, including 1 3-bp deletion in exon 3 of a patient with 
sporadic ALS and 2 missense mutations in exon 15 of 1 patient with familial ALS and 2 patients with sporadic 
ALS [297]. Chio identified a heterozygous p.R514S missense mutation in a family of northern Italian origin, 
and a heterozygous p.P525L missense mutation in a family of Sicilian origin [298]. Corrado examined 1009 
patients (45 FALS and 964 SALS) with another 293 of the SALS patients identifying seven missense 
mutations (G191S, R216C, G225V, G230C, R234C, G507D and R521C) in nine patients (seven SALS and 
two FALS), and none in 500 healthy Italian controls [299]. Damme sequenced the FUS gene in a cohort of 
patients from Belgium with familial ALS and identified a R521H mutation in 4 patients [300]. Kwaiatkowski 
sequenced all 15 exons in 81 other unrelated FALS cases and 293 sporadic ALS (SALS) DNA samples, and 
an additional 209 ALS families were screened for mutations in exon 15 detecting 13 different mutations 
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(H517Q, R521G, insGG, delGG, R244C, R514S, G515C, R518K, R521C, R521H, R522G, R524T, R524S, 
P525L) in 17 different FALS families [301]. Ticozzi identified 4 distinct missense FUS gene mutations (R521C, 
R521G, G156E, R234L, R522R) and 5 novel variants in intronic (c.832 + 36A>G, c.833 - 29C>T, c.1066 + 
82C>G) and 3' UTR (c.*10C>T, c.*41G>A) in a cohort of 5 Italian patients with FALS [302]. Vance conducted 
a survey of 197 familial ALS British Kindred cases and identified the same R521C mutation in four additional 
families, as well as two additional missense mutations (R521H, R514G) in another four families [303]. 
In 2010, Baumer sequenced all 15 exons of the FUS gene in 3 patients revealing a novel deletion mutation 
(c.1554_1557delACAG) in 1 individual and the c.1574C>T (P525L) mutation in 2 others [304]. Belzil amplified 
all 15 exons of FUS, sequenced in 154 unrelated FALS cases and 475 ethnically matched healthy individuals 
identifying a new splicing mutation (R514R) in the highly conserved C-terminal of the FUS protein [305]. Blair 
examined 247 SALS and 124 FALS Australian patients with European ethnicity and discovered R521C and 
R521H mutations [306]. Bosco found a novel R495X mutation in a family when 2 patients’ DNA was examined 
[307]. Broustal found R521H mutation in a French ALS patient [308].  Groen studied 52 unrelated Netherland 
FALS patients observing R521C, R521H, a novel S462F and a polymorphic Q210H mutations [309]. Hewitt 
screened an initial cohort of 42 familial ALS (FALS) and 117 sporadic ALS (SALS) cases with subsequent 
larger cohort of 431 SALS cases. Four heterozygous mutations (Gly507Asp, Arg524Trp, Gly174del, 
Gly228_Gly229insGly), 1 of which is novel, were identified by Corrado in 6 patients with ALS (4 with FALS and 
2 with SALS) [299]. DeJesus-Hernandez identified two novel mutations ((g.10747A>G; IVS13-2A>G) and 
p.G466VfsX14) in FUS in two out of 99 (2.0%) sporadic ALS patients [310]. Huang found P525L mutation in 
exon 15 of a case [311]. Millecamps screening a cohort of 162 families enrolled in France and 500 controls 
identifying 31 pathogenic missense mutations found in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP 
and 7 FUS - R521C (3 patients) and R514S, R521S, R521H, R521L) [236]. Rademakers screened FUS in a 
cohort of 200 ALS patients [32 FALS and 168 sporadic ALS (SALS)] identifying a mutation (R521C) that was 
also present in her affected daughter and a novel mutation (G187S) in one SALS patient [312]. Suzuki found 
the R521C FUS mutation in a Japanese family with FALS after screening 40 FALS families in Japan and 
found 4 more mutations (S513P, K510E, R514S, H517P) in exon 14 and 15 of FUS [313]. Tsai screened a 
cohort of 15 index patients of Taiwanese Han Chinese descent with adult-onset FALS identifying 7 different 
mutations in 8 patients, including 3 in SOD1, 2 in exon 15 of FUS (H517D and R521H), and 2 in exon 6 of 
TARDBP [242]. Van Langenhove performed mutational analysis of FUS in 122 patients with FTLD and 15 
patients with FTLD-ALS, 47 patients with ALS  and in 638 control individuals in a Belgian population and 
observed the known R521H mutation in 1 patient with ALS apart from 1 patient with FTLD mutation [314]. 
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Yamamoto-Watanabe examined a Japanese ALS6 family with mutation R521C in the FUS/TLS gene [315]. 
Waibel analyzed a German amyotrophic lateral sclerosis (ALS) cohort, including 133 patients with sporadic 
ALS and 58 patients with FALS identifying 2 novel heterozygous FUS/TLS mutations in 4 German ALS 
families including the novel missense mutation R510K and the truncating mutation R495X [315]. Yan identified 
a total of 17 FUS mutations(S96del, G174-G175del, G206S, G223-226del, Y485AfsX514, R495X, 
R495EfsX527, K510WfsX517, R521C, R521G, R521H, R521L, R524S, R525L, 5’-2A>T) including 11 novel 
mutations in 22 FALS families [316]. 
In 2011, Belzil tested 475 SALS cases of European origin and 475 matched controls for coding variations in 
the 15 exons of the FUS gene identifying novel FUS mutations (P18S, N159Y, R383C, R502fsX15, Q519X) in 
a total of five SALS patients [317]. Chio presented the first case of an ALS patient carrying a de novo 
missense mutation of the FUS gene (c.1561C>T, p.R521C) [318]. Drepper identified R521C, in one familial 
and one sporadic ALS patient in Germany [319]. Lai in mutational screening of all coding exons of FUS in a 
total of 1523 ALS cases having 228 sporadic ALS cases, six variants (R521C, R521H, Y66Y, G507D, R518G, 
P525P) in six different cases were found [320]. Robertson performed a mutation analysis of FUS in a 
Canadian ALS patient of Chinese origin which revealed an unusual novel heterozygous double point mutation 
(R514S/E516V) confirming that exon 15 is a mutation hot-spot [321]. In a Spanish cohort, Syriani screened 25 
FALS patients identifying 2 mutations R521C and K510E in 2 patients [322]. H517D and R521H mutations in 
two Taiwanese patients were found  in exon 15 of FUS by Tsai [242]. 
In 2012, Belzil found a novel 1-base pair deletion frameshift R495QfsX527 in exon 14 in a 19-year old male 
patient [323]. Brown reported 4 new mutations (Ser439Ser,c.105dup, c.132C>A, c.190C>A) and replicated 
mutations (Gly144_Tyr149del, Gly174del, Ser439Ser, Arg521Gly, Pro525Leu) in a US ALS cohort [252]. 
Conte found a juvenile form of ALS mutation P525L in a young Italian girl of 11 years of age [324]. Mochizuki 
found a replicated mutation P252L in 3 members of a Japanese family [325]. Nagayama discovered a novel 
mutation p.Met464Ile in a SALS patient with corticobassal degeneration. Sproviero screened 327 Italian 
patients and found replicated mutations R521G, R521C and P525L in 4 patients [326]. Zou sequenced all 
exons in 10 FALS, 210 SALS and 151 healthy controls discovering R521L, R521H, P151P, R216R, G228G, 
Y97Y, G49G, G488G and 14C>T mutations [327]. Van Blitterswijk examined 111 FALS from 97 families, 1192 
SALS and 970 controls reporting S115N, Q210H, R487C, R495X, R521H and R521C mutations [328]. 
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1.18.1.6 ALS8 - VAPB 
VAMP-associated protein B gene is associated with autosomal dominant form having 6 exons on chromosome 
20q13.33 consisting of 347 amino acids with 30 mutations reported so far. 
In 2004, Nishimura initially described a single P56S mutation in 12 affected individuals in a Brazilian family of 
Portuguese descent [329]. Landers screened 80 familial ALS cases and identified an exon 5 three-base pair 
deletion of the serine residue at position 160 (∆S160) [330]. 
In 2005, Nishimura observed the same mutation in seven additional Brazilian families [331]. 
In 2006, according to Marques, all the affected members tested presented the Pro56Ser mutation on exon 2 of 
the VAPB gene, which was absent in the remaining 34 non affected members [332]. Conforti suggested that 
sporadic ALS is not associated with VAPB gene mutations in Southern Italy [333]. 
In 2010, Funke identified P56S in a German pedigree [334]. Millecamps screening a cohort of 162 families 
enrolled in France and 500 controls identifying 31 pathogenic missense mutations found in 36 patients (20 
SOD1, 1 ANG, 1 VAPB - P56S, 7 TARDBP and 7 FUS) [236]. 
1.18.1.7 ALS9- ANG 
Angiogenin gene is a causative gene for a juvenile autosomal recessive form of motor neuron diseases 
(MNDs) having 33 introns and 2 exons on chromosome 14q11.1 consisting of 1657 amino acids with 18 
mutations reported so far. 
In 1999, Hayward identified three rare polymorphisms in the untranslated region of the APEX nuclease gene 
and one common two-allele polymorphism (D148E) on chromosome 14 [335]. 
In 2004, Greenway identified a novel mutation in two individuals with sporadic ALS that potentially inhibits 
angiogenin function thereby propose a candidate region for ALS on chromosome 14q11.2 [336]. Skvortsova 
also analyzed M235T polymorphism of ANG gene as part of his study [337] . 
In 2006, Greenway reported the finding of seven missense mutations (Q12L, K17E, K17I, R31K, C39W, K40I 
and I46V) in 15 individuals, of whom four had familial ALS and 11 apparently 'sporadic' ALS after genotyping 
the rs11701 SNP in 1,629 individuals with ALS and 1,264 controls from five independent populations. This 
confirmed the association in the Irish and Scottish populations with ALS, although no association was 
observed in the populations from the US, England or Sweden [338].  
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In 2007, Crabtree further showed that the ribonucleolytic activity of 6 of the 7 ANG-ALS implicated variants is 
significantly reduced or lost and some variants also show altered thermal stability [339]. Corrado screened 262 
Italian SOD1 negative ALS patients (250 sporadic) and 415 matched controls for sequence variations in the 
regions of the ANG gene and did not detect the association with rs11701 in the Italian population [340]. 
Subramanian identified Q12L, C39W and K40I [341]. Wu sequenced the coding region of ANG in an 
independent cohort of North American ALS patients and identified four mutations which are associated with 
functional loss of ANG activity (P(-4)S, S28N, and P112L are novel, and K17I previously reported) in the 
coding region of ANG from 298 ALS patients [342]. In 2008, Conforti investigated the role of ANG gene in ALS 
patients from southern Italy and found a novel mutation ( in the signal peptide of the ANG gene in a sporadic 
patient with ALS supporting the evidence that the ANG gene is involved in ALS [343]. Del Bo also argued 
against the hypothesis of both genes as risk factors for motoneuron neurodegeneration, at least in an Italian 
population [344]. Gellera collected peripheral blood samples from 737 Italian patients (455 males and 282 
females) identifying seven different mutations, five of which are novel (g.446C→T, F-13S, G20G, V113I and 
H114R), in nine patients (six SALS and three FALS), but not in 515 healthy controls. These findings however 
suggested the hypothesis that ANG gene mutations may not only increase the risk of ALS but may also be 
pathogenic due to the absence of these mutations in healthy individuals, their overrepresentation in FALS 
compared to SALS cases in the cohort, and the strong evidence from functional assays that ALS-linked ANG 
mutations affect the biological properties of the protein raise [345]. Paubel observed a previously identified a 
heterozygous mutation (pI46V) in 2 patients with ALS without a known family link and found a novel 
heterozygous mutation (pR121H) in 1 male patient who developed ALS with rapid progression but no 
association with rs11701 SNP when 855 French patients with sporadic ALS were analyzed. No mutation was 
observed in 234 healthy control individuals [346]. 
 
In 2009, Fernandez-Santiago investigated the role of ANG in the German population, screening for mutations 
by sequencing the entire coding region of the ANG gene in a large sample of 581 German ALS cases and 616 
sex- and age-matched healthy controls and identifying two heterozygous missense variants, F(-13)L and 
K54E, in two sporadic ALS cases but not in controls. It was suggested that this finding provided further 
evidence to support the hypothesis that angiogenic factors up-regulated by hypoxia are involved in the 
pathophysiology of ALS [347]. 
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In 2010, Millecamps screening a cohort of 162 families enrolled in France and 500 controls identifying 31 
pathogenic missense mutations found in 36 patients (20 SOD1, 1 ANG - K17I, 1 VAPB, 7 TARDBP and 7 
FUS) [236]. 
In 2011, Luigetti found a novel heterozygous ANG missense variant (c.433 C>T, p.R145C) which was not 
found in controls [348]. 
In 2012, Brown identified 2 novel mutations Tyr38His and Asp46Gly [252]. Kirby identified a replicated 
mutation K54E in a single SALS case when 517 patients and 278 normal controls were screened from North 
England [349]. Zou sequenced 10 FALS, 202 SALS and 151 healthy controls in a Chinese cohort, discovering 
a novel variant V103I in a sporadic patient and a novel H84R variant in a healthy control [327]. 
1.18.1.8 ALS10 - TDP43 
TAR DNA-binding protein gene is associated with autosomal dominant form having 6 exons on chromosome 
1p36.22consisting of 414 amino acids with 50 mutations reported so far. 
In 2007, Dickson suggested that the study of TDP-43 is useful in differentiating FTLD-MND and ALS from 
other conditions connected with upper or lower motor neuron manifestations [350]. 
In 2008, Daoud screened the TARDBP gene in 285 French sporadic ALS patients identifying the insertion of 
an adenine in exon 6 (c.1255-1256insA) that creates a premature stop codon (Y374X) and three heterozygous 
missense mutations (P363A and A382P and G348C) in five unrelated patients [351]. Gitcho identified A315T 
mutations segregated with all affected members of an autosomal dominant motor neuron disease family which 
was not found in 1,505 healthy control subjects [352]. Kabashi reported eight missense mutations in nine 
individuals—six (D169G, G287S, G348C, R361S, N390D, N390S) from individuals with sporadic ALS (SALS) 
and three (A315T, A382T -in 2 individuals) from those with familial ALS (FALS) after screening 200 individuals 
with ALS (80 FALS, 120 SALS) from France and Quebec; and 185 controls matched for age and ethnicity 
[353]. Kuhnlein screened 134 patients with sporadic ALS, 31 patients with familial ALS, and 400 healthy 
control subjects identifying 2 missense mutations (G348C and the novel N352S)in 2 small German kindreds 
[354]. Rutherford analyzed a cohort of 296 patients with variable neurodegenerative diseases associated with 
TDP-43 histopathology and 3 different heterozygous missense mutations in exon 6 of TARDBP (M337V, 
N345K, and I383V) were identified in the analysis of 92 familial ALS patients with no mutations detected in 24 
patients with sporadic ALS or 180 patients with other TDP-43–positive neurodegenerative diseases neither in 
825 controls and 652 additional sporadic ALS patients [355]. Sreedharan screened 154 index FALS cases for 
mutations in TARDBP identifying a missense mutation (M337V) in exon 6 from a Caucasian family of English 
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descent [356]. Van Deerlin identified 2 TARDBP variants Gly290Ala and Gly298Ser in two kindreds with 
familial ALS when 259 patients with ALS, FTLD, or both were sequenced [357]. Winton identified a single 
living patient with a A90V substitution in exon 3 in FTLD/ALS case [358]. 
In 2009, Baumer identified in one patient the novel A321G variant, also A315A and A66A which were 
previously reported in 2 other patients in Oxford [359]. Corrado screened a large cohort of 666 Italian ALS 
patients (125 familial and 541 sporadic cases) identifying 12 different heterozygous missense mutations 
(N267S, G294V, G295S, G295R, S332N, G335D, M337V, S379P, S379C, A382T, G287S, S393L ) absent in 
771 matched controls [360]. Del Bo carried out a genetic analysis data on TARDBP in 314 ALS mainly Italian 
patients, identifying four heterozygous missense mutations (G348C, A382T, G294V and G295S) in five 
unrelated ALS patients [361]. Kamada performed mutational screening of TARDBP in 30 SOD1-negative 
FALS patients and found a N352S mutation in  one case of FALS, but no TARDBP mutations were found in 
cases of SALS [362]. Kirby screened 42 FALS, 9 ALS-FTD, 474 SALS and 45 PMA identifying 4 mutations in 
a Northern England cohort of which 2 are novel (Ala321Val and Gly348Val) [363]. Lemmens suggested a 
novel pathogenic missense mutation in exon 6 of TARDBP (M311V) in one patient with autosomal dominant 
FALS but absent in 601 healthy controls [364]. Ticozzi screened DNA from 397 ALS patients (208 FALS and 
188 SALS) cohort revealing 10 different heterozygous missense mutations (of which three are novel - N352T, 
N378D and G384R, and others previously reported are G295R, A315T, N345K, G348C, S379P, I383V, 
N390D) in 14 patients [365].Williams conducted a mutation analysis of TARDBP in an Australian cohort of 74 
sporadic and 30 familial ALS cases identifying a novel familial ALS mutation G294V [366].  
In 2010, Iida screened the TARDBP mutation in 721 Japanese ALS by direct sequencing identifying a novel 
mutation (Gly357Ser) and a known mutation (Asn352Ser) in sporadic ALS [367]. Millecamps screened a 
cohort of 162 families enrolled in France and 500 controls identifying 31 pathogenic missense mutations found 
in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP – G295S, A315T, G348C, A382T (2 patients), G384R, 
W385G and 7 FUS) [236]. Origone discovered S393L variant in an Italian cohort [237] and was replicated in a 
study by Praline in an ALS family[368]. Tsai screened a cohort of 15 index patients of Taiwanese Han Chinese 
descent with adult-onset FALS identifying 7 different mutations in 8 patients, including 3 in SOD1, 2 in exon 15 
of FUS and 2 in exon 6 of TARDBP (M337V and N378D) [242]. Xiong performed a direct sequencing of 71 
SALS patients and 5 FALS Chinese families identifying a novel heterozygous variation, Ser292Asn but not 
found in 200 unrelated control subjects. Also, two silent mutations (Gly40Gly and Ala366Ala) and one novel 
polymorphism (239-18t>c) were found [369]. Yokoseki found a Q343R substitution in three affected individuals 
in two generations of one family [370].  
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In 2011, Borghero discovered a 53 year-old patient carrying a homozygous A382T mutation [371] supporting 
the publication by Chio who found a heterozygous A382T mutation in 39 patients when 135 Sardinian ALS 
patients and 156 controls were screened [372].  Fujita identified A315E mutation in one FALS patient [373] 
while Ticozzi screened exon 6 in 3 Italian cohorts (376 AD, 463 PD and 376 ALS patients) discovering two 
novel mutations N352T and G384R [374]. De Marco conducted a study identifying G368S and A382T 
mutations [375]. 
In 2012, Brown identified two previously reported mutations Gly348Val and Ala382Thr amongst other 
mutations in other genes [252]. Chiang, Lida, Lattante, Mosca replicated the homozygous A382T mutation in 2 
subjects in a family of 2 generations [376]. Piaceri found a single SOD1 mutation and 3 TARDBP mutations  
(Ala382Thr, Gly295Ser, Gly294Val) in 5 SALS patients from 61 Italian ALS patients [377]. Solski found a novel 
insertion/deletion (indel), c.1158_1159delAT; c.1158_1159insCACCAACC heterozygous mutation [256]. Zou 
examined 312 SALS, 13 FALS and 245 healthy controls in a Chinese cohort identifying 2 SALS patients with 
the heterozygous S292N, 1 SALS patient with heterozygous G348V and 2 SALS patients with A366A [378].  
1.18.1.9 ALS11 - FIG4 
FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) gene is associated with autosomal 
dominant form having 23 exons on chromosome 6q21 consisting of 347 amino acids with 10 mutations 
reported so far. 
In 2009, Chow identified ten unique non synonymous variants of FIG4 in nine patients, including six with SALS 
and three with FALS (R183X, Q403X, D53Y, D48G, R388G, I411V, Y647C, I902T, R23del(23-55), S424del 
insR) [379]. 
1.18.1.10 ALS12 - OPTN 
Optineurin gene is a causative gene of hereditary primary open-angle glaucoma for a both recessive and 
dominant traits having 33 introns and 34 exons on chromosome 10p13 consisting of 1657 amino acids with 23 
mutations reported so far. 
In 2010, Maruyama investigated six Japanese individuals and found three types of OPTN mutations in three 
patients: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous 
E478G missense mutation within its ubiquitin-binding domain confirming that these findings strongly suggest 
that OPTN is involved in the pathogenesis of ALS [380]. Belzil evaluated OPTN mutations in a sample of 
familial and sporadic ALS cohorts in 95 unrelated familial ALS (FALS), 95 sporadic ALS (SALS) cases and 
190 control participants of European descent discovering two newly identified variants (p.K59N and c. 1242 _ 
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1G _ A_insA) and a previously unreported missense p.A481V in 3 individual FALS cases but not identified in 
any SALS patients [381].  
In 2011, Del Bo screened a group of 274 ALS Italian patients, including 161 familial (FALS) and 113 sporadic 
(SALS) cases which revealed six novel heterozygous variants in both FALS and SALS patients (three 
missense -  p.T282P, p.Q314L, p.K557T, one nonsense p.G23X and two intronic mutations c.552+1delG, 
c.1401 +4A/G) but absent in 280 Italian controls and over 6800 worldwide glaucoma patients. Among the six 
novel variants identified in our cohort, the missense p.Q314L and p.K557T mutations were predicted to be 
pathological and probably affecting protein function by three distinct prediction softwares (PMUT, PolyPhen 
and SNPs3D), while the p.T282P was scored as neutral by the same programs thereby supporting the 
possible pathological role of optineurin in motor neuron disease, but not in FTD [382]. Iida screened the entire 
coding region (exons 4-16) and exon-intron boundaries of OPTN mutation in 713 ALS (687 sALS and 26 fALS) 
patients to validate previous result using a different cohort and found 17 kinds of sequence variations of which 
two are novel (p.A93P and p.R271C) and not observed in 940 controls. PolyPhen and the SMART programs 
predicted that p.Ala93Pro has a possibly damaging function against the gene product while p.R271C was 
benign and not evolutonarily conserved thereby concluding that OPTN mutation is not a common cause of 
ALS in Japanese population [383]. Millecamps sequenced the coding exons of OPTN in 126 French patients 
with familial ALS (FALS) identifying heterozygote nonsense 691_692insAG and p.Arg96Leu variant in a family 
with dominant ALS [384]. Sugihara screened 563 sporadic ALS (SALS) subjects and 124 familial ALS (FALS) 
subjects who were mainly Caucasian and found a new c.964T_C synonymous variation (p. S218S) in exon 8 
apart from some previously reported variations. It was concluded that further pathological or biochemical 
investigation studies are needed to show that OPTN may be involved in the pathogenesis of a wide range of 
ALS [384]. van Blitterswijk identified 1 novel nonsense mutation (Q165X) and 1 unreported missense mutation 
(Q454E) in individual SALS patients after screening a large Dutch cohort of 1191 patients with SALS, 94 
patients with FALS, and 1415 control subjects for mutations and SNPs in OPTN. G159V and Q454E are 
predicted as probably damaging and possibly damaging respectively [385]. Tumer investigated 64 Danish 
SALS and FALS cases for mutations in the OPTN gene and identified a heterozygous nonsense p.Gln165X 
mutation in exon 6 segregating in a family with ALS but not present in 1070 healthy Danish controls and 1000 
Danish individuals with metabolic phenotypes or among 3928 glaucoma patients (2803 non-Japanese and 
1125 Japanese) and 2943 controls (2340 non-Japanese and 603 Japanese) [386] as reviewed by Maruyama 
[380]. 
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1.18.1.11 ALS13 – ATXN2 
Ataxin 2 gene is significantly associated with ALS having intermediate-length polyQ expansions (27–33 
glutamines). It is situated on chromosome 12q23-q24.1 with a record of 1 mutation so far. 
In 2010, Elden discovered that ATXN2 were significantly associated with ALS from studying 915 patients 
[387]. 
In 2011, 1294 European ALS patients and 679 matched healthy controls were examined by Lee in an 
European cohort [388]. Also, in another study by Van Damme, 1948 SALS,  FALS cases and 2002 controls 
from Belgium and  Netherlands were analysed [389]. 
1.18.1.12 ALS14 - VCP 
Valosin-containing protein is a gene on chromosome 9p13 with 7 mutations reported so far. 
In 2010, Johnson sequenced 210 cases from unrelated families and 78 pathologically proven ALS cases, and 
identified four mutations in the VCP gene (R191Q, R159G, R159C, D592N) found in three affected individuals 
within an Italian family, and a fourth affected member was an obligate carrier. None of these mutations were 
found in 569 US control samples, in 636 Italian control samples, in 364 African and Asian samples. 
In 2012, Kopper screened a cohort of 93 FALS, 754 SALS, 58 SALS-FTD, and 264 PMA patients discovering 
a replicated mutation R159H in a FALS patient and .I114V in 1 SALS patient [390]. Miller analysed British 
FALS and SALS patients but failed to identify an exonic variant in the subset [391]. 
1.18.1.13 ALS15/UBQLN2 
Ubiquilin 2 is a gene on chromosome Xp11.21 with 6 mutations reported so far. 
In 2011, mutations in UBQLN2, which encodes the ubiquitin-like protein ubiquilin  2, cause dominantly 
inherited, chromosome-X-linked ALS and ALS/dementia [63].  
1.18.1.14 ALS16/SIGMAR1 
Sigma non-opioid intracellular receptor 1 is a gene on chromosome 9p13 with 1 mutation reported so far. 
In 2011, the role of sigma-1 receptors in motor neuron function and disease was described in a 
consanguineous family segregating juvenile ALS in an autosomal recessive pattern and  how the genetic 
variant is responsible for the disorder [64]. 
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1.18.1.15 ALS17/ CHMP2B 
Chromatin modifying protein 2B is a gene on chromosome 3p12.1 with 2 mutations reported so far. 
In 2006, ALS patients were screened for the CHMP2B gene in chromosome 3p12.1 which is associated with 
frontotemporal dementia and two mutations were discovered in two patients [65]. 
1.18.1.16 ALS18/PFN1 
profilin 1 is a gene on chromosome 17p13.3 with 4 mutations reported so far. 
In 2012, two large ALS families were exome sequenced with results suggesting that mutations within the 
profilin 1 (PFN1) gene can cause FALS [66]. 
1.18.1.17 ALS19/ ERBB4 
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 is a gene on chromosome region 2q33.3-q34 
with 2 mutations reported so far. 
In 2013, a whole genome sequencing of an autosomal-dominant mode of inheritance with incomplete 
penetrance revealed the mutations c.2780G>A (p. Arg927Gln) and c.3823C>T (p. Arg1275Trp) in ERBB4 [67]. 
1.18.1.18 ALS20/ HNRNPA1 
Heterogeneous nuclear ribonucleoprotein A1 is a gene on chromosome 12q13.1 with 1 reported so far. 
In 2013, heterogeneous nuclear ribonucleoproteins was discovered in one case of familial ALS [68]. 
1.18.1.19 ALSFTD1 – C9ORF72 
C9orf72 gene is located on chromosome 9p21.2 with hexanucleotide repeat expansion causing amyotrophic 
lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). 
Efforts made towards discovering a link between ALS and Chromosome 9 in the year 2000 was when Hosler 
conducted a genome wide linkage analysis discovering  that a defective gene on chromosome 9 may be 
linked to amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) [273] while In 2003, Ostojic 
studied a Swedish ALS-FTD pedigree in 17 individuals in 2 generations but found no evidence of linkage to 
chromosome 9q21-22 [392]. 
In 2006, Morita confirmed a link on chromosome 9p21.3-p13.3 to ALS-FTD when a genome wide linkage 
analysis was performed on 50 members of a Scandinavian family [393] . Vance also conducted a genome 
wide linkage study on a large ALS-FTD kindred using Affymetrix microarrays[394]  
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In 2007, Valdmanis identified 3 ALS-FTD families from Canada and France showing evidence on linkage to 
chromosome 9p [395]. 
In 2008, Luty discovered a genetic linkage on chromosome 9p21 from FTD, MND and TARDBP patients [396]. 
In 2009, Le Ber tested 10 French families linking them to chromosome 9p [397] while van Es screened 2323 
SALS and 9013 controls on regions chromosome 19p13.3 and 9p21.2 detecting a high linkage to 
SNP rs12608932 [398]. 
In 2010, Boxer conducted a study on chromosome 9p-linked FTD-ALS family to find features of affected 
patients [399].  Gijselinck conducted a genome wide linkage study of loci at chromosomes 9 and 14 on a 
Belgian family and found a significant evidence of a linkage to chromosome 9p23-q21 [400]. Laaksovirta 
conducted a genome wide association study on a Finnish population sampling 442 ALS patients and 521 
control individuals and concluding that chromosome 9p21 is a major cause of FALS [401]. Pearson studied a 
large family from Gwent in South Wales identifying a large haplotype on chromosome 9p21 [402]. Shatunov 
found a strong evidence of two SNPs (rs3849942 and rs2814707) associated with SALS by conducting a 
genome wide association study on SALS and controls from 20 UK hospitals which included 599 patients and 
4144 controls [403]. 
In 2011, DeJesus-Hernandez and Renton in their independent studies found expanded GGGGCC 
Hexanucleotide Repeat in the C9ORF72 gene as the major cause of FTD and ALS while Renton specifically 
discovered that one-third of European descent FALS have HRE in C9orf72 making it the most common cause 
of ALS [404, 405]. Iida conducted a replication study on 2 SNPs: rs2814707 on 9p21.2 and rs12608932 on 
19p13.3 previously found in SALS Caucasian patients and concluding that no association exists in SALS East 
Asian patients (comprising of Japanese and Chinese) [406].   
In 2012, Andersen, Bigio, Murray, Wood and Orr wrote to confirm the association of HRE of C9orf72 with ALS 
patients [407-412]. Boeve screened a total of 53 subjects from 43 families to determine the characteristics of 
patients with repeat expansion in C9orf72 [413]. Brettschneider performed genetic analysis on autopsy 
confirming the association of hexanucleotide repeat expansions with ALS-FTD patients [414]. Byrne examined 
the characteristics  of ALS patients from the population register collated since 1995 in Ireland [415] while Coon 
also researched the features in a Scandinavian kindred [416]. Calvo also confirmed the association of 
GGGGCC expansion in ALS-FTD patients [417]. Chester suggested that bulbar progression in C9orf72 HRE 
is common and destructive in Portuguese patients [418] while Chio discovered 2 Sardinian families with 
C9orf72 and TARDBP mutations causing a rapid degeneration [419]. Cooper-Knock studied the features of 
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ALS-FTD patients with expansions in C9orf72 in a Northern England cohort of 563 cases [420]. García-
Redondo assessed 781 SALS, 155 FALS, 248 controls from a Spanish cohort and from various populations 
globally as reported in HapMap [421]. Gijselinck studied 465 patients with ALS and/or FTD and 856 controls 
from Flanders-Belgium identifying a HRE in C9orf72 [400]. Herdewyn conducted a whole genome sequencing 
on 5 members of a family with classical ALS confirming repeat expansion as a cause of FALS [422]. Irwin also 
examined ALS-FTD patients with HRE in C9orf72  confirming a severe rate of cognitive decline in 
affected patients [423]. Ishiura analysed a total of 310 ALS and PDC patients from Kii peninsula of Japan and 
its environs concluding that a severe prevalence of the disease leads to HRE in ALS patients of Kii population 
[424]. Jang investigated 8 FALS and 246 SALS Korean patients but found no patient with expansion thereby 
concluding that repeat expansion is not a common cause of ALS in Korean patients [425].  Konno 
found 2 FALS patients in 58 cases examined which suggests that HREs exist in a Japanese cohort but in 
small proportion [173]. Koppers examined 1019 SALS and 1103 controls from Dutch cohort by analysing 
mutations in chromosomes 9p21.2 and 19p13.3 concluding that variants in these coding regions are rare in 
ALS Dutch patients [390]. Lattante identified C9orf72 patients apart from 6 other genes screened in an Italian 
cohort of 480 SALS and 48 FALS patients [426]. Majounie screened 1425 FTD patients and 4448 ALS 
patients confirming that a common C9orf72 gene is involved in many cases of familial and sporadic ALS and 
FTD [427]. Millecamps studied 950 French ALS patients and 580 controls confirming that expanded repeats in 
C9orf72 plays a vital role as a causative for ALS [428]. Mok discovered that expansions in the C9orf72 gene is 
a common cause of ALS in the Greek population [429]. Ogaki found no evidence of C9orf72 in FTLD 
Japanese patients [430]. Pamplett studied 43 Australian SALS patients and found  expanded repeats in 
patients [431].  Rademakers found hexanucleotide repeat expansion in ALS-FTD patients [432]. Ratti found a 
hexanucleotide repeat expansion when a  large cohort of 259 familial ALS, 1275 sporadic ALS, and 862 
control individuals of Italian descent were screened [433]. Rutherford identified HREs in patients with ALS 
[434]. Sabatelli reported HREs as the most common mutation in a Sardinian and Italian SALS population 
[435]. Savica examined the behavioural pattern of 3 ALS-FTD subjects [436]. Simón-Sánchez investigated a 
Dutch cohort of 353 FTDsporadic or familial  patients with or without ALS [437]. Smith Stewart found HRE 
mutation in 17FALS and 6 SALS when 231 ALS patients were examined [438].  
In 2013, Beck discovered HREs in multiple neurodegenerative diseases in the UK population [439]. Dombroski 
studied Guam patients with Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex in the Chamorros 
population suggesting that C9orf72 expansion is not a common cause of ALS-PDC [440]. Gomez-Tortosa 
confirmed an association of C9orf72 HREs with ALS-FTD patients studied in a Spanish cohort [441]. Jones 
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performed a genome wide association testing on ALS samples and found SNPs  rs3849942 and rs903603 
strongly associated with ALS [442]. Zou screened the HRE in C9orf72 in a Chinese ALS cohort of 324 SALS 
and 20 FALS but could not identify an expanded hexanucleotide repeat [443]. 
1.18.1.20 ALSFTD2 – Unknown 
In 2013, Dobson-Stone reported a locus on chromosome 16p12.1-q12.2 in a genetic analysis on a large 
European Australian kindred [440]. 
1.18.1.21 OTHERS 
1.18.1.21.1 DAO 
D-amino acid oxidase gene is associated with classical adult onset familial amyotrophic lateral sclerosis 
(FALS) having 10 exons on chromosome 12q24 consisting of 347 amino acids with 2 mutations reported so 
far. 
In 2010, Mitchell reported an exon 7 heterozygous variant R199W in a UK three generational FALS kindred 
while Millecamps identified an exon 2 heterozygous variant R38H in a French woman [444, 445]. 
1.18.1.21.2 DCTN1 
Dynactin gene is associated with autosomal dominant form and 31 exons on chromosome 2p13 consisting of 
347 amino acids with 2 mutations reported so far. 
In 2003, Puls identified G59S variant in a North American family with a slowly progressive, autosomal 
dominant form of lower motor neuron disease without sensory symptoms [446]. 
In 2004, Munch screened 250 patients with ALS and 150 unrelated controls identifying three mutations 
T1249I, M571T and R785W [447]. 
In 2005, Munch reported another heterozygous R1101K mutation in a family with ALS [448]. 
In 2008, Takahashi identified a novel putative pathogenic R997W mutation in exon 18 apart from other novel 
variants in SOD1, ALS2, ANG and VEGF [225]. 
1.18.1.21.3 NEFH 
Fusion gene is associated with autosomal dominant form having 3 introns on chromosome 22q12.2 consisting 
of 347 amino acids with 30 mutations reported so far. 
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In 1994, Figlewicz found some deletions within the C-terminal KSP repeat region of the neurofilament heavy-
subunit gene some human ALS patients [449] 
In1996, Rooke found no variation in the NEFH gene in 117 unrelated cases of familial ALS when the C-
terminal KSP repeat region was examined [450] and Vechio also found no deletions in the NEFH gene [451]. 
In 1998, Tomkins identified an 84-bp insertion in the NEFH tail in a study of 164 ALS cases and 207 age-
matched controls [452]. 
In 1999, Al-Chalabi analyzed samples from 2 different populations (UK, 207; Scandinavia, 323) with age-
matched controls for each group (UK, 219; Scandinavia, 228) and found 4 novel NEFH tail deletions [453]. 
In 2004, Skvortsova examined ALS patients from a Russian cohort suggesting that the S genotype of the gene 
is associated with sporadic MND in patients in Moscow [337] 
In 2011, Daoud screened 190 ALS patients sequencing 29 candidate genes and discovered 40 novel variants 
including NEFH variants –Lys867Asn, Glu918Gly, Arg346His, Ala40Val [454]. 
1.18.1.21.4 KIFAP3 
In 2009, Landers conducted a genome wide association study on 1821 SALS and 2258 controls from US and 
Europe yielding the SNP rs1541160 with a pvalue of 1.84 x 10(-8) [455]. 
In 2010, Traynor made an attempt to replicate the study in 504 Italian ALS patients but the gene had no effect 




The word data is a plural of ‘datum’ – a latin word meaning ‘to give’. It originated from the pre-computer days 
of ‘trade by barter’ where goods were measured, exchanged and stored. Data in our modern days is a piece of 
information which could either be quantitative or qualitative. A collection of the set of variables or data requires 
organization, storage and availability for use when needed. This therefore invented the idea of the term 
‘database’ [457]. 
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1.19.2 Evolution of Database 
At the start of early civilization, medical records, government documentations, library materials and businesses 
required means of storing and retrieving information but only got easier, cheaper and more compact at the 
advent of computers in the sixties [457]. Navigational database system was the first generation of database in 
which records were retrieved through navigation from one record to another. The two models were network 
model and hierarchical model [458]. 
 In 1970, Edgar F. Codd conceived the idea of a relational database  [459] (searching for data by content 
rather than through links) which is different from the previous models. Relational database consists of a 
schema (structure) and a table (rows and columns) with records linked together with a ‘key’. 
1.19.3 Relational model: review 
A database is a collection of relations (or tables); Each relation has a list of attributes (or columns); Each 
attribute has a domain (or type) and Each relation contains a set of tuples (or rows) [460, 461]. 
1.19.4 Database Management Systems 
DataBase Management System (DBMS): a software system that facilitates the creation and maintenance and 
use of an electronic database [458]. The main roles are to keep data around (persistent), answer queries 
(questions) about data and update data administratively. 
1.19.5 Examples of Databases 
Oracle, IBM DB2 (from System R, System R*, Starburst), Microsoft SQL Server, NCR Teradata, Sybase, 
SAP, SQLite, dBASE, FoxPro, IBM DB2, LibreOffice Base, FileMaker Pro, Informix (acquired by IBM),  
PostgreSQL (from UC Berkeley’s Ingres, Postgres), Tandem NonStop (acquired by Compaq, now HP), 
MySQL, Microsoft Access. 
1.20 Genetics database 
A genetics database can be simply defined as a structured and comprehensive collection of data on genes, 
heredity, and variation of organisms [462].  
1.20.1 History of Genetics Databases 
1949 saw a description of the first mutation that caused human disease, in the haemoglobin gene. Many more 
mutations led to the need to track these. In the1970s, Prof Victor McKusick rose to this challenge by creating 
the first database of mutations and inherited diseases, known as Mendelian Inheritance in Man. A transformed 
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version of this database was later developed for free and easy access online, and is now known as OMIM 
[463]. 
The development of an accurate, integrated, complete and systematic database by some geneticists became 
essential in 1994 to attend to the issue of mutation documentation. A need arose for a regularly updated list of 
gene mutations accessible online and gene-specific databases integrated with central databases where a 
systematic mutation naming convention based on amino acid change were agreed [464, 465]. 
Mutation databases of human genes are becoming more prominent and indispensable in all areas of health 
care. Also, increasing number of experts in the mutations and diseases of particular genes are curating 
published and unpublished mutations in locus-specific databases (LSDB) extensively [466]. Apart from being 
considered as tools that provide vital information on protein function and structure, databases of mutations 
causing Mendelian disease play a fundamental role in research, diagnostic, and genetic health care [467, 
468]. It is therefore pertinent to keep these databases updated and relevant to daily research work. 
With the advent of high-throughput sequencing technologies which provide genome sequencing within a 
shorter time at less cost but with terabytes of data produced. Management of these data could pose storage 
and administrative problems if not properly carried out [469]. Large-scale Genome Wide Association Studies 
reveal more genes associated with diseases like ALS. The administrator of the database is therefore posed 
with the challenge of keeping users of the database informed of new information in the field of ALS. 
1.20.2 Non-locus specific mutation databases 
Considering the wide range of large databases freely available online, I compiled a list of a few relevant large 
databases from Pubmed and Google Scholar using the keyword “Databases”. Databases with broken links 
and locus-specific mutation databases and were excluded from the list as seen in Table 2.  
 
Table 2: Non-locus specific mutation databases 






U. S. National Science 
Foundation 
ExPASy Expert Protein http://www.expasy.org/ Swiss Institute of 
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Analysis System Bioinformatics 










http://www.LOVD.nl/ European Community's 
Seventh Framework 
Programme, Netherlands 





now redirected to: 
http://www.gwascentral.org/ 
GlaxoSmithKline, the 
University of Leicester, and 
the European Community’s 
Sixth Framework 





http://www.hapmap.org funding agencies from 
Canada, China, Japan, 
Nigeria, the United 
Kingdom and the United 
States 






National Center for 
Biotechnology Information, 
U.S. National Library of 
Medicine 





http://pga.gs.washington.edu/ the National Heart Lung 
and Blood Institute's 
(NHLBI) Programs for 
Genomic Applications 
(PGA) 






University hospital Medical 









Institute of Genetic 
Medicine, Johns Hopkins 
Medicine and National 
Human Genome Research 
Institute 
 
1.20.2.1 ALFRED  
ALFRED (ALlele FREquency Database) is a resource of gene frequency data on human populations 
supported by the U. S. National Science Foundation. ALFRED has been designed to make allele frequency 
data on anthropologically defined human population samples readily available to the scientific community and 
to link these polymorphism data to the molecular genetics-human genome databases. Due to the large volume 
of data available from the human genome project (HGP) to study human variation, collecting the resulting data 
into a single, easily accessible resource is vital to facilitate this research [470-472]. 
1.20.2.2 ExPASy 
The ExPASy (Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics (SIB) 
is dedicated to the analysis of protein sequences and structures. 
1.20.2.3 HGMD 
The HGMD (Human Gene Mutation Database) maintained in Cardiff. HGMD represents an attempt to collate 
known (published) gene lesions responsible for human inherited disease. HGMD comprises various types of 
 - 57 - 
germ-line mutation within the coding, splicing and regulatory regions of human nuclear genes. As at December 
2007, HGMD contained 76,011 different mutations in 2876 human genes [473, 474].  
1.20.2.4 LOVD 
LOVD is a platform-independent Web-based LSDB-in-a-Box package which lists 71 public LOVD installations 
hosting 3,294 gene variant databases with 199,000 variants in 84,000 patients.[475] 
1.20.2.5 HGVbaseG2P  
The Human Genome Variation database of Genotype-to-Phenotype information (HGVbaseG2P) provides a 
centralized compilation of summary level findings from genetic association studies, both large and small. It is 
built upon a basal layer of Markers that comprises all known SNPs and other variants from public databases 
such as dbSNP and the DBGV [476, 477]. 
1.20.2.6 HapMap 
The goal of the International HapMap Project is to develop a haplotype map of the human genome, the 
HapMap, which will describe the common patterns of human DNA sequence variation. The HapMap is 
expected to be a key resource for researchers to use to find genes affecting health, disease, and responses to 
drugs and environmental factors [478, 479]. 
1.20.2.7 dbSNP 
Large-scale sampling designs using association studies, gene mapping and evolutionary biology led to the 
idea of developing a general catalog of genome variation now known as the dbSNP database by the National 
Center for Biotechnology Information (NCBI) [480]. 
 
1.20.2.8 SeattleSNPs 
The SeattleSNPs PGA is focused on identifying, genotyping, and modelling the associations between single 
nucleotide polymorphisms (SNPs) in candidate genes and pathways that underlie inflammatory responses in 
humans [481].  
1.20.2.9 PicSNP  
PicSNP is a catalogue of non-synonymous SNPs (Single Nucleotide Polymorphism) in the human genome. 
SNPs were retrieved from annotations in the draft sequence available in GenBank. Current version of PicSNP 
is based on the GenBank database of Feb 6, 2002. Details of assembly of the catalogue is described in 
reference [482]. 
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1.20.2.10 OMIM 
Mendelian Inheritance in Man (MIM) is a brief but comprehensive bibliographic material with examinations on 
inherited disorders and genes maintained by geneticists and molecular biologists. Its online version, Online 
Mendelian Inheritance In Man (OMIM), is freely available on the World Wide Web. Unlike other databases that 
preserve primary sequence, mapping, or reference material, OMIM offers authoritative free text overviews 
about genetic disorders and gene loci that can be used by researchers [483, 484]. 
1.20.3 ALS-specific mutation databases 
These are disease databases with particular reference to Amyotrophic Lateral Sclerosis only. Apart from 
ALSoD, the following are independent ALS databases:  
Table 3: ALS-specific mutation databases 
Databases Website Support Last Update  






Tokyo Univ. Hosp., Tokyo 







Max-Planck Institute for 
Molecular Genetics, Berlin, 
Germany with Prize4Life 
12/02/2014 
 
1.20.3.1 ALS Mutation Database 
Recently, an ALS mutation database constructed as part of the Life Science Integrated Database Project 
conducted by the Japan Ministry of Education, Culture, Sports, Science, and Technology was published. It 
contains their original experimental results and published data extracted from scientific journals. The database 
is expected to play a complementary role to the ALSoD database especially in collecting variations in the 
Asian region [485]. 
1.20.3.2 ALSGene 
The ALSGene database provides an unbiased regularly updated results of genetic association studies in ALS 
[486].  
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1.21 Collection 
1.21.1 Data mining, Text mining and Web mining 
The advancement in data generation using innovative technologies like high throughput sequencing for GWAS 
studies and whole exome sequencing has provoked an enormous volume of genetic data by researchers. 
Methods and techniques development are required for discovering patterns in huge datasets with the aim of 
extracting sensible information and this process is known as KDD (Knowledge Discovery in Databases). There 
is a great increase in interest of extracting and mining information from literature due to the free availability of 
electronic publications in large databases like PubMed [487-489]. 
Text mining is the process of extracting quality information from text. This is utilized in spam filters to define 
the pattern of advertisements or spam emails or other unsolicited materials [490-494]. In the field of biological 
research, the National Centre for Text Mining (NaCTeM - http://www.nactem.ac.uk) – which is a collaboration 
between University of Manchester and  Korea Institute of Science and Technology Information (KISTI) – was 
publicly funded  to conduct research on text mining [495]. BioText is a software developed to assist in analysis 
and mining of texts [496]. 
Humans have approximately 24,000 genes [497]. However, communicating and sharing these data is difficult 
as there is no universal standard terminology to represent biological terms. Gene ontology (GO) therefore 
helps to provide terms synonymous to a word or string of words covering three domains: biological process, 
cellular component and molecular function [498-500]. It is what I will refer to as the dictionary of genes. 
Most of the bulk of work in text and data mining has already been developed by larger databases like the 
NCBI, UCSC, HUGO etc., hence the desire not to reinvent the wheel. The motivation for utilizing these larger 
databases is by manually extracting and storing identity numbers allocated to each gene on ALSoD. 
1.21.2 External Databases 
Researchers studying ALS genetics are currently obliged to use several major resources (or their equivalents) 
to find genetic, transcriptomics, protein and clinical information. Examples are PubMed, The HapMap, the 
1000 Genomes Project, ArrayExpress, OMIM, Ensembl, the UCSC Genome Browser, Swiss-Prot, EBI and 
dbGAP. PubMed lists scientific publications and includes links to full articles where available. The HapMap is 
an international consortium aiming to map all common, bi-allelic human genetic variation in ancestral 
populations, with the emphasis on Europeans, Chinese/Japanese and Africans. This allows the correlation 
structure of the human genome to be visualized and for example, makes it simple to develop ancestry 
informative genetic markers or to use so-called tag SNPs that reduce and simplify genetic association studies. 
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The 1000 Genomes Project aims to sequence 1000 human genomes to identify rare genetic variation and 
understand how this relates to human phenotypes. OMIM (Online Mendelian Inheritance in Man) is a 
searchable database of Mendelian diseases and genes, with referenced reviews that are kept up-to-date. 
Ensembl and the UCSC Genome Browser are annotated versions of the human and other animal genome 
assemblies, and include information on gene and genetic variation positions, conservation between species, 
RNA and protein variation and expression and other information. The exploration of protein findings requires 
researchers to explore Swiss-Prot or similar protein databases. The European Bioinformatics Institute (EBI) 
and the genetic association database, dbGAP, are repositories of published genome-wide association data, 
which researchers have to interrogate to identify negative studies, or to download public genotypes for 
subsequent analysis. 
1.21.3 The need for a Single Resource 
Accessing too many data sources or databases could be confusing. What is required is a single resource that 
can act as a coordinated gateway for the relevant links with a summary, a repository for data that would not be 
stored elsewhere, and a quick analysis tool that does not require multiple registrations or downloads of huge 
datasets. 
1.22 Integration 
Concepts and information are freely shared in the field of science which is the reason for a huge number of 
curated, up-to-date non-commercial or non-profit databases are freely available [465].  Extracting relevant 
gene variation information from the massive comprehensive central databases like Genbank, EMBL, Swiss-
Prot has become increasingly impossible due to their structure, hence a time-saving and internet-accessible 
need for locus-specific databases (LSDBs) [465, 468].  
 
ALS genetic data are increasing exponentially with a rising need for combining data existing in different 
sources to present the ALS-research community with a unified examination of these data [501].  
 
1.22.1 What is needed in ALS 
A flawless integration of the two types of online variation databases (which are the genomic and locus-
specific) can be achieved with the use of a unique identifier as there exists various ways to create a variation 
database [465]. Unique ids can be used to systematically link to other bioinformatic tools and comprehensive 
databases that do not require registration and are freely available online. Apart from NCBI, UCSC, OMIM, 
KEGG, UNIPROT, GeneMANIA, Genecards, Pubmed, AmiGO, iHop and a host of others, there are other 
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general information from non-biological databases that could be hyperlinked  to have a more general overview 
of each gene without bias. 
1.22.2 Curators/Contributors 
Published data and unpublished data curated by the database administrator and registered ALS researchers 
could be incorporated into the database to avoid unfairness. To keep the database updated with novel variants 
discovered in various laboratories around the world, I hope to accept and encourage increased participation 
from more researchers globally.  
1.22.3 Google API 
 Google APIs can display the popularity of a database around the world. It could be used to enable 
researchers or patients to view the geographical distribution of reported gene variations associated with ALS. 
Other essential information I hope to make available on the database through data integration from other 
sources are chromosomal overview of all ALS-related genes, gene overview of all published ALS-related 
genes, key published studies on all current ALS-related genes from relevant publications and latest news on 
ALS from various sources automatically made available through Really Simple Syndication (RSS) feeds. 
1.22.4 Animal Models 
The use of animal models in research helps to provide a distinctive prospect to study incurable and deadly 
human diseases like ALS both clinically and pathologically by performing studies which are considered 
unrealistic or impossible to undertake in human patients with motor neuron degeneration [502]. To contribute 
to a better understanding of the pathogenesis of ALS, links to information on animal models will be a valuable 
facility on the database. I hope to integrate the dataset into the animal model section of each gene overview 
as a combination of information from MGI (Mouse Genome Informatics) and Pubmed databases. 
1.23 Analysis 
The challenge of providing information as required by researchers can only be found in a database that 
accurately stores, reports and analyses these helpful data [503]. The sequencing of the human genome and 
the HapMap project [504] have impacted the study of human disease in a significant way and are enabling 
many genome-wide association studies that aim to elucidate the genetic component of complex diseases 
[104].  
One problem facing researchers, particularly those who may not be geneticists but who rely on genetics data, 
is knowing how credible any report of linkage or association is. Having an independent measure of credibility 
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that might guide non-geneticists in knowing the level of confidence to place in reported findings would be an 
additional useful tool.  
1.23.1 Genome Wide Association Study (GWAS) 
A major challenge but an extremely desirable outcome would be the online availability of all genome-wide 
association study (GWAS) data [505] for selective interrogation by users and comparison with other 
information sources such as linkage, candidate gene or other genome data. GWAS have generated 
bioinformatics challenges on how to model the complexity of genotype-phenotype connections, integration of 
biological databases for interpreting genetic associations and the development of a software that enhances 
collaboration among biologists and bioinformaticians [506]. GWAS is a frequently used method for discovering 
disease loci by researchers, it is a useful and impartial approach to uncover the risk alleles for genetically 
complex non-Mendelian disorders. GWAS results are frequently arranged according to level of significance by 
combining studies via meta-analysis to increase power [507]. Implementing a GWAS interface on a publicly 
available database for ALS will yield a desirable outcome for researchers to view the results graphically using 
straight forward queries.  
The introduction of GWAS provides the opportunity to cross-examine the entire genome with increased 
resolution and power. GWAS have already been conducted for a variety of complex diseases, with varying 
degrees of success. Larger GWAS samples are more likely to discover larger numbers of common 
susceptibility variants with small effects.  A study of controversies and perspectives in the genetics of ALS 
suggests that human genetic studies in ALS, including GWAS and the study of structural genetic variation, is a 
strong tool to recognize the molecular pathways involved in ALS. It is necessary to genotype the whole 
genome both within and between populations as being done by the genome project team in order to fully 
define the relevance of SNPs to SALS [508].  
1.23.2 On-the-fly Meta Analysis 
Meta-analysis is the analysis of analyses. A large collection of analysis results from individual studies are 
statistically analyzed with the intention of amalgamating the findings. A useful tool to perfom a meta-analysis 
of datasets based on user’s defined selection would be desirable. An additional feature to an on-the-fly 
analytical GWAS tool would be to comapare data from users with available data stored on the database.   
1.23.3 Predicting gene interactions 
Gene interactions are important for biologists and scientists and would therefore be useful to include. 
GeneMANIA is an interaction prediction tool described as follows: “the high accuracy of the GeneMANIA 
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prediction algorithm, an intuitive user interface and large database make GeneMANIA a useful tool for any 
biologist” [509]. The relevance of a gene interaction tool is indispensable on a freely available genetics 
database. 
1.24 Smartphone Development 
Complex diseases like ALS pose a great challenge to researchers worldwide. Research in the field of health 
sciences is advancing rapidly hence the need for an effective facility that provides storage, analysis, and 
interpretation of data constantly generated by researchers.  
The advent of the internet is one of the useful things that has happened to this generation because it provides 
efficient and swift online resources within a short time. Apart from social networking, data sharing through 
websites has widened the horizon of scientific research work. People can now communicate ideas easily to 
anyone anywhere in the world without any form of physical contact using a computer. Internet services are 
now available almost everywhere and users access the internet either for fun by playing games or social 
networking with friends or for more serious work like reading latest news or accessing online resources 
through websites [510]. 
Gone are the days of stationery, immovable and gigantic computers that took days to analyze data which were 
manually punched in using punched tapes. Desktop computers were later introduced as small-sized, movable 
systems with better input devices like keyboards, mouse and joysticks. Nowadays, Laptop computers are 
becoming outdated and pocket-sized mobile devices like smartphones and tablets are commonly used to 
access information online. Most websites were initially built to display valuable information online to users of 
desktops and laptops. The pages are configured to suit the height and width of the screen perfectly. More 
people now access websites on various types of devices thereby making it essential to have a usable and 
effective mobile website that can be displayed correctly on a user’s device [511, 512].  
Desktop computers were mainly used to browse websites but this has been taken over by mobile devices in 
the last decade. Data traffic on mobile devices just for the purpose of mobile browsing has risen over four 
times in 2008 [511]. Apart from making phone calls, mobile phone technology has greatly improved from 
monochrome screens for sending SMS to colourful graphical touch screens for mobile browsing. [513] The 
former issues of low bandwidth and low resolution screens on mobile devices are constantly being resolved 
and due to the regular changes to create a worthwhile browsing experience for mobile device users, 
smartphones and tablets are getting smarter and are often referred to as “mobile computers” [514-517]. 
According to Netmarketshare, the introduction of iOS (Apple mobile device operating system), between March 
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2010 and October 2010 doubled the use of iPad and iPhone for mobile browsing [518] thereby predicting that 
in 3 years mobile “should” take over desktop internet usage as seen in Figure 1 [519]. This information shows 
that more users of the ALS database will require access to the database outside the office environment on 
their mobile devices. A vital tool necessary for a more useful database is to develop a website reachable on 
any mobile device with an internet connection. 
 
Figure 1: Mobile Marketing Statistics adapted from Netmarketshare webpage 
1.24.1 Mobile Websites 
Just like any other website, a mobile website has HTML pages which are connected and accessible over the 
internet (even though mobile websites are typically accessed through WiFi 3G or 4G networks). Mobile 
websites are designed for smaller handheld and touch screens. Contents of mobile websites like any other 
website are texts, videos, data and images [520]. Due to the ever-changing technologies for mobile devices, 
former issues of mobile browsing due to bandwidth has been overcome to a large extent [513]. 
1.24.2 Apps 
These are applications downloaded and installed on a mobile device like a smartphone or tablet instead of 
accessing the content through a browser. It enables users’ accessibility of contents where there are no 
connections to the internet. There are various categories of apps downloadable from portals like Blackberry 
App World, Apple App Store and Android Market [520]. IPhone was first introduced in 2007 thereby leading to 
the introduction of apps stored in the Apple’s App store for download by iphone and ipad mobile devices. 
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A comparison between a mobile website and an app is displayed in Table 4with explanation following. 
 
Table 4: Comparison between mobile website and app 
Features Mobile Website App 
Instant Availability Yes No 
Compatibility Yes No 
Integration Yes No 
Instant Update Yes No 
Easily searched Yes No 
Shareability Yes No 
Reachability Yes No 
Permanency Yes No 
Convertibility Yes No 
Cost and Time Yes No 
Support Yes No 
Speed No Yes 
Complex reports No Yes 
Habitual usage No Yes 
Functionality No Yes 
Connectivity No Yes 
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Discoverability No Yes 
 
 
1.24.3 Advantages of a mobile website over an app 
If the motive behind establishing an extensive mobile presence is just to distribute contents of the website to 
users and be found on search engines, then a logical option is a mobile website. Here are details of the 
advantages [520]: 
1.24.3.1 Instant Availability 
Devices like Blackberry, iPhone and Android allow immediate access to users through a browser whereas, 
apps need users to first download and install the applications before the content can be viewed. 
1.24.3.2 Compatibility 
 All users are reachable on a single mobile website across various mobile devices whereas apps separate 
versions are designed specifically for each type of mobile device. 
1.24.3.3 Integration 
Mobile website URLs are effortlessly incorporated within other mobile technologies like NFC, SMS, QR Codes 
unlike apps. 
1.24.3.4 Instant Update 
 Changes made to the content of a mobile website are seen immediately whereas an app can only be updated 
if downloaded by users of each type of device. 
1.24.3.5 Easily searched 
Mobile websites could be found easily by search engines especially for automatic redirection of regular visitors 
using handheld devices. But for apps, device manufacturers’ app stores restrict the visibility of apps. 
1.24.3.6 Shareability 
An app cannot be shared easily by publishers within text messages or social network sites or emails using a 
simple hyperlink like a mobile website.  
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1.24.3.7 Reachability 
An app is only restricted to users of the app-specific device whereas a mobile website can be accessed by a 
larger number of users across platforms. 
1.24.3.8 Permanency 
Apps are deleted from users’ devices if they are no more relevant to the user thereby having a short lifespan 
but a mobile website cannot be deleted by a user so they are able to access it when required. 
1.24.3.9 Convertibility 
A database-controlled mobile website can be extended to act as an app. 
1.24.3.10 Cost and Time 
Developing a mobile website can be achieved within less time and costs less than having multiple apps across 
different device platforms.  
1.24.3.11 Support 
Over time, it is easier to support and sustain a mobile website than an app. Issues of upgrades, compatibility, 
maintenance and testing are more expensive in apps than in mobile websites. 
1.24.4 Advantages of an app over a mobile website  
If the aim of developing an app which works more like a computer program instead of a website primarily for 
interactivity is profit-orientated, then it is more reasonable to develop an app rather than a mobile website. It 
will be time-wasting, pointless and worthless to embark on an expensive venture of building an app which 
performs basic functions achievable with a mobile website. Below are more reasons to realize an optimal profit 
on the investment of app development [520]: 
1.24.4.1 Speed 
Where Interactivity is essential in accessing data effectively on a mobile device, speed is the main focus. 
1.24.4.2 Complex reports 
Complex calculations are better performed on apps. 
1.24.4.3 Habitual usage 
Apps are more efficient at achieving personalized usage of the mobile phone e.g using EverNote on a mobile 
device is an extremly faster, easier, more proficient way to store and arrange all data, regardless of variety 
(text, website, video, audio, PDF). 
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1.24.4.4 Functionality 
Apps use the full native functionalities of the handheld device like text messaging, calling, sensors and using 
the camera more effectively unlike a mobile website. 
1.24.4.5 Connectivity 
App contents are accessible offline without a need for network or wireless connections unlike mobile websites 
which can only be made available on a device connected to the internet. 
1.24.4.6 Discoverability 
Despite charges involved in submitting an app to Android’s App Market or Blackberry’s App World or Apple’s 
App Store, it is more exciting and offers more publicity when an app is downloadable from the global App 
market. 
1.25 The Project 
The title of my project is “DEVELOPMENT OF TOOLS FOR AUTOMATED COLLECTION, INTEGRATION 
AND ANALYSIS OF GENETIC DATA IN ALS”.  
1.25.1 Problem Statement 
The purpose of the research proposed is to develop a dynamic computational web page which tests the 
hypothesis that a central, automated database can successfully collate the genetic data available and present 
it in easily accessible forms for researchers. The approach will analyze existing genome-wide association 
study data that have been collected for meta-analysis and uploaded unpublished user-data. The product of 
this analysis is an on-the-fly meta-analysis in which unpublished user-data is combined with existing studies 
confidentially and the result fed back in minutes.  
During the course of the research, methods for providing a web-based integration of databases to analyze the 
function of SNPs found in ALS-related genes will be explored and data will be pooled from various sources like 
Hapmap, dbSNP etc. 
1.25.2 Research Questions 
Description of the novel research questions proposed for my thesis project is: 
1) Is it possible to generate a database that summarizes genetic data for a disease and allow meta-analysis 
online? Amyotrophic lateral sclerosis (ALS) will be used as a model disease. 
2) Can all genetic data useful to ALS be automatically collected?  
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3) How achievable is an on-the-fly analysis of genetic data online?  
4) To what extent can the database (the ALS Online Genetics Database) be integrated with other 
bioinformatics resources available online? 
5) With the advent of various ALS-related genes, can a database generate levels of evidence to support or 
refute genetic associations and linkages with ALS?  
1.25.3 Overall aim 
The overall aim of this proposed research work is to generate and develop a central, automated database that 
can successfully organise the genetic data available and present it in easily manageable forms for 
researchers.  
1.25.4 Objectives 
• To restructure the database by rewriting the schema in order to deal with irregularities and 
inconsistencies experienced by users. 
• The use of up-to-date APIs (Application Programmable Interface) and chart controls compatible with 
the current webpage application package. This is to present data graphically in a more understandable way. 
• To curate data from publicly available databases using automated and manual text mining techniques 
where necessary. 
• To rewrite queries and implement appropriate stored procedures by integrating scripts in SQL 
(Structured Query Language), javascript, perl language and other relevant scripts required to perform this 
task. 
• To implement more in-house scripts to monitor users visiting the webpage. 
• To develop a webpage summarizing, analysing and displaying data from genome wide association 
studies in ALS. 
• To develop a webpage that grabs current news in ALS using RSS (Really Simple Syndication) feeds 
and other available technology fit for this purpose. 
• To explore the use of XML (Extensible Markup Language), Haploview, R, Perl, JavaScript, C#, Visual 
BASIC integrated under the ASP.NET platform to create a more user-friendly webpage. 
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Chapter 6 METHODS 
6.1 Research questions with an overview of proposed methods 
Description of the novel research questions proposed for my thesis project is: 
1) Is it possible to generate a database that summarizes genetic data for a disease and allow meta-analysis 
online? Amyotrophic lateral sclerosis (ALS) will be used as a model disease. 
I will create gene and chromosomal overview pages of all available ALS-related genes; collate published 
genome-wide association study (GWAS) data from the largest genome-wide association study of ALS to date 
completed by our group; collate published linkage studies and merge results from GWAS; and allow user-
defined queries of meta analysis of both association and linkage studies. 
2) Can all genetic data useful to ALS be automatically collected? 
I will implement data mining and then manual curation of genetic data used by most databases; a tool to 
interrogate larger databases like UNIPROT (which is a consortium between the European Bioinformatics 
Institute (EBI), the Swiss Institute of Bioinformatics (SIB) and the Protein Information Resource (PIR)) will be 
developed. 
3) How achievable is an on-the-fly analysis of genetic data online?  
A tool for dynamically uploading GWAS data from users will be developed; I will compare user data with 
available GWAS data in the database, including appropriate statistical corrections and allow user-configurable 
queries using a simple interface. 
4) To what extent can the database (the ALS Online Genetics Database) be integrated with other 
bioinformatics resources available online?  
To provide users of the database with maximal cross-referenced bioinformatics investigation, I hope to utilize 
information from other well-known databases like Entrez Gene, UCSC, OMIM, Genecards, KEGG, Uniprot, 
iHop, dbSNP, Pubmed, Wolfram Alpha, PDB, Gene Onology and others. 
5) With the advent of various ALS-related genes, can a database generate levels of evidence to support or 
refute genetic associations and linkages with ALS?  
Various criteria were intended to generated scores for prioritizing the importance of each gene. The initially 
proposed criteria for each gene are: A score for the number of mutations related to ALS on ALSoD; a score for 
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the number of published articles related to ALS available in Pubmed; a score for the number of significant 
SNPs within a threshold derived from the meta-analysis tool; a score for how each gene relates to other genes 
using Ingenuity pathway tool; a score for the number of countries where mutations or disease-associated 
variants are found. 
 
6.2 Keeping up with genetic discoveries in amyotrophic lateral sclerosis: 
6.2.1 Data Submission 
ALSoD allows users to submit new gene, mutation and patient data from publications or unpublished research 
work as displayed in Appendix 1 – Data Submission Flowchart. This is the only time a user requires a 
username and password to log in. A new submitter is required to register by providing details which will be 
stored on the database while an existing submitter logs in with login details already available on the database. 
Log in with a username and password either directly on the homepage or by clicking on the ‘login’ hyperlink to 
take you to the login page.  
 
Figure 2: Logging in section 
The protected page displaying a list of tasks that could be carried out by the secure user is shown in Figure 3. 
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Figure 3: Protected page after log in 
At the end of any successful submission to the database, a confirmation page appears as seen in Figure 4. 
 
Figure 4: Confirmation page 
6.2.2 Submit mutation data 
6.2.2.1 SQL Script generating mutation table 
A mutation table shown in Figure 5 was created to store data like codon, sequence position, gene, 
documentation and publication details on variants of genes recorded in publications or submitted by authentic 
researchers. 
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Figure 5: Mutation table on SQL Server 
6.2.2.2 Submission process into ALSoD 
Click on option 3 saying “click here to submit a gene” and it takes you to a list of genes to choose from. When I 
took over the database, there were only 4 genes (SOD1, ALS2, NEFH, and VAPB) available for mutation 
submission. Additional genes coded to the page are for TARDBP, ANG, FUS, SETX and OPTN as shown in 
Figure 6. More development for gene submission is still under construction. 
 
Figure 6: Gene submission page 1 
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Enter a mutation location (Exon or Intron) and type (Substitution, Insertion, Deletion, Polymorphism, Silent or 
Repeat) seen in Figure 7. 
 
Figure 7: Gene submission page 2 
 
Select the codon for the new mutation in Figure 8. 
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Figure 8: Gene submission page 3 
 
Select the position of the trinucleotide mutated in Figure 9. 
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Figure 9: Gene submission page 4 
 
Select the new amino produced by the mutation in Figure 10. 
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Figure 10: Gene submission page 5 
Enter publication references of the mutation in Figure 11. 
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Figure 11: Gene submission page 6 
Verify mutation details and submit in Figure 12. 
 - 118 - 
 
Figure 12: Gene submission page 7 
 
6.2.3 Submit new gene 
6.2.3.1 SQL Script generating gene table 
A gene table was created to store data like ids of other databases, chromosomal position and documentation 
details on genes recorded in publications shown in Figure 13. 
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Figure 13: Gene table on SQL server 
6.2.3.2 Submission process into ALSoD 
I designed a single page for entering data required as a format for the gene table. The data are unique identity 
number for each gene in various databases to allow for database integration with other freely available 
databases related to specific genes shown in Figure 14. Most of these ids are extracted or curated from NCBI 
Entrez Gene, HUGO and iHop websites. 
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Figure 14: Gene submission page on ALSoD 
Click on submit button and the data are automatically inserted into the gene table of the SQL ALSoD 
database. 
6.2.4 Submit patient data 
6.2.4.1 SQL Script generating patient table 
A patient table was created to store data like age of onset, duration of the disease, site of onset, mutation and 
documentation details on patients with variants recorded in publications or submitted by authentic researchers 
as seen in Figure 15. 
 - 121 - 
 
Figure 15: Patient table in SQL server 
6.2.4.2 Submission process into ALSoD 
A check is carried out to find out if the patient data needs to be submitted by asking the submitter some 
preliminary questions about the subjects like “Is the subject affected?” or “Does the subject have a mutation?” 
seen in Figure 16. If the answer to any of the questions is a “no”, the submission process is terminated but if 
“yes”, the process continues to the next page. 
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Figure 16: Patient submission page 1 
The user is asked if the submission is for a new family or an old family. Before I took over, this field was used 
to allocate a unique family identity number to a family seen in Figure 17. This was however changed to the 
name of the first author with the year e.g. Al_Chalabi 1999. This was changed because not all patients are 
familial and it was my way of knowing the patient data submitted from a particular publication. Also, it is now 
illegal to disclose the identity of a patient [524] which could be traced from the family id. Confidentiality of 
patients is crucial in research work because it is illegal to disclose a patient’s identity. 
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Figure 17: Patient submission page 2 
Patient details like the gene, gender, family history are filled in. Some fields like the date of birth and family id 
were compulsory fields and the submitter could not move forward if the data was not provided. This has since 
been changed and no field is compulsory. The dropdownlist for a patient’s country of origin and ethnicity with 
all the genes on the database are now included on this page in Figure 18. 
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Figure 18: Patient submission page 3 
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Onset details like the site of onset, age of onset (in years) and duration (in months) are required here. Some of 
the fields are not important anymore and some like the site of onset was modified and updated as seen in 
Figure 19. 
 
Figure 19: Patient submission page 4 
Check the details inputted and click on ‘Submit’ button shown in Figure 20. 
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Figure 20: Patient submission page 5 
The mutation data are inserted into the patient record, patient clinical records and the patient genetic record 
tables. 
 
6.2.5 Submit replicated mutation data 
6.2.5.1 SQL Script generating replicated mutation table 
A replicated mutation table was created to store mutation data that have previously been found in a population 
and being found in another population recorded in publications or submitted by authentic researchers as 
shown in Figure 21. 
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Figure 21: Replicated mutation table on SQL server 
6.2.6 Submission process into ALSoD 
I designed a single page in Figure 22 for entering replicated mutation data. The data curated here are gene 
mutations that have been submitted before but discovered in another population by another researcher and 
published by another author.  
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Figure 22: Replicated mutation submission page 
  
Click on submit button and the data are automatically inserted into the ‘mutation replicated’ table of the SQL 
database. 
 
6.2.6.1 Database Schema 
The design of the database involves various tables in the database schema from storing data on sequence 
mutation data on genes to anonymized patient data including phenotypic features and country of origin. The 
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tables are the basic foundational blocks of the database from which queries are carried out to produce results. 
Here is the list of tables and how they are connected in Figure 23 with a larger view on Appendix 40. 
 
Figure 23: Database Schema 
6.2.7 Search terms on search engines 
Published and unpublished data are continually curated by the database administrator and registered ALS 
researchers. Published data are obtained by regular searches from PubMed and Google Scholar, and 
screening of cross-references from relevant publications. The protocol for data extraction is shown in 
Appendix 6 - Data extraction from publications. 
6.2.7.1 Pubmed 
After a long search for the most encompassing search term which would not miss out publications required 
and which would not include too many irrelevant publications, I was able to get these keywords together. 
(mutation[Title] OR variant[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron 
Disease[Title] OR ALS[Title]) AND 2013[All Fields] 
6.2.7.2 Google Scholar 
The same process used in the pubmed search above applies to the Google search and I came up with theses 
search terms: 
novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" and select Year as 
‘2013’ 
 - 130 - 
 
6.2.7.3  Automated search 
Email Alerts are sent regularly from Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration journal to 
alsonlinedatabase@gmail.com. 
News page http://alsod.iop.kcl.ac.uk/Search/searchWeb.aspx displays current research information using 
“New gene mutation Amyotrophic Lateral Sclerosis ALS” as the search term on the Google search plug-in 
attached to ALSoD. 
http://alsod.iop.kcl.ac.uk/misc/Top10.aspx displays the last 10 mutation and patient data submitted. 
 
6.2.8 Contributors and Collaborators 
Unpublished data are uploaded by users (as described above) or made available to the ALS investigators by 
collaborations, and are published on the ALSoD website after consistency checks are performed by the 
database administrator.  
6.2.8.1 Contributors 
These are found on webpage http://alsod.iop.kcl.ac.uk/misc/contributors.aspx. Connections are made using 
the hyperlink. 
6.2.8.2 Collaborators 
Some of the tools for analysis of data were made possible through partnership with external researchers found 
on the webpage http://alsod.iop.kcl.ac.uk/misc/resources.aspx. 
6.2.9 Unique Identifiers 
To allow integration of different databases through one gateway, ALSoD uses unique identifiers to 
systematically link to other bioinformatics tools and comprehensive databases. How they are extracted and 
used will be discussed later in 6.3.10. This is used especially in the gene table where ids from other databases 
for a particular ALS gene are stored on ALSoD database.  
6.2.10 Graphical display of phenotypic data 
An overview page is available for all genes when selected from the homepage. There are 6 sections on this 
page displaying information on the gene, a graphical display of patient data, a tabular summary of patient data 
for the gene, bioinformatics links to webpages specific to the gene, animal models that have been used in 
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research relating to the gene and key publications that have reported mutations or replicated data on the 
gene. 
6.2.11 Mapping variants on Google Earth 
The mapping of gene variants on Google Earth allows researchers or patients to view the geographical 
distribution of reported gene variations associated with ALS. The same computational method allows us to 
map the origin of users and show which countries predominantly access ALSoD. This section is discussed in 
more details in section 6.3.2.3 
6.2.12 Meta-analysis and on-the-fly analysis of association data 
For users with their own association data, an on-the-fly analysis is available to combine the data available in 
ALSoD with unpublished user data that can be confidentially uploaded. The user data is formatted accordingly 
before upload and the result is fed back in minutes without storing users’ data on the database. This section is 
discussed in more details in section 6.3.4 
6.2.13 Instruction Manual on updating database 
Due to the volume of curation required in ALSoD regularly, help is required outside the team to update the 
database. Helpers are not allowed to submit data directly into the database to minimise errors and 
inconsistencies. So, spreadsheets have been prepared to allow helpers store data intended for the database. 
Once the data have been verified by the Administrator, an SQL query is used to insert the data into the 
relevant table of the ALSoD database. 
6.2.14 Updating Database 
Searching through pubmed for mutations and corresponding patient data from current publications between 
2011 and 2013 with search criteria provided for the available 105 genes on ALSoD  
Genes to concentrate on are: ALS2, ANG, DCTN1, FUS, FIG4, DAO, VCP, LUM, SETX, C9orf72, SOD1, 
TARDBP, VAPB, SPG11, NEFH, OPTN, PFN1, TAF15, EWSR1, SIGMAR1, UBQLN2, SQSTM1 
For example SOD1, open http://www.ncbi.nlm.nih.gov/pubmed 
Type: “SOD1 ALS mutation” click on ‘Humans’ and ‘5years’ on the left section 
Go through the list, select the relevant ones, send to ‘file’ and save the file. 
Check the gene overview page of the selected gene e.g. 
http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=SOD1 
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If the result list contains one of the publications on the key publication section of ALSoD, ignore it and move to 
the next on the list until there exists a publication that is not available on the ALSoD list.  
For patients, open the ALSoD_update_july_2013 spreadsheet, go to patients sheet 
Fill in the relevant columns 
Remember to save the file 
For mutations, open the spreadsheet, go to mutations sheet 
Fill in the relevant columns 
Remember to save the file 
6.2.14.1 Add ALS animal publications to database 
open http://www.ncbi.nlm.nih.gov/pubmed 
Type: “SOD1 ALS” click on ‘other animals’ on the left section 
On the ‘Send to’ dropdownlist, select File 
Choose CSV format, Recently Added and click on ‘Create File’ button 
A pubmed.csv file is displayed in excel by default then save the file to represent the gene e.g 
SOD1_animalmodel. If not, open excel spreadsheet then open the saved file. 
On cell L1, Type ‘Year’ 
On cell L2, Type ‘=RIGHT(E2,4)’ then double-click the right hand bottom corner to copy and paste the formula 
on all cells of the column. 
On cell M1, Type ‘Author’ 
On cell M2, Type ‘=RIGHT(K2,LEN(K2)-SEARCH("|",K2,3))’ then double-click the right hand bottom corner to 
copy and paste the formula on all cells of the column. 
On cell N1, Type ‘Gene’ 
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On cell N2, Type gene name ‘SOD1’ then double-click the right hand bottom corner to copy and paste the 
formula on all cells of the column. If it doesn’t show everything as ‘SOD1’, click on the autofill option icon on 
the right hand corner of the column and select ‘Copy Cells’ 
Create sheets for mouse(or mice), zebrafish, chicken, chimpanzee, rat, cow, dog and drosophila (or any other 
you notice). Then rename them accordingly eg. Mouse 
On the main SOD1_animalmodel file, take the cursor to A2, Click the Data menu and click on Filter. 
Click on the dropdownlist button, Select ‘Text Filters’, select ‘contains’ 
Type (‘mouse’ or ‘mice’) 
Select the top left hand box to highlight the entire sheet, right-click on the box and select copy or CTRL+C, 
open the ‘mouse sheet’ and paste values or CTRL+V. 
On cell O1, Type ‘Model’ 
On cell O2, Type model name ‘mouse’ 
Repeat from (m) for each of the models until done  
Go back to (a) for another gene. 
6.2.14.2 Adding data from replicated studies using the available online submission forms 
On the left hand side of the homepage, register to get a username and password. 
For temporary access, use ‘Tester’ and ‘Testing’ for username and password respectively. 
Select submit a replicated mutation link 
Fill in only details of mutations available in the list and details available in publication. 
Click ‘submit’ button when completed. 
6.2.14.3 Completing animal model file with missing data 
Open the ‘animalmodels.xls’ file 
Go through each row from the beginning and fill in the missing data for columns Mouse MGI ID, HGNC ID and 
OMIM Gene ID. 
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Take note of the copy and paste using autofill option by remembering to use ‘copy cells’ 
6.2.14.4 Finding rsid for variation in the human genome using HGVS nomenclature 
Have a list of mutations recently added to the website that do not have complete ids like the NM or NP. 
Open the Human Variation website: http://www.ncbi.nlm.nih.gov/projects/SNP/tranSNP/tranSNP.cgi to search, 
annotate and submit sequence. 
Type the NM id e.g .NM_006940.4:c.T193>C on the Input an HGVS name and follow the screen dump 
process in Appendix 6. 
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6.3 ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral 
sclerosis Genetics 
6.3.1 Funding and Sponsorship 
The ALSoD database is a joint project of some organizations like MNDA, ALSA, WFN, ENCALS. To get the 
logos displayed and linkable to their corresponding websites, the ImageMap function was used. Below is a 
screen print of the codes used to develop a clickable image on the MasterPage.  
 
6.3.1.1 WFN-ALS 
Name: World Federation of Neurology-Amyotrophic Lateral Sclerosis 
Website: http://www.wfnals.org 
Logo:   
Figure 24: WGN-ALS logo 
6.3.1.2 ENCALS 
Name: European Network for the Cure of ALS 
Website: http://www.euromotorproject.eu 
Logo:  
Figure 25: ENCALS logo 
6.3.1.3 ALSA 
Name: Amyotrophic Lateral Sclerosis Association 
Website: http://www.alsa.org/research/funding.cfm?CFID=153&CFTOKEN=65998082 
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Logo:  
Figure 26: ALSA logo 
6.3.1.4 MNDA 
Name: Motor Neuron Disease Association 
Website: http://www.mndassociation.org 
Logo:  
Figure 27: MNDA logo 
 
6.3.1.5 How to create a clickable image using ImageMap control in ASP.net 
On ASP.net, a server side control called <asp:ImageMap> allows you to create an image where some parts of 
the image is clicked and links to a desired web page. For example, I made the ALS-FTD diagram shown on 
the home page clickable. 
 
Figure 28: Clickable image using ImageMap control 
To use the Paint Application on Windows 8 (or any windows OS) navigate to Start -> Programs -> Windows 
Accessories -> Paint. 
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Figure 29: Opening the Paint application 
 




 <asp:PolygonHotSpot>  
I decided to use <asp:RectangleHotSpot> instead of the <asp:CircleHotSpot> because of the overlap of 
circles in the original image. Open the filename in Paint and get the hotspot coordinates for a gene like MAPT: 
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Figure 30: Using <asp:RectangleHotSpot> control 
On ASP.NET, the full codes are as seen in Figure 31 
 
Figure 31: Full code for mapping image 
Click on the gene (MAPT) and it opens up a new window displaying the gene overview of that gene in ALSoD. 
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Figure 32: Clickable image showing gene overview of MAPT 
 
The same technique was used to make the sponsor logos clickable on the MasterPage. The ImageMap 
section used to derive this is as below in Figure 33. 
 
Figure 33: Using <asp:RectangleHotSpot>  for logos 
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6.3.2 Programming 
Open source programming software such as JavaScript, C#, T-SQL, Perl, XML, and VB.NET integrated under 
the ASP.NET platform are implemented to write codes and scripts. 
6.3.2.1 Microsoft .NET framework 
ALSoD uses the Microsoft .NET framework and Microsoft Visual Web Developer 2008 Express Edition to 
develop the user-interface dynamic Web pages. 
 
Figure 34: Calling Microsoft .NET framework 
6.3.2.2 Microsoft SQL server 2008 
Microsoft SQL server 2008 is used to manage the database stored on the VM3 server of the Institute of 
Psychiatry, King's College London but linked to the developer’s PC as displayed above. Below is the 
description on how to link to the SQL server on VM3 provided the softwares have been installed on the 
developer’s machine and the Institute’s database administrator has configured the VM3 accessiblility using a 
college-recognized username and password. 
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Figure 35: Microsoft SQL Server 2008 startup page 
 
Figure 36: Microsoft SQL Server 2008 application 
6.3.2.3 Google Earth API 
Google AJAX search and Google Earth API have been combined to overlay geographical mutation information 
of ALS-related genes on the globe as seen below. Browsers used to test the application for purpose of 
compatibility to a large extent are Firefox, Google Chrome and Internet Explorer. 
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6.3.2.4 Eclipse software 
The most recent programming skill I acquired through personal study is the Eclipse software which is a Plug-in 
allowing a mobile device programmer to develop, test and debug a Java application. Eclipse software was 
utilised primarily to develop an app for ALSoD. It had a very long technical process and required a lot of 
intricacies to finally get it working on the computer. More details on mobile application development in ALSoD 
are described later in section 6.5 and the whole process in form of screen dumps is in Appendix 10. 
6.3.2.5 Perl 
I learnt how to write scripts in Perl to manipulate large datasets. PolyPhen, SIFT and PANTHER data were 
restructured to suit the SQL database tables. Some codes for transposing a sequence are as shown in 
Appendix 22. 
6.3.2.6 Python 
I installed python 3.3 on my machine to run the population frequency and enable me map the mutations on 
ALSoD to 1000 genome and EVS. Even though the codes were written by my colleague to enable me achieve 
a true result, I used my programming skills to decode the script and amended it to suit the purpose. The script 
is in Appendix 21. 
 
Figure 37: Using Python to map population frequency 
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6.3.3 Web Design 
With the schema restructured, a facelift was given to the Web page and some pages were redesigned for 
better visual representation of data. The Graphical User Interface allows data to be interpreted and viewed at 
a glance instead of using the tabular format of viewing data. 
6.3.3.1 ALSoD Homepage Timeline (2007-2013) 
The database began in 1995 without a website but a database for storing genetic data of SOD1 mutations. In 
1999, the increase in the use of technology especially the easy access to the internet propelled a collaboration 
work of SOD1 mutations with the ALS scientific community to develop a uniform centralized database 
accessible through the internet in real time. Under the web address www.alsod.org, the database was made 
available to the public but was short-lived due to domain name registration and web host issues. Collaboration 
with the Institute of Psychiatry and the sponsors of the database established the current web address 
http://alsod.iop.kcl.ac.uk which is still running to date.  
To see how the website metamorphosed at different stages of development, ALSoD was captured by the 
crawler tool of an internet archive website called ‘WayBackMachine’, I queried the website on 
http://archive.org/web/web.php. Some of the unavailable views were taken from archived old files. 
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Figure 38: WayBackMachine showing ALSoD homepage timeline 
6.3.3.1.1 Year 2007-2008 
I took over the development and maintenance of the then ‘ALSOD’ database from Dr Richard Wroe in July 
2008 with no working knowledge of .NET framework software or SQL Server database. I was only familiar with 
HTML for developing a website and Microsoft Access for databases. I was confident that it would not take too 
long to learn these new softwares as the basic structures are almost the same. So, for the first six months, I 
went through the structure of the SQL database and the website, I installed softwares on machines from 
scratch and I played around with some of the codes. My role was to implement the future plan for ALSOD. 
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Figure 39: Home page 2007-2008 
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6.3.3.1.2 Year 2009 
 
Figure 40: Home page 2009 
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6.3.3.1.3 Year 2010 
 
Figure 41: Home page 2010 
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6.3.3.1.4 Year 2011 
 
Figure 42: Home page 2011 
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6.3.3.1.5 Year 2012 
 
Figure 43: Home page 2012 
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6.3.3.1.6 Year 2013 
 
Figure 44: Home page 2013 
6.3.3.2  MasterPage- A pattern for other pages with common layout and functionality. 
The layout of the master page is a greyish-background table divided into five: Row1-Column1 (Header), 
Row2-Column1 (Top), Row3-Column1 (Left), Row3-Column2 (Contentholder) and Row4-Column1 (Footer) as 
seen in Figure 45. 
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Figure 46: Masterpage Header 
Seven hyperlinks are displayed on the topmost part of the website for constant view and use by a user of the 
website. 
Login - http://alsod.iop.kcl.ac.uk/login/loginAuthenticate.aspx to submit gene, mutation and patient data. 
Feedback - http://alsod.iop.kcl.ac.uk/contact/guestbook.aspx to help us with feedback from users. 
Help - http://alsod.iop.kcl.ac.uk/misc/FAQs.aspx to provide users with help required using our website. 
Content 
Holder 
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Register - http://alsod.iop.kcl.ac.uk/login/preSign0.aspx to enable researchers contribute data to the ALSoD 
database, registration is required. 
Cookies - http://www.aboutcookies.org/default.aspx?page=5 to make users of the website aware of ALSoD’s 
cookie policy. 
Print - javascript:window.print() to allow users print a page on the website by a click of a link rather than 
copying and pasting. 
Cite us - http://alsod.iop.kcl.ac.uk/contact/contact.aspx to point user to the right direction on how to cite our 
work in publications. 
6.3.3.2.2 Footer 
 
Figure 47: Masterpage Footer 
A statement showing the copyright, duration, host, writer and coordinator is displayed. It reads: “© Copyright 
2007-2013 King's College London, The Institute of Psychiatry | Rewritten + Version 4.0 by Olubunmi Abel | 
Project coordinated by Prof Ammar Al-Chalabi”. 
6.3.3.2.3 Top 
 
Figure 48: Masterpage Top section 
ALSoD logo has a size of 49KB with 318 by 177 pixels designed on PowerPoint and stored as 
"~/Images/alsodlogo.png". It is displayed as a linkable image redirecting a user to the default or index page 
when clicked and reduced to 186px by width. 
The name of the database “ALS ONLINE GENETICS DATABASE” is shown and a sitemap showing a 
breadcrumb of where a user is on the website. The sitemap is stored as a file (Web.sitemap ) with details 
available in Appendix 13. A line of solid yellow fills highlighting a new message is shown e.g. “Check ALSoD 
on your smartphones and tablets”. It also consists of the menu leading to submenus explained 
below. 
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The first search button allows a user easy access to search through the NCBI (National Center for 
Biotechnology Information) website for information on search term typed in the textbox. 
protected void SearchSite(object sender, EventArgs e) 
    { 
        while (q.Text != "") 
        { 
        
Response.Redirect("~/Search/SearchResultPage.aspx?cx=007276566013418379788%3Ak6lhzyopur4&cof=F
ORID%3A9&ie=UTF-8&q=" + q.Text + "&sa=Search"); 
        } 
 } 
The second search button allows a user to search the ALSoD database for specific information using the 
Google search plug-in. 
protected void SearchSite2(object sender, EventArgs e) 
    { 
        while (q2.Text != "") 
        { 
        
Response.Redirect("~/Search/SearchResultPage2.aspx?cx=007276566013418379788%3Ak6lhzyopur4&cof=
FORID%3A9&ie=UTF-8&q=" + q.Text + "&sa=Search"); 
        } 
    } 
MENU BAR 
A layout of available functions and tools can be accessed through the navigation bar and are categorized into 
menus and submenus below. Placing the mouse over each element displays more information about each 
menu as a tooltip and a dropdown submenu for more options. 
Home - http://alsod.iop.kcl.ac.uk/Index.aspx 
Analysis 
Side-by-side comparison - http://alsod.iop.kcl.ac.uk/Statistics/statistics.aspx 
Interactions - http://alsod.iop.kcl.ac.uk/overview/interaction.aspx 
Summary report - http://alsod.iop.kcl.ac.uk/Statistics/report.aspx 
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Detailed analysis - http://alsod.iop.kcl.ac.uk/Statistics/analysis.aspx 
Summary 
Search - http://alsod.iop.kcl.ac.uk/Summary/summary.aspx 
Summary - http://alsod.iop.kcl.ac.uk/index7.aspx 
GWAS 
GWAS - http://alsod.iop.kcl.ac.uk/GWA2/index.aspx 
Help! - http://alsod.iop.kcl.ac.uk/misc/analysiserror.aspx 
News - http://alsod.iop.kcl.ac.uk/Search/searchWeb.aspx 
Data 
Mutation - http://alsod.iop.kcl.ac.uk/misc/dataDownload.aspx#C1 
Patient- http://alsod.iop.kcl.ac.uk/misc/dataDownload.aspx#C2 
Contributors 
Laboratories - http://alsod.iop.kcl.ac.uk/misc/labs.aspx 
Contributors - http://alsod.iop.kcl.ac.uk/misc/contributors.aspx 
Feedback 
Contact/Cite us - http://alsod.iop.kcl.ac.uk/contact/contact.aspx 
Visitors Statistics - http://alsod.iop.kcl.ac.uk/charts/index.aspx 
FAQs - http://alsod.iop.kcl.ac.uk/misc/FAQs.aspx 
Feedback - http://alsod.iop.kcl.ac.uk/contact/guestbook.aspx 





The first section here is the chromosomal overview of all the genes available on the database. For example, to 
check for all the ALS-related genes in chromosome 9, click on 9 and a list of genes (C9orf72, VCP, SUSD1, 
ALAD, SETX) with arrows pointing to the location on chromosome 9 are displayed.  Click on any of the linked 
genes and an overview page showing information for the gene is displayed. 
Section 1 Section 2 Section 3 Section 4 
Figure 49: Masterpage Left section 
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Figure 50: Chromosomal overview of chr 9 
The image of the 23 chromosomes were searched and chosen online. In powerpoint application, the images 
were inserted on the worksheet with arrows pointing to corresponding locations on the chromosome. This 
indicates where the ALS gene is situated and each chromosome with the image, arrows and gene symbol are 
grouped and stored as an image bearing the name of the chromosome for the purpose of organising the files 
properly. 
Imagemap function as described previously is used to link the gene symbols to the overview page of that 
particular gene. 
<asp:ImageMap ID="Image1" ImageUrl="~/Chromosomes/chromo9genes.png" runat="server" 
HotSpotMode="Navigate"> 
                    <asp:RectangleHotSpot AlternateText="C9orf72" Left="285" Top="84" Right="371" Bottom="96" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=C9orf72"/> 
                    <asp:RectangleHotSpot AlternateText="VCP" Left="289" Top="130" Right="326" Bottom="145" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=VCP"/> 
                    <asp:RectangleHotSpot AlternateText="SUSD1" Left="288" Top="379" Right="345" Bottom="392" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=SUSD1"/> 
                    <asp:RectangleHotSpot AlternateText="ALAD" Left="289" Top="416" Right="333" Bottom="427" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=ALAD"/> 
                    <asp:RectangleHotSpot AlternateText="SETX" Left="289" Top="458" Right="336" Bottom="475" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=SETX"/> 
 </asp:ImageMap> 
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The second section showing “ALSoD is a joint project of World Federation of Neurology and European 
Network to Cure ALS”. The work leading to these results has received funding from the European 
Community’s Health Seventh Framework Programme FP7/2007-2013 under grant agreement number 
259867.” and the hyperlinked logos of WFN and ENCALS are visible on the website. 
The third section displays an image of the funders of ALSoD which are ALSA and MNDA. 
The final section shows a list of labels which are the number of times the website has been visited, the number 
of unique users since the monitoring code was developed in 2009, where the user of the website is accessing 
the website from and the last time the website was updated as seen in the flowchart in Figure 51.   
 
Figure 51: Flowchart for monitoring visitors 
              
It appears on the website in form of labels whose texts are derived from a database query in real time. 
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6.3.3.2.5 Contentholder 
This is the ContentPlaceHolder section where the content of a webpage is displayed within the content tag: 
<asp:Content ID="Content1" ContentPlaceHolderID="ContentPlaceHolder1" Runat="Server"> 
</asp:Content> 
6.3.3.2.6 Hidden codes (behind the scene) 
These are codes in form of scripts for example, tracking IP addresses, search tools, mobile device detection 
and social media  widgets on masterpage described beow: 
6.3.3.2.6.1 Mobile detection 
void CheckBrowserCaps() 
    { 
        //String labelText = ""; 
        System.Web.HttpBrowserCapabilities myBrowserCaps = Request.Browser; 
        if (((System.Web.Configuration.HttpCapabilitiesBase)myBrowserCaps).IsMobileDevice) 
        { 
            //labelText = "Browser is a mobile device."; 
            Response.Redirect("~/Mobile/index.aspx"); 
        } 
        else 
        { 
            //labelText = "Browser is not a mobile device."; 
            Response.Redirect("index1.aspx"); 
        } 
 
        //Label1.Text = labelText; 




string strUserAgent = Request.UserAgent.ToString().ToLower(); 
if (strUserAgent != null) 
{ 
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 if (Request.Browser.IsMobileDevice == true || strUserAgent.Contains("iphone") || 
         strUserAgent.Contains("blackberry") || strUserAgent.Contains("mobile") ||     
           strUserAgent.Contains("windows ce") || strUserAgent.Contains("opera mini") || 
              strUserAgent.Contains("palm") || strUserAgent.Contains("android") 
  || strUserAgent.Contains("samsung") || strUserAgent.Contains("nokia")) 
 { 




6.3.3.2.6.2 Track visitors 
Appendix 14 displays the script for tracking users of the website by recording the IP address of the user on the 
database and analysing the location of the user. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
6.3.3.2.6.3 Search 
To search for specific ALS terms in Google Search application 
protected void SearchSite(object sender, EventArgs e) 
    { 
        while (q.Text != "") 
        { 
        
Response.Redirect("~/Search/SearchResultPage.aspx?cx=007276566013418379788%3Ak6lhzyopur4&cof=F
ORID%3A9&ie=UTF-8&q=" + q.Text + "&sa=Search"); 
        } 
 } 
To search for specific keywords in ALSoD database using Google Search plugin 
protected void SearchSite2(object sender, EventArgs e) 
    { 
        while (q2.Text != "") 
        { 
        
Response.Redirect("~/Search/SearchResultPage2.aspx?cx=007276566013418379788%3Ak6lhzyopur4&cof=
FORID%3A9&ie=UTF-8&q=" + q.Text + "&sa=Search"); 
        } 
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    } 
 
6.3.3.2.6.4 Social Media 
Using Like button of facebook as one of the ways of monitoring the relevance of the database to users, It 
allows a form of feedback and approval by users who recommend the website to a ‘friend’ connected to their 
facebook profile. It also helps to create awareness of this database to the world. 
<div id="fb-root"></div> 
<script>    (function(d, s, id) { 
        var js, fjs = d.getElementsByTagName(s)[0]; 
        if (d.getElementById(id)) return; 
        js = d.createElement(s); js.id = id; 
        js.src = "//connect.facebook.net/en_GB/all.js#xfbml=1"; 
        fjs.parentNode.insertBefore(js, fjs); 
    } (document, 'script', 'facebook-jssdk')); 
</script> 
 
6.3.3.3  Homepage – An overview of all genes in ALS with chromosomal view 
1.1) This section shows a list of all the available genes discovered to date arranged alphabetically with the 
total number of the genes also displayed. There are 5 sortable columns: View Details, Locus, Gene, Gene 
name and Chromosome (as shown above in Figure 44) 
1.3) To view the available information on a gene like FUS, scroll down to locate the FUS gene name, click on 
SELECT and it navigates to the gene overview page of key published studies for ALS. 
1.4) Five sections displayed particularly for the gene are Brief information, graphical representation of genetic 
data, bioinformatics links, key publications and genetic variations. 
1.5) Brief information shown are the Gene symbol, Other names, Gene name, Gene inheritance category 
(FALS, SALS, FALS found in SALS or Phenotype-modifying genes), Category, Chromosome, Background, 
Result, Total Mutations, Total affected patients recorded on the database.  
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1.6) Graphical representation showing a box plot on Age of Onset and 3 pie charts on Site of Onset 
(Limb/Bulbar ratio),  Gender proportion (Male/Female ratio) and Inheritance type (FALS/SALS ratio). A single 
row tabular summary of the graphical representation is also displayed. 
1.7) Bioinformatics links to freely available scientific websites (HGNC [525], Entrez Gene [526], UCSC 
Browser [527], Protein Structure[528], OMIM [529, 530], Genecards[531], ProtScale [532], KEGG [533], 
Uniprot [534], iHop [535],  Pathway in KEGG [533], GeneTest [536], AmiGO [537], Ensembl [538], NCBI [480] 
, Life Science DB (Japan) [485], ALSGene [539]) and non-scientific knowledge-based websites (GeneWiki 
[540], WolframAlpha [541], Free online access to the Wolfram|Alpha computational knowledge engine Free 
online access to the Wolfram|Alpha computational knowledge engine Free online access to the Wolfram|Alpha 
computational knowledge engineWikiGenes [542]). 
 
1.8) Key publications are displayed with 4 sortable columns showing the total number. The linkable first author 
connected to the Pubmed abstract on the NCBI website, the year of publication, title of the publication and a 
link to the full paper (where available). 
1.9) Animal models section displays images as hyperlinks to details of animals that have been used for 
research in ALS. It links to information about chromosomal position, genomic coordinates, biological name, 
key publications with reference to pubmed and links to other animal model bioinformatics databases like 
Entrez Gene, UCSC Browser, Find a mice, OMIM and KEGG. The MGI id is used mainly as a key to integrate 
information from these databases into ALSoD. 
 
1.10) Genetic variation section displays a 7-column sortable table on the Single Nucleotide 
Polymorphism(SNP id), basepair position, pvalue, first author, year, term and  paper title. 
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6.3.3.4  Analysis webpage – Statistical analysis of mutation and patient data submitted to ALSoD from 
published and unpublished sources 
 
Figure 52: Analysis menu 
2.1.) There are currently five web pages under the analysis menu: Detailed analysis, Interactions, Side-by-side 
comparison, Predict pathogenicity and Gene credibility. 
2.2.) Clicking on the Detailed analysis submenu, an automatically populated checkbox list of genes with 
patient data, two dropdownlists on age of onset range (in years) from 0 to 100 and radiobuttons for further 
selections on gender, inheritance type and site of onset. 
 
Figure 53: Detailed Analysis submenu 
For example, a user wants to find out a summary detail on 3 genes TARDBP, FUS and ANG for patients with 
age of onset between 40 and 60. Check the boxes of the 3 genes, select 40 from the first dropdownlist and 60 
from the second dropdownlist. Leave the default checkbox checked to view all selections. Once all the 
selections required have been done, the query is executed by clicking on the ANALYSE button. Pie charts of 
Gender ratio, Family ratio and Site of Onset ratio; a column chart of the mean age of onset for the 3 selected 
genes; a box plot of the mean age of onset, a doughnut chart of the country ratio where the affected patients 
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come from on the globe; and 2 tables showing specific and cumulative figures on the selected genes. Where a 
mistake has been made or a new set of selections is required, the RESET button needs to be clicked. 
2.3.) Clicking on the Interactions submenu, a checkboxlist of all available genes in ALS are displayed. A group 
of checkboxes dynamically derived from the gene table is displayed to allow users select as many gene 
interactions they would like to analyse. Once the genes are selected, the list is presented as confirmation. The 
“Execute” link is clicked to display the prediction on the same page. If the “Reset” link is clicked, all the 
selected boxes are automatically deselected and the graphical analysis is cleared to allow for fresh analysis. 
GeneMANIA is a free public resource that offers a simple, intuitive web interface that shows the relationships 
between genes in a list and analyzes and extends the list to include other related genes. It currently Indexes 
1,256 association networks containing 357,605,768 interactions mapped to 134,871 genes from 6 organisms. 
Its flexibility and user-friendliness allows users to interact with the web interface through ALSoD stating 
weights as the predictive value [509].  
 
 
Figure 54: Interaction submenu 
2.4.) Clicking on the Side-by-side submenu, runs a query analysis on genetic data displaying 4 dropdownlists 
to select any two genes and the age range of patients. A side-by-side comparison of mutation and patient data 
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on two selected genes is submitted to the database. The query is analysed and displayed graphically on the 
website automatically in a split of a second. It shows the site of onset, mean age using box plot, gender, family 
history, nationalities of patients and other joint analysis of both genes. 
 
 
Figure 55: Side by side comparison submenu 
2.5.) Clicking on the Predict pathogenicity submenu, a list of genes are automatically pooled from the 
database based on the availability of genes with at least a substitution mutation. 
 
Figure 56: Pathogenicity prediction submenu 
Once the gene is selected, a filtered list of mutations for the gene is displayed in the second dropdown list. 
Two tables could appear on the same page if there are patient data available for that mutation else one table 
appears.  For example, a user wishes to know if an A4V mutation in SOD1 is pathogenic or not. Select the 
SOD1 gene and the A4V mutation. A single row table displays and combines predictions from 3 freely 
available online bioinformatics tools: PANTHER, PolyPhen and SIFT. The Pathogenic result is determined by 
combining the predictions of each tool and rating them in binary form. The result column allows a ‘Yes’ 
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prediction if at least one of the bioinformatics tools gives a positive prediction ‘1’ else it is ‘No’. In this case, a 
‘Yes’ means that A4V is pathogenic. A tabular list of patients affected with the A4V mutation from replicated 
studies with references to publications are displayed also. Clicking on the VIEW CHARTS button shows. Pie 
charts of Gender ratio, Family ratio and Site of Onset ratio; a column chart of the mean age of onset for the 
selected mutation; a box plot of the mean age of onset, a doughnut chart of the country ratio where the 
affected patients originates from or lives are displayed. 
2.6.) Clicking on the Gene credibility submenu, 11 checkboxes appear as user-configurable criteria.  
 
Figure 57: Credibility score analysis submenu 
For example, a user needs to know the top 5 genes based on the number of pathogenic mutations and the 
number of countries mutations are found. The number of patients recorded and the number of mutations in a 
gene are selected by default and so it is greyed out. The user selects Rank_Pathogenicity and  
Rank_Populations checkboxes and clicks on the ANALYSE button. All the 14 FALS genes are ranked 
accordingly. The second section showing the details of the ranked credibility data are displayed on the same 
page. The user is able to click on ‘NUMBER OF PREDICTED PATHOGENIC MUTATIONS BY RANK’ to view 
the full list of pathogenic mutations and the ‘NUMBER OF UNIQUE COUNTRIES ON GENES’ to view the full 
list and total number of unique countries where patients with mutations are from. A more elaborate explanation 
on credibility analysis is given later in section 6.4. 
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6.3.3.5  Summary webpage – A cumulative report and general overview of links to sections of the 
database  
 
Figure 58: Summary menu 
3.1) Genetic data report submenu displays the summary report of mutation and patient data on the database 
in 4 sections: One is a line graph of Average age of onset versus genes, a table summarizing the genetic data 
on each gene, a single row table showing the total number of patients with gender ratio, site of onset ratio and 
family ratio and finally, the top 20 most frequent mutations recorded. 
3.2) Search submenu displays 2 sections for a user to easily search the database for genes and mutations 
either by individual gene or gene effects. For example, a user wants to find out the FALS genes found in SALS 
genes and details of a certain mutation V2053M in SPG11 gene. 
Click on gene effect dropdownlist under the second section, select FALS genes found in SALS and this filters 
the gene list on the second dropdownlist. A list of all FALS genes found in SALS genes are shown. To further 
find the mutation details required, select SPG11 and this filters the list of all SPG11 mutations recorded on the 
database. Select the Val2053Met mutation, ignore the mutation type as this is not necessary for this mutation 
and click on the SUBMIT button. 
The user is taken to a different page showing the summary of the mutation and a SELECT hyperlink which 
when clicked, displays mutation details, patients with this specific mutation and administrative/institution 
details of the mutation. 
3.3) Database summary submenu displays the graphical frequency of mutations by genes and the frequency 
of patients by genes in bar charts. A second section also displays quick links to webpages like case summary, 
mutation data, patient data, data tables, last 10 mutations and patients submitted, statistics of visitors, disease 
information, literature, contributors, Frequently asked questions, useful external resource links and how to 
contact the administrators of the database. 
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For example, a researcher wishes to find out the last mutation and patient data added to the database. Click 
on cell 5 link, LAST 10 MUTATIONS & PATIENTS. Two tables are displayed and the user sees details of the 
last 10 mutations and the last 10 patients added to the database. 
6.3.3.6  GWAS webpage - Meta-analysis and on-the-fly analysis of Genome Wide Association Studies  
 
Figure 59: GWAS menu 
4.1) This webpage allows users to observe the graphical overview of all submitted GWAS results in ALS, to 
perform an on-the-fly meta-analysis of uploaded data from users, to search for a particular SNP which could 
be of interest to the researcher, to view a chromosome in UCSC genome browser, to view all GWAS 
publications, to view all complementary GWAS websites associated with ALS and a more detailed list of 
published GWAS data in ALS extracted from GWAS Catalogue [543]. 
4.2) For example, a researcher has a list of SNPs to analyse and find out how significant these SNPs are in 
relation to data available on the database. 
4.3) Apart from a username and password which is given to every user after registration, a text file containing 
the user's data is also required in the correct format.  
4.4) The correct and acceptable format for the text file is the plink format but without headings. There MUST 
be four (4) columns: CHROMOSOME, SNP, POSITION, P-VALUE. Each field or column should be seperated 
with TABs. After the P-Value, there should only be return to the next line and not another TAB. On the last 
row, the cursor must stop at the end of the P-value column. Column specification: CHROMOSOME – Integer, 
SNP - String (Alphanumeric), POSITION – Integer, P-VALUE - Float (with decimals). You can export file from 
plink but remember to edit the text file by removing the first line (heading). The text file must be with a .txt 
extension and nothing else. 
4.5) There are four simple steps to analyse your GWAS data in ALSoD Figures 60-62 
1) Upload data - to insert text file to database,  
2) Run Analysis - to run scripts,  
3) View Graph - to display chart of the combined p-values 
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4) Chromosome on UCSC Genome Browser with track codes in Appendix 29 and 30. 
 
Figure 60: Customizing UCSC tracks process 1 
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Figure 61: Customizing UCSC tracks process 2 
 
 
Figure 62: Customizing UCSC tracks process 3 
 
4.6) GWAS by Fogh 2013 submenu is a meta-analysis of 8 independent studies from the latest and largest 
genome wide association study in ALS [544]. 
4.7) The Help submenu helps the user on steps to take to analyze their data. 
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6.3.3.7  News webpage - Latest News, blogs, books and web info on ALS 
 
Figure 63: News menu 
5.1) There are 3 submenus for the News menu: Latest News, Blog and Social Media. 
5.2) The latest news displays current information in the press using RSS feeds. It is up-to-date with 
information on genes, mutations in ALS. 
5.3) I developed a blog for users to add comments on the BlogList.aspx web page and for comments to be 
viewed on the BlogEntry.aspx web page. The title of a discussion, the content of the discussion, the name of 
user posting the comment which are filled in a form are viewed. The date and time of submitting a comment 
are automatically included. 
The data set and structure are stored and retrieved from an XML file having four columns: Name, Time, Title 
and Blog [545]. Once the blog form is submitted, a new blog is updated into the XML file immediately and 
appears on the blog page. 
5.4) A social media page in 2 columns with one column for facebook and the other for twitter. 
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6.3.3.8  Data webpage – All mutation and patient data available for download 
 
Figure 64: Data menu 
6.1) The data access page shows in tabular formats full lists of all mutation and patient data submitted to 
ALSoD. A very useful feature is the download button ‘HERE’. For example, a user wants to have the list of all 
mutation data on the database to find out if the mutations found in their laboratory has been previously 
discovered with reference. 
6.2) Click on the download button on the mutation list section, a file download window pops up asking to either 
open or save or cancel the spreadsheet file. 
6.3) An excel list of the Mutation name, Mutation code, Gene, Type, Original Amino acid, Mutated Amino Acid, 
Codon and mutant structure as seen on the webpage. 
6.4) The mutant structure column has a SELECT hyperlink to an external database, www.bioinf.org.uk (Dr. 
Andrew C.R. Martin's Group) at UCL. This link is only partly developed for the SOD1 gene which was the initial 
focus of the database. 
6.3.3.9  Contributors webpage - Names of institutions around the world collaborating with the ALSoD 
team on data submission 
 
Figure 65: Contributors menu 
7.1) Laboratories submenu displays a table of 7-columns ( Laboratory, Address, Country, Expert, Email, 
Profile, Lab details). This shows a list of some major laboratories where ALS researchers conduct experiments 
and generate massive data. 
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7.2) Contributors submenu lists the names of institutions where researchers who have submitted data to 
ALSoD are based. 
7.3) Resources submenu shows the hyperlinked logos of websites that have collaborations with ALSoD. 
ALSGene [539], ALS mutation database , HGMD[546], Uniprot[547], FALS Connect, PANTHER[548], 
SIFT[549], PolyPhen[550], PubMed, Google scholar and Jalview[551]. 
6.3.3.10  Feedback webpage – Interacting with users of the database 
 
Figure 66: Feedback menu 
8.1) Contact and Cite us submenu gives a brief description of where and whom to send queries, comments or 
suggestions to. It also describes the various versions and links to publications of ALSoD. 
8.2) Visitors Statistics submenu shows a map of the world and the frequency of visits by visitors from different 
parts of the world. The second graph shows a column chart of country by frequency statistics since 3rd 
January 2009 (when the database table for the page was developed) and the total number of countries. The 
third graph is also a column chart of the webpages visited by the frequency of visitors. The fourth graph shows 
the number of unique users who have visited the website while the fifth graph shows the column chart of 
country by frequency of visitors who visited the website a day before. A daily visit scatter chart is the sixth 
graph while the last section on the page displays hyperlinks to where the ALSoD website has been mentioned 
online through Google search script embedded on the webpage. This helps the administrators to establish the 
usefulness of the website. 
8.3) FAQs submenu displays top 15 frequently asked questions by users of the database. 
8.4) Feedback submenu is a guestbook for visitors to fill-in some information and their candid comments. To 
avoid injection of automatic spams into the database by hackers, a recaptcha tool which brings up two random 
words required before a comment can be submitted. 
8.5) Survey submenu displays the latest survey conducted by the ALSoD team. 
 - 173 - 
8.) Feedback webpage – Interacting with users of the database 
6.3.4 On-the-fly Meta-Analysis of Genome Wide Association Studies in ALS 
6.3.4.1 Description of data 
From a recent study in 2010 by Shatunov [403], we got data of a total of 288,357 SNPs used for genome wide 
analysis screened in a set of 1,821 sporadic ALS cases and 2,258 controls from the U.S. and Europe. 
Datasets each containing Chromosome, SNP, Base Pair, Amino Acid1, Frequency_in_Affected, 
Frequency_in_Unaffected, Amino Acid2, Chi-square, P-Value and Odd Ratio were acquired from five different 
sources. These sources are National Institute of Health (USA), France, Holland, United Kingdom and  Boston 
were combined for meta-analysis as seen in Table 5.  
6.3.4.2 Flowchart of GWAS on ALSoD 
At the time of developing this section of ALSoD, a paper was published on protecting the confidentiality of 
patient data in publications [524]. I therefore had to put some features in place to safeguard the identity of 
patients whose data are included on the database. One of the features was to allow only researchers who 
login with their username and password to view the data. So, the flowchart of using GWAS on ALSoD is seen 
below in Figure 67. 
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Figure 67: GWAS flowchart 
 
6.3.4.3 Meta-Analysis 
The ALSoD database schema was restructured, table designs were changed, queries were rewritten and 
appropriate stored procedures were implemented to allow room for expansion. 
The available methods of testing for differential gene expression are not as hopeful as combining p values. 
Also, the combined p method is above all appropriate as a problem-solving tool for exploratory analysis of 
microarray data and for combining scores of a biological sequence (DNA or protein).    P-Values of datasets 
were combined using the Fisher’s method by clicking on the ‘Fisher Combine P-Values’ button in Haploview. 
That is, using the traditional chi-square test, If there are ‘x' independent measurements, the resulting p-values 
will be independent and then the sum of x such p-values as (-2log p1) + (-2log p2) + . . . . . . . . + (-2log px) will 
follow chi-square distribution with 2x degree of freedom.7 
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I plotted an X-Y axis graph where the X axis is for chromosomes and the Y axis is –log10 scale of the 
combined P-Values. This is saved and used to verify the dynamically generated graph as seen in Figure 1. I 
later exported the PLINK format result data to text files. These text files were inserted into the SQL database 
using a bulk-insert stored procedure. 
6.3.4.4 GWAS tables 
The steps below will show how the tables and views used for the genome wide association data analysis were 
derived. 
Five text files of rows and columns separated by tabs were copied on a USB stick from my supervisor. These 
files are for UK, Boston, Holland, NIH and France.  
These individual files were stored in a newly created folder on the web server called ‘DataSets’. The first row 
containing the headers was removed and the filename was changed to avoid conflict. An example of a boston 
text file named assoc_bos.txt (with header) was changed to bos_result_assoc.txt (without header) and stored 
in \\vm3\Alsod\DataSets\bos\bos_result_assoc.txt as shown below: 
 
Figure 68: GWAS text file stored on SQL database 
On SQL database, a table for boston data was created and called GWA_BOS as shown: 
CREATE TABLE dbo.[GWA_BOS]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
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 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
 
The text file was uploaded into the GWA_BOS table using the ‘BULK INSERT’ function: 
BULK INSERT dbo.[GWA_BOS] 
FROM '\\vm3\Alsod\DataSets\bos\bos_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




The steps above are repeated for GWA_UK, GWA_FRA, GWA_HOL and GWA_USA using 
uk_result_assoc.txt, fra_result_assoc.txt, hol_result_assoc.txt and usa_result_assoc.txt as text files 
respectively. 
The GWA_NOKEY is the single table created to house all five individual population text files by uploading the 
files one at a time into the same table as shown in Appendix 15. 
I took note of the number of rows uploaded each time a population text file was uploaded to GWA_NOKEY 
table and this table was modified using the ‘ALTER TABLE’ function as shown in Appendix 16. 
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Figure 69: Genome Wide Association Study webpage 
A user is taken to the page above where 4 tasks could be carried out as seen in Figure 69. 
6.3.4.5 Whole Genome 
For a graphical overview of all submitted genome wide results in ALS click on ‘Whole Genome’ button 
A list of checkboxes for 5 populations (UK, Boston, Holland, France, NIH) are displayed on the screen. A user 
is asked to select population(s) to view graph and click the submit button as shown below in Figure 70. 
 
Figure 70: Whole Genome analysis 
6.3.4.5.1.1 Populations and combinations 
The database table ‘GWA_NOKEY’ –already described above -  contains 1,420,350  rows on the VM3 server 
and it takes 46 seconds to retrieve the table as seen below in the yellow status bar: 
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Figure 71: GWA_NOKEY table 
This GWA_NOKEY table contains all the genome wide data for the 5 populations and POP column 
distinguishes the name of the population where: 
UK is United kingdom 
BOSTON is Boston 
HOLLAND is Netherlands 
FRANCE is France 
NIH is National Institutes of Health in USA 
GWA_NOKEY is queried using: 
SqlDataSource2 = “SELECT DISTINCT [POP] FROM dbo.[GWA_NOKEY]” 
A list of checkboxes are displayed according to the generated number of populations in the database using 
<asp:CheckBoxList ID="CheckBoxList1" runat="server" DataSourceID="SqlDataSource2" 
DataTextField="POP" DataValueField="POP" RepeatColumns="5" RepeatDirection="Horizontal" 
CellSpacing="5" OnSelectedIndexChanged="viewChart_Click" /> 
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To concatenate the selected values of the checkboxes I used: 
 For Each item As ListItem In CheckBoxList1.Items 
                        If (item.Selected = "true") Then 
                 Label3.Text += item.Text 
              End If 
         Next 
With n populations, the possible combinations in r ways are derived using the formula: 
Equation 1 : Combination formula 
 
To choose 5 combinations out of 5 countries is 5!/ (5-5)!5! = 1/1 = 1 
To choose 4 combinations out of 5 countries is 5!/ (5-4)!4! = 5/1 = 5 
To choose 3 combinations out of 5 countries is 5!/ (5-3)!3! = 20/2 = 10 
To choose 2 combinations out of 5 countries is 5!/ (5-2)!2! = 20/2 = 10 
To choose 1 combination out of 5 countries is 5!/ (5-1)!1! = 5/1 = 5 
Total = 1 + 5 + 10 + 10 + 5 = 31 possible combinations 
Meanwhile, I downloaded the haploview.jar software on the primary drive of my machine. This software 
enabled me to combine the 5 populations into 31 combinations of tables and to plot graphs. 
6.3.4.5.1.2 Haploview-generated result 
A program called ‘Haploview’ developed in the lab of Mark Daly at the Broad Institute of MIT and Harvard was 
designed to analyze association study tasks on HapMap data,  choosing tag-SNPs, evaluate the value of 
genotype data for a disease, investigate for association, and evaluate the area of a chromosome with a 
positive association. [552, 553] 
Using Haploview software downloaded from http://www.broad.mit.edu/mpg/haploview/ on my PC, an image 
was generated and coded on the webpage  http://alsod.iop.kcl.ac.uk/GWA2/whole.aspx. Steps below were 
used to generate the haploview image. 
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6.3.4.5.1.2.1 Installing Haploview software 
From the Broad Institute website, I followed the instruction by installing Java software on my computer first by 
clicking on ‘download Java’ and the process continued. 
 
Figure 72: Downloading java software 
I Installed haploview.jar file on a preferred location (desktop) on my machine. Haploview opens directly using 
java if java is installed first else, it would ask the user how the file should be opened if there is no java on their 
machine. 
6.3.4.5.1.2.2 Uploading data on Haploview 
Double-click on haploview.jar file and a welcome screen comes up as shown in Figure 73. 
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Figure 73: Haploview interface 
 
The PLINK format embedded in the Haploview software (http://www.broadinstitute.org/mpg/haploview) was 
used to combine the data into groups by identifying the common SNPs from various combinations of datasets 
in an organized manner starting with the Holland population as seen in Table 5: GWAS of 5 populations 
below. 
If combining two populations, open the bigger text file first and then the smaller one e.g to combine UK and 
Boston, open the Boston file first as it has 20,360KB size while UK is uploaded next. 
Table 5: GWAS of 5 populations 
S/N Abbreviation Population File size (KB) No of rows 
1 UK United Kingdom 19,873 275,619 
2 BOSTON Boston 20,360 282,448 
3 HOLLAND Netherlands 20,767 288,136 
4 FRANCE France 20,650 286,507 
5 NIH United States 20,734 287,640 
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Use the ‘Load Additional Results’ button to add more data until the 5 populations are included. The order of 
data upload is Holland, NIH, France, Boston, UK. 
 
 
6.3.4.5.1.2.3 Attaching image to webpage 
The possible graphs of 31 combinations were plotted and saved on the database with their corresponding 
names as seen in Appendix 25. 
The image is attached to the webpage using: 
<asp:Image ID="Image4" runat="server" Width="750px" Height="300px" /> 
6.3.4.5.1.2.4 Code-generated result 
The generated chart is embedded on the home page as the dynamically generated version of the haploview 
static image. 
A group of radio buttons allows users to choose the p-value threshold from >=2 to >=5 
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 <asp:RadioButtonList ID="RadioButtonList1" runat="server" Height="95px" Width="67px" RepeatColumns="1" 
CellSpacing="5" RepeatDirection="Vertical"                     OnSelectedIndexChanged="viewChart_Click"> 
   <asp:ListItem Value="0"> >=2</asp:ListItem> 
   <asp:ListItem Selected="True" Value="1"> >=3</asp:ListItem> 
   <asp:ListItem Value="2"> >=4</asp:ListItem> 
   <asp:ListItem Value="3"> >= 5</asp:ListItem> 
   </asp:RadioButtonList> 
A label is assigned to the selected radio button 
Label4.Text = RadioButtonList1.SelectedValue 
The Chart is configured to display –log10 p-values for the chosen population combinations. By default, the 
negative log10  p-values are set to start from 3.0 or greater 
   If Label4.Text = "0" Then  
          query = "log_ukbos >= 2" 
          Chart1.Titles.Add("GWA P-VALUES [UK, BOSTON] THRESHOLD >= 2") 
      ElseIf Label4.Text = "1" Then 
          query = "log_ukbos >= 3" 
          Chart1.Titles.Add("GWA P-VALUES [UK, BOSTON] THRESHOLD >= 3") 
      ElseIf Label4.Text = "2" Then 
          query = "log_ukbos >= 4" 
          Chart1.Titles.Add("GWA P-VALUES [UK, BOSTON] THRESHOLD >= 4") 
      ElseIf Label4.Text = "3" Then 
          query = "log_ukbos >= 5" 
          Chart1.Titles.Add("GWA P-VALUES [UK, BOSTON] THRESHOLD >= 5") 
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End If 
X- and Y-axis values of the chart are derived from the database depending on the population(s) selected. 
Using the UK and Boston example, the database query reads: 
"SELECT TOP (100) PERCENT chr, log_ukbos, snp FROM dbo.[GWA_UK_BOS] where " + query + " ORDER 
BY chr" 
I attached the X and Y values to the chart area for each of the 31 combinations: 
Chart1.Series("Gwa").XValueMember = "snp" 
   Chart1.Series("Gwa").YValueMembers = "neglogpval" 
6.3.4.5.2 On-the-fly Analysis 
Stored procedures were written to clear old tables from the database used for analysis by a previous user, to 
verify the format of the user’s data and to upload it to the database as a new table. 
I then wrote some T-Sql queries to compare the existing tables with the newly created table made up of the 




The Y axis (negative log of the new P value) is plotted against the chromosomes on the X axis. 
A chi-squared distribution dialogue box is also included in the tool for verifying the chi-square and natural log 
values where the cumulative p value and the degree of freedom are known as seen above. 
6.3.4.5.3 Search for SNP id 
The search button links to a webpage http://alsod.iop.kcl.ac.uk/GWA2/gwa.aspx. A SNP id is typed into the 
textbox e.g. rs1025542 and displays a table with the population, p-value and the combined p-value; a non-
clickable static graph generated from haploview, a clickable dynamic graph generated in realtime, the 
graphical position of the SNP on the chromosome and it’s base pair location. Codes are in Appendix 31. 
P Value = Chi-sq [{(-2log p1) + (-2log p2) + . . . . . . . . + (-2log p6)} , 12 d.f.] 
Equation 2: Fisher's method 
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6.3.4.5.4 Chromosomal view on UCSC genome browser 
On UCSC genome browser, http://genome.ucsc.edu/, I customized the dataset of 5 populations and 
embedded the web address into ALSoD website using <Iframe>. For example, using chromosome 1 dataset, 
follow the steps below: 
Step 1 – Open the UCSC web address, click on ‘Genome Browser’ menu, click on ‘add custom tracks’, add 
the track file in form of web address 
‘http://alsod.iop.kcl.ac.uk/DataSets/Tracks/resultchromo1track.txt’ to the  textbox, click 
on ‘go to genome browser’ and after a few seconds, the result is displayed as shown in Figure 74, Appendices 
29 and 30. 
 
Figure 74 : UCSC genome browser track configuration 
  
Step 2 – Dynamically analyse and embed image generated automatically on the webpage 
http://alsod.iop.kcl.ac.uk/DataSets/Tracks/chromo1.aspx. This image is hypelinked to the UCSC browser 
webpage. Below is the ASP.NET code for embedding the iframe into ALSoD. 
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<iframe id="Iframe1" name="I1" src= "http://genome.ucsc.edu/cgi-
bin/hgTracks?org=human&position=chr1&hgt.customText=http://alsod.iop.kcl.ac.uk/DataSets/Tracks/resultchr
omo1track.txt" title="Chromosome 1 SNP Track as at 1st October 2010"                                             
style="width: 80%; height: 558px;"> 
<p>Your browser does not support iframes.</p> 
      </iframe> 
6.3.4.5.5 Hyperlinks 
HuGE Navigator  - is an integrated, searchable knowledge base of genetic associations and human genome 




HGVbaseG2P v3.0 - is a comprehensive GWAS database, with powerful browser support for multi-study 
viewing and comparison.  
URL: http://www.hgvbaseg2p.org/study/HGVST127     
Published GWAS data in ALS - Data here are derived from GWAS Catalogue which is a catalogue of 
Genome-Wide Association Studies  
URL: http://www.genome.gov/gwastudies/ 
ALSGene - database will provide a comprehensive, unbiased and regularly updated field synopsis of genetic 
association studies performed in ALS.     
URL: http://www.alsgene.org/ 
6.3.4.5.6 Publications 
Research publications containing GWAS data are listed on the website e.g.  
"Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-
wide association study" Lancet Neurol. 2010 Aug 27. [Epub ahead of print] Abstract 
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Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den 
Berg LH, Robberecht W, Van Damme P, Hardiman O, Farmer AE, Lewis CM, Butler AW, Abel O, Andersen 
PM, Fogh I, Silani V, Chiò A, Traynor BJ, Melki J, Meininger V, Landers JE, McGuffin P, Glass JD, Pall H, 
Leigh PN, Hardy J, Brown RH Jr, Powell JF, Orrell RW, Morrison KE, Shaw PJ, Shaw CE, Al-Chalabi A 
Each list contains the title of the publication, a pubmed link to the abstract on NCBI website and names of 
authors. 
6.3.5 Collaborations  
Because many ALS gene variants are found in both familial and apparently sporadic ALS, a two-way link out 
to the ALSGene database provides evidence of association to complement the genotype-phenotype 
correlation available from familial ALS information in ALSoD [486]. A similar link out to fALS Connect, which is 
a collaboration between multiple interested agencies in the US, including the patient organization The ALS 
Association and the research group The Northeast ALS (NEALS) Clinical Trials Consortium, makes ALSoD 
relevant for patients and carers as well as the scientific community. The database is adopted into the Human 
Variome Project (http:// www.humanvariomeproject.org) and the GWAS Phenomap Project 
(http://www.gwascentral.org/gwasphenomap/index.php/collaborators). 
6.3.6 Embedded bioinformatics tools 
ALSoD uses third party open source bioinformatics tools to embed computational analysis within the database 
using Java applets. For example, Figure 2: A screenshot of the Multiple Alignment and Mutations on SOD1 
gene using a combination of Claustalw and Jalview [551] is used to provide multiple sequence alignments in 
other species for selected genes. GeneMANIA [509] allows users to select genes of interest for prediction of 
interactions. A Google Earth API is used for viewing maps of mutation, risk and exposure distributions. 
6.3.6.1 Claustalw and Jalview 
Other species with their sequence and multiple alignments are shown for each gene although only SOD1 is 
the updated working version available in Appendix 18. 
6.3.6.2 GeneMANIA 
This interface shows other genes that interact with this gene in humans. An algorithm of how genes were 
selected for analysis is shown in Appendix 19. 
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6.3.6.3 Google Earth API 
The Google Earth Plug-in with the use of JavaScript API allowed me to embed a 3D digital globe into the 




Figure 75 : Flowchart of Google Earth 
The codes written on the webpage embedding the Google Earth tool are in Appendix 20. 
6.3.7 Imported bioinformatics data 
Data were generated from some useful external bioinformatics sites. 
6.3.7.1 Haploview - www.broadinstitute.org/haploview 
This was used to analyse p-values of 5 populations in the Genome Wide Analysis System producing a 
colourful image of SNPs graphically plotted as scattered chart with distinct colours for each chromosome. 
6.3.7.2 PANTHER – http://www.pantherdb.org/tools/csnpScoreForm.jsp 
In the process of finding the pathogenicity of mutations, I used the website to get the subPSEC score for every 
possible mutation in a gene. 
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6.3.7.3 SIFT - http://sift.jcvi.org/www/SIFT_BLink_submit.html 
I also extracted the score from the analysis of every possible codon on a gene while finding the pathogenicity 
of mutations available on the database. 
6.3.7.4 POLYPHEN - http://genetics.bwh.harvard.edu/pph2/index.shtml 
PolyPhen-2 (Polymorphism Phenotyping v2) is a tool for predicting possible effect of an amino acid 
substitution on the structure and function of a human protein[554] . PSIC scores were analysed for each 
mutation individually to determine the pathogenicity of each mutation. 
6.3.7.5 GWAS Phenomap Project – http://www.gwascentral.org/gwasphenomap 
The GWAS PhenoMap project unifies the GWAS databasing research community to synchronize the 
phenotypic explanations used across GWAS databases with the aim of enhancing GWAS data exchange and 
analysis. 
6.3.7.6 ALS Mutation Database - 
https://reseq.lifesciencedb.jp/resequence/SearchDisease.do?targetId=1  
In 2010, an ALS mutation database constructed as part of the Life Science Integrated Database Project 
conducted by the Japan Ministry of Education, Culture, Sports, Science, and Technology was published. It 
contains their original experimental results and published data extracted from scientific journals. The database 
is expected to play a complementary role to the ALSOD database especially in collecting variations in the 
Asian region [485]. I was able to retrieve some unpublished mutation and patient data although this was done 
with caution. This database was mainly used to populate the replicated mutation table of ALSoD as the novel 
mutations are already available on ALSoD. 
6.3.7.7 ALSGene – http://www.alsgene.org  
Meta-analysis images generated by ALSGene team from SPSS were displayed on the ALSGene website and 
permission was given to display these images on ALSoD under the condition that a form of reference will be 
made to their website. These images were displayed on gene overview page of corresponding genes were 
available. 
'Shows ALSgene Forest plots available 
 - 190 - 
        If ((geneid = "APEX1") Or (geneid = "PON1") Or (geneid = "PON2") Or (geneid = "PON3") Or (geneid = 
"ANG") Or (geneid = "HFE") Or (geneid = "C9orf72") Or (geneid = "VEGFA") Or (geneid = "APOE") Or (geneid 
= "UNC13A")) Then 
            ImageMap1.Visible = "true" 
        Else 
            ImageMap1.Visible = "false" 
        End If 
<asp:ImageMap ID="ImageMap1" runat="server" Visible="false"  
            Height="358px" Width="650px"> 
<asp:RectangleHotSpot AlternateText="ALSGene: A database for amyotrophic lateral sclerosis genetic 
association studies developed by the Max Planck Institute for Molecular Genetics Berlin, the Alzheimer 
Research Forum and Prize4Life.  Last Update: 14th August 2011" Left="0" Top="0" Right="800" Bottom="506" 
NavigateUrl="http://www.alsgene.org/" Target="_blank" </asp:ImageMap> 
6.3.7.8 MGI – http://www.informatics.jax.org/marker/ 
I downloaded a text file of 164225 rows and 10 columns from Jackson’s lab into a spreadsheet. These column 
headers are: HomoloGene ID, Common Organism Name, EntrezGene ID, Mouse MGI ID, HGNC ID, OMIM 
Gene ID, Genetic Location, Genomic Coordinates (mouse: GRCm38, human: GRCh37.p10), Strand Name, 
Synonyms 
6.3.7.9 HGVS nomenclature – http://www.ncbi.nlm.nih.gov/projects/SNP/tranSNP/tranSNP.cgi 
A script written by my colleague (Simon Topp) was used to retrieve NM, NP, basepair location and rsids for 
mutations without these information on the ALSoD database. This was initiated as a way of improving the 
functionality of ALSoD and to make it more integrateable with other databases freely available online. A 
publication on genetic variations in reference databases [555] for analysing mutation data partly derived from 
ALSoD originated the idea of filling the gaps on our database so that the internationally accepted format for 
generating mutation names could be applied on the database. From their methods section it is clear, that after 
downloading the contents of ALSoD, it was necessary for them to map each variant to a genomic co-ordinate 
before they could perform their analysis. Hence the addition of genomic co-ordinates and dbSNP ids were 
generated to greatly improve the usability and functionality of ALSoD. 
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6.3.7.10 NCBI - http://www.ncbi.nlm.nih.gov 
The National Center for Biotechnology Information develops science and health by allowing freely available 
access to biomedical and genomic information online. Some of the gene ids and SNP ids with other 
information like publication documentation are extracted from here. 
6.3.7.11 HGMD - http://www.hgmd.org/ 
The Human Gene Mutation Database (HGMD®) represents an attempt to collate known (published) gene 
lesions responsible for human inherited disease. and is maintained at the Institute of Medical Genetics in 
Cardiff [474, 556]. This database was used at the initial stage of taking over ALSoD in 2008. 
6.3.7.12 1000 genome - ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20110521/ 
A perl script written by a colleague (Simon Topp PhD) was used to download and extract relevant data from 
an external database on www.100genomes.com. This was later stored on the ALSoD database using T-Sql 
scripts. 
6.3.7.13 EVS - http://evs.gs.washington.edu/EVS/ 
Here also, Exome Variant Sequence was downloaded from www.EVS.com and extracted using perl scripts. 
This was later stored on the ALSoD database using T-Sql scripts. 
6.3.8 Population Frequency from 1000genome and EVS 
A python script generated by a colleague (Kuang Lin PhD) was written and run on a text file containing 
mutations, their respective genes, basepair locations and HGVS nomenclature of the variants.  
I downloaded python software from www.python.com, installed it on my computer and navigated to it. 
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Figure 76: Navigating to Python application on desktop 
From the command line, the executable file of python was navigated to and the code file executed. The code 
is shown in Appendix 21 while I typed “C:\Python33\python.exe snp_match.py” to execute the code as seen 
below in Figure 77. 
 
Figure 77: Screenshot of executing python 
The file sent via email by my colleague was run on the command line yielding the same result as shown in 
Figure 78. 
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Figure 78: Result of running Python script 
The output file is opened in a spreadsheet to keep the data in a proper format acceptable on the database. 
Each column is separated by tabs and formatted to text. 
 
Figure 79: Screenshot of reformatting Python output in spreadsheet 
A table was created to store as a text file and uploaded to the database. 
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6.3.9 Animal Models 
Images of animals used to represent the models were extracted from Google image. These are freely 
available images which require no permission. 
Huma (Homo Sapien)   
Cattle (Bos Taurus)   
Chimpanzee (Pan troglodytes)  
Dog (Canis lupus familiaris)  
Mouse (Mus musculus)  
Rat (Rattus norvegicus)  
Rhesus monkey (Macaca mulatta)  
Zebrafish (Danio rerio)  
On Mouse Genome Informatics website on http://informatics.jax.org/, click on Download menu , click on 
Genes & Markers submenu, scroll down to Vertebrate Homology and then on HOM_AllOrganism.rpt file. 
When it opens in a browser, right click and save. 
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Figure 80: Accessing data from MGI website 
Open the saved file in a spreadsheet (Microsoft Excel). I opened Excel application first before opening the text 
file. It would not work if done the other way round.  Insert columns, add biological names, write formulae for 
the chromosomes and fill the missing rows as discussed under the Instruction manual section. Save the file as 
a text file ‘animals.txt’ 
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Figure 81: Screenshot on the process of creating Animal model table 
Open a new query on database to create a table called ‘AnimalModels’, bulk insert  the text file into the table 
as seen below: 
CREATE TABLE [dbo].[AnimalModels]( 
 [HomoloGeneID] [varchar](50) NULL, 
 [Organism_Name] [varchar](30) NOT NULL, 
 [Biological_Name] [varchar](100) NOT NULL, 
 [Kegg_id] [varchar](30) NULL, 
 [ncbi_locuslink_id] [varchar](50) NULL, 
 [gene_id] [varchar](24) NOT NULL, 
 [EntrezGene_id] [varchar](30) NOT NULL, 
 [MGI_id] [varchar](50) NULL, 
 [hgnc_id] [varchar](24) NULL, 
 [omim_id] [varchar](124) NULL, 
 [chromosome] [varchar](50) NULL, 
 [genomic_coordinates_strand] [varchar](150) NULL, 
 [genomic_chromosome] [varchar](50) NULL, 
 [genomic_location] [varchar](50) NULL, 
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 [chromosome_split] [varchar](100) NULL, 
 [genomic_range] [varchar](50) NULL, 
 [strand] [text] NULL, 
 [gene_name] [varchar](1024) NULL, 
 [Synonyms] [text] NULL) 
GO 
 
BULK INSERT dbo.[AnimalModels] 
FROM '\\vm3\Alsod\DataSets\Animalmodels\animals.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[AnimalModels] 
ADD [ID] [int] IDENTITY(1,1) NOT NULL; 
GO 
 
6.3.10 Integrated Bioinformatics links 
To avoid bias, users can retrieve broad information specific to the genes through external links which have 
been programmed automatically for each gene. Unique identifiers are utilized by systematically linking to 
broad databases and bioinformatics tools freely available online. Apart from links itemised below, ids were 
also derived from HGNC [525]. External links open in new windows and some of these bioinformatics tools are 
integrated into ALSoD using data from our database to create analysis. These links are categorised into three 
headings: 
6.3.10.1 SCIENTIFIC 
The scientific category is a list of hyperlinks associated with databases created by researchers for 
researchers. 
Entrez Gene [526] – An NCBI information database centred on genes. 
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UCSC Browser [527] – Genome browser database by The University of California Santa Cruz for visualizing 
and querying data speedily at http://genome.ucsc.edu 
Protein Structure[528] – Protein Domain and structure information as displayed on the UCSC Website 
OMIM [529, 530] – It shows extensive information from the Online Mendelian Inheritance in Man database 
updated –though not regularly- by the research community. 
Genecards[531] – These also show users an overview of gene information curated for research purpose. 
Full Literature – This displays the result of a pubmed query e.g. for SOD1 gene, “SOD1[All Fields] AND 
amyotrophic lateral sclerosis/genetics[mh] AND motor neuron disease/genetics[mh] AND "humans"[MeSH 
Terms] AND english[la]” 
ProtScale [532] – Links to an external website programmed to automatically use the uniprot identifier for the 
selected gene. This enables a computation and representation of the profile generated by an amino acid scale 
on the chosen protein. 
KEGG [533] – shows the AA and NT sequence from the KEGG database to save valuable time spent by 
researchers in searching for sequences of specific genes online. 
Uniprot [534] - The UniProt consortium provides access to the multiple data sets from the Swiss Institute of 
Bioinformatics (SIB), the European Bioinformatics Institute (EBI) and the Protein Information Resource (PIR). 
iHop [535]  – Information Hyperlinked over Proteins database is a vastly connected network making human 
literature research more intuitive and efficient using a text-mining method as described in their publication. 
This is linked from ALSoD to allow researchers an unbiased list of published materials relating to the selected 
gene. 
Pathway in KEGG [533] – A KEGG pathway map of human Amyotrophic Lateral Sclerosis under the 
Neurodegenerative diseases of the Human disease section is hyperlinked from our website to display a 
pathway overview map. 
GeneTest [536] -  The GeneTests database and Web site which is hosted at NCBI displays gene reviews and 
information on laboratories and clinics related to the gene.  
ALS review – A link to the bookshelf page of NCBI displaying regularly reviewed information on ALS overview 
to enable researchers view up-to-date research in the field of ALS. 
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AmiGO [537] – A link to this free open source web application developed and kept up-to-date by the GO 
Consortium lets users query, browse and view ontology and annotation data on definite genes. 
Ensembl [538] – This displays a broad genome information system featuring an amalgamated set of genome 
annotation, databases, and other information. 
NCBI [480]  – This comprehensive database and website is linked from ALSoD showing a statistical overview 
of the dataset across its network of databases e.g. for ANG gene, the search query automatically coded to our 
database is “ANG HOMO ALS” displaying a total of 31 pubmed citations and abstracts. 
Life Science DB (Japan) [485] – ALS mutation database developed in 2010 was constructed as part of the 
Life Science Integrated Database Project conducted by the Japan Ministry of Education, Culture, Sports, 
Science, and Technology was published. It contains their original experimental results and published data 
extracted from scientific journals. The database is expected to play a complementary role to the ALSoD 
database especially in collecting variations in the Asian region. A link to this website allows a wider 
perspective of mutations available in ALS without geographical bias. 
http://reseq.lifesciencedb.jp/resequence/GeneDetail.do?targetId=1&geneId=EG6647 
ALSGene  [539] – “ALSGene freely available on http://www.alsgene.org aims to serve as an exhaustive, 
unbiased, and regularly updated resource of genetic association studies in ALS. One of its key features will be 
up-to-date meta-analyses of all eligible genetic polymorphisms that have been investigated for association 
with ALS risk”. 
Gen2Phen [557, 558] – Gen2Phen project is focussed on combining genetic variation databases of human 
and model organism by giving a complete view of Genotype-To-Phenotype (G2P) data. 
Orphanet [559, 560] – This is an initiative in Europe aimed at improving the treatment and management of 
rare diseases. Information on rare diseases and orphan drugs are stored on a database www.orpha.net. 
GeneNetwork [561] – This is an interactive tool which allows genetic network reconstruction without an proper 
knowledge of mathematical models. 
MGI [562, 563] – Mouse Genome Informatics database resource contains information on mouse genes and 
markers. 
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LOVD [564, 565] – This is a Leiden Open-source Variation Database developed to store gene sequence 
variation information associated with human phenotype. It hosts 3,294 gene variant databases with 199,000 
variants in 84,000 patients. 
6.3.10.2 NON-SCIENTFIC 
The non-scientific category is a list of hyperlinks associated with databases created by non-researchers for the 
public. 
GeneWiki [540] – A hyperlinked website from ALSoD presents the free encyclopaedia of a selected gene from 
Wikipedia as this affords users the opportunity of viewing impartial details which may not be seen in scientific 
write-ups. E.g. http://en.wikipedia.org/wiki/SOD1 
WolframAlpha [541] – With access to the freely available online computational knowledge engine, a link to 
the general knowledge about a gene is made available for proper understanding of a selected gene by non-
scientists visiting the website. E.g. http://www.wolframalpha.com/input/?i=SOD1 
WikiGenes [542] – A link to an active collaborative knowledge base for the life sciences has become an 
imminent scientific tool showing a references and broad information relating to psychiatry, chemical 
compound, biological context, anatomical context, associations, physical interactions, enzymatic interactions, 
regulatory relationships, high impact publications, analytical, diagnostic and therapeutic context of each gene. 
E.g. http://www.wikigenes.org/e/gene/e/6647.html 
 
6.3.10.3 IN-HOUSE  
The in-house category is a list of hyperlinks I designed within the database for easy access to details of  data 
on ALSoD. These data are analysed and represented in various forms. 
Mutations – Apart from a list of all genes available in a selected gene showing total number of mutations, 
mutation type, mutation location and a link to a brief detail of the mutations, a graphical overview of all the 
reported mutations for that gene and how they are dispersed along the codon are shown. 
Mutation Google Map – A geographical overview of mutations in a selected gene are displayed on the globe 
in the form of labelled yellow pins representing countries where the mutations have been found. Users can 
interact with these pins to show the name of the country or click the pin to display all the mutations discovered 
 - 201 - 
from the chosen country by splitting the pins into subs as seen in Figure 136. Due to software compatibility 
plug-in issues, this displays better in Internet Explorer.  
Species – Users can view a multiple alignment of gene sequences. The Claustalw [566] which is a general 
purpose multiple sequence alignment program for DNA or proteins from EBI was used to provide multiple 
alignment for species on selected genes. The results from Claustalw are displayed colourfully in Jalview [551] 
which is a multiple alignment editor.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
GeneMANIA – This was integrated into ALSoD to display predicted interactions between genes selected by 
checkboxes and passed into a the geneMANIA [509] web server framed and displayed on ALSoD website. It 
enables users to predict the interaction between genes by a few clicks on one page without going back and 
forth between websites. Due to technical difficulties, the analysis works better on Google chrome or Firefox 
web browsers than on Internet Explorer.  
6.3.11 Borrowed Diagrams 
Some images were designed either by colleagues or downloaded from the internet. These static images were 
redesigned with html codes to make them dynamic. A user can interact with the images with hyperlinks 
programmed on them which when clicked opens up detailed information. 
6.3.11.1 Chromosomes 
The image of each chromosome is imported from google image, downloaded to the PC and viewed on a 
powerpoint slide. Each gene location is mapped to the corresponding chromosome image with the gene name 
hyperlinked to its corresponding overview page on the database. 
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Figure 82: Chromosomal overview of all ALS-related genes 
6.3.11.2 SOD1 subpsec score 
The image was created to graphically display the location of the identified variants in SOD1 gene with its 
calculated subpsec score shown. 
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Figure 83: SOD1 subpsec score created in 2008 by Amy Butler 
6.3.11.3 ALS-FTD relationship 
This displays how ALS and FTD are related and compares the number of publications released on FTLD 
alone, ALS alone and ALS-FTD. 
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Figure 84: ALS-FTD relationship created in 2013 by Ashley Jones 
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6.3.12 Feedback 
Feedback is gained from users of the database in four main ways: 
6.3.12.1 Facebook 
A Facebook page for ALSoD is found on the link 
http://www.facebook.com/srch.php#!/pages/ALSoD/307667685943735  
<script>    (function(d, s, id) { 
        var js, fjs = d.getElementsByTagName(s)[0]; 
        if (d.getElementById(id)) return; 
        js = d.createElement(s); js.id = id; 
        js.src = "//connect.facebook.net/en_GB/all.js#xfbml=1"; 
        fjs.parentNode.insertBefore(js, fjs); 
    } (document, 'script', 'facebook-jssdk'));</script> 
<div class="fb-like" data-href="http://alsod.iop.kcl.ac.uk/" data-send="true" data-layout="button_count" 
data-width="100" data-show-faces="false" data-action="recommend"></div> 
6.3.12.2 Twiiter 
<a class="twitter-timeline" href="https://twitter.com/ALSoD_Database" data-widget-





6.3.12.3 Feedback page 
This is a direct feedback page on the ALSoD website where forms are embedded. Comments are publicly 
displayed and a reCAPTCHA tool displays texts readable only by human users to prevent spammers from 
infiltrating the system. A news page generates automated summaries of ALS genetics news; and surveys 
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conducted through the freely available online survey tool ‘SurveyMonkey’ are embedded in the user 
interface as shown in Appendix 11. 
6.3.12.4 Blog 
A blog built in-house was developed to communicate with users on http://alsod.iop.kcl.ac.uk/BlogList.aspx. 
The script used to run the blog is shown in Appendix 12. 
6.3.13 Tracking Visitors 
6.3.13.1 Visitors’ statistics page 
In addition, by tracking the registered country of origin of page viewing and download requests, 
accessibility of the ALSoD database to the international ALS community can be monitored directly. Codes 
have been described earlier under web design. 
6.3.13.2 Google Analytics tool 
ALSoD has a Google account and this enabled me to have access to the free-of-charge Google Analytics 
tool which is used to generate detailed statistics about a website's traffic. I logged in with my username and 
password, configured the step-by-step service in August 2012 and it keeps a daily log of activities taking 
place by users on ALSoD. 
A code generated from the Google Analytics website was inserted on the MasterPage using: 
<script type="text/javascript"> 
    var _gaq = _gaq || []; 
    _gaq.push(['_setAccount', 'UA-34155904-1']); 
    _gaq.push(['_trackPageview']); 
 
    (function() { 
        var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; 
        ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-
analytics.com/ga.js'; 
        var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); 
    })(); 
</script> 
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6.3.14 ChangeLog 
6.3.14.1 ALSOD v0.1 Beta 
First online in 1995 ALSOD (as formerly known) which was hosted at www.alsod.org  was developed to 
store genetic and clinical information and to assist researchers in identifying correlations between 
phenotype and genotype in ALS for SOD1 mutations. The data available in the database were purely for 
the SOD1 gene as this was the only available familial gene linked to ALS at the time [567]. 
6.3.14.2 ALSOD v1.0 
In 1999, the database was first fully functional and available for the research community on www.alsod.org 
6.3.14.3 ALSOD v2.0 
In 2008, about 100 different mutation points across the SOD1 sequence with corresponding clinical 
information were collated. Genetic mutations of the SOD1 protein were linked to the hypothetical 3-D 
mutant structure hosted on a University College London server developed by Andrew Martin’s team [568]. 
50 users from 17 institutions registered with ALSOD to submit ALS patient and mutation data. 97 familial 
individuals with 122 mutation data on SOD1 were stored. 
The website was relocated to http://alsod.iop.kcl.ac.uk/als in 2007 following the loss of alsod.org domain. 
Data could be downloaded freely and the database queried to look for a specific mutation type in four ALS 
genes (SOD1, ALS2, VAPB, NEFH) or for specific information on patient data. 
6.3.14.4 ALSOD v2.5 
In 2010, the database had records for 52 genes, 13 genome-wide association studies, 254 mutation data 
and 255 patient data. This required continued curation and maintenance to remain up-to-date. While I have 
automated much of this, there was still a need for human review, selection and intervention. 
6.3.14.5 ALSoD v 3.0  
ALSoD (ALS online genetics Database) is now a relational database with a massive increase in available 
data through submissions by researchers and regular update by the database curators. The schema has 
been redesigned for uncomplicated future addition of familial and sporadic ALS patient data, associated 
mutations and published ALS genes. 
6.3.14.6 ALSoD v 4.0 current structure 
The ALS Online genetics Database (formerly hosted on www.alsod.org) is currently available on 
http://alsod.iop.kcl.ac.uk providing detailed comparative analysis, gene overview, literature curation and 
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integrated bioinformatics tools. The main entry point to the database is a two-section list of all ALS-related  
genes leading to the gene overview page                                                                                                                                                                                                                                                                                                 
providing a uniform display of information about a gene. 
6.3.15 Search keyword(s) externally or internally 
On the masterpage, two search buttons are embedded to allow users search ALS keywords on other 
databases and/or within ALSoD. The first search button searches the keyword(s) typed into the textbox 
next to it in the Google search engine to produce results embedded on the webpage for viewing. The 
second search box opens a new page and searches the webpages of ALSoD website for the keyword(s) 
using Google plugin customized to search ALSoD. The result is displayed on a floating page. 
 
Figure 85: Search externally and internally 
6.3.15.1 Externally 
<td align="right"><span lang="en-gb"> 
  <asp:Button runat="server" id="sa" text="Search"         OnClick="SearchSite" style="margin-top: 
5px" Height="21px" Width="57px" /> 
     <asp:TextBox runat="server" id="q" style="margin-left: 0px; margin-right: 1px;" />  
</td> 
6.3.15.2 Internally 
<td align="right"><span lang="en-gb"> 
      <asp:Button runat="server" id="sa2" text="Search" OnClick="SearchSite2" style="margin-top: 5px" 
Height="21px" Width="57px" /> 
    <asp:TextBox runat="server" id="q2" style="margin-left: 0px; margin-right: 1px;" /> 
</td> 
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6.4 Credibility analysis of putative disease-causing genes using 
bioinformatics 
Overview of the method is graphically shown below in Figure 86. 
 
Figure 86: Overview of credibility analysis method 
6.4.1 Data collection 
Genes with at least one publication suggesting involvement in adult onset familial ALS were studied [108]. I 
excluded genes with limited clinical data, absent mutational data or unreplicated results. Publicly listed 
variants for the included genes derived from ALSGene, Uniprot, ALS Mutation and HGMD databases were 
merged with variant lists in ALSoD, and filtered for duplicates (Figure 1). 
6.4.2 Pathogenicity analysis using bioinformatic tools 
PANTHER (Protein Analysis Through Evolutionary Relationships) [548], SIFT (Sorting Intolerant From 
Tolerant) [549] and POLYPHEN (Polymorphism Phenotyping) [569] programs were used to analyse 
variants for possible pathogenicity. These tools generated a set of scores for the variants analysed, which 
for PANTHER are given as a subSPEC (substitution position-specific evolutionary conservation) score and 
for POLYPHEN given as score differences for PSIC (position-specific independent counts). In PANTHER, 
all possible mutations for each gene were generated using perl scripts and run on the web service in 
batches. SubPSEC scores <=-5.0 were defined as damaging and subPSEC scores >-5.0 defined as not 
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damaging. In SIFT, all possible unique codons in each gene were generated using perl script with scores 
<=0.05 defined as damaging and scores >0.05 defined as not damaging. In POLYPHEN, all mutations 
available in a gene on ALSoD were run through the web service one after the other and PSIC score 
differences >=1.5 defined as damaging and PSIC score differences <1.5 as not damaging.  
6.4.2.1 Write scripts to generate all possible mutations 
Using tdp43 gene as the sample gene, access the overview page of the gene using 
http://alsod.iop.kcl.ac.uk/Overview/gene.aspx?gene_id=TARDBP(TDP43). Under bioinformatics section,  
select sequence link which opens the KEGG[533] page. The process of running and combining scripts to 
generate the end result is as shown in Appendix 33                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
. 
 
Figure 87: Generating all possible gene mutation process 1 
From the KEGG page, select, copy and paste the Amino Acid sequence to an empty text file and save as 
tdp_codon.txt 
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Figure 88: Generating all possible gene mutation process 2 
Once the TDP43_codon.txt is saved, open the perl script for transposing the sequence vertically named as 
transpose_sequence.pl 
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Figure 89: Generating all possible gene mutation process 3 
The script generates a file TDP43_codon.txt.tr displaying a single column. This single column of data was 
copied from the text file to a new excel spreadsheet. This column was replicated across 20 columns as 
shown below in Figure 90. 
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Figure 90: Generating all possible gene mutation process 4 
To create 153 of the 20 amino acids ARNDCQEGHILKMFPSTWYV, run script 
repeat_twenty_amino_acids.pl to produce possibilities.txt, then run transpose_twenties.pl with infile as 
possibilities to generate possibilities.txt.tr 
To combine the three files generated, run join_column_notabs.pl script : 
 TDP43_sequence_twenties.txt.tr  +   TDP43_codon.txt.tr = result3.txt 
 result3.txt  +  possiblilities.txt.tr = result4.txt 
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Figure 91: Generating all possible gene mutation process 5 
 
6.4.2.2 PANTHER results submitted in batches 
Open result4.txt, on edit menu select goto submenu and type 1000. Select and cut the first 1000 lines 
which cuts one thousand substitutions  
On a browser, open the url to PANTHER (http://www.pantherdb.org/tools/csnpScoreForm.jsp ) and under 
the ‘Enter a protein sequence’ section, paste the amino acids for TDP43 as seen in KEGG (only in SOD1 
you paste the amino acids without the first letter M). Paste the 1000 lines of possible mutations under the 
‘Enter substitution(s)’ section. 
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Figure 92: Pathogenicity prediction in PANTHER process 1 
Wait for approximately 3mins to see the batch of analysis generated. Open the generated file known as                                                                                                                                                                                                                                                                                                                
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Figure 93: Pathogenicity prediction PANTHER process 2 
Select the next 1000 lines of possible substitutions, once result is generated, select all, copy and paste on 
a new line at the end of the pantherCsnpAnalysis.txt file 
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Figure 94: Pathogenicity prediction in PANTHER process 3 
Repeat last step until all possible substitutions have been submitted for analysis. 
 
Figure 95: Pathogenicity prediction in PANTHER process 4 
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6.4.2.3 SIFT results submitted and data extracted 
On a browser, open the url to SIFT ( http://sift.jcvi.org/www/SIFT_BLink_submit.html) and under the 
‘Protein Sequence ID’ section, type the NCBI Gi_number for TDP43 which is 49065494 (acquired from the 
NCBI website). Also, browse the filename ‘result4.txt’ and submit for analysis.  
 
Figure 96: Pathogenicity prediction in SIFT process 1 
Wait for about 2 mins and the result is generated. 
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Figure 97: Pathogenicity prediction in SIFT process 2 
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Figure 98: Pathogenicity prediction in SIFT process 3 
To prepare the generated information for a database-acceptable format, select all, copy and paste in 
Microsoft word. Under the home or edit  menu (depending on the version of MS Word used or CTRL H) 
which pos up the Replace dialogue box, under the find what section, type score of ?.?? , check the 
highlight all items found, check use wildcards. This selects all the scores generated , copy and paste in a 
new spreadsheet. Add a column of TDP43’s amino acids, a column for V replicated to the end of the row. 
Another row of function describing the result of each row is created using the following excel function: 
IF (F1<=005, “AFFECT PROTEIN FUNCTION”, “TOLERATED”) 
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Figure 99: Pathogenicity prediction in SIFT process 4 
The final spreadsheet is copied and pasted into a text file named ‘SIFT_Prediction_TDP43.txt’ 
6.4.2.4 PolyPhen results submitted one by one for existing mutations  
On a browser, open the url to PolyPhen ( http://genetics.bwh.harvard.edu/pph/) and under Query Data 
section e.g for A4V in SOD1 
Protein or SNP identifier : P00441 
Position: 5 
Substitution: AA1 is A and AA2 is V 
Query description: A4V 
Submit Query button 
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Figure 100: Pathogenicity prediction in PolyPhen process 1 
The PolyPhen server was later upgraded to PolyPhen-2 [554] version 2.2.2 on 15
th
 February 2012 to with a 
new url (http://genetics.bwh.harvard.edu/pph2/index.shtml). Processing a variant for prediction is the same 
but the scores are sometimes different. The “HumDiv” prediction was used rather than the “HumVar” 
 - 223 - 
 
Figure 101: Pathogenicity prediction in PolyPhen process 2 
The Gateway interface displaying the status of request sent to the server is shown. If an error is 
discovered, it shows a ‘view’ link under the Errors header but if a result is generated, it shows a ‘view’ link 
under the Results header. A ‘Refresh’ button can be clicked if the status of the query is not displayed on 
the screen. 
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Figure 102: Pathogenicity prediction in PolyPhen process 3 
The view link displays the report of a queried variant predicting one of three status (probably damaging, 
possibly damaging or benign) with an associated score. 
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Figure 103: Pathogenicity prediction in PolyPhen process 4 
6.4.2.5 Store data from generated analyses into database tables 
A list of prediction text files with scores and predictions using the three bioinformatics tools (PANTHER, 
SIFT and  POLYPHEN) on variants in genes are stored in a folder. 
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Figure 104: Storing data from generated analyses into database tables process 1 
T-SQL scripts are written to create tables and a ‘Bulk Insert’ function is used to import the text files into the 
tables created. Column data automatically generated from the prediction tools are separated by ‘tabs’ 
which I used my discretion to select fields that are included in the tables. 
dbo.[PANTHER_scores] table has 13 columns (subPSEC, P_deletrious, gene, mutation, codon, name, 
Accession, score, position, Pwt, Psubstituted, NIC, message) 
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Figure 105: Storing data from generated analyses into database tables process 2 
dbo.[SIFT_scores] table has 7 columns (position, codon, gene, mutation_from, mutation_to, message, 
subPSEC) 
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Figure 106: Storing data from generated analyses into database tables process 3 
dbo.[PolyPhen_scores] table has 6 columns (gene, mutation, codon, position, PSIC_score, prediction) 
 - 229 - 
 
Figure 107: Storing data from generated analyses into database tables process 4 
6.4.2.6 Query database on 3 tables for scores 
The  flowchart for querying the database is shown in Figure 108. 
 
Figure 108: Flowchart of pathogenicity prediction query 
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SELECT     TOP (100) PERCENT dbo.PANTHER_scores.gene, 
dbo.PANTHER_scores.mutation, dbo.PANTHER_scores.codon,  
                      dbo.PANTHER_scores.subPSEC AS PANTHER, 
dbo.PANTHER_scores.message AS Prediction1,  
                      dbo.POLYPHEN_scores.PSIC_score_new AS POLYPHEN, 
dbo.POLYPHEN_scores.prediction AS Prediction2, dbo.SIFT_scores.subPSEC AS SIFT,  
                      dbo.SIFT_scores.message AS Prediction3, CASE WHEN 
dbo.PANTHER_scores.message = 'Deletrious' THEN '1' ELSE '0' END AS 
Panther_rate,  
                      CASE WHEN (dbo.POLYPHEN_scores.prediction = 'Benign' OR 
                      dbo.POLYPHEN_scores.prediction = 'NA') THEN '0' ELSE '1' 
END AS Polyphen_rate,  
                      CASE WHEN dbo.SIFT_scores.message = 'AFFECT PROTEIN 
FUNCTION ' THEN '1' ELSE '0' END AS Sift_rate 
FROM         dbo.PANTHER_scores INNER JOIN 
                      dbo.POLYPHEN_scores ON dbo.PANTHER_scores.mutation = 
dbo.POLYPHEN_scores.mutation AND  
                      dbo.PANTHER_scores.gene = dbo.POLYPHEN_scores.gene INNER 
JOIN 
                      dbo.SIFT_scores ON dbo.POLYPHEN_scores.codon = 







SELECT     gene, mutation, codon, PANTHER, Prediction1, POLYPHEN, Prediction2, 
SIFT, Prediction3, Panther_rate, Polyphen_rate, Sift_rate,  
CAST(Panther_rate AS int) + CAST(Sift_rate AS int) + CAST(Polyphen_rate AS int) 
AS Result, CASE WHEN (CAST(Panther_rate AS int) + CAST(Sift_rate AS int) + 
CAST(Polyphen_rate AS int)) >= '1' THEN 'Yes' ELSE 'No' END AS Pathogenic 
FROM         [KCLAD\spngoka].Pathogenicity_Check 
 
                                                                    
SELECT     gene, COUNT(gene) AS Pathogenic 
FROM         (SELECT     gene, mutation, Panther_rate, Sift_rate, 
Polyphen_rate, Result, Pathogenic FROM          
[KCLAD\spngoka].Pathogenicity_Check_Summary 
WHERE      (Pathogenic = 'Yes')) AS derivedtbl_1 GROUP BY gene        
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
6.4.3 Data extraction from publications 
I conducted a systematic review of all publications related to ALS genetics with an exhaustive combination 
of search queries on the 15 genes mentioned above. (Review_protocol in Appendix 1, Flow_diagram in 
Appendix 6). 
In the PubMed database, I used title keywords consisting of the gene name, "mutation" and "ALS" or 
“Motor Neuron Disease”, or gene name and "novel" to identify key publications and then used the related 
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citations function to generate a list of publications for data extraction. For example, (SOD1[Title] OR 
(superoxide dismutase[Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral 
Sclerosis[Title]) OR (Motor Neuron Disease[Title]) OR ALS[Title])  yielding 181 results. These results were 
further filtered by choosing “Humans” as Species and sorted by “Recently Added” thereby displaying 160 
unique publications. From the list displayed, I also searched the “Related citations” link on the first 
publication[91] of the selected gene SOD1 yielding 204 results. 
I used Google Scholar (http://scholar.google.co.uk/) to identify publications for import into the ALSoD 
database, starting with basic search queries to generate a large number of publications. For example, 
“SOD1” gave about 28,600 results but “SOD1 novel mutations variants ALS "amyotrophic lateral sclerosis"  
"motor neuron disease"” gave 2050 results. I went through the first 20 pages containing 20 publications on 
each page and already sorted by relevance. Publications with animal models or associated with other 
diseases were excluded from the long list. A manual comparison with already discovered publications from 
pubmed was conducted and these were excluded from the list. 
Manually curated data extracted from all publications included family history, El Escorial category [35, 36] 
mutations per gene, number of cases and controls used in the studies, mutations in the same codon, 
number of patients with family history (FALS), number of patients without family history, mutations 
replicated in other studies, number of countries replicating the mutation and for linkage studies, LOD 
scores. Several genes implicated in ALS are also implicated in other diseases, including frontotemporal 
dementia, spinocerebellar ataxia and parkinsonism. To avoid the problem of non-ALS patients being 
included in the database, I restricted data curation to publications specifying ALS.  
6.4.4 Automated gene ranking 
Eleven queries stored as procedures were performed on data collated. These were: 1. The total number of 
affected patients with El Escorial defined ALS having a mutation in each gene [570]. 2. The total number of 
ALS affected patients used in each study.  This measure was used to account for sampling variance and 
power [571]. 3. The total number of healthy individuals with a mutation reported in each study. 4. The total 
number of healthy individuals used in each study. 5. The total number of mutations sharing the same 
codon. 6. The total number of variants detected in ALS patients for each gene. 7. The total number of 
mutations with positive pathogenic predictions from the use of the three bioinformatics tools described 
above. 8. The number of patients with a family history defined as at least one other affected member of the 
family. 9. The number of patients without a family history of ALS. 10. The number of times a particular 
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variation was replicated across different studies. 11. The number of unique populations where affected 
patients originated. 
6.4.4.1 Selecting criteria for analyses 
 
Figure 109: Criteria for Credibility score analysis 
The criteria are checkboxes and users are asked to click the checkboxes next to the criteria they want to 
include in the analysis.  The Rank_Patients and Rank_Mutations are automatically selected and used as 
compulsory variable to query the database. This is why they are greyed out. 
<asp:CheckBoxList ID="tables" runat="server" AutoPostBack ="false"  
  ToolTip="Select checkbox if desired as one of the criteria for analysing credibility score" RepeatColumns="3" 
RepeatDirection="Horizontal"> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_affected_patients_in_ALSoD]" Text="Rank_Patients" Enabled="false" > 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_mutations_per_gene]" Text="Rank_Mutations" Enabled="false"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_cases_recorded]" Text="Rank_Cases"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_controls_recorded]" Text="Rank_Controls"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_mutations_in_same_codon_by_rank]" Text="Rank_Codon"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_patients_with_family_history_FALS]" Text="Rank_FALS"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_patients_without_family_history_SALS]" Text="Rank_SALS"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_times_mutation_is_replicated]" Text="Rank_Replications"> 
</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_pathogenic_mutations_by_rank]" Text="Rank_Pathogenicity"> 
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</asp:ListItem> 
<asp:ListItem Value="[KCLAD\spngoka].[Number_of_unique_countries_on_genes]" Text="Rank_Populations"> 
</asp:ListItem> 
                      
</asp:CheckBoxList> 
6.4.4.2 Data display on webpage 
<h2> Details of ranked credibility data </h2> 
<br /> 
<a href="#C1">1) Number_of_affected_patients_in_ALSoD</a><br /> 
<a href="#C2">2) Number_of_mutations_per_gene</a><br /> 
<a href="#C3">3) Number_of_cases_recorded</a><br /> 
<a href="#C4">4) Number_of_predicted_pathogenic_mutations_by_rank</a><br /> 
<a href="#C5">5) Number_of_controls_recorded</a><br /> 
<a href="#C6">6) Number_of_mutations_in _same_codon_by_rank</a><br /> 
<a href="#C7">7) Number_of_patients_with_family_history_FALS</a><br /> 
<a href="#C8">8) Number_of_patients_with_no_family_history_SALS</a><br /> 
<a href="#C9">9) Number_of_times_mutation_is_replicated</a><br /> 
<a href="#C10">10) Number_of_unique_countries_on_genes</a><br /> 
     
6.4.4.3 Query generation in SQL 
For each procedure above, a query was generated using Structured Query Language (SQL) on Microsoft 
SQL Server 2008 and displayed on the ASP.NET platform webpage, ranking the gene.  
6.4.4.3.1 Number_of_affected_patients_in_ALSoD 
SELECT [Gene], [Frequency] As Patients, [Rank] FROM 
[KCLAD\spngoka].[Number_of_affected_patients_in_ALSoD] 
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Figure 110: Number of affected patients in ALSoD 
6.4.4.3.2 Number_of_mutations_per_gene 
SELECT [Gene], [Frequency] As Mutations, [Rank] FROM 
[KCLAD\spngoka].[Number_of_mutations_per_gene] 
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Figure 111: Number of mutations per gene 
6.4.4.3.3 Number_of_cases_recorded 
SELECT DISTINCT [gene], [cases], [author], [year], [pubmed_id] FROM 
[KCLAD\spngoka].[Gridview_total_cases] 
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Figure 112: Number of cases recorded 
6.4.4.3.4 Number_of_predicted_pathogenic_mutations_by_rank 
SELECT [Gene], [Total_cases_affected], [Rank] FROM [KCLAD\spngoka].[Number_of_cases_affected] 
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Figure 113: Number of predicted pathogenic mutations by rank 
6.4.4.3.5 Number_of_controls_recorded 
SELECT [Gene], [Total_controls_affected], [Rank] FROM 
[KCLAD\spngoka].[Number_of_controls_affected] 
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Figure 114: Number of controls recorded 
6.4.4.3.6 Number_of_mutations_in _same_codon_by_rank 
SELECT gene_id AS Gene, codon AS Codon, COUNT(codon) AS Frequency, DENSE_RANK() OVER 
(ORDER BY COUNT(codon) DESC) AS Rank FROM (SELECT  TOP (100) PERCENT gene_id, 
mutation_mnemonic, codon FROM  dbo.mutation  WHERE  (codon IS NOT NULL) AND (codon <> 0) 
ORDER BY codon) AS table1 GROUP BY gene_id, codon ORDER BY Gene 
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Figure 115: Number of mutations in same codon by rank 
6.4.4.3.7 Number_of_patients_with_family_history_FALS 
SELECT [Gene], [Total_family_history], [Rank] FROM 
[KCLAD\spngoka].[Number_of_patients_with_family_history_FALS] 
 
Figure 116: Number of patients with family history FALS 
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6.4.4.3.8 Number_of_patients_with_no_family_history_SALS 
SELECT [Gene], [Total_no_family_history], [Rank] FROM 
[KCLAD\spngoka].[Number_of_patients_without_family_history_SALS] 
 
Figure 117: Number of ptients with SALS 
6.4.4.3.9 Number_of_times_mutation_is_replicated 
SELECT [Gene], [Mutation], [Frequency], [Rank_Mutation] FROM 
[KCLAD\spngoka].[Gridview_Replicated_mutations] WHERE ([Frequency] >= @Frequency) 
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Figure 118: Number of times mutation is replicated 
6.4.4.3.10 Number_of_unique_countries_on_genes 
SELECT [gene_id], [country] FROM [KCLAD\spngoka].[Gridview_unique_countries] 
SELECT [Gene], [Total_Countries], [Rank] FROM 
[KCLAD\spngoka].[Number_of_unique_countries_on_genes] 
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Figure 119: Number of unique countries on genes 
6.4.4.4 Ranking criteria 
The predicted pathogenicity score for each tool was scored 1 for predicted pathogenic and 0 for predicted 
not pathogenic and then summed to generate a final score for ranking 
(http://alsod.iop.kcl.ac.uk/Statistics/pathogenicity.aspx ).  
There are two possible ways of ranking results in SQL.  
6.4.4.4.1 RANK( ) 
The default method allocates rank based on the true position, such that if two genes are given equal first 
position for example, the next gene is in third position, not second.  
6.4.4.4.2 DENSE RANK( ) 
The dense rank method allocates the next gene as second so that there are no gaps in the rank 
numbering. I used the dense ranking system. 
6.4.4.5 Testing 
I started planning on how to derive a formular to run an SQL script depending on the checked criteria. So, 
on SQL, I included all the criteria to get a lengthy script as shown in Appendix 21. 
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I later ran an SQL on two criteria (rank_mutation and rank_patient) to compare with the first step (selecting 
all criteria). The script is shown below: 
SELECT Rank_Mutations, Rank_Patients, Gene ,SUM( Rank_Mutations + Rank_Patients + 0) As 
Rank_Sum, DENSE_RANK() OVER (ORDER BY SUM( Rank_Mutations + Rank_Patients + 0) ASC) AS 
Final_Rank FROM (SELECT [KCLAD\spngoka].Number_of_mutations_per_gene.Rank As 
Rank_Mutations,[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Rank AS Rank_Patients, 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene FROM 
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD INNER JOIN 
[KCLAD\spngoka].Number_of_mutations_per_gene ON 
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Gene = 
[KCLAD\spngoka].Number_of_mutations_per_gene.Gene ) As table1 GROUP BY Rank_Mutations, 
Rank_Patients, Gene 
A formula was derived as shown below: 
SELECT All_Rank_Criteria, Gene, SUM (Total (All_Rank_Criteria)) As Rank_sum,  
DENSE_RANK() Over (ORDER BY SUM (Total(All_Rank_Criteria)ASC) AS Final_Rank 
FROM (SELECT [Table*.*.Rank As All_Rank_Criteria] FROM CONCATENATE  
(Table*.* INNER JOIN Table.Number_of_mutations_per_gene ON Table*.*.Gene= 
Table.Number_of_mutations_per_gene.Gene) As table1 GROUP BY All_Rank_Criteria, Gene 
 
Where : 
All_Rank_Criteria= Rank_Mutations, Rank_Patients, Rank_Cases, Rank_Controls, Rank_Codon, 
Rank_FALS, Rank_SALS, Rank_Replications, Rank_Pathogenicity, Rank_Populations, Gene 
SUM (Total (All_Rank_Criteria) = Rank_Mutations + Rank_Patients + Rank_Cases + Rank_Controls + 
Rank_Codon + Rank_FALS + Rank_SALS + Rank_Replications + Rank_Pathogenicity + 
Rank_Populations 
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The visibility of the labels on the website was set to false so that it would not be seen by users as shown in 
Appendix 25. 
 
6.4.5 Validation of the method 
The purpose of the credibility score tool is to generate a list of genes in order of the weight of evidence 
supporting involvement in ALS. Such a list should correlate closely with one generated by ALS genetics 
experts, since such experts should have a good working knowledge of the available evidence. We 
therefore conducted a survey of ALS genetic experts, defined as being individuals who had published as 
first or senior author on ALS genetics. 
6.4.5.1 Survey webpage 
I embedded the questionnaire as a submenu on the feedback menu of the ALSoD website. Survey filled in 
here are linked to survey monkey so that there could be a single result from the same port irrespective of 
where the survey is filled. The link is found under Feedback -> Survey with direct link to 
http://alsod.iop.kcl.ac.uk/database/gene/credibilitySurveymonkey.aspx 
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Figure 120: Survey displayed on webpage 
6.4.5.2 Surveymonkey 
Experts were surveyed using the freely available online questionnaire tool, Surveymonkey on 
http://www.surveymonkey.com/s/WRDW5WT (Figure 120). The survey link showed the genes randomly 
ordered differently every time the link was clicked to prevent bias in the responses that might occur based 
on ordering. Experts were randomly assigned to one of two groups, one in which the same rank could be 
assigned to several genes, and one in which responders were forced to rank each gene in order. The first 
group mimics the final score of the automated method closely, while the second group mimics the detail of 
the automated ranking method closely, since the automated method is forced to rank each query uniquely 
but the combined ranking could result in the same value for different genes. 
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6.4.5.2.1 Forced ranking 





 position. This type of ranking is selected while configuring the survey on the surveymonkey website. 
 
Figure 121: Forced ranking output 
6.4.5.2.2 Non-forced ranking 
The non-forced ranking group allows researchers to rank the 14 genes in the way that best suits them. So, 
more than one gene could be assigned the first position. 
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Figure 122: Non-forced ranking 
6.4.5.3 Emails 
Emails were sent to 25 randomly selected experts in the field of ALS, inviting them to take part in a short 
survey. A sample of the letter is shown in Appendix 34. 
6.4.6 User interface 
The Credibility Analysis page at (http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx) has a list of 11 
checkboxes which are the available choices of criteria a user can make. The code behind the scene for the 
checkboxes is as seen in Appendix 23. 
6.4.7 Statistical methods 
Cronbach’s Alpha was initially used and then Spearman's Rho [572-574]  was used to compare rankings 
generated by the automated method and the ALS genetics experts. We agreed that Spearman's rho is a 
valid test while Cronbach's alpha may not be the best statistic in this instance.  
6.4.7.1 Cronbach’s Alpha 
From Appendix 32, Cronbach’s Alpha was calculated using SPSS software. 
6.4.7.2 Spearman's Rho 
We considered using tau or rho since we are comparing sets of rankings. We therefore used Spearman's 
rho which is much easier to implement and is widely cited. 
 - 248 - 
6.5 Development of a smartphone app for a genetics website, ALSoD 
6.5.1 Searched online for direction 
On Google Search Engine, I engaged in an extensive search using clauses like “How to convert website to 
mobile app”, “develop mobile app”, “wrap mobile website to app”. The first page containing 25 results were 
scanned through to see the websites which were most appropriate explaining how to develop either a 
mobile website or an app. 
6.5.2 Choosing between a mobile website or an app 
Initially, the idea of accessing the website in a more usable form on mobile devices was to develop an 
application (known as an ‘app’). Due to the similarity that exists between mobile websites and apps, some 
factors that determined our choice of a mobile website over an app are Target Audience, Budget 
Availability, Purpose Intended and Features Required [520]: 
The team had to weigh the pros and cons of developing a website or an app or both. I decided to focus first 
on developing a mobile web-based platform because I wanted the content to work across all mobile 
platforms [512]. 
6.5.3 Optimization of webpage 
Using our in-house built analytic data showing the most frequently viewed information coupled with the 
Google Analytics service configured for ALSoD website, the most frequently accessed webpages are on 
the pathogenicity of mutations, gene information and data analysis of mutation and patient data. 
Google Analytics tool was configured in August 2012 to cross-check the results of visitors’ statistics built in-
house. I based the data analysis on the three months (August, September and October). These first 3 
months represented the period from when the Google Analytics tool was implemented to the point where I 
started the development of the mobile website (which will be referred to as the pre-mobile website period). 
The post-mobile website period is the second 3 months from November 2012 to January 2013 where the 
mobile website has been fully developed and an app implemented. In the pre-mobile website period, 
Pageviews (which is the total number of pages viewed) were analysed to discover the commonly visited 
pages on the website and counting repeated views of a single page. 
The blog page was also added to allow for comments from researchers and patients who make use of the 
database extensively. 
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6.5.4 Design heuristics 
Designing a mobile website that works on several platforms does not mean shrinking a complete webpage 
into a mini-size webpage. Users of mobile website have a pleasurable experience on a website when there 
are not too many tiny prints to read or they do not have to scroll left or right or they do not have to do too 
much typing. They are mostly interested in getting a quick answer by clicking once [512]. These points 
were utilized by designing a mobile website by [575]: 
Creating a Separate Style Sheet. 
Retaining some of the original images like the logo to prevent regular users of the full desktop website from 
being confused or creating an impression that they are working on a different website. 
Reducing the size of images by a standard percentage. 
Configuring the content layout of the screen to wrap texts to avoid any use of the horizontal bar. 
Summarizing the information on the desktop version to fit a smaller screen. 
 
6.5.5 Mobile Device Detection 
On the Master page which allows us to create a consistent layout for the pages in our application, I first 
used the .NET framework mobile detection property (IsMobileDevice in the Request.Browser object). To 
detect if the request comes from a mobile device the .NET Framework fortunately provides the 
isMobileDevice property which returns a true value if the browser is a recognized mobile device or vice 
versa. This did not work fully on all mobile devices because some mobile device browsers disguise 
themselves as desktop browsers [576]. 
Detecting a mobile device was eventually determined here by the use of UserAgent strings sent by the 
browser from the mobile device to the server in conjuction with the isMobileDevice property as seen in 
Figure 123 and Figure 124.  
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Figure 123: A method for redirecting to the appropriate view 
 
 
Figure 124: Overview of mobile website development 
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6.5.6 User Interface redirection 
If the UserAgent string contains words like blackberry, palm, mobile, iphone, ipad (and other words used by 
mobile devices), then the user’s device is redirected to http://alsod.iop.kcl.ac.uk/Mobile/index.aspx 
displaying a compact version of the website instead of the full version. That is, 
If 
 [(IsMobileDevice = true) AND (UserAgent = true)] then (device = mobile) 
View = “Full version” 
Else   
 (device = computer) 
 View = “Mobile version” 
6.5.7 Compact version of website 
Web address link was sent to mobile phones of users through text messages and they were encouraged to 
click the facebook ‘Recommend’ button designed into the masterpage of the mobile version. Positive 
feedback were received from all - 2 Android users, 1 Nokia user, 5 Blackberry users, 2 iphone users and 3 
ipad users. The success of the mobile version propelled us into developing an application. 
6.5.8 Choosing to develop an app 
Due to the intricacies involved in developing an app, I found out that the 5 most common smartphones to 
start developing applications for are iPhone, Blackberry, Android, Nokia98 and Windows Mobile. I decided 
to develop for Andriod since the Android market (now known as Google Play) allows an affordable fee for 
submission of apps unlike others. The market share of Android has grown and it is predicted as the most 
dominant mobile platform in the nearest future despite claims that lack of quality checks on regularly 
submitted sub-standard apps to the Android market is a downside [577]. 
With Android and Blackberry, the following processes were executed [578-582]: Install Eclipse software as 
the IDE; Download the Android SDK; Install the ADT plugin for Eclipse; BlackBerry Plug-in for Eclipse; 
Download the latest SDK tools and platforms using the SDK Manager; and Download Android and 
Blackberry Simulators. 
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The Plug-ins allows developers to develop, test and debug a Java application using the Eclipse IDE. The 
processes outlined above could be a daunting task for even a good programmer to get a grip of [583].  
6.5.9 Using WebView to open a website 
The process of developing an app easily and getting it into the App Market is to convert an already built 
mobile website into a native app. WebView object which is an in-app web browser is used to exhibit a 
website just as if the website is viewed on the browser of an Android smartphone [515]. Steps towards 
achieving this are [584]: 
To build a new Android Application Project by navigating through  File -> New-> Project -> Android -> 
Android Application Project -> type “ALSoD” as the project name, “android.uk.ac.iop.alsod” as the Package 
name and follow the rest of the wizard. 
On the Activity Layout add a WebView by navigating through the Project Explorer to 
“res\layout\activity_main.xml” and open the XML file to add : 
<android.webkit.WebView  
 android:id="@+id/wvwMain"  
 android:layout_width="fill_parent"  
 android:layout_height="fill_parent" /> 
On the manifest file add a permission code to ask the user for permission to access the internet before 
WebView can load a webpage. From the Project Explorer, open “AndroidManifest.xml” to add: 
<uses-permission android:name="android.permission.INTERNET" /> 
On the Activity add some codes by navigating and opening the “ALSoD.java” file from the Project Explorer -
> src -> com.projects.ALSoD -> MainActivity.java is a seen in Appendix 27. 
6.5.10 Testing 
When a regular website is developed, there is a necessity to view it on different browsers to ascertain 
compatibility across platforms and this is the same way a mobile application must be viewed on a wide 
diversity of mobile devices [515].  
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I initially downloaded emulators for iphone, andriod and nokia but a shortage of storage space on the 
computing system used made me to uninstall the software development kits. Since ALSoD has a facebook 
account and a Facebook ‘Recommend’ Button is embedded on the mobile masterpage, text messages 
were sent to as many contacts with internet access on my phone as possible. Blackberry Messenger was 
also sent to all my contacts asking them to view the web address (http://alsod.iop.kcl.ac.uk) on their phones 
and tablets. They were also asked to click on the facebook ‘recommend’ button so as to have an estimate 
of the number of users who were satisfied with the outcome of the display on their phone as seen in Figure 
125. 
 
Figure 125: Mobile view of website optimize 
Feedback from real users (2 Android users, 1 Nokia user, 5 Blackberry user, 1 iphone user, 3 ipad users) 
were collated in the development process. 
Ammendments made after testing: 
 Caching for offline viewing [585-587] 
 Loading page when connecting 
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 Make users aware of Cookies 
 Use option menu button [588] to display analysis webpages: interaction.aspx, credibility.aspx,  
analysis.aspx 
6.5.11 App submission 
From Eclipse, the application was compiled producing a .apk file. This file was submitted to a registered 
Google Play account with a generated keystore containing a private key [589]. The ALSoD app can be 
downloaded from Google Play and currently, our Google app account confirms that ALSoD app has had 
between 100 and 500 downloads as seen in Figure 126. The app then displays the ASP.NET website with 
no status bar or URL navigation on the screen. 
 
Figure 126: ALSoD Google play account showing number of downloads as at June 2013 
 
6.5.12 Creating awareness 
A marquee function scrolling a text from right to left was inserted on the desktop master page to create 
alertness for regular users of the website as seen in Figure 127. This was deliberately highlighted with a 
bright yellow bar for easy visibility. At symposiums and seminars, researchers were exposed to the recent 
development of the mobile app which has contributed to increased web traffic to ALSoD and a projected 
growth. 
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Figure 127: Desktop view creating awareness using a Facebook and marquee 
 
6.5.13 Feedback from app users 
During the various presentations of the mobile app development through posters and seminars, practical 
assessment of the website on mobile phones was carried out by attendants.  Apart from the positive 
responses, questions asked, concerns raised and critical analysis given by the audience were recorded 
and considered. 
6.5.14 Analysis of visits 
The Google Analytics account for ALSoD was created in August 2012 to compare results generated by the 
two independent tools and to gain insight into the improvement of the design and content of the website. 
[590] The development of the mobile website started in October 2012 so I decided to compare visits from 
August 2012 to October 2012 and visits from November 2012 to January 2013. 
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Chapter 7 RESULTS 
7.1 Keeping up with genetic discoveries in amyotrophic lateral sclerosis: 
7.1.1 Data Submission 
Once a user successfully logs into the ALSoD website for the purpose of submitting data, the user is able 
to submit a new gene or a new mutation or a replicated mutation data or patient data. A form is displayed 
on the website to fill in data which will eventually be submitted into the ALSoD SQL database. Submitted 
data are crosschecked regularly for any false submissions and the security of the database is regularly 
monitored. Below is a list of submissions and the tables where data are submitted to. Column list of each 
table is as shown in Appendix 24. 
7.1.1.1 Submit new gene
 
Figure 128: Submit new gene 
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7.1.1.2 Submit mutation data 
 
Figure 129: Submit mutation data 
7.1.1.3 Submit patient data 
 
Figure 130: Submit patient data 
 - 258 - 
7.1.1.4 Submit replicated mutation data 
 
Figure 131: Submit replicated mutation data 
 
7.1.2 Database Schema 
The database schema now allows for flexibility and expansion because of changed table designs, rewritten 
queries, and implementation of stored procedures. Redundant tables have been removed, and a more 
supple structure is in place. The original database has been archived. New genes have been added to the 
tables, and a facility to easily add further genes designed. ALSoD now permits only registered users to 
submit novel gene, mutation, and patient data, and this is regularly validated by an ALS expert. Apart from 
system tables available on the database by default, there are 107 tables and 58 views on the database.  
7.1.3 Search terms on search engines 
A search term for novel mutations on a gene for example SOD1 is displayed. As at September 2013, on 
Pubmed, 37 results were retrieved while on Google scholar, 330 results were retrieved (Figure 132). 
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Figure 132: Screenshot of search terms on pubmed 
 
Figure 133: Screenshot of search terms on Google Scholar 
Email Alerts, News page and List of last 10 submitted mutation and patient data are well designed and 
utilized to keep up with new genetic discoveries in the field of ALS. Initially, the website was designed to 
show the last 10 mutations submitted so, I modified the page to also show the last 10 patient data 
submitted and a graphical display of all mutation and patient data available in ALSoD in form of a bar chart. 
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A news page consisting of social media and blogs helps me to keep a tab on current issues in the ALS 
community and this is where news about genes and new technology for ALS is disclosed. This uses the 
Google RSS feed plugin to reveal current news. As at September 2013, the result is shown below: 
 
Figure 134: Latest News webpage 
 
7.1.4 Contributors and Collaborators 
There are currently 30 contributors from various international institutions. Due to regular updates on the 
website and constant involvement of experts in the field, contributors have increased from 12 to 30 since 
2009. They voluntarily enter their details and a login and password are generated for them as regular 
submitters. 
Andrew Martin’s lab at UCL was the only collaborator with ALSoD before 2009 but the contact has since 
been lost due to changes in infrastructure and personnel change in his lab. Continuity has therefore been 
jeopardised and efforts made to restore the links from ALSoD has proved abortive. 
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So, at the moment, collaborations are with databases with freely available access to their resources online. 
Our current collaborators are geneMania group,  
7.1.5 Unique Identifiers 
Selecting a link automatically interrogates the relevant third party website with the appropriate genetic 
information. Thus, it is possible to identify the most up-to-date list of genes implicated in ALS, explore their 
interactions and pathways, and review the relevant literature.  
7.1.6 Graphical display of phenotypic data 
Customized and routine analyses of mutational relationships with phenotype are possible, either for genes 
with phenotypic data, such as SOD1, TARDBP, FUS, SETX and others, or as a general overview of familial 
and sporadic phenotypic patterns. 
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Figure 135: Gene Overview page 
7.1.7 Mapping variants on Google Earth 
The mapping of gene variants on Google Earth allows researchers or patients to view the geographical 
distribution of reported gene variations associated with ALS (Figure 3). The same computational method 
allows us to map the origin of users and show which countries predominantly access ALSoD.  
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Figure 136: Mapping variants on Google Earth 
7.1.8 Meta-analysis and on-the-fly analysis of association data 
For users with their own association data, an on-the-fly analysis is available to combine the data available 
in ALSoD with unpublished user data that can be confidentially uploaded. The user data is formatted 
accordingly before upload and the result is fed back in minutes without storing users’ data on the database. 
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7.2 ALSoD: A user-friendly online bioinformatics tool for Amyotrophic 
Lateral Sclerosis Genetics 
7.2.1 Funding and Sponsorship 
The ALSoD database is a joint project of the World Federation of Neurology and European Network for the 
Cure of ALS, and is funded through grants from the ALS Association, Motor Neurone Disease Association. 
The research leading to these results has received funding from the European Community’s Health 
Seventh Framework Programme FP7/2007-2013 under grant agreement number 259867. Others are ALS 
Canada, ALS Therapy Alliance, and MNDA Iceland. 
7.2.2 Programming 
Open source programming software such as JavaScript, C#, T-SQL, Perl, XML, and VB.NET integrated 
under the ASP.NET platform are implemented to write codes and scripts. ALSoD uses the Microsoft .NET 
framework. Microsoft SQL server 2008 is used to manage the database stored on the VM3 server of the 
Institute of Psychiatry, King's College London. Microsoft Visual Web Developer 2008 Express Edition is 
used to develop the user-interface dynamic Web pages. Google AJAX search and Google Earth API have 
been combined to overlay geographical mutation information of ALS-related genes on the globe. 
7.2.3 Web Design 
A facelift was given to the Web page and some pages were redesigned for better visual representation of 
data. The Graphical User Interface allows data to be interpreted and viewed at a glance instead of using 
the tabular format of viewing data. A summary of ALSoD’s  site map is shown in Figure 137  below using 
the treeview. A full version as shown on http:alsod.iop.kcl.ac.uk/maps/treeview.aspx is seen in Appendix 
13. 
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Figure 137: Sitemap of ALSoD 
7.2.3.1  MasterPage  
The Master page which is a file on “../master/MasterPage.master” allows the web designer to create a 
regular look and behaviour for all the pages (or group of pages) on the website. It outlines placeholders for 
the content, which can be superseded by content pages. The final outcome is an amalgamation of the 
master page (template) and the content page (content to display). 
7.2.3.2 Homepage  
The publications are directly accessed using the first author linked to pubmed, year, title and the external 
web link to the full paper (where full text is publicly available online). Key publications with a reported novel 
mutation or novel gene or novel patient data are displayed. The database was restructured to enhance 
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flexibility. ALSoD version 3 began with the manual curation of more genes and mutations from review 
publications [209, 508] while patient data were curated from publications referenced in ALSoD available in 
Pubmed. 
7.2.3.3 Analysis webpage  
For example, a user wishes to predict gene interactions between the two genes (TARDBP and FUS). 
These two genes are checked on the list, a list of the selected genes are displayed for confirmation and 
once the user is satisfied, the EXECUTE link is clicked to link with the webservice on GeneMANIA website. 
The output is then displayed on the same ALSoD webpage without having to move back and forth between 
websites. The RESET link can be clicked if another query is desired. 
 
Figure 138: Interaction result using GeneMANIA 
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To compare genetic data between any two selected genes, the dropdownlist aids the user to view the list of 
genes available for analysis on the database. For example, a user wants to compare the genetic data of all 
patients between two genes (FUS and TARDBP). Click on the first dropbox to select FUS and click on the 
second dropbox to select TARDBP. Leave the default age range of 0 to 100 for all patients, then click on 
the COMPARE button. A graphical representation showing a box plot on Age of Onset and 3 pie charts on 
Site of Onset (Limb/Bulbar ratio), Gender proportion (Male/Female ratio) and Inheritance type (FALS/SALS 
ratio) are displayed side by side for the two selected genes. On the same page, a joint analysis of both 
genes and a tabular list of the patient and mutation data with references to the publications where these 
data are curated are also displayed. 
 
Figure 139: Side by side comparison result between FUS and TDP43 
  
For detailed analysis, a list of genes with mutations are shown in checkboxes. A more detailed analysis of 
selected genes with a range of age of onset with or without further selections (on the site of onset, gender 
and family history) are performed and graphically displayed as seen in Figure 140. 
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Figure 140: Detailed analysis of a selected gene 
 
7.2.3.4 Summary webpage  
Report page displays a graphical statistical representation of the mutations (Mean, Median, Variance, 
Standard deviation) of all genes available in ALSoD. These analyses are not produced from static data and 
any change or update in the dataset will recalculate and be displayed online dynamically.  Images below 
show the patient summary report on each gene, the top 20 most frequent mutations in patients and 
mutation data summary with their gene effects deposited in ALSoD respectively. 
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Figure 141: Summary report of genetic data 
 
7.2.3.5 GWAS webpage  
7.2.3.5.1 Whole Genome 
A user is required to log on with a registered username and password in order to display a static haploview 
graphical overview of all submitted genome wide results in ALS and a dynamically generated graph with 
selected threshold. These two graphs help to verify the same information graphically but the clickable 
graph navigates to the NCBI Single Nucleotide Polymorphism website for more bioinformatics information 
on the selected SNP (Fig 1). Despite selecting a default threshold of 3, the page is loaded in 18 seconds 
due to the large volume of data. Although the ten SNPs shown in Table 3 have unknown clinical 
associations, with larger sets of data analyzed in future there is a possibility of finding significant SNPs with 
known clinical associations. 
If all the 5 populations (UK, Boston, Holland, France, NIH) are selected, it takes approximately 20 seconds 
to display the result as shown. 
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Figure 142: Displaying GWA result of 5 populations on Whole Genome 
The top result is a screen dump of the analysis manually performed on haploview while the second result is 
a dynamically generated scatter chart corresponding with the screen dump as a form of check. 
7.2.3.5.2 On-the-fly meta analysis 
The on-the-fly tool enables a registered user to upload and analyse their data by comparing these data with 
the dataset in ALSOD. Data must be in a text format with four (4) compulsory fields: Chromosome, SNP, 
BP and P-Value fields respectively. There must be no headings on the first row, each field must be 
separated with a TAB and each row terminated with a RETURN key. An on-the-fly graphical representation 
of this comparison is shown and the significance of the SNPs are shown and linked to a bioinformatics 
source on NCBI webpage for further information. This takes an average of 65 seconds to appear on the 
page. 
7.2.3.5.3 Verifying a particular SNP 
This shows the p values from each source of dataset. The combined p value is derived after logging on 
with a username and password. This is to conceal the privacy or identity of the DNA information as 
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suggested in the study which proves that the probability that a person or relative participated in a GWA 
study can be assessed. It is a known fact that much effort is put into making experimental data publicly 
available in order to combine the data with other studies [12] The populations to be combined are selected 
using a set of checkboxes which later produces a static haploview graph, a dynamically generated graph 
with selected threshold and a graph showing significant SNPs of the selected chromosome as seen in 
Figure 143. 
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Figure 143: Displaying output of querying database for a single SNP 
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7.2.3.5.4 Chromosomal view on UCSC genome browser 
 
 
Figure 144: UCSC Genome Browser on chromosome 9 
 
GWAS by Fogh 2013 is a summarizes SNPs statistic table from logistic regression analyses combined in 
the GWAS meta-analytical study which includes 8 independent studies  with 13,225 individuals analyzed 
for 6,138,740 overlapping markers [544]. 
 
Figure 145: GWAS by Fogh 2013 
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7.2.3.6 News webpage  
Using the Google search engine integrated into ALSoD, external links to published articles on the latest 
news in the ALS research community are displayed using the keywords “New gene mutation Amyotrophic 
Lateral Sclerosis ALS”.  The current information are separated into 5 categories: News, Web, Blog, Book 
and Patent. 
Other useful hyperlinks such as ALS forum, ALS.NET forum, BBC website news, Medical news and RSS 
feeds from pipelines are also available on the webpage for users. 
7.2.3.7 Data webpage 
This page is popularly accessed by researchers due to the ability to download mutation data or patient data 
or 1000 genome or EVS genome in a spreadsheet format. It is a very useful page for cross-checking data 
on the database for the purpose of transparency. The genome data displayed on a flat file on the webpage 
shows global count and frequency, counts and frequencies from different populations like South America, 
Asia, Africa and Europe. 
7.2.3.8 Contributors webpage 
Collaboration with other databases like ALSGene, ALS mutation database , HGMD, Uniprot,  FALS 
Connect, PANTHER, SIFT,  PolyPhen,  PubMed, Google scholar and Jalview has improved the 
functionality of ALSoD. Integration with these external but free databases have been made possible with 
unique identifiers for each gene. 
7.2.3.9 Feedback webpage  
Main users of the database are Researchers, Clinicians, Patients and their families. So, feedback is 
essential to the development of the database to direct our improvement design and tools. 
7.2.4 On-the-fly Meta-Analysis of Genome Wide Association Studies in ALS 
Published data from our laboratory and Landers’ group are available in ALSoD [403, 455]. An on-the-fly 
meta-analysis allows users to upload their formatted data (according to specifications available on the help 
page) confidentially to examine the joint analysis result. A simplified list of published GWAS data in ALS 
alone derived programmatically from the very long list on the GWAS Catalogue [591] is displayed for easy 
use by researchers without having to download and write codes to filter the gigantic dataset themselves. 
Information tabulated are rs number (linked to corresponding details on NCBI Single Nucleotide 
Polymorphism webpage), chromosomal region, gene, first author (linked to the pubmed article), year, initial 
sample size, replication sample size, risk allele, risk allele frequency, P value, odd ratio, confidence interval 
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and platform used. A total number of SNPs with a link to other comprehensive GWAS databases like HuGE 
Navigator [592], HGVbaseG2P [477] and ALSGene [539] are shown. ALSoD only gives users basic up-to-
date GWAS information as a more comprehensive and unbiased GWAS meta-analysis can be queried 
directly from the ALSGene website or a hyperlink from a gene overview page [486]. 
This GWAS analytical tool is displayed in three ways: 
7.2.4.1 Verifying a particular SNP 
This shows the p values from each source of dataset. The combined p value is derived after logging on 
with a username and password. This is to conceal the privacy or identity of the DNA information as 
suggested in the study which proves that the probability that a person or relative participated in a GWA 
study can be assessed. It is a known fact that much effort is put into making experimental data publicly 
available in order to combine the data with other studies [524]. The populations to be combined are 
selected using a set of checkboxes which later produces a static haploview graph, a dynamically generated 
graph with selected threshold and a graph showing significant SNPs of the selected chromosome as seen 
in Figure 143. 
7.2.4.2 Whole genome 
A user is required to log on with a registered username and password in order to display a static haploview 
graphical overview of all submitted genome wide results in ALS and a dynamically generated graph with 
selected threshold. These two graphs help to verify the same information graphically but the clickable 
graph navigates to the NCBI Single Nucleotide Polymorphism website for more bioinformatics information 
on the selected SNP (Figure 142). Despite selecting a default threshold of 3, the page is loaded in 18 
seconds due to the large volume of data. Although the ten SNPs shown in Table 3 have unknown clinical 
associations, with larger sets of data analyzed in future there is a possibility of finding significant SNPs with 
known clinical associations. 
7.2.4.3 On-the-fly analysis 
The on-the-fly tool enables a registered user to upload and analyse their data by comparing these data with 
the dataset in ALSOD. Data must be in a text format with four (4) compulsory fields: Chromosome, SNP, 
BP and P-Value fields respectively. There must be no headings on the first row, each field must be 
separated with a TAB and each row terminated with a RETURN key. An on-the-fly graphical representation 
of this comparison is shown and the significance of the SNPs are shown and linked to a bioinformatics 
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source on NCBI webpage for further information. This takes an average of 65 seconds to appear on the 
page. 
7.2.5 Collaborations and Embedded Tools 
ALSoD uses third party open source bioinformatics tools to embed computational analysis within the 
database using Java applets. For example, in Figure 146, a screenshot of the Multiple Alignment and 
Mutations on SOD1 gene using a combination of Claustalw and Jalview [Waterhouse et al., 2009] is used 
to provide multiple sequence alignments in other species for selected genes. GeneMANIA [Warde-Farley et 
al., 2010] allows users to select genes of interest for prediction of interactions. A Google Earth API is used 
for viewing maps of mutation, risk, and exposure distributions. Because many ALS gene variants are found 
in both familial and apparently sporadic ALS, a two-way link out to the ALSGene database provides 
evidence of association to complement the genotype–phenotype correlation available from familial ALS 
information in ALSoD [Lill et al., 2011]. A similar link out to fALS Connect, which is a collaboration between 
multiple interested agencies in the United States, including the patient organization The ALS Association 
and the research group The Northeast ALS (NEALS) Clinical Trials Consortium, makes ALSoD relevant for 
patients and carers as well as the scientific community. The database is adopted into the Human Variome 
Project (http://www.humanvariomeproject.org) and the GWAS Phenomap Project 
(http://www.gwascentral.org/gwasphenomap). 
For example, if SOD1 gene is selected, the webpage links to the webpage 
http//:alsod.iop.kcl.ac.uk/Applets/SOD1species.aspx. A screenshot of the Multiple Alignment and Mutations 
view of the SOD1 gene using a combination of Claustalw and Jalview is displayed. 
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Figure 146: Multiple Alignment on SOD1 
7.2.6 Integrated Bioinformatics Links 
To avoid bias, users can retrieve gene-specific information through external links which have been 
programmed automatically for each gene, and which open in new windows. Unique identifiers are utilized 
by systematically linking to broad databases and bioinformatics tools freely available online. The scientific 
and nonscientific external links integrated into ALSoD include HGNC [White et al., 1997], Entrez Gene 
[Maglott et al.], UCSC Browser [Fujita et al.], Protein Structure [Rose et al.], OMIM [Amberger et al., 2011; 
Amberger et al., 2009], Genecards [Safran et al.], ProtScale [Gasteiger et al., 2005], KEGG [Kanehisa et 
al., 2000], Uniprot [Jain et al., 2009], iHop [Hoffmann and Valencia, 2004], Pathway in KEGG [Kanehisa et 
al., 2000], GeneTest [Pagon et al., 2002], AmiGO [Carbon et al., 2009], Ensembl [Hubbard et al., 2009], 
NCBI [Sherry et al., 2001], Life Science DB (Japan) [Yoshida et al., 2010], ALSGene [Lill et al., 2010], 
GeneWiki [Huss III et al., 2008], WolframAlpha (Maret), and WikiGenes [Hoffmann, 2008]. 
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7.2.7 Feedback 
Feedback is gained in two main ways: a Facebook page for ALSoD 
http://www.facebook.com/srch.php#!/pages/ALSoD/307667685943735, and a direct feedback page on the 
ALSoD Website. Comments are publicly displayed and a reCAPTCHA tool displays texts readable only by 
human users to prevent spammers from infiltrating the system (Appendix 42). A news page generates 
automated summaries of ALS genetics news; and surveys conducted through the freely available online 
survey tool “SurveyMonkey” are embedded in the user interface. 
A blog page was created to allow users make comments and a social media page consisting of Twitter and 
Facebook was developed to allow those not connected to these social media have access to information 
shared by others. This form of communication helps to answer the kind of question posted by a user 
saying, “What is the latest mortality rate of ALS?”.  
 
Figure 147: Social media accounts of ALSoD 
7.2.8 Tracking Visitors 
In addition, by tracking the registered country of origin of page viewing and download requests, 
accessibility of the ALSoD database to the international ALS community can be monitored directly. A 
tracking tool was developed to monitor the influx of visitors to the website by identifying unique ipaddresses 
per day. This revealed that there were visitors from over 125 countries with 18,290 users in the month of 
November 2010 alone (Figure 4) which requires an enormous amount of storage facility on the database. 
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This has helped to compare visits between 2009 and 2010 as shown in Figure 5. An example of a day’s 
visit to the ALS Online database is seen in Figure 6 
7.2.8.1 Visitors’ webpage 
From Feedback -> Visitors’ statistics which is on http://alsod.iop.kcl.ac.uk/charts/index.aspx. A graph of 
visits from January 2009 to August 2013 shown below confirms that ALSoD is constantly and increasingly 
being accessed by users. For example, in Australia, so far, there have been 2360 visits. 
 
Figure 148: Visitors' statistics 
Every year, there is a higher number of visits than the previous year even though it dwindles in the number 
of visits monthly due to downtimes or holidays across the globe. 
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7.2.8.2 Google Analytics tool 
As a form of parallel monitoring of the use of ALSoD worldwide, I used the Google analytics plugin tool to 
find out information on how frequently ALSoD is accessed, from where, the popular webpages users visit 
etc. Just within a year, from August 2012 to present date in September 2013, about 6550 unique visitors 
have visited the website from around the world. 
 
Figure 150: Google Analytics display 
7.2.8.3 ALSoD Impact 
Apart from the number of unique users and the number of times the database has been visited as shown 
on the homepage, other interesting statistics are found on http://alsod.iop.kcl.ac.uk/charts/index.aspx. 
As at the 18
th
 of October 2013, visitors’ statistics from http://alsod.iop.kcl.ac.uk/charts/index.aspx are: Total 
number of countries where ALSoD has been accessed (152); Highest access from USA, China, 
Netherlands and UK; and Total number of visitors daily (like previous day 17
th
 October) is 706 (varies from 
day to day). 
From Google scholar, using the search term “alsod.iop.kcl.ac.uk”, a total of 234 results were displayed on 
“http://scholar.google.co.uk/scholar?start=15&q=%22alsod.iop.kcl.ac.uk%22&hl=en&as_sdt=0,5” while 
some publications cited the ALSoD database using the old web address. So with the search term 
“alsod.org”, a total of 174 results were shown on 
“http://scholar.google.co.uk/scholar?hl=en&q=%22alsod.org%22&btnG=&as_sdt=1%2C5&as_sdtp=”. 
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7.2.9 ChangeLog 
The ALS Online Genetics Database website was initially located at http://www.alsod.org  and is now 
located at http://alsod.iop.kcl.ac.uk. This change in web address and hosting of this valuable tool became 
imminent due to an insatiable crave for huge storage.  ALSoD allows users to submit new gene, mutation 
and patient data. It also has various tables in the database schema, storing data on genes, mutations, 
patients, codons, gene sequence, trinucleotides, country details, users and stored procedures. It uses the 
Microsoft .NET framework. Microsoft SQL server 2008 is used to manage the database stored on the VM3 
server of the Institute of Psychiatry, KCL (size about 10830 MB). Microsoft Visual Web Developer 2008 
Express Edition is used to develop web pages (current size about 707MB containing 387 files and 53 
folders). 
More than 110 ALS-related genes have now been added to the database with a current total of 431 
mutations (195 pathogenic) and 589 patient data. 15 of the mutations are unpublished except in ALSoD. 
ALSoD webpages have been visited over 280,000 times since 2009 by more than 22,900 unique visitors 
from 140 countries. There are 26 registered contributors excluding those from the host institution. 33 
different publications have cited functionalities or updates available on ALSoD. 
7.2.10 Search keyword(s) externally or internally 
Using Google Search engine for both searches, the external search finds a keyword on the World Wide 
Web while the internal search finds a keyword on ALSoD website only. For example, using the keyword : 
‘C9orf72’ 
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Figure 151: Search output using Google search engine interface for external search 
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Figure 152: Search output using Google search engine interface for internal search 
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7.3 Credibility analysis of putative disease-causing genes using 
bioinformatics 
PRISMA revision [593] with respect to development and reporting of results were taken into consideration 
as seen in Appendix 8.  
7.3.1 Data collection 
Genes with at least one publication suggesting involvement in adult onset familial ALS were studied [108]. I 
excluded genes with limited clinical data, absent mutational data or unreplicated results. Publicly listed 
variants for the included genes derived from ALSGene, Uniprot, ALS Mutation and HGMD databases were 
merged with variant lists in ALSoD, and filtered for duplicates (Appendix 8). 
7.3.2 Pathogenicity analysis using bioinformatics tools 
Database is queried as discussed in 6.4.2.6 dispaying a summary of predicted pathogenicity shown in 
Figure 153. 
 
Figure 153: Query result of predicted pathogenic FALS genes mutations 
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For the pathogenicity prediction, using a threshold score >1 (that is, where the combination score is 2 or 3) 
to define pathogenicity,  just 110 mutations out of 531 were identified as pathogenic, with particularly poor 
predictions for FUS and TARDBP when compared with biological evidence of pathogenicity. Using a 
threshold score of > 0 (that is, where the combination score is 1 or 2 or 3) to define pathogenicity brought 
the number of pathogenic mutations to 227, suggesting that about 50% of recorded FALS mutations are 
pathogenic based on bioinformatics predictions as at March 2014.  
7.3.3 Data extraction from publications 
After conducting a systematic review of all publications related to ALS genetics, there were 14 genes that 
fulfilled the inclusion criteria for generation of credibility score at the time of the survey, and had sufficient 
data manually curated from publications as explained in the data extraction process above. These were 
ALS2, FUS, DAO, VCP, VAPB, ANG, DCTN1, FIG4, SETX, SOD1, TARDBP, SPG11, NEFH, and OPTN. 
7.3.4 Automated gene ranking 
Using the full set of 11 procedures, the automated method ranked these as ALS-causing genes in the 
following order: SOD1, TARDBP, FUS, ANG, SPG11, NEFH, OPTN, ALS2, SETX, FIG4, VAPB, DCTN1, 
TAF15, VCP, DAO.  
Subsets of the 11 procedures may be defined by the user if needed. This allows flexibility in which 
evidence is regarded as useful. For example in Figure 3, using the number of mutations reported in a single 
gene and the number predicted as pathogenic as test criteria ranks the genes in the following order: SOD1, 
TARDBP, FUS, ANG, OPTN, SETX, ALS2, SPG11, FIG4, DCTN1, VAPB, VCP, DAO. The output shows 
that the first six genes, SOD1, TARDBP, FUS, ANG, OPTN  and SETX, have a total of 121, 17, 19, 12, 5 
and 4 pathogenic mutations respectively and, for example, the I113T, D90A and A4V pathogenic mutations 
of the SOD1 gene were replicated in 17, 14 and 12 studies. It also shows there are 6 different mutations in 
codon 93 of SOD1 and 5 different mutations in codon 521 of FUS. Other displayed information includes the 
number of countries in which gene mutations have been reported. For example, SOD1 mutation has been 
reported in 34 countries with representation from every continent of the world, while TARDBP, ALS2, ANG, 
FUS, SETX and NEFH have been reported in 13, 9, 7, 7, 6 and 5 unique countries respectively. Genes like 
FIG4, DPP6, DCTN1, UBQLN2, TAF15 which were recorded in only 1 country each have the lowest ranks. 
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7.3.4.1 Query generation in SQL 
7.3.4.1.1 Number_of_affected_patients_in_ALSoD 
 
Figure 154: Number of affected patients 
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7.3.4.1.2 Number_of_mutations_per_gene 
 
Figure 155: Number of mutations per gene 
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7.3.4.1.3 Number_of_cases_recorded 
 
Figure 156: Number of cases recorded 
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7.3.4.1.4 Number_of_predicted_pathogenic_mutations_by_rank 
 
Figure 157: Number of predicted pathogenic mutations by rank 
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7.3.4.1.5 Number_of_controls_recorded 
 
Figure 158: Number of controls recorded 
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7.3.4.1.6 Number_of_mutations_in _same_codon_by_rank 
 
Figure 159: Number of mutations in the same codon by rank 
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7.3.4.1.7 Number_of_patients_with_family_history_FALS 
 
Figure 160: Number of patients with family history 
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7.3.4.1.8 Number_of_patients_with_no_family_history_SALS 
 
Figure 161: Number of patients with no family history 
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7.3.4.1.9 Number_of_times_mutation_is_replicated 
 
Figure 162: Number of times a mutation is replicated 
7.3.4.1.10 Number_of_unique_countries_on_genes 
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Figure 163: Number of unique countries on genes 
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7.3.4.1.11 Number of publications 
 
Figure 164: Number of publications 
 
7.3.4.2 Ranking criteria 
The rank score for each query was summed to generate an overall rank for the gene under study. For 
example, from Figure 3, the last row for the DAO gene gives the column score 15 for Rank_Mutations, 14 
for Rank_Patients and 9 for Rank_Pathogenicity. This produces a total of 38 (that is 15 + 14 + 9) in the 
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Rank_Sum column. The generated Rank_Sum for all the genes are arranged in ascending order  placing 
DAO 12th by final rank. On the other hand, FUS is placed 3rd by final rank as the corresponding scores are 
3 + 3 + 2 = 8. 
7.3.5 Validation of the method 
8/25 ALS genetics experts selected based on having published at least one paper on ALS genetics 
responded.  
7.3.6 User interface 
The Credibility Analysis page at (http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx) allows criteria to be 
selected by users in the form of checkboxes. Clicking the ‘Analyse’ button then displays the ranked result. 
A detailed summary of ranked credibility data are also displayed for further reference by users giving the 
outcome of each procedure based query. Any combination of queries can be included in generating the 
score except Number of patients and Number of mutations found in each gene which are mandatory 
selections.  
7.3.7 Statistical methods 
A high Cronbach’s Alpha of 0.8 shows that there’s a high reliability and correlation between the three 
methods of testing credibility as seen in Figure 165. Comparison of the full automated method with the ALS 
genetics experts' rankings gave a Spearman's Rho of 0.69 (P = 0.009) for the forced expert rankings, and 
0.57 (P = 0.042) for the unforced rankings, indicating a good correlation between the methods.  
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Figure 165: Reliability Analysis using Cronbach's alpha 
 
7.4 Development of a smartphone app for a genetics website, ALSoD 
7.4.1 Searched online for direction 
A list of useful websites describing how to develop a mobile website ranging from third-party softwares 
(done by a click of a button) to developer’s plug-in (developed from scratch by a programmer). 
7.4.2 Choosing between a mobile website or an app 
I eventually decided to develop a mobile website first. The outcome of the mobile website across multiple 
devices inspired me to develop an application for a platform like Android. Factors determining my decision 
were Target Audience (The focus on users of the mobile app is researchers and patients); Budget 
Available (We have a £0 budget); Purpose Intended (For easy access of the website across multiple mobile 
devices) and Features Required (The mobile app requires a user to have a smartphone and/or tablet and 
an internet connection). 
7.4.3 Optimization of Webpages 
In the 6-month data analysis period from August 2012 to January 2013, there were 5051 visits to the 
website, of which 2698 were unique (53%). There were 19,785 page views, of which 8883 (45%) were to 4 
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sets of pages. These pages focused on the pathogenicity of mutations, gene information, data analysis of 
mutations, and patient data. 
7.4.4 Design Heuristics 
Pages were optimized for mobile browsing by reducing image size to 5% of the original size, creating a 
mobile master page different from the desktop master page, and creating a link page to allow users to 
switch seamlessly between the mobile and desktop views. 
7.4.5 Mobile Device Detection 
If the UserAgent string contained keywords suggesting a mobile platform, for example, BlackBerry, Palm, 
mobile, iPhone, or iPad, then the user’s device was redirected to the mobile site [36] displaying the 
compact version (Figure 125) of the website instead of the full version (Figure 44) [10]. 
7.4.6 Requesting Responses 
To test this, I sent the mobile site URL to mobile phones of 14 users (colleagues and friends from whom I 
could easily obtain verbal feedback): 3 on the Android platform, 1 on the Windows Phone, 5 on BlackBerry 
OS, and 5 on iOS (2 iPhone and 3 iPad). All users gave positive feedback except for the Windows Phone 
user who could not utilize the pages with dropdown boxes. 
7.4.7 App Development 
Following successful implementation of the mobile website, I began app development. One straightforward 
method to achieve this is to automatically convert an already-built mobile website into a native app. This is 
done through the “WebView” object, which is an in-app Web browser used to display a website as if viewed 
on the browser of an Android smartphone [10]. For testing, I downloaded and used Android simulators. The 
plugins allow programmers to develop, test, and debug a Java application using the Eclipse IDE, but it 
requires a high level of programming skill [24]. We also tested and manipulated the .apk file on a real 
Android phone before submitting to Google Play. 
7.4.8 Creating Awareness 
Following the development of the mobile version, on the ALSoD Facebook page, 34 users recommended 
the website by May 29, 2013, using the Facebook “Recommend” button embedded on the website. Current 
tabular data are available on the website [37], displaying the growth of visits to the genetic database, as 
seen graphically in Figure 127. 
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7.4.9 Feedback From App Users 
After the creation, testing, and publicity of the app, we received feedback from users about: caching for 
offline viewing [25-27], which would enable users to continue work; having a “page loading” icon when 
connecting; making users aware of the cookies policy; using an option menu button [28] to display analysis 
webpages (interaction.aspx, credibility.aspx, analysis.aspx); and creating a link to allow users to switch 
from mobile view to desktop view, as this would be useful on tablets like the iPad. I was able to implement 
all changes except for the offline viewing, which is difficult to implement because the database is large and 
held online. 
7.4.10 Analysis of Visits 
Our Google Analytics account showed that visits to the website increased from 2231 to 2820, yielding a 
26% increase from pre-mobile period to post-mobile period and a 230% increase on the use of mobile 
devices (including tablets) to access the ALSoD website. On average, there were 300 unique visitors a day 
suggesting a high demand from the research community. A total of 1595 unique visitors in the post-mobile 
era accessed 11,376 page views on the website as opposed to 1220 unique visitors in the pre-mobile 
period (an increase of 31%), showing the relevance of a mobile-friendly website. Five mobile operating 
systems (Android, iOS, BlackBerry, Windows Phone, Symbian) were detected to have accessed the 
website within 6 months. Although BlackBerry OS visits declined from 34 to 14 visits (58%), iOS for 
iPhones and iPads increased from 40 to 105 visits (162%), and visits by Android devices increased from 29 
to 213 visits (634%) (Table 6). The Google search engine was the most used to search for the website (see 
Table 7). The likely explanation for the great increase in the use of Android devices is the development and 
introduction of the Android app submitted to Google Play. 
Table 6: Comparison of website visits between the pre-mobile and post-mobile development. 









Totals       
  26.40% 7.03% 1.48% 4.25 2.98 
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Windows             
 01/Nov/2012 - 
31/Jan/2013 
1945 4.25 00:04:20 49.56 44.78 
 01/Aug/2012 - 
31/Oct/2012 
1564 3.85 00:04:13 56.46 48.34 
 % Change 24.36 10.47 2.71 -12.21 -7.36 
Macintosh             
 01/Nov/2012 - 
31/Jan/2013 
435 3.26 00:02:36 51.26 53.33 
 01/Aug/2012 - 
31/Oct/2012 
490 3.27 00:02:50 51.02 54.08 
 % Change -11.22 -0.28 -8.71 0.48 -1.38 
Android            
  01/Nov/2012 - 
31/Jan/2013 
213 2.35 00:01:29 76.53 63.85 
  01/Aug/2012 - 
31/Oct/2012 
29 4.93 00:03:12 65.52 44.83 
  % Change 634.48 -52.30 -53.69 16.80 42.43 
iOS             
  01/Nov/2012 - 
31/Jan/2013 
105 4.52 00:02:31 82.86 48.57 
  01/Aug/2012 - 
31/Oct/2012 
40 4.55 00:02:06 87.50 50.00 
  % Change 162.50 -0.58 19.77 -5.31 -2.86 
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Linux            
  01/Nov/2012 - 
31/Jan/2013 
85 6.51 00:08:11 28.24 29.41 
  01/Aug/2012 - 
31/Oct/2012 
61 3.23 00:03:13 34.43 32.79 
  % Change 39.34 101.45 154.08 -17.98 -10.29 
Other systems            
  01/Nov/2012 - 
31/Jan/2013 
15 1.07 00:00:28 100.00 93.33 
  01/Aug/2012 - 
31/Oct/2012 
13 1.92 00:00:43 92.31 84.62 
  % Change 15.38 -44.53 -35.61 8.33 10.30 
BlackBerry            
  01/Nov/2012 - 
31/Jan/2013 
14 8.14 00:11:10 0.00 28.57 
  01/Aug/2012 - 
31/Oct/2012 
34 7.12 00:14:12 5.88 17.65 
  % Change -58.82 14.40 -21.31 -100.00 61.90 
Windows Phone             
  01/Nov/2012 - 
31/Jan/2013 
4 6.75 00:08:02 50.00 50.00 
  01/Aug/2012 - 
31/Oct/2012 
0 0 00:00:00 0.00 0.00 
  % Change ∞ ∞ ∞ ∞ ∞ 
 - 303 - 
LG             
  01/Nov/2012 - 
31/Jan/2013 
3 1.33 00:00:11 0.00 66.67 
  01/Aug/2012 - 
31/Oct/2012 
0 0 00:00:00 0.00 0.00 
  % Change ∞ ∞ ∞ 0.00 ∞ 
Samsung             
  01/Nov/2012 - 
31/Jan/2013 
1 1 00:00:00 100.00 100.00 
  01/Aug/2012 - 
31/Oct/2012 
0 0 00:00:00 0.00 0.00 
  % Change ∞ ∞ 0.00 ∞ ∞ 
 






% new visits 
Bounce rate, 
% 
Totals / Site avg      
 4506 4.09 00:04:55 42.92 46.25 
 
44.65%  3.68  00:04:03  51.26  51.95  
Google 4339 4.06 00:04:54 42.73 46.58 
Yahoo 62 3.63 00:02:42 51.61 41.94 
Bing 32 5.53 00:07:11 62.50 31.25 
Baidu 21 6.19 00:12:50 23.81 23.81 
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Daum 13 3.46 00:06:35 30.77 30.77 
Ask 10 4.9 00:08:33 20.00 20.00 
Conduit 8 17.62 00:08:27 37.50 25.00 
AOL 7 1 00:00:00 71.43 100.00 
Other search engines 5 6 00:04:24 0.00 0.00 
Yandex 4 1.25 00:00:04 100.00 75.00 
Babylon 3 1.33 00:00:33 100.00 66.67 
AVG 1 1 00:00:00 100.00 100.00 
Comcast 1 1 00:00:00 100.00 100.00 
7.4.11 Analysis to date (January 2014) 
From Google Scholar, the analysis of ALSoD website since August 2012 to January 2014 which is 
approximately 17 months has a record of 16871 visits, 8534 unique visitors and 62246 pageviews where 
half of the visitors are new as shown in Figure 166. 
 
Figure 166: Visits on ALSoD for 17 months on devices 
As shown in Table 8, out of 16871 visits, 456 visits were from unknown mobile devices, 329 from Apple 
iPad, 214 from Apple iPhone, 97 from Samsung GT-I9100 Galaxy SII, 84 from Samsung GT-I9300 Galaxy 
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Table 8: First 10 Browser and OS used to access ALSoD from August 2012 to January 2014 
  
Visits % New visits New visits 
  
16,871 50.64% 8,543 
1 Chrome 5,673 43.45% 2,465 
2 Firefox 3,402 52.94% 1,801 
3 Internet Explorer 3,027 63.79% 1,931 
4 Safari 2,568 40.97% 1,052 
5 Android Browser 1,787 61.56% 1,100 
6 Opera 193 17.62% 34 
7 Opera Mini 38 92.11% 35 
8 Mozilla Compatible Agent 36 97.22% 35 
9 IE with Chrome Frame 33 51.52% 17 
10 Safari (in-app) 31 87.10% 27 
 
As seen inFigure 167: First 10 Countries accessing database, the US has the largest number of visitors 
followed by the UK. This corresponds with the result on the ALSoD monitoring page but there is a bit of 
discrepancy with the third largest number of visitors from India which is quite different from the result on the 
in-house built monitoring page. An explanation to this could be that the IP address from India has not been 
recognised so it classifies visits from India as Unknown, hence the large number of Unknown countries. 
 





















Visits 4,140 3,057 1,111 1,038 1,027 650 500 395 381 312 








First 10 Countries accessing database 
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In Figure 168, item 1 is the main web address http://alsod.iop.kcl.ac.uk which leads a user to either the 
desktop homepage view on item 2 or the mobile homepage view on item 3. This result proves the high 
accessibility to mobile devices by users of the database. 
 
Page Pageviews % Pageviews 
1 / 9,668 15.53% 
2 /Index.aspx 4,141 6.65% 
3 /Mobile/index.aspx 2,851 4.58% 
4 /misc/dataDownload.aspx 2,789 4.48% 
5 /Overview/gene.aspx?gene_id=SOD1 2,498 4.01% 
6 /index.aspx 1,828 2.94% 
7 /Mobile/Mutation.aspx 1,430 2.30% 
8 /Statistics/pathogenicity.aspx 1,370 2.20% 
9 /Overview/gene.aspx?gene_id=ANG 1,273 2.05% 
10 /Statistics/analysis.aspx 1,161 1.87% 
Figure 168: First 10 Pageviews 
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Chapter 8 DISCUSSION AND FUTURE WORK 
8.1 Bioinformatics exploration of ALS genetics 
Since the first discovery of mutations in the locus ALS1 of chromosome 21q22.11 in the Cu/Zn superoxide 
dismutase 1, soluble gene (SOD1), there has been an explosion in the number of mutations discovered in 
various populations. A rapid increase from 11 mutations in 1993 [91] to 43 mutations in 1996 [594]  in 
SOD1 gene alone propelled the ALSOD Consortium to set up a uniform centralized database with the aim 
of pooling all available genetic and clinical data in one location [567, 594].  
Due to improved technology, SOD1 mutations alone have increased from  about 100 mutations in 2008 
[568] to more than 170 mutations as at January 2014 on http://alsod.iop.kcl.ac.uk. Currently, over 470 
mutations in more than 110 genes are recorded on the database with expectations for more genetic data to 
be discovered in the future. Currently, the number of disease loci associated with classical or typical ALS 
as at January 2014 as displayed on the website are 20 [595] while 2 loci have been reported as ALS with 
frontotemporal dementia (ALS-FTD) [596].  
Genetic studies of ALS are often difficult for non-geneticists to understand. For geneticists, the sheer 
number of studies means it can be difficult to remain up-to-date. For researchers it would be helpful to have 
all genetic research findings in one place with tools to help understand them or to follow up the results with 
other analyses. The ALS Online Genetics Database, ALSoD, is a website housing the database of up-to-
date ALS genetics research. For each listed gene there are links to information or analysis tools. For some 
genes such as SOD1 that have been extensively studied, there are additional specific links for example to 
predict the effect of mutations on structure and function. ALSoD was therefore developed to handle genetic 
data produced in ALS. Mutation and patient data were collated to understand the relationships between 
genotype and phenotype analysis.  
Bioinformatics tools are being developed regularly to analyze these data and ALS researchers are keen on 
getting up-to-date information about genes, publications, mutations and analysis provided through the 
website. [486, 521]. ALSoD keeps up with the rapid advances in genetics by adding new gene findings as 
they occur and developing new tools for researchers. The remit of ALSoD was expanded to include 
findings from frontotemporal dementia research because there is an overlap with ALS in some cases.  
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The ALSoD and the ALSGene databases which were independently developed have been working 
together to collate both Mendelian and non-Mendelian genetically complex ALS results from up-to-date 
studies [486].  
An independent measure of credibility that might guide non-geneticists in knowing the level of confidence to 
place in reported findings was developed [522]. There are several analysis tools available in ALSoD at 
present, including a visualiser for geographical distribution of mutations, visual tools for the display of 
mutations and genetic variations, and tools for reanalysis of genome-wide association data, including the 
ability to combine existing data with newly uploaded user data confidentially.  
I developed tools to store and analyze information from genome-wide association studies, whole genome 
sequences and gene expression information. We implemented the largest GWAS meta-analysis in ALS 
based on data available in our laboratory on the ALSoD platform using the Fisher’s method of combining  
P-values, which is a traditional approach [597, 598] accessible from 
http://alsod.iop.kcl.ac.uk/GWA2/index.aspx. There are also other analytical models like the Bayesian 
approach [507] which may be introduced in the near future. An On-the-fly analysis of GWAS data is carried 
out by combining data available on the database with unpublished user-data confidentially uploaded to 
carry out dynamic analysis on existing studies. The user data is formatted accordingly before they are 
uploaded and the result is fed back in minutes without storing users’ data on the database. The most 
current meta-analysis on ALS patients as at December 2013 is available on the database [544]. A 
significant problem is how to deal with population stratification [599], but we are exploring methods using a 
principal components analysis approach. A more comprehensive and detailed meta-analysis of all ALS 
GWAS is available at www.alsgene.org. I also included GeneMANIA web interface for predicting gene 
interactions in ALSoD as a bioinformatics tool to forecast the functional relationship between two genes 
[600]. 
8.2 ALSoD versus Others 
“ALSOD” is the original name of the database suggesting association with ALS and SOD1 gene. It is now 
renamed ‘ALSoD’. ALSoD is an open source data repository designed for sharing clinical and genetic data. 
It now provides both the scientific community and wider public with up to date information on ALS-related 
genes. Genetic research is advancing at an extremely rapid pace. The purpose of ALSoD is to curate the 
available evidence for genetic risk and modifying factors for ALS with summaries of the literature and links 
to appropriate genetic resources. ALSoD first came online in 1999 solely for reporting SOD1 gene 
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mutations [567] but with the rapid advances in genetics was in need of a major overhaul and required 
redesigning to allow complex genetic analyses and data comparisons automatically. With the aim of 
providing users with maximal cross-referenced bioinformatics investigation, the redevelopment process is 
currently being carried out [568]. With the advent of newer technologies, international collaborations 
between scientists and greater awareness of research aims by those affected by ALS, what is being learnt 
about ALS is expanding every day. 
The ALS Online Genetics Database website was initially located at http://www.alsod.org  and is now 
located at http://alsod.iop.kcl.ac.uk. Funding is obtained from the MND Association of Great Britain and 
Ireland, the ALS Association, ALS Canada, MNDA Iceland and the ALS Therapy Alliance.  
ALSoD allows users to submit new mutation and patient data. It also has various tables in the database 
schema designed for storing data on genes, mutations, patients, codons, gene sequence, trinucleotides, 
country details, users and stored procedures. Microsoft .NET framework with Microsoft SQL server 2008 
are used to manage the database stored on the VM3 server of the Institute of Psychiatry, KCL (size about 
10830 MB). Microsoft Visual Web Developer 2008 Express Edition is used to develop the web pages 
(current size about 1.05TB containing 387 files and 53 folders). 
The second publication on ALSoD in 2008 proposed future plans for the database which is to expand and 
incorporate mutational data for additional genes linked to ALS; developing more graphical and statistical 
summary webpage and further improving the appearance and functionality of ALSoD [568]. The present 
PhD project has helped to achieve this plan and beyond. 
Further to the discussion in 1.20.2 about other databases, ALSoD has an edge over other databases as 
described below. 
8.2.1 Daily Updates 
The usefulness of LSDBs is determined by how current the data in them is. From a study conducted in 
2002, 38% of databases were last updated in the previous 6 months, 10% in the first 6 months of 2001, 
and 12% in 2000 [601]. A date of last update was not shown in 36% of LSDBs leaving the user confused 
about how current the information was [463]. Updates are carried out daily in ALSoD using scripts and 
internet bots. Apart from dead databases with broken links, many of the databases are updated weekly, 
monthly or not updated at all. I checked the Tokyo ALS mutation database 
(https://reseq.lifesciencedb.jp/resequence/SearchDisease.do?targetId=1) on 23
rd
 January 2014 discovering 
that this website has not been updated since 18
th
 November 2010 which is more than 3 years ago. 
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8.2.2 Data submission 
Databases of genetic polymorphisms such as ALFRED and dbSNP rely on author submissions and contain 
little additional data analysis [602], whereas ALSoD has a network of contributors worldwide and a curator 
who administers the database regularly. 
8.2.3 Missing genetic data 
I compared the features of OMIM and HGMD databases and found significant inconsistencies like absent 
genes and missing mutations between the two databases. For example, the last check in December 2013 
records 105417 mutations in the public entries (for Academics/non profit users) and 148413 mutations in 
the Professional domain. A search for total mutations available for the FUS gene on 
http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FUS showed 42 mutations in the public site but 83 mutations 
in the professional site while on ALSoD database, there are 77 mutations available. On OMIM, 9 
pathogenic FUS mutations were recorded on http://www.ncbi.nlm.nih.gov/clinvar?term=137070[MIM].  
 This evidence therefore strengthens the case for gene specific curation of mutations and a general plan for 
collection, curation, storage and publication of mutation data as in ALSoD. 
8.2.4 Global representation 
There are country-based mutation databases like the Iranian Human Mutation Database [603] and the 
Turkish Mutation Database [464, 604]. The recently developed Mutation database in Japan is also a 
region-centred database focusing more on data from Asia. ALSoD is unique in having data extracted from 
and submitted by researchers worldwide. Currently there are contributors from 24 institutions from all 
around the world who contribute data to ALSoD regularly. 
8.2.5 Popularity of database 
When accessed online on 26 June 2010, ALFRED had been visited 171,236 times since March 29 1999 
while HGMD had 1,599,773 hits on its page since June 2005. That is, ALFRED is visited on an average of 
15,567 times per year, and HGMD 319,955 per year. The ALSoD visitors’ statistics page shows that since 
January 2009 (within 1.5 years), the site has been visited over 145,000 times averaging about 100,000 
visits per year.  
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8.3 Limitations of Genetic Databases 
8.3.1 Continued Funding 
After much work has been carried out by curators to bring genetic databases to life, there is a great risk of 
loss of continued funding. Many databases are either outdated or have broken inaccessible links because 
the sponsorship expired and was not renewed. This could result from the lack of manpower or economic 
recession. ALSoD faced that situation between 2000 and 2007 which resulted in losing the domain name 
and website www.alsod.org. 
8.3.2 Duplication of Efforts 
Duplication of efforts is not impossible especially where there are hindrances to collaborating with other 
researchers. No curator would like to waste time ‘reinventing the wheel’ hence the use of hyperlinks in 
ALSoD to already available data on other external databases was implemented. 
8.3.3 Limited resources 
Resources like storage spaces will be easily used up due to high volume of genetic data produced regularly 
especially with advancement in technology. ALSoD keeps track of all IP Addresses visiting the website, 
stores all mutation and published patient data and hosts Genome Wide Association Meta Analysis data. All 
of these require storage space of which could pose a problem if the KCL institute hosting the database 
caps the storage space for each website.  
8.3.4 Political boundaries on data sharing policies 
Different countries have policies on data protection of its citizens. Some allow part of the data to be 
displayed as long as the individual remains anonymous, some require an endless list of paperwork and 
approval before collaborating outside their own country, some even do not allow any form of sharing at all. 
So, patient data in ALSoD is limited to data from publications and very few from individual researchers in 
countries where data-sharing restrictions are less strict. 
8.4 Limitations of the ALS Online Database 
8.4.1 Storage 
Volume and size of data allowed for upload by the host server is limited to avoid an exhaustion of disk 
space provided for ALSoD on the server and to secure the accessibility of the server to external intruders 
trying to hack the entire system. As this tool becomes popularly used, we shall be faced with the challenge 
of providing a larger disk space to host this tool. A resource able to handle next generation sequencing 
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data and deliver useful analysis for processing and displaying such information is desirable. There is a 
question of whether the current ALSoD network can cope with multiple users trying to download data 
simultaneously. Dealing with FASTQ, BAM and VCF files to align raw data reads to the genome will be a 
great challenge. 
8.4.2 Funding 
The life line of any successful project is financial stability which involves both human and non-human 
resources. Many databases have come and gone while not many can boast of continuity. Broken links to 
websites are experienced often due to lack of maintenance. Domain names and host servers are not free 
and so a need for annual fees by organisations hosting websites is mandatory to keep the website alive. 
ALSoD went through that phase when the alsod.org domain name was lost due to lack of funds and 
manpower. The aspect of technological facilities has been solved by using the Institute of Psychiatry server 
but the sustenance of the Curator, Web Developer, Programmer, Database Administrator and/or Content 
Manager of the database is a pending issue. 
8.4.3 Browser Incompatibility 
Incompatibility issue with browsers (FireFox, GoogleChrome, Internet Explorer, Safari etc) is a technical 
problem beyond a developer’s control. We are working on how to integrate various tools from other groups 
with minimal interruption from the technicalities embedded in browsers used. 
8.4.4 Upgraded versions of third-party applications 
An upgrade in the version of a previously used web service like PolyPhen which made a part of the results 
in predicting pathogenicity has become obsolete.  
Also, spammers and hackers target websites regularly. I noticed in February 2014 that despite the use of 
Recaptcha by Google, a problem of unsolicited comments posted regularly on the feedback page 
resurfaced (Appendix 42). Removing the login barrier (where users provide a username and password) is 
the negative side to allowing the public free access to pages. Even though the software Recaptch.Net zip 
file was extracted, it seems to work but there is a possibility that this problem may reoccur when the current 
recaptcha.dll file becomes obsolete. 
 
 - 313 - 
8.5 Concluded Research Questions 
Firstly, is it possible to generate a database that summarizes genetic data for a disease and allow meta-
analysis online? ALS is used as a model disease in the present study. This was done by creating gene and 
chromosomal overview pages of all available ALS-related genes; collating published GWAS data from the 
largest GWAS study of ALS to date completed by our group; collating published linkage studies and merge 
results on GWAS; and allowing user-defined queries of meta analysis of association studies. 
Secondly, can all genetic data useful to ALS be automatically collected? Data mining from large external 
databases like UNIPROT (which is a consortium between the European Bioinformatics Institute (EBI), the 
Swiss Institute of Bioinformatics (SIB) and the Protein Information Resource (PIR)) were interrogated. Also 
manual curation of genetic data from publications has been carried out. 
Thirdly, how achievable is an on-the-fly analysis of genetic data online? A tool for dynamically uploading 
GWAS data from users was generated; user data were compared with available GWAS data in the 
database; and user-configurable queries using a simple interface was created. 
Fourthly, to what extent can the database (the ALS Online Genetics Database) be integrated with other 
bioinformatics resources available online? This was done by providing users of the database with maximal 
cross-referenced bioinformatics and investigation utilized using information from other well-known scientific 
and non-scientific databases like Entrez Gene, UCSC, OMIM, Genecards, KEGG, Uniprot, iHop, dbSNP, 
Pubmed, Wolfram Alpha, PDB, Gene Onology and others. 
Lastly, with the advent of various ALS-related genes, can a database generate levels of evidence to 
support or refute genetic associations and linkages with ALS? Various criteria were intended to generated 
scores for prioritizing the importance of each gene. The initially proposed criteria for each gene are a score 
for the number of mutations related to ALS on ALSoD; a score for the number of published articles related 
to ALS available in Pubmed; a score for the number of significant SNPs within a threshold derived from the 
meta-analysis tool; a score for how each gene relates to other genes using Ingenuity pathway tool; and a 
score for the number of countries where mutations or disease-associated variants are found. This was 
eventually done by ranking queries on the number of affected patients, number of mutatios per gene, 
number of cases recorded, number of predicted pathogenin mutations, number of FALS, number of SALS, 
number of replicated studies and number of unique countries found. 
 - 314 - 
8.6 Extra Development 
In the process of developing the database, various needs arose from current developments in technological 
advancement, feedbacks received from users of the database and suggestions from conferences and 
symposiums attended. These were not included in the original research questions. 
8.6.1 Development of mobile computing applications 
Current trends in computing mean that users expect services to be available from any device and platform. 
Researchers often travel and might have a new idea while they are away from the office. It would therefore 
be helpful for the ALSoD data and analysis tools to be available through an application interface specifically 
designed for a small screen. I hence developed an application (app) for Android mobile computing systems 
to allow ALSoD functionality easily accessible from a smartphone or similar interface. Other developments 
will be carried out on iPhone and Blackberry. 
8.6.2 Expansion of phenotypic inclusion criteria to include frontotemporal dementia 
An interesting genetic region is on chromosome 9p21.2, identified in linkage studies of familial ALS with 
frontotemporal dementia (ALS-FTD), familial and sporadic ALS, and sporadic FTD [605-609]. Since there is 
clinical and pathological overlap of ALS and FTD it is likely that variants of the same gene are responsible 
for all these findings. Only three annotated genes are in the region: c9orf72, IFNK and MOBKL2B and there 
was a very active search for the disease gene [398, 610] until a study showed that a large hexanucleotide 
(GGGGCC) repeat expansion of C9ORF72 is present in the first intron of majority of ALS-FTD cases [405]. 
There is very strong evidence for the clinical and pathological overlap of ALS and FTD, hence the exclusion 
of FTD data from ALSoD risks leaving out important information. We therefore widened our inclusion 
criteria for genes, papers, and stored data to include FTD and ALS-FTD syndromes. We began the process 
of advertising ALSoD to the FTD community and in this way helps to establish new links to different types 
of information. 
8.6.3 Suggestions from feedback 
Users of the database have played a significant role in the development of ALSoD through valuable 
suggestions in the past. We depend on feedbacks through Social Media, feedback page, blogs, poster 
presentations, seminars, conferences, surveys etc. for further improvement. 
 - 315 - 
8.7 Future of ALSoD 
ALS Online Genetics Database has been considerably developed over the last decade, taking it from a 
broken web server with no backup, storing out of date information restricted to SOD1-induced familial ALS, 
and transforming it into a sleek computing engine with automated backup, optimal security, and very up-to-
date information on all familial and sporadic ALS genetics, currently including several GWAS data and 
more than 110 genes. 
The last publication on ALSoD in 2008 (before I took over the project) proposed future plans for the 
database which is to expand and incorporate mutational data for additional genes linked to ALS; 
developing more graphical and statistical summary webpage and further improving the appearance and 
functionality of ALSoD [6]. The database has since then exploded with up-to-date gene list which are 
publicly available useful tools to aid researchers in the field of ALS. 
For the future of the Amyotrophic Lateral Sclerosis Online genetics Database – all things being equal – I 
hope to cover the subtopics explained below: 
8.7.1 Collaborations 
High-throughput and Next generation sequencing has transformed genetics. The quantity of data makes it 
difficult to handle, display and analyse with current technology. There are methods for simplifying this and 
as the costs drop further, whole genome sequencing will become the analysis method of choice. It is 
therefore important for ALSoD to be able to store next generation sequencing data and make the 
information readily accessible within the constraints of maintaining confidentiality when such detail exists 
and the data transfer implications of very large files. A noble goal will be to to make ALSoD a central 
repository for all ALS-related genome/exome sequencing. Careful consideration needs to be taken on 
setting up pipelines, the level of computing power required to carry out this enormous task and the type of 
files to use. Tools currently in development by the research community include PlinkSeq, which is an 
offshoot of the popular genetics analysis program Plink using a SQL server back end [611]. 
With the advent of newer technologies, international collaborations between scientists and greater 
awareness of research aims by those affected by ALS, what we are learning about ALS is expanding every 
day. We therefore aim to make the ALS Online genetics Database a one-stop shop integrating all genetic 
data in ALS. 
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More bioinformatics hyperlinks and integration to websites for the use of clinicians and non-clinicians, 
scientists and laymen are gradually being developed to serve both the scientific and non-scientific 
community by developing various sections on the website. Currently, the database serves only ALS 
researchers and clinicians but we hope to involve more with the patients through a collaborative effort with 
the PatientsLikeMe web team [612]. Plans are currently being carried out to extend the use of information 
on the database to ALS patients worldwide. Apart from the ability to search the database for information on 
mutations and the patients as published in journals, a direct link from a patient-based website like 
patientslikeme.com will be highly desirable. Modalities on the execution of this process are currently being 
discussed by both database teams. Links to and from both websites will allow patients currently registered 
on PatientsLikeMe website access to more information on their details about their diagnosis. 
ALSoD collaborated with Dr Andrew Martin’s bioinformatics group at UCL in 2008 but every effort to 
establish the broken link has proved abortive. So, I hope to either collaborate with another bioinformatics 
group who have mutant structures on SOD1 and SOD2 genes [613] or program the mutant structures for 
variants in ALSoD ourselves within the team. A positive response has been received from the Bioinfogroup 
team (http://bioinfogroup.com/database) and we hope to commence communication, planning and 
implementation in the nearest future. 
A more advanced development of an integrated application that enhances collaboration among biologists 
and bioinformaticians [506] will be incorporated into ALSoD.  
8.7.2 Larger Datasets 
Genetic analyses of existing and future genetic studies is hereby automated, and presented in such a way 
as to allow meta-analysis in user-configurable ways, with follow-up of user-defined queries using a simple 
interface. In future, this will include larger populations for larger analysis especially with the introduction of 
improved technology on next generation sequencing. 
8.7.3 Graphical displays 
“A picture is worth a thousand words” is a common saying. The introduction of graphical display on ALSoD 
has increased the usability of the database. Further graphical representation of information proposed is to 
create a more detailed geographical display of epidemiology study data on Google Earth. Also, structural 
display of variants on genes will be developed for genes available in ALSoD. 
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8.7.4 Analysis 
A publication utilised ALSoD dataset with other databases to evaluate the pathogenicity of ALS disease 
variants [555]. I hope to expand the credibility analysis of genes by including his formula as one of the 
criteria for ranking genes. I also hope to include information from animal models as one of the criteria. 
Also, talks have commenced with one of my colleagues who is a Bioinformatician, Dr Kuang Lin of 
Neuroscience department. The lack of an established golden standard in the field of ALS is a major 
challenge. We hope to develop a ‘silver standard’ for ranking genes by selecting random controls which 
should help us to define the rules of detecting correlated pathogenic genes. We are trying to find the 
contrast between our controls and established genes. We will try to formulate a mathematical 
computational model to achieve this. 
The publication on credibility score is drawing a lot of attention and so, in future, we hope to apply more 
criteria like prior information from animal models. Also, we hope to extend the functionalities to make it a 
template for other diseases that can provide these data as criteria. 
8.7.5 Development 
Feedback from users suggesting that extension of ALSoD could include integrated information from other 
species such as mouse and drosophila is welcomed. This was implemented by including publications on 
genes associated with animal models on the website and commencing the multiple alignments on SOD1 
gene only. Once we have a critical mass of information we will seek collaboration with experts in each field 
to help with analysis and presentation of data. 
An Android application was developed following a mobile website creation which allows users to switch 
between the full version and the mobile version. A further development on a wider platform will include a 
windows app and an iOS application (for iPhone and iPad). 
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Chapter 9 CONCLUSIONS 
The original rationale for the ALSoD database in 1999 was as a central resource collating information on 
SOD1 mutations so that researchers could data-mine for clinical/genetic correlations or other patterns in 
the data. This remains an important goal of the database. A few issues with the original design meant that 
registration and access was cumbersome, discouraging users from registering. In addition, the database 
relied completely on the goodwill of the research community for updates, there was no easy way to include 
new genes, and there was no easy way to incorporate the latest advances in bioinformatics. These issues 
have all been addressed in modernizing ALSoD over the last few years. 
9.1 Summary for Chapter 3 
Chapter 3 is the publication on “ALSoD: A User-Friendly Online Bioinformatics Tool for Amyotrophic Lateral 
Sclerosis Genetics”.  
The ALSoD database has been transformed from a storage database into an analytical tool for ALS genetic 
data. It has metamorphosed from a single gene, locus-specific mutation storage facility to a multigene, 
disease-specific analytical database. Patterns in the curated genotype and phenotype information are 
discovered. 
Feedback information received from users before the current development revealed that researchers who 
went on the database to utilize the resources were discouraged from the lengthy registration process 
required before access could be granted to use the database. There were also issues raised about the low 
frequency of data update. 
It is difficult for a researcher to keep up with the vast volume of data regularly reported in the field of ALS 
globally. The role of ALSoD is to collate this prodigious amount of information into an easily 
comprehensible and convenient dataset.  
9.2 Summary for Chapter 4 
Chapter 4 is the publication on “Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The 
ALSoD and ALSGene databases”. 
Web resources (http://alsod.iop.kcl.ac.uk/) and (http://www.als-gene.org) were independently developed to 
provide a summary of up-to-date most interesting genetic discoveries in ALS resulting from the utilisation of 
these resources. A joint publication was written to explain the main focus of the databases, the different 
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approaches imbibed to reach a common goal and the uniqueness of each resource through collaboration. 
The main focus for me as a first joint author is ALSoD and how the development of this unique resource 
benefits the ALS research community worldwide. 
A GWAS analysis from five different populations was developed and open access to registered users is 
provided to compare their data with the GWAS data. Codes and scripts were written in programming 
languages like JavaScript, C#, T-SQL, XML and VB.NET integrated under the ASP.NET platform. This 
enhances flexibility and manipulation by users of the database through the webpage. 
This tool enlightens researchers on significant SNPs where larger data are available as one of the 
limitations of GWAS is the unavailability of larger data. The accessibility of several thousand well-
phenotyped cases is a paramount aspect of any GWA study focussed at finding genetic factors with 
inconspicuous effects [614]. Hence, an on-the-fly analytical tool enlarging the dataset for better analysis of 
the ALS disease was established.  
A recent GWAS study from eight independent studies (the largest Genome Wide collaboration in ALS so 
far) is available on http://alsod.iop.kcl.ac.uk/GWA2/gwas_fogh.aspx. This is the latest development to the 
database allowing users to query ALSoD for a specific SNP id and the result is a display of the SNP, 
genomic position, odds ratio and P-Value in a tabular form. The meta-analysis includes data from 13,225 
individuals analyzed for 6,138,740 overlapping markers [544]. A graphical representation of the data in 
haploview form will be included on the webpage as part of the future work for this meta- analysis display in 
ALSoD. 
ALSoD systematically links to other bioinformatics tools, scientific and non-scientific external 
comprehensive databases using unique identifiers which are stored on the gene table. Gene variants are 
mapped to Google Earth and embedded on the website for viewing. A user interacts with this application by 
zooming in and out, clicking on the yellow pins to show the name of the gene and its geographical location 
on the globe. Interactions between selected genes on ALSoD are explored on GeneMANIA interface which 
is an interactive collaboration with the bioinformatics tool.  
ALSGene and ALSoD have joined forces by hyperlinking related information existing on the two 
independent databases to provide a unified and stress-free navigation to users. 
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9.3 Summary for Chapter 5 
Chapter 5 is the publication on the “Credibility Analysis of Putative Disease-Causing Genes Using 
Bioinformatics”. 
The focus of the credibility analysis is to weigh the evidences that a gene could be regarded as an ‘ALS 
gene’ in comparison to other genes available on the database. Credibility as defined in a previous 
association study utilised three criteria: amount of evidence, replicability of result and protection from bias 
[112]. 
Three bioinformatics tools freely available online were used to predict the pathogenicity of a variant in an 
ALS gene. These are PANTHER (Protein Analysis Through Evolutionary Relationships), SIFT (Sorting 
Intolerant From Tolerant) and PolyPhen (Polymorphism Phenotyping). 
Mutation and patient data on 14 Familial ALS genes available in ALSoD where updated using publication 
search engines and other locus-specific databases. Nine criteria were embedded on the user-configurable 
page for researchers to select. Genes were ranked according to the dense ranking system where gaps are 
avoided and two compulsory criteria (Rank by mutation and Rank by patients) common to all the genes are 
automatically selected. 
Using Surveymonkey tool, a survey was carried out on experts in the field of ALS who have publications as 
first or last author on ALS genetics. This was to protect the design from bias by examining responses from 
experts. 
One of the downsides to the prediction of pathogenicity is in the use of Polyphen software which allows 
single entry of mutation on their website. So, on ALSoD, only mutations recorded have been analysed by 
the 3rd bioinformatics tool (polyphen). If new mutations are added by a user to the database, the 
Administrator requires a manual online generation of analysis on the polyphen website and then involves 
the update of the displayed result to the POLYPHEN_Score table. 
Another issue is the C9orf72 gene which has been excluded from the analysis due to its varied repeat 
expansion nature. This makes it unadjustable to the structure of the credibility ranking despite the 
overwhelming amount of evidence from publications. 
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9.4 Summary for Chapter 6 
Chapter 6 is the publication on the “Development of a Smartphone App for a Genetics Website: The 
Amyotrophic Lateral Sclerosis Online Genetics Data”. 
A mobile version of the desktop version was created to allow more accessibility and easy readability of 
information on the ALSoD website on any device. A summarized version of the full desktop version was 
developed for mobile devices like a smartphone or tablet with an internet access. 
Blogs are social networking media for presenting ideas or sharing ones thoughts around the globe. A blog 
was built on this website for both the desktop and mobile views to enable users of the database discuss hot 
topics or controversies in the field of ALS. Users are not obliged to sign on or log in before comments could 
be posted even though this constitutes an unusual risk unlike other blog sites.  Also, without a registration 
process, users could pose sensitive questions or hot topics anonymously without fear or favour. 
Analysis was carried out within 12 months to analyse the effect of introducing a mobile platform and 
through the in house-built monitoring system and the external Google Analytics tool, it was discovered that 
ALSoD has experienced a surge in the use of the website.  
9.5 Conclusion 
The main goal of genetics is to determine the genotypes that explain phenotypes. Due to the availability of 
inexpensive technology and instruments capable of producing millions of sequence data in genetics at an 
amazing speed, it is important that researchers are able to utilise the information provided [104]. ALSoD is 
therefore a valuable tool to aid researchers in accomplishing this goal. 
Because the database summarizes ALS genetics including family and genome-wide association studies, 
the relevance of different findings can be quickly assessed and prioritized by researchers. Furthermore, the 
raw data can be more easily accessed because of the strong collaborative links with other groups and the 
inclusive nature of ALSoD. 
Linkage and association studies, both of candidate genes and as part of genome-wide scans have 
generated many potential genetic findings of interest, and some of these are specific to certain geographies 
or ethnic groups [615]. The pace of new discoveries is rapid and the interpretation of findings, their 
relationship to existing phenotypes and gene discoveries, and the integration of new genetic data requires 
a coordinated, systematic and logical approach, which ALSoD provides. 
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Efforts are growing rapidly by the ALS-research community to complement the role of ALSoD around the 
world. Recently, an ALS mutation database constructed as part of the Life Science Integrated Database 
Project conducted by the Japan Ministry of Education, Culture, Sports, Science, and Technology was 
published. It contains their original experimental results and published data extracted from scientific 
journals. The database is expected to play a complementary role to the ALSoD database especially in 
collecting variations in the Asian region [485].  
The ALSGene database has also emerged to “provide a comprehensive, unbiased and regularly updated 
field synopsis of genetic association studies performed in ALS. Once content creation is completed, one of 
its main features will consist of up-to-date meta-analyses for all eligible polymorphisms with sufficient data” 
[539]. A successfully implemented methodology earlier developed for meta-analyses in the field of 
Alzheimer [616], Multiple Sclerosis [617], Parkinson’s [618] and Schizophrenia [619] were extended to 
Amyotrophic Lateral Sclerosis [539]. 
Scripts and tables have been rewritten to remove redundant fields and converted to SQL from Cold Fusion, 
bringing the system up-to-date. The signup process has been simplified and a user feedback page added. 
Different levels of access are available for non-registered, registered and administrator users. 
The internal database structure has been redesigned, so that it is now a relatively simple process for new 
genes or loci to be added with the same template of links and data available, and automatically integrated 
into the search and table schemes of the website. 
We have reciprocal links to the HGVbaseG2P website at Leicester University Genetics Department, which 
is a genotype to phenotype database, so that visitors to either site can follow links to the other. ALSoD is 
also listed in the Online Mendelian Inheritance in Man (OMIM) database, again allowing visitors to either 
site access to the other. 
Each gene page has specific hyperlinks to relevant bioinformatics sources. There are typically more than 
20 such links for any gene, including the expected links to PubMed, HapMap, genome browsers at UCSC 
and Ensembl and OMIM, but also directly querying more unusual information sources such as Wolfram 
Alpha. Where possible, I have also mapped ALS-associated genetic variations geographically on Google 
Earth. 
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ALSoD automatically searches online for new information that is likely to be of interest to ALS genetics 
researchers, and alerts the development team for review. As a result it is easier to keep the database up-
to-date. Some of this information is automatically made available before review through the ALS News link. 
Genetic studies and findings on ALSoD are classified into those found by linkage of familial ALS genes, 
those found by candidate gene association, and the results of genome-wide association studies. 
One of the goals of the project is to automatically collect and integrate data. This was partly achieved by 
automatically getting notifications of new ALS genes or mutations from journals but not without the human 
intervention of checking the publications manually to update the database with current relevant information. 
For a genetic database that requires accurate information like ALSoD, human intervention is inevitable. 
ALSoD is truly a representative of the research community. It is an adopted project of the World Federation 
of Neurology and European ALS Consortium and currently funded by four different research charities, 
ALSA, MNDA, ALS Canada and MNDA Iceland. An average of 450 visitors uses the database daily from 
more than 150 countries. The most frequent users are from the USA, countries in EU, China and UK 
including some visits from countries in Africa and Asia. The web resource has been cited over 800 times 
outside the UK. 53% of visitors recorded monthly are new and more than 40 thousand unique visits have 
been recorded in the past 4 years. 
Although there are other databases available online as discussed above, ALSoD is unique in being a 
genotype: phenotype database, disease specific and detailed regularly updated database by ALSoD 
curators and the research community around the world. 
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Appendix 1 – Data Submission Flowchart 
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Appendix 2 – Genome Wide Association Study Flowchart 
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Appendix 3 – Visitors’ Statistics 
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Appendix 4 – Embedding Google Earth Flowchart 
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Appendix 5 – Flowchart for integrating Animal model into ALSoD 
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Appendix 6 - Data extraction from publications 
Review protocol 
Primary database: PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and Google Scholar (http://scholar.google.co.uk/) 
Search terms on PubMed:  
(SOD1[Title] OR (superoxide dismutase[Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron Disease[Title]) 
OR ALS[Title]) = 181 results 
ALS2 [Title] OR Alsin[Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 6 
results 
ANG [Title] OR Angiogenin[Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 6 
results 
(FUS [Title] OR (fusion [Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron Disease[Title]) OR ALS[Title]) = 
21 results 
((TARDBP [Title]) OR (TDP-43 [Title]) OR (fusion [Title])) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron 
Disease[Title]) OR ALS[Title]) = 24 results 
(VAPB [Title]) OR (Vesicle-associated membrane [Title])) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron 
Disease[Title]) OR ALS[Title]) = 6 results 
(NEFH [Title]) OR (neurofilament [Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron Disease[Title]) OR 
ALS[Title]) = 1 results 
(SPG11 [Title] AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron Disease[Title]) OR ALS[Title]) = 0 result 
OPTN [Title] OR optineurin [Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 
11 results 
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SETX [Title] OR Senataxin [Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 2 
results 
FIG4 [Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 0 
DCTN1 [Title] OR Dynactin [Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 3 
results 
TAF15 [Title] AND (mutation[Title] OR novel[Title]) AND (Amyotrophic Lateral Sclerosis[Title] OR Motor Neuron Disease[Title] OR ALS[Title]) = 1 results 
(VCP [Title] OR (valosin-containing protein [Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron 
Disease[Title]) OR ALS[Title]) = 4 results 
(DAO [Title] OR (D-amino-acid oxidase [Title]) AND (mutation[Title] OR novel [Title] )AND ((Amyotrophic Lateral Sclerosis[Title]) OR (Motor Neuron Disease[Title]) 
OR ALS[Title]) = 1 result 
 
Search terms on Google Scholar:  
SOD1 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 2050 results 
ALS2 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 546 results 
ANG novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 470 results 
FUS novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 2520 results 
TARDBP  TDP-43  novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 608 results 
VAPB novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 396 results 
NEFH novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 79 results 
SPG11 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 53 results 
OPTN novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 1850 results 
SETX novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 1020 results 
FIG4 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 930 results 
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DCTN1 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 261 results 
TAF15 novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 68 results 
VCP novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 404 results 
DAO novel mutations variants ALS "amyotrophic lateral sclerosis"  "motor neuron disease" = 52 results 
 
Additional databases: 
The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff on http://www.hgmd.cf.ac.uk/ac/index.php 
ALSGene by the Max Planck Institute for Molecular Genetics Berlin, the Alzheimer Research Forum and Prize4Life on http://www.alzgene.org/ 
ALS mutation database supported by the Ministry of Education Japan on http://reseq.biosciencedbc.jp/resequence/SearchDisease.do?targetId=1 
Online Mendelian Inheritance in Man (OMIM) on http://www.ncbi.nlm.nih.gov/omim 
Inclusion criteria: 
Amyotrophic Lateral Sclerosis 





Associated with other diseases 
Patients already examined in another study 
 
Data abstraction forms 
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Identification of data abstractor: 
Log in with username and password 
Add a mutation 
Select gene 
Select mutation location 
Select mutation type 
Select sequence position and trinucleotide 
Select new trinucleotide after mutation 
Select zygosity 
Select mutation documentation 
Input first author 
Input year of publication 
Input paper title 
Input full paper link 
Input Doi key (where available) 
Input country(s) where mutation is found 
Selected Phenotype by default (Amyotrophic Lateral Sclerosis) 
Input dbSNP 
Submit a patient 
Conduct preliminary screen to check if patient data needs to be submitted to database (like is subject affected?, any mutation found?, any mutations in subject’s 
family members?) 
Select or add a new family id (represented by first author and year e.g Smith 2009) 
Select gender 
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Select country of origin (where not available, consider where research was conducted) 
Select ethnic origin (where available) 
Select if dead or alive 
Choose gene 
Has patient been screened? 
Was mutation found? 
Is there a family history? 
Select affected or unaffected status. 
Select zygosity 
Select mutation 
Select site of onset and side of the body 
Input age of onset 
Input disease duration (in months) 
Select UMN or LMN or Cognitive signs 
Select phenotype (ALS or FTD or ALS-FTD or Unknown) 
Submit a gene 
Input  Gene ID  (e.g SOD1) 
Input  HGNC ID (e.g. 11179) 
Input  Ensemble ID (e.g. ENSG00000142168) 
Input  Swissport ID (e.g. P00441) 
Input  NCBI gene ID (e.g. 6647) 
Input  NCBI refseq ID (e.g. NM_000454) 
Input  Structure ID (e.g. uc002ypa.1) 
Input  OMIM ID (e.g. 147450) 
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Input  Genecards ID (e.g. SOD1) 
Input  Gene Name (e.g. Cu/Zn superoxide dismutase 1,...) 
Input  Keywords (e.g. SOD1) 
Input  Chromosome Name (e.g. 21) 
Input  Chromosome Position(e.g. q) 
Input  Chromosome Band (e.g. 22) 
Input  Chromosome Bp (e.g. 11) 
Input  Chromosome (e.g. 21q22.11) 
Input  Protein Name (e.g. superoxide dismutase 1, soluble) 
Input  Protein Function (e.g.destroys radicals which are.... ) 
Input  Phenotype (e.g. defects in sod1 are the cause of ALS...) 
Input  Gene comments (e.g. gene: sod1. [153 amino acids; 15 kd]) 
Input  Other_names (e.g. ALS1) 
Input  Accession ID (e.g. AY04978) 
Input  reason for investigation (e.g. Mutations in SOD1 account for 20% of familial ALS) 
Input  Result (e.g. 2-7% sporadic cases have mutations) 
Input  category (e.g OXIDATIVE STRESS) 
Input  Gene effect (e.g. FALS genes found in SALS) 
Input  iHop (e.g. 92317) 
Input  pdb_id (e.g. 2C9V) 
Input  dbSNP (e.g. rs92317) 
Input  pubmed_id 
Submit a replicated mutation 
Input  Gene ID 
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Input  Mutation 
Input  Codon 
Input  Exon 
Input  Number of Independent families 
How many generations were examined? 
How many PATIENTS were affected with the mutation? e.g. 5 
How many CONTROLS were affected with the mutation? e.g. 0 
How many Sporadic ALS patients were examined? e.g. 55 
How many Familial ALS patients were examined? e.g 50 
Is this mutation reported as SALS or FALS? 
Total number of cases examined e.g 15 
Total number of controls examined e.g 10 
LOD Score reported e.g 6.66 
Is a pedigree or Linkage analysis shown? 
Input  Country of origin 
Input  Ethnic Origin : 
Input  SNP (e.g. rs11010): 
Is mutation pathogenic ? 
Input  first Author 
Input  Year  
Input  Pubmed ID (e.g. 2020294) 
 
Characteristics of extracted data:  
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    ''' if the string is like '21:123455' or 'X:123' etc ''' 
    parts=pos_str.split(':') 
    if len(parts) != 2: 
        return False 
    if parts[0] not in ('1','2','3','4','5','6','7','8','9','10','11','12','13', 
          '14','15','16','17','18','19','20','21','22','X'): 
        return False  
    if parts[1].isdigit(): 
        return True 
    return False 
 
################################################################### 
# read the list of SNP positions from the input table  
snp_pos=set([]) 
ifile=open('population_frequency.txt') 
for line in ifile: 
    cols=line.split('\t') 
    if is_pos(cols[6]): 
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        snp_pos.add(cols[6]) 
    else:  
        continue 
ifile.close() 
# the input table is a bit missformatted on some lines (447,480) 
# for example: line 480 
# one extra tab after 'NP_001136.1:p.Phe100Ile'.  
# The position string is now in column 8, instead of column 7. 
# Removed it manually.  
################################################################### 
# for all files in directory 1kg  





for pos in snp_pos: 
    snp_lines[pos]='' 
 
for filename in os.listdir('.'): 
    ifile=open(filename) 
    for line in ifile: 
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        cols=line.split('\t') 
        pos_str=cols[0] 
        if pos_str in snp_pos: 
            if len(cols[1])==1 and len(cols[2])==1: # SNP  
                snp_lines[pos_str]=snp_lines[pos_str]+'\t'+line[:-1] 
            else: # indels 
                continue 






# re-open the input table, appending the lines from 1kg 
ifile=open('population_frequency.txt') 
for line in ifile: 
    cols=line.split('\t') 
    if cols[6] not in snp_pos: 
        print(line[:-1]) 
    else: 
        print(line[:-1]+'\t'+snp_lines[cols[6]]) 
ifile.close() 
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Appendix 8 - Data extraction from publications 
 





















Records after duplicates removed  
(n = 928) 
Records identified through 
database searching  



































Additional records identified 
through other sources  
(n = 134) 
Records screened  
(n = 723) 
Records excluded  
(n = 344) 
Articles assessed for eligibility  
(n = 379) 
Articles excluded  
(n = 154) 
- Animal models 
- Associated with other 
diseases 
- same patient cohort 
 
Studies included in qualitative 
synthesis  
(n = 225) 
Studies included in quantitative 
synthesis (meta-analysis) 
(n = 225) 
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Appendix 9 – Population Frequency script using python 
#!/usr/bin/env python3 
def is_pos(pos_str): 
    ''' if the string is like '21:123455' or 'X:123' etc ''' 
    parts=pos_str.split(':') 
    if len(parts) != 2: 
        return False 
    if parts[0] not in ('1','2','3','4','5','6','7','8','9','10','11','12','13','14','15','16','17','18','19','20','21','22','X'): 
        return False  
    if parts[1].isdigit(): 
        return True 
    return False 
 
################################################################################ 




for line in ifile: 
    cols=line.split('\t') 
    if is_pos(cols[6]): 
        snp_pos.add(cols[6]) 
    else:  
        continue 
ifile.close() 
# the input table is a bit missformatted on some lines (447,480) 
# for example: line 480 
# one extra tab after 'NP_001136.1:p.Phe100Ile'.  
# The position string is now in column 8, instead of column 7. 
# Removed it manually.  
 
################################################################################ 
# for all files in directory 1kg  
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for pos in snp_pos: 
    snp_lines[pos]='' 
 
for filename in os.listdir('.'): 
    ifile=open(filename) 
    for line in ifile: 
        cols=line.split('\t') 
        pos_str=cols[0] 
        if pos_str in snp_pos: 
            if len(cols[1])==1 and len(cols[2])==1: # SNP  
                snp_lines[pos_str]=snp_lines[pos_str]+'\t'+line[:-1] 
            else: # indels 
                continue 
    ifile.close() 
os.chdir('..') 
################################################################################ 
# re-open the input table, appending the lines from 1kg 
ifile=open('population_frequency.txt') 
for line in ifile: 
    cols=line.split('\t') 
    if cols[6] not in snp_pos: 
        print(line[:-1]) 
    else: 
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Using Google Engine for app development 
 
 





checked all java processes 
 























































 - 389 - 
 
  
 - 390 - 
Appendix 11 – SurveyMonkey screenshot 
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Appendix 12 – Script for Blog 
<script language="c#" runat="server"> 
protected void Page_Load(object sender, System.EventArgs e) 
  { 
   // Put user code to initialize the page here 
   if (IsPostBack) 
   { 
 
   } 
   else 
   { 
    // initialize Blog and read it into a dataset 
    DataSet ds = ReadBlogIntoTable(); 
 
    // if we created a new entry, append it to the BlogList 
    // and save it to the xml file 
    if ( (bool)Session["Changed"]) 
    { 
     AppendComments(ds); 
     WriteXmlComments(ds); 
     Session["Changed"] = false; 
    } 
 
    // Dynamically build the blog into a WebControls.Table 
    RebuildTableView(ds); 
   } 
  } 
 
  DataSet ReadBlogIntoTable() 
  { 
   return ReadXmlComments(); 
  } 
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  private DataSet ReadXmlComments() 
  { 
   // construct the DataSet 
   DataSet ds = new DataSet(); 
 
   // form the server path of the feedback database 
   string filename = Server.MapPath(".\\") + "comments.xml"; 
 
   // if the file exists, read  the blog database into the data set 
   if (File.Exists(filename)) 
   { 
    ds.ReadXml(filename); 
   } 
   else 
   { 
    // otherwise we need to create a new new in-memory  
    // Database table from scratch 
    DataTable theTable = new DataTable("Comments"); 
    ds.Tables.Add(theTable); 
 
    // add a name, time, title, and blog columns to our mock-up blog 
database 
    theTable.Columns.Add("Name", Type.GetType("System.String")); 
    theTable.Columns.Add("Time", Type.GetType("System.DateTime")); 
    theTable.Columns.Add("Title", Type.GetType("System.String")); 
    theTable.Columns.Add("Blog", Type.GetType("System.String")); 
   } 
 
   return ds; 
  } 
 
  private void WriteXmlComments(DataSet ds) 
  { 
   string filename = Server.MapPath(".\\") + "comments.xml"; 
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   ds.WriteXml(filename); 
  } 
 
  /// <summary> 
  ///  Append comments to xml file 
  /// </summary> 
  /// <param name="ds"></param> 
  void AppendComments(DataSet ds) 
  { 
   // create a new DataRow 
   DataRow dr = ds.Tables["Comments"].NewRow(); 
   // Populate the row from the text boxes filled by the user 
   dr[0] = Session["Name"]; 
   dr[1] = DateTime.Now; 
   dr[2] = Session["Title"]; 
   dr[3] = Session["Blog"]; 
 
   // add the row to the DataSet 
   ds.Tables["Comments"].Rows.InsertAt(dr, 0); 
 
   WriteXmlComments(ds); 
  } 
 
  void RebuildTableView(DataSet ds) 
  { 
   string previousUser = "";  // track previous 
 
   // loop through each row in the data set and create 
   // the row on the web page in a web table 
   foreach (DataRow dr in ds.Tables[0].Rows) 
   { 
     // add title (use a single column) 
     TableRow tr = new TableRow(); 
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     tr.Cells.Add(new TableCell()); 
 
     // change title color slightly 
     tr.Cells[0].ForeColor = Color.Navy; 
     tr.Cells[0].Width = 500; 
      
    //  make the text title big and purple 
     tr.Cells[0].Text = "<FONT SIZE=5 COLOR=purple 
FACE=Rockwell><B>" + dr[2].ToString() + "</B></FONT>"; 
     this.BlogTable.Rows.Add(tr); 
 
     // add blog in a single column and span 2 columns 
     tr = new TableRow(); 
     tr.Cells.Add(new TableCell()); 
     tr.Cells[0].Width = 550; 
     tr.Cells[0].ColumnSpan = 2; 
     tr.Cells[0].Text = dr[3].ToString(); 
     this.BlogTable.Rows.Add(tr); 
 
     // add user who posted and date (use two columns in the 
row) 
     tr = new TableRow(); 
     tr.Height = 50; 
     tr.HorizontalAlign = HorizontalAlign.Left; 
     tr.VerticalAlign = VerticalAlign.Bottom; 
     tr.Cells.Add(new TableCell()); 
     tr.Cells.Add(new TableCell()); 
      
 
     tr.Cells[0].Text = "Posted by " + dr[0].ToString(); 
     DateTime postTime = DateTime.Parse(dr[1].ToString()); 
     tr.Cells[1].HorizontalAlign = HorizontalAlign.Right; 
      
     tr.Cells[1].Text = String.Format("<i>{0}</i>", 
postTime.ToString("MMM dd, 2005 @ hh:mm")); 
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     this.BlogTable.Rows.Add(tr); 
 
     // add separtor graphic and span 2 columns 
     tr = new TableRow(); 
     tr.Cells.Add(new TableCell()); 
     tr.Cells.Add(new TableCell()); 
     tr.Cells[0].ColumnSpan  = 2; 
      
     this.BlogTable.Rows.Add(tr); 
 
     string imageFile = this.ResolveUrl( 
@".\images\separator.jpg"); 
     System.Web.UI.WebControls.Image separator = new 
System.Web.UI.WebControls.Image(); 
     separator.ImageUrl = imageFile; 
     separator.Width = 600; 
     separator.Height = 32; 
     separator.Visible = true; 
      
     tr.Cells[0].Controls.Add(separator); 
     tr.Cells[0].HorizontalAlign = HorizontalAlign.Center; 
      
 
    } 
 
  } 
 
 
  #region Web Form Designer generated code 
  override protected void OnInit(EventArgs e) 
  { 
   // 
   // CODEGEN: This call is required by the ASP.NET Web Form Designer. 
   // 
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   InitializeComponent(); 
   base.OnInit(e); 
  } 
   
  /// <summary> 
  /// Required method for Designer support - do not modify 
  /// the contents of this method with the code editor. 
  /// </summary> 
  private void InitializeComponent() 
  {     
 
  } 
  #endregion 
 
  protected void btnOpenEntry_Click(object sender, System.EventArgs e) 
  { 
   Response.Redirect("BlogEntry.aspx"); 
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Appendix 13 – Masterpage Websitemap 
Treeview 
<%@ Page Language="C#" MasterPageFile="~/master/MasterPage.master"%> 
              
<asp:Content ID="Content1" ContentPlaceHolderID="ContentPlaceHolder1" 
Runat="Server"> 
<asp:TreeView ID="TreeView1" runat="server"> 
          <Nodes> 
            <asp:TreeNode Text="ALSoD Masterpage"> 
            <asp:TreeNode Text="Homepage" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/index.aspx"/> 
              <asp:TreeNode Text="Analysis"> 
                <asp:TreeNode Text="Detailed Analysis" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/analysis.aspx" />   
                <asp:TreeNode Text="Interactions" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/overview/interaction.aspx"/>   
                <asp:TreeNode Text="Side-by-side comparison" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/statistics.aspx" />  
                <asp:TreeNode Text="Predict Pathogenicity" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/pathogenicity.aspx" />  
                <asp:TreeNode Text="Gene Credibility" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx" />    
                </asp:TreeNode> 
               <asp:TreeNode Text="Summary"> 
                <asp:TreeNode Text="Genetic Data Report" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/report.aspx" />   
                <asp:TreeNode Text="Search" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/index7.aspx"/>   
                <asp:TreeNode Text="Database Summary" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Summary/summary.aspx" /> 
                </asp:TreeNode> 
                <asp:TreeNode Text="GWAS"> 
                <asp:TreeNode Text="GWAS 5 populations" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/GWA2/index.aspx" />   
                <asp:TreeNode Text="GWAS by Fogh 2013" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/GWA2/gwas_fogh.aspx"/>   
                <asp:TreeNode Text="Help" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/misc/analysiserror.aspx" />  
                </asp:TreeNode> 
                <asp:TreeNode Text="News"> 
                <asp:TreeNode Text="Latest News" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Search/searchWeb.aspx" > 




                    <asp:TreeNode Text="als.net forum" 
NavigateUrl="http://www.als.net/forum/ "/> 
                    <asp:TreeNode Text="bbc.co.uk" 
NavigateUrl="http://news.bbc.co.uk/1/hi/health/8045795.stm"/> 
                    <asp:TreeNode Text="medical news" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/misc/diseaseDetails.aspx"/> 
                    <asp:TreeNode Text="RSS feeds" 
NavigateUrl="http://pipes.yahoo.com/pipes/pipe.run?_id=7d74ac65a4586449b1d7
579dfbae9beb&_render=rss" /> 
                    <asp:TreeNode Text="Google Search" > 
                        <asp:TreeNode Text="News" /> 
                        <asp:TreeNode Text="Web" /> 
                        <asp:TreeNode Text="Blog" /> 
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                        <asp:TreeNode Text="Book" /> 
                        <asp:TreeNode Text="Patent" /> 
                    </asp:TreeNode> 
                </asp:TreeNode>   
                <asp:TreeNode Text="Blogs" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/BlogList.aspx" />   
                <asp:TreeNode Text="Social Media" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/misc/socialmedia.aspx" > 
                    <asp:TreeNode Text="Facebook" /> 
                    <asp:TreeNode Text="Twitter" /> 
                </asp:TreeNode>     
                </asp:TreeNode> 
                <asp:TreeNode Text="Data"> 
                <asp:TreeNode Text="Detailed Analysis" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/analysis.aspx" />   
                <asp:TreeNode Text="Interactions" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/overview/interaction.aspx"/>   
                <asp:TreeNode Text="Side-by-side comparison" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/statistics.aspx" />  
                <asp:TreeNode Text="Predict Pathogenicity" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/pathogenicity.aspx" />  
                <asp:TreeNode Text="Gene Credibility" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx" />    
                </asp:TreeNode> 
                <asp:TreeNode Text="Contributors"> 
                <asp:TreeNode Text="Detailed Analysis" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/analysis.aspx" />   
                <asp:TreeNode Text="Interactions" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/overview/interaction.aspx"/>   
                <asp:TreeNode Text="Side-by-side comparison" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/statistics.aspx" />  
                <asp:TreeNode Text="Predict Pathogenicity" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/pathogenicity.aspx" />  
                <asp:TreeNode Text="Gene Credibility" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx" />    
                </asp:TreeNode> 
                <asp:TreeNode Text="Feedback"> 
                <asp:TreeNode Text="Detailed Analysis" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/analysis.aspx" />   
                <asp:TreeNode Text="Interactions" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/overview/interaction.aspx"/>   
                <asp:TreeNode Text="Side-by-side comparison" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/statistics.aspx" />  
                <asp:TreeNode Text="Predict Pathogenicity" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/pathogenicity.aspx" />  
                <asp:TreeNode Text="Gene Credibility" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Statistics/credibility.aspx" />    
                </asp:TreeNode> 
              </asp:TreeNode> 
              <asp:TreeNode Text="Top section"> 
                <asp:TreeNode Text="Login" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/login/loginAuthenticate.aspx"/> 
                <asp:TreeNode Text="Feedback" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/contact/guestbook.aspx"/> 
                <asp:TreeNode Text="Help" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/misc/FAQs.aspx"/> 
                <asp:TreeNode Text="Register" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/login/preSign0.aspx" /> 
                <asp:TreeNode Text="Cookies" 
NavigateUrl="http://www.aboutcookies.org/default.aspx?page=5"/> 
                <asp:TreeNode Text="Print" /> 
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                <asp:TreeNode Text="Cite us" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/contact/contact.aspx"/> 
                <asp:TreeNode Text="Sitemap" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/maps/treeview.aspx"/> 
              </asp:TreeNode> 
              <asp:TreeNode Text="Left section"> 
                <asp:TreeNode Text="Chromosomes"> 
                <asp:TreeNode Text="Chromosome 1" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo1.aspx"/> 
                <asp:TreeNode Text="Chromosome 2" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo2.aspx"/> 
                <asp:TreeNode Text="Chromosome 3" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo3.aspx"/> 
                <asp:TreeNode Text="Chromosome 4" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo4.aspx"/> 
                <asp:TreeNode Text="Chromosome 5" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo5.aspx"/> 
                <asp:TreeNode Text="Chromosome 6" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo6.aspx"/> 
                <asp:TreeNode Text="Chromosome 7" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo7.aspx"/> 
                <asp:TreeNode Text="Chromosome 8" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo8.aspx"/> 
                <asp:TreeNode Text="Chromosome 9" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo9.aspx"/> 
                <asp:TreeNode Text="Chromosome 10" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo10.aspx"/> 
                <asp:TreeNode Text="Chromosome 11" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo11.aspx"/> 
                <asp:TreeNode Text="Chromosome 12" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo12.aspx"/> 
                <asp:TreeNode Text="Chromosome 13" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo13.aspx"/> 
                <asp:TreeNode Text="Chromosome 14" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo14.aspx"/> 
                <asp:TreeNode Text="Chromosome 15" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo15.aspx"/> 
                <asp:TreeNode Text="Chromosome 16" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo16.aspx"/> 
                <asp:TreeNode Text="Chromosome 17" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo17.aspx"/> 
                <asp:TreeNode Text="Chromosome 18" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo18.aspx"/> 
                <asp:TreeNode Text="Chromosome 19" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo19.aspx"/> 
                <asp:TreeNode Text="Chromosome 20" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo20.aspx"/> 
                <asp:TreeNode Text="Chromosome 21" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo21.aspx"/> 
                <asp:TreeNode Text="Chromosome 22" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromo22.aspx"/> 
                <asp:TreeNode Text="Chromosome ALL" 
NavigateUrl="http://alsod.iop.kcl.ac.uk/Chromosomes/chromoALL.aspx"/> 
                </asp:TreeNode> 
                <asp:TreeNode Text="Funders" /> 
                <asp:TreeNode Text="Visit Statistics" /> 
                <asp:TreeNode Text="Facebook" /> 
              </asp:TreeNode> 
          </Nodes> 
        </asp:TreeView> 
</asp:Content> 
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Map on http://alsod.iop.kcl.ac.uk/maps/treeview.aspx 
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Map on http://alsod.iop.kcl.ac.uk/Web.sitemap 
 
<?xml version="1.0" encoding="utf-8" ?> 
<siteMap xmlns="http://schemas.microsoft.com/AspNet/SiteMap-File-1.0" > 
    <siteMapNode url="~/index.aspx" title="Home"  description=""> 
        <siteMapNode url="~/reports/reportSummary.aspx" title="Genes"  
description="" > 
      <siteMapNode url="~/Applets/TARDBP(TDP43)species.aspx" 
title="TARDBP(TDP43) Alignment and Mutation"  description="" /> 
      <siteMapNode url="~/Applets/SOD1species.aspx" title="SOD1 Alignment 
and Mutation"  description="" /> 
      <siteMapNode url="~/Applets/FUSspecies.aspx" title="FUS Alignment and 
Mutation"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo1.aspx" title="Chromosome 
1"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo2.aspx" title="Chromosome 
2"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo3.aspx" title="Chromosome 
3"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo4.aspx" title="Chromosome 
4"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo5.aspx" title="Chromosome 
5"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo6.aspx" title="Chromosome 
6"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo7.aspx" title="Chromosome 
7"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo8.aspx" title="Chromosome 
8"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo9.aspx" title="Chromosome 
9"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo10.aspx" title="Chromosome 
10"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo11.aspx" title="Chromosome 
11"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo12.aspx" title="Chromosome 
12"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo13.aspx" title="Chromosome 
13"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo14.aspx" title="Chromosome 
14"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo15.aspx" title="Chromosome 
15"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo16.aspx" title="Chromosome 
16"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo17.aspx" title="Chromosome 
17"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo18.aspx" title="Chromosome 
18"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo19.aspx" title="Chromosome 
19"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo20.aspx" title="Chromosome 
20"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo21.aspx" title="Chromosome 
21"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo22.aspx" title="Chromosome 
22"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromo23.aspx" title="Chromosome 
23"  description="" /> 
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          <siteMapNode url="~/Chromosomes/chromo24.aspx" title="Chromosome 
24"  description="" /> 
          <siteMapNode url="~/Chromosomes/chromoAll.aspx" title="All 
Chromosomes"  description="" /> 
    </siteMapNode> 
      <siteMapNode url="~/Statistics/analysis.aspx" title="Analysis"  
description=""> 
        <siteMapNode url="~/Overview/interaction.aspx" title="Interactions"  
description="" /> 
        <siteMapNode url="~/Statistics/statistics.aspx" title="Side-by-side 
Comparison"  description="" /> 
        <siteMapNode url="~/Statistics/report.aspx" title="Summary Report"  
description="" /> 
        <siteMapNode url="~/Statistics/credibility.aspx" title="Gene 
Credibility Score"  description="" /> 
        <siteMapNode url="~/Statistics/pathogenicity.aspx" 
title="Pathogenicity"  description="" /> 
      </siteMapNode> 
      <siteMapNode url="~/index7.aspx" title="Summary"  description="" /> 
      <siteMapNode url="~/Overview/search.aspx" title="Search"  
description="" /> 
      <siteMapNode url="~/summary/summary.aspx" title="Database Search"  
description=""> 
        <siteMapNode url="~/subjects/index.aspx" title="Patient data"  
description="" /> 
        <siteMapNode url="~/misc/Top10.aspx" title="Last 10 submissions"  
description="" /> 
        <siteMapNode url="~/misc/diseaseDetails.aspx" title="Disease"  
description="" /> 
        <siteMapNode url="~/misc/literature.aspx" title="Literature"  
description="" /> 
        <siteMapNode url="~/misc/usefulLinks.aspx" title="Useful Links"  
description="" /> 
      </siteMapNode> 
      <siteMapNode url="~/Search/searchWeb.aspx" title="ALS News"  
description="" > 
          <siteMapNode url="~/BlogList.aspx" title="View comments"  
description="" /> 
          <siteMapNode url="~/BlogEntry.aspx" title="Make a comment"  
description="" /> 
        </siteMapNode> 
 
 
      <siteMapNode url="~/charts/index.aspx" title="Visitors Statistics"  
description="" /> 
      <siteMapNode url="~/GWA2/index.aspx" title="GWAS"  description=""> 
        <siteMapNode url="~/GWA2/whole.aspx" title="Whole Genome"  
description="" /> 
        <siteMapNode url="~/GWA2/chisquare.aspx" title="On-the-fly 
analysis"  description="" /> 
        <siteMapNode url="~/GWA2/gwa.aspx" title="meta-analysis"  
description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo1.aspx" title="Chromosome 
1"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo2.aspx" title="Chromosome 
2"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo3.aspx" title="Chromosome 
3"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo4.aspx" title="Chromosome 
4"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo5.aspx" title="Chromosome 
5"  description="" /> 
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        <siteMapNode url="~/DataSets/Tracks/chromo6.aspx" title="Chromosome 
6"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo7.aspx" title="Chromosome 
7"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo8.aspx" title="Chromosome 
8"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo9.aspx" title="Chromosome 
9"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo10.aspx" 
title="Chromosome 10"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo11.aspx" 
title="Chromosome 11"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo12.aspx" 
title="Chromosome 12"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo13.aspx" 
title="Chromosome 13"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo14.aspx" 
title="Chromosome 14"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo15.aspx" 
title="Chromosome 15"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo16.aspx" 
title="Chromosome 16"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo17.aspx" 
title="Chromosome 17"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo18.aspx" 
title="Chromosome 18"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo19.aspx" 
title="Chromosome 19"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo20.aspx" 
title="Chromosome 20"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo21.aspx" 
title="Chromosome 21"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromo22.aspx" 
title="Chromosome 22"  description="" /> 
        <siteMapNode url="~/DataSets/Tracks/chromoX.aspx" title="Chromosome 
X"  description="" /> 
      </siteMapNode> 
        <siteMapNode url="~/Overview/gene.aspx" title="Gene Overview"  
description="" > 
          <siteMapNode url="~/reports/allPatients.aspx" title="Patients in 
database"  description="" /> 
          </siteMapNode> 
      <siteMapNode url="~/Overview/protein.aspx" title="Protein Overview"  
description="" /> 
        <siteMapNode url="~/Overview/study.aspx" title="Gene Study"  
description="" /> 
        <siteMapNode url="~/misc/contributors.aspx" title="Contributors"  
description="" > 
        <siteMapNode url="~/registration/contributors_detail.aspx" 
title="Contributors' details"  description="" />   
        </siteMapNode> 
      <siteMapNode url="~/misc/labs.aspx" title="Laboratories"  
description="" /> 
        <siteMapNode url="~/contact/contact.aspx" title="Contact Us"  
description="" /> 
        <siteMapNode url="~/misc/dataDownload.aspx" title="Mutation Data"  
description="" /> 
        <siteMapNode url="~/contact/guestbook.aspx" title="Feedback"  
description="" /> 
        <siteMapNode url="~/misc/FAQs.aspx" title="FAQs"  description="" /> 
      <siteMapNode url="~/misc/resources.aspx" title="Resources and Links"  
description="" /> 
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      <siteMapNode url="~/database/gene/credibilitySurveymonkey.aspx" 
title="Credibility Survey by ALS Experts"  description="" /> 
        <siteMapNode url="~/mutations/mutationsFound.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundCodon.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundGeneOnly.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundMnemonicOnly.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundNoMnemonic.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundNoType.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/mutations/mutationsFoundTypeOnly.aspx" 
title="Mutations"  description="" /> 
      <siteMapNode url="~/results/showMutationDetails.aspx" title="Mutation 
Details"  description="" /> 
      <siteMapNode url="~/results/showPatients.aspx" title="Patient 
Details"  description="" /> 
      <siteMapNode url="~/login/loginAuthenticate.aspx" title="Login"  
description="" /> 
 <siteMapNode url="~/database/patient/submitPatient000.aspx" 
title="Submit patient data (1 of 5)"  description="" /> 
      <siteMapNode url="~/database/patient/submitPatient001.aspx" 
title="Submit patient data (2 of 5)"  description="" /> 
 <siteMapNode url="~/database/patient/submitPatient002.aspx" 
title="Submit patient data (3 of 5)"  description="" /> 
      <siteMapNode url="~/database/patient/submitPatient003.aspx" 
title="Submit patient data (4 of 5)"  description="" /> 
      <siteMapNode url="~/database/patient/submitPatient004.aspx" 
title="Submit patient data (5 of 5)"  description="" /> 
      <siteMapNode url="~/database/gene/credibilitySurvey.aspx" 
title="Credibility Survey by ALS Experts"  description="" /> 
        <siteMapNode url="~/misc/Thankyou.aspx" title="Thank you"  
description="" /> 
        <siteMapNode url="~/login/securePage.aspx" title="Login"  
description="" > 
          <siteMapNode 
url="~/database/mutation/deletionEnterMutationDetails.aspx" title="Enter 
details"  description="" /> 
          <siteMapNode 
url="~/database/mutation/enterIntronMutationDocumentation.aspx" 
title="Enter Documentation"  description="" /> 
          <siteMapNode 
url="~/database/mutation/enterMutationDocumentation.aspx" title="Enter 
Documentation"  description="" /> 
          <siteMapNode 
url="~/database/mutation/enterMutationTypeLocation.aspx" title="Enter 
Mutation Location"  description="" /> 
          <siteMapNode url="~/database/mutation/exonChooseCodon.aspx" 
title="Choose Codon"  description="" /> 
          <siteMapNode 
url="~/database/mutation/exonChooseNucleotidePosition.aspx" title="Choose 
Nucleotide Position"  description="" /> 
          <siteMapNode 
url="~/database/mutation/exonEnterMutationDetails.aspx" title="Enter 
Details"  description="" /> 
          <siteMapNode url="~/database/mutation/exonMutationDetails.aspx" 
title="Mutation Details"  description="" /> 
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          <siteMapNode 
url="~/database/mutation/intronEnterMutationDetails.aspx" title="Enter 
Details"  description="" /> 
          <siteMapNode url="~/database/mutation/readyToSubmitMutation.aspx" 
title="Submit"  description="" /> 
          <siteMapNode 
url="~/database/mutation/verifyIntronMutationDetails.aspx" title="Verify 
Details"  description="" /> 
          <siteMapNode url="~/database/mutation/verifyMutationDetails.aspx" 
title="Verify Details"  description="" /> 
        </siteMapNode> 
      <siteMapNode url="~/maps/mutationmap.aspx" title="Google Earth 
Mutation Map"  description="" /> 









 - 408 - 
Appendix 14 – Tracking visitors script 
protected void Page_Load(object sender, EventArgs e) 
    { 
 
//Method for Mobile device detection 
        DetectUserAgent(); 
        this.countMe(); 
  DataSet tmpDs = new DataSet(); 
        tmpDs.ReadXml(Server.MapPath("~/count/counter.xml")); 
        lblCounter.Text = tmpDs.Tables[0].Rows[0]["hits"].ToString(); 
 
//Track Visitors’ hostname  
        string hostName = 
System.Net.Dns.GetHostEntry(Request.ServerVariables["SERVER_NAME"]).HostName;  
        
      //Convert IP Address to IP Number 
        string ipAddress = GetIP4Address(); 
        string[] arrDec; 
        UInt64 ipnum = 0; 
        if (ipAddress != "") 
        { 
            arrDec = ipAddress.Split('.'); 
            ipnum = (UInt64.Parse(arrDec[3])) + (UInt64.Parse(arrDec[2]) * 256) + 
(UInt64.Parse(arrDec[1]) * 65536) + (UInt64.Parse(arrDec[0]) * 16777216); 
        } 
  Label4.Text = ipnum.ToString(); 
//Get country of visitor 
        String country; 
        DataView dv2 = (DataView)SqlDataSource2.Select(DataSourceSelectArguments.Empty); 
        if (dv2.Table.Rows.Count > 0) 
        { 
            country = (string)dv2.Table.Rows[0][0]; 
        } 
        else 
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        { 
            country = "Unknown"; 
        } 
        Label7.Text = country; 
         
        //Get country code of visitor 
        String countrycode; 
        DataView dv3 = (DataView)SqlDataSource2.Select(DataSourceSelectArguments.Empty); 
        if (dv3.Table.Rows.Count > 0) 
        { 
            countrycode = (string)dv2.Table.Rows[0][1]; 
        } 
        else 
        { 
            countrycode = "NIL"; 
        } 
        Label8.Text = countrycode; 
      
         //Write to visitors.log 
        StreamWriter wrtr = new StreamWriter(Server.MapPath("~/visitors.log"), true); 
        wrtr.WriteLine(DateTime.Now.ToString() + " | " + ipAddress + " | " + hostName + " | " + country + 
" | " + Request.Url.ToString()); 
        wrtr.Close(); 
     
      //Write same data saved in visitor’s log into database 
    String DBconnection = 
ConfigurationManager.ConnectionStrings["alsodConnectionString1"].ToString(); 
    SqlConnection con = new SqlConnection(DBconnection); 
    SqlCommand cmd = new SqlCommand("INSERT INTO [visitors] (DateTime, IPAddress, Host, 
Country, CountryCode, Page)VALUES(@DateTime, @IPAddress, @Host, @Country, 
@CountryCode, @Page)", con); 
    cmd.Parameters.Add(new SqlParameter("@DateTime", DateTime.Now.ToString("F"))); 
    cmd.Parameters.Add(new SqlParameter("@IPAddress", ipAddress)); 
    cmd.Parameters.Add(new SqlParameter("@Host", hostName)); 
    cmd.Parameters.Add(new SqlParameter("@Country", country)); 
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    cmd.Parameters.Add(new SqlParameter("@CountryCode", countrycode)); 
    cmd.Parameters.Add(new SqlParameter("@Page", Request.Url.ToString())); 
    cmd.Connection.Open(); 
    cmd.ExecuteNonQuery(); 
    cmd.Connection.Close(); 
         
        //Using Database to store counter 
        DataView dv1 = (DataView)SqlDataSource1.Select(DataSourceSelectArguments.Empty); 
        int count = (int)dv1[0][0]; 
        count = count + 1; 
        SqlDataSource1.UpdateCommand = "UPDATE [COUNTER] SET [COUNT] = " + count; 
        SqlDataSource1.Update(); 
        DataView users = ((DataView)SqlDataSource3.Select(DataSourceSelectArguments.Empty)); 
        Label9.Text = users.Table.Rows[0][0].ToString();  
         
   } 
 
    private string IpAddress() 
    { 
        string strIpAddress; 
        strIpAddress = Request.ServerVariables["HTTP_X_FORWARDED_FOR"]; 
        if (strIpAddress == null) 
            strIpAddress = Request.ServerVariables["REMOTE_ADDR"]; 
        return strIpAddress; 
    } 
 
    public static string GetIP4Address() 
    { 
    string IP4Address = String.Empty; 
foreach (IPAddress IPA in Dns.GetHostAddresses(HttpContext.Current.Request.UserHostAddress)) 
    { 
      if (IPA.AddressFamily.ToString() == "InterNetwork") 
      { 
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        IP4Address = IPA.ToString(); 
        break; 
      } 
    } 
 
    if (IP4Address != String.Empty) 
    { 
      return IP4Address; 
    } 
 
    foreach (IPAddress IPA in Dns.GetHostAddresses(Dns.GetHostName())) 
    { 
      if (IPA.AddressFamily.ToString() == "InterNetwork") 
      { 
        IP4Address = IPA.ToString(); 
        break; 
      } 
    } 
 
    return IP4Address; 
   } 
 
    private void countMe() 
    { 
        DataSet tmpDs = new DataSet(); 
        tmpDs.ReadXml(Server.MapPath("~/count/counter.xml")); 
        int hits = Int32.Parse(tmpDs.Tables[0].Rows[0]["hits"].ToString()); 
        hits += 1; 
        tmpDs.Tables[0].Rows[0]["hits"] = hits.ToString(); 
        tmpDs.WriteXml(Server.MapPath("~/count/counter.xml")); 
    }  
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Appendix 15 – Inserting association text files into SQL Server 
BULK INSERT dbo.[GWA_NOKEY] 
FROM '\\vm3\Alsod\DataSets\uk\uk_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 





BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\bos\bos_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\hol\hol_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\fra\fra_result_assoc.txt'             
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WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\usa\usa_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 
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Appendix 16 – ALTER TABLE for inserting ID and population 
column 
---Insert ID and Population column 
ALTER TABLE dbo.GWA_NOKEY 
ADD ID INT IDENTITY(1,1); 
GO 
 
ALTER TABLE dbo.GWA_NOKEY 
ADD POP VARCHAR(50); 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'UK' 
WHERE ID BETWEEN 1 AND 275619 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'BOSTON' 
WHERE ID BETWEEN 275620 AND 558067 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'HOLLAND' 
WHERE ID BETWEEN 558068 AND 846203 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'FRANCE' 
WHERE ID BETWEEN 846204 AND 1132710 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'USA' 
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Appendix 17 – Codes for creating scientific hyperlinks section 
Entrez Gene [526] – An NCBI information 
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6647&ord
inalpos=3&itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum 
 The codes on ASP.NET to generate this link are as shown below: 
Dim ALSgene As String = http://www.alsgene.org/geneoverview.asp?geneid= 
Dim dv20 As DataView 
Dim ALSgene_id As String 
dv20 = CType(SqlDataSource20.Select(DataSourceSelectArguments.Empty), DataView) 
ALSgene_id = CType(dv20.Table.Rows(0)(0), String) 
Label32.Text = ALSgene + ALSgene_id 
HyperLink32.NavigateUrl = Label32.Text 
 
'Shows ALSgene links available 
        If (ALSgene_id <> 0) Then 
     HyperLink32.Visible = "true" 
        Else 
            HyperLink32.Visible = "false" 
        End If 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource20" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ALSgene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 
UCSC Browser [527] – Genome browser 
http://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&db=hg19&position=chr21:33,031,935-
33,041,241 
 The codes on ASP.NET to generate this link are as shown below: 
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Dim UCSCDetails As String = “http://genome.ucsc.edu/cgi-
bin/hgTracks?Submit=Submit&db=hg19&position=” 
Dim dv2 As DataView 
Dim UCSC As String 
dv2 = CType(SqlDataSource4.Select(DataSourceSelectArguments.Empty), DataView) 
      UCSC = CType(dv2.Table.Rows(0)(0), String) 
Label2.Text = UCSCDetails + UCSC 
HyperLink2.NavigateUrl = Label2.Text 
 
<asp:HyperLink ID="HyperLink2" runat="server" Target="_blank" ToolTip="UCSC Genome Browser 
in Human">UCSC Browser</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource2" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [Lastname], [Year],[gene_id],[Title],[PMID],[Paperlink] FROM 
dbo.gene_study WHERE ([gene_id] = @gene_id) UNION SELECT DISTINCT first_author, year, 
gene_id, title, pubmed_id, link FROM dbo.mutation WHERE (gene_id = @gene_id) AND (first_author 
<> 'NULL') UNION SELECT DISTINCT First_Author, Year, gene_id, paperlink, pubmed_id, link 
FROM dbo.gene_SNP_updated WHERE (First_Author <> 'NULL') AND (paperlink <> 'NULL') AND 
(gene_id = @gene_id)"> 
        <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
Protein Structure[528] – Protein Domain and structure information as displayed on the UCSC Website 
http://genome.cse.ucsc.edu/cgi-bin/hgGene?hgg_gene=uc002ypa.1#domains 
 The codes on ASP.NET to generate this link are as shown below: 
Dim StructureDiagram As String = "http://genome.cse.ucsc.edu/cgi-bin/hgGene?hgg_gene=" 
Dim dv3 As DataView 
Dim Diagram As String 
dv3 = CType(SqlDataSource5.Select(DataSourceSelectArguments.Empty), DataView) 
      Diagram = CType(dv3.Table.Rows(0)(0), String) 
Label3.Text = StructureDiagram + Diagram + exactlocation 
HyperLink3.NavigateUrl = Label3.Text 
 
<asp:HyperLink ID="HyperLink3" runat="server" Target="_blank" ToolTip="3D structure of 
gene">Protein Structure</asp:HyperLink>&nbsp;&nbsp; 
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<asp:SqlDataSource ID="SqlDataSource5" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [structure_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource>  
OMIM [529, 530] – It shows extensive information from the Online Mendelian Inheritance in Man 
database updated –though not regularly- by the research community. 
http://www.ncbi.nlm.nih.gov/omim/147450 
 The codes on ASP.NET to generate this link are as shown below: 
Dim OmimUrl As String = “http://www.ncbi.nlm.nih.gov/omim/” 
Dim omim As String 
Dim dv4 As DataView 
dv4 = CType(SqlDataSource6.Select(DataSourceSelectArguments.Empty), DataView) 
      omim = CType(dv4.Table.Rows(0)(0), String) 
Label4.Text = OmimUrl + omim 
HyperLink4.NavigateUrl = Label4.Text 
  
 
<asp:HyperLink ID="HyperLink4" runat="server" Target="_blank" ToolTip="Shows the Online 
Mendelian Inheritance In Man">OMIM</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource6" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [omim_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
Genecards[531] – These also show users an overview of gene information curated for research 
purpose. 
http://www.genecards.org/cgi-bin/carddisp.pl?id=11179&id_type=hgnc&search=11179 
 The codes on ASP.NET to generate this link are as shown below: 
Dim geneCardUrl1 As String = "http://www.genecards.org/cgi-bin/carddisp.pl?id=" 
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Dim geneCardUrl2 As String = "&id_type=hgnc&search=" 
Dim dv5 As DataView 
Dim hgnc As String 
dv5 = CType(SqlDataSource7.Select(DataSourceSelectArguments.Empty), DataView) 
hgnc = CType(dv5.Table.Rows(0)(0), String) 
Label5.Text = geneCardUrl1 + hgnc + geneCardUrl2 + hgnc 
HyperLink5.NavigateUrl = Label5.Text 
 
<asp:HyperLink ID="HyperLink5" runat="server" Target="_blank" ToolTip="Shows the summary on 
gene">Genecards</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource7" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [hgnc_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 
Full Literature – This displays the result of a pubmed query e.g. for SOD1 gene, “SOD1[All Fields] 
AND amyotrophic lateral sclerosis/genetics[mh] AND motor neuron disease/genetics[mh] AND 
"humans"[MeSH Terms] AND english[la]” 
The codes on ASP.NET to generate this link are as shown below: 
Dim literatureSearchUrl1 As String = 
"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&term=" 
 Dim literatureSearchUrl2 As String = 
"+AND+amyotrophic+lateral+sclerosis+/+genetics*[mh]+Motor+Neuron+Disease+/+genetics*[mh]+AN
D+humans[mh]AND+english[la]&db=PubMed&orig_db=PubMed&filters=on" 
Dim dv7 As DataView 
      Dim keywords As String 
dv7 = CType(SqlDataSource9.Select(DataSourceSelectArguments.Empty), DataView) 
      keywords = CType(dv7.Table.Rows(0)(0), String) 
Label6.Text = literatureSearchUrl1 + keywords + literatureSearchUrl2 
HyperLink6.NavigateUrl = Label6.Text 
 
<asp:HyperLink ID="HyperLink6" runat="server" Target="_blank" ToolTip="Shows all available 
literature in pubmed on this gene">Full Literature</asp:HyperLink>&nbsp;&nbsp; 
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<asp:SqlDataSource ID="SqlDataSource9" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [keywords] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
ProtScale [532] – Links to an external website programmed to automatically use the 
uniprot identifier for the selected gene. This enables a computation and 
representation of the profile generated by an amino acid scale on the chosen protein. 
http://www.expasy.org/cgi-bin/protscale.pl?P00441 
 The codes on ASP.NET to generate this link are as shown below: 
Dim protScaleUrl As String = “http://www.expasy.org/cgi-bin/protscale.pl?” 
Dim dv8 As DataView 
Dim protScale As String 
dv8 = CType(SqlDataSource10.Select(DataSourceSelectArguments.Empty), DataView) 
protScale = CType(dv8.Table.Rows(0)(0), String) 
Label7.Text = protScaleUrl + protScale 
HyperLink7.NavigateUrl = Label7.Text 
 
<asp:HyperLink ID="HyperLink7" runat="server" Target="_blank" ToolTip="Shows the amino acid 
scale">ProtScale</asp:HyperLink>&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource10" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [swissport_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 KEGG [533] – shows the AA and NT sequence from the KEGG database to save 
valuable time spent by researchers in searching for sequences of specific genes 
online. 
http://www.genome.jp/dbget-bin/www_bget?hsa:6647 
 The codes on ASP.NET to generate this link are as shown below: 
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Dim sequenceUrl As String = http://www.genome.jp/dbget-bin/www_bget?hsa: 
Dim dv9 As DataView 
Dim sequence As String 
dv9 = CType(SqlDataSource11.Select(DataSourceSelectArguments.Empty), DataView) 
sequence = CType(dv9.Table.Rows(0)(0), String) 
Label8.Text = sequenceUrl + sequence 
HyperLink8.NavigateUrl = Label8.Text 
 
<asp:HyperLink ID="HyperLink8" runat="server" Target="_blank" ToolTip="Shows the gene sequence 
in KEGG">Sequence</asp:HyperLink>&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource11" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ncbi_locuslink_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
Uniprot [534] - The UniProt consortium provides access to the multiple data sets from 
the Swiss Institute of Bioinformatics (SIB), the European Bioinformatics Institute 
(EBI) and the Protein Information Resource (PIR). 
http://www.uniprot.org/uniprot/P00441 
 The codes on ASP.NET to generate this link are as shown below: 
Dim uniprotUrl As String = "http://www.uniprot.org/uniprot/" 
Dim dv8 As DataView 
Dim protScale As String 
dv8 = CType(SqlDataSource10.Select(DataSourceSelectArguments.Empty), DataView) 
protScale = CType(dv8.Table.Rows(0)(0), String) 
Label10.Text = uniprotUrl + protScale 
HyperLink10.NavigateUrl = Label10.Text 
 
<asp:HyperLink ID="HyperLink10" runat="server" ToolTip="Shows the summary of gene in Uniprot" 
Target="_blank">Uniprot</asp:HyperLink> 
 
<asp:SqlDataSource ID="SqlDataSource10" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
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        SelectCommand="SELECT [swissport_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 iHop [535]  – Information Hyperlinked over Proteins database is a vastly connected 
network making human literature research more intuitive and efficient using a text-
mining method as described in their publication. This is linked from ALSoD to allow 
researchers an unbiased list of published materials relating to the selected gene. 
http://www.ihop-net.org/UniPub/iHOP/bng/92317.html?ORGANISM_ID=1 
 The codes on ASP.NET to generate this link are as shown below: 
Dim ihopUrl1 As String = "http://www.ihop-net.org/UniPub/iHOP/bng/" 
Dim ihopUrl2 As String = ".html?ORGANISM_ID=1" 
Dim dv11 As DataView 
Dim ihop As String 
dv11 = CType(SqlDataSource13.Select(DataSourceSelectArguments.Empty), DataView) 
      ihop = CType(dv11.Table.Rows(0)(0), String) 
Label11.Text = ihopUrl1 + ihop + ihopUrl2 
HyperLink11.NavigateUrl = Label11.Text 
 
<asp:HyperLink ID="HyperLink11" runat="server" Target="_blank" ToolTip="Shows the latest 
information">iHop</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource13" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ihop] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
Pathway in KEGG [533] – A KEGG pathway map of human Amyotrophic Lateral 
Sclerosis under the Neurodegenerative diseases of the Human disease section is 
hyperlinked from our website to display a pathway overview map. 
http://www.genome.jp/dbget-bin/show_pathway?hsa05014 
 The codes on ASP.NET to generate this link are as shown below: 
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Dim pathway As String = "http://www.genome.jp/dbget-bin/show_pathway?hsa05014" 
Label12.Text = pathway 
HyperLink12.NavigateUrl = Label12.Text 
 




GeneTest [536] -  The GeneTests database and Web site which is hosted at NCBI displays gene 
reviews and information on laboratories and clinics related to the gene. 
http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/research_disease_id/229174?db=genetests&report=
Full 
 The codes on ASP.NET to generate this link are as shown below: 
Dim genetest As String = 
"http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/research_disease_id/229174?db=genetests&report
=Full" 
Label19.Text = genetest 
HyperLink19.NavigateUrl = Label19.Text 
 
<asp:HyperLink ID="HyperLink19" runat="server" Target="_blank" ToolTip="Shows related genes on 
ALS in the geneTest webpage">GeneTest</asp:HyperLink>&nbsp;&nbsp; 
 
 
ALS review – A link to the bookshelf page of NCBI displaying regularly reviewed information on ALS 
overview to enable researchers view up-to-date research in the field of ALS. 
AmiGO [537] – A link to this free open source web application developed and kept up-to-date by 
the GO Consortium lets users query, browse and view ontology and annotation data on definite 
genes. 
http://amigo.geneontology.org/cgi-bin/amigo/gp-assoc.cgi?gp=UniProtKB:P00441 
 The codes on ASP.NET to generate this link are as shown below: 
Dim Amigo As String = "http://amigo.geneontology.org/cgi-bin/amigo/gp-assoc.cgi?gp=UniProtKB:" 
dv8 = CType(SqlDataSource10.Select(DataSourceSelectArguments.Empty), DataView) 
protScale = CType(dv8.Table.Rows(0)(0), String) 
Label24.Text = Amigo + protScale 
HyperLink24.NavigateUrl = Label24.Text 
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<asp:HyperLink ID="HyperLink24" runat="server" Target="_blank" ToolTip="Gene 
Ontology">AmiGO</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource10" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [swissport_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 
Ensembl [538] – This displays a broad genome information system featuring an 
amalgamated set of genome annotation, databases, and other information. 
http://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000142168 
 The codes on ASP.NET to generate this link are as shown below: 
Dim Ensemblurl As String = "http://www.ensembl.org/Homo_sapiens/Gene/Summary?g=" 
Dim ensembl As String 
Dim dv17 As DataView 
dv17 = CType(SqlDataSource17.Select(DataSourceSelectArguments.Empty), DataView) 
      ensembl = CType(dv17.Table.Rows(0)(0), String) 
Label27.Text = Ensemblurl + ensembl 
HyperLink27.NavigateUrl = Label27.Text 
 
<asp:HyperLink ID="HyperLink27" runat="server" Target="_blank" 
ToolTip="Ensembl">Ensembl</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource17" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ensembl_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
NCBI [480]  – This comprehensive database and website is linked from ALSoD 
showing a statistical overview of the dataset across its network of databases e.g. for 
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ANG gene, the search query automatically coded to our database is “ANG HOMO 
ALS” displaying a total of 31 pubmed citations and abstracts. 
http://www.ncbi.nlm.nih.gov/sites/gquery?term=SOD1%20HOMO%20ALS 
 The codes on ASP.NET to generate this link are as shown below: 
Dim ncbi1 As String = "http://www.ncbi.nlm.nih.gov/sites/gquery?term=" 
Dim ncbi2 As String = "%20HOMO%20ALS" 
Dim dv7 As DataView 
Dim keywords As String  
dv7 = CType(SqlDataSource9.Select(DataSourceSelectArguments.Empty), DataView) 
keywords = CType(dv7.Table.Rows(0)(0), String) 
Label29.Text = ncbi1 + keywords + ncbi2 
HyperLink29.NavigateUrl = Label29.Text 
 
<asp:HyperLink ID="HyperLink29" runat="server" Target="_blank" ToolTip="NCBI database summary 
of this gene">NCBI</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource9" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [keywords] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
 
Life Science DB (Japan) [485] – A recently developed ALS mutation database constructed as part 
of the Life Science Integrated Database Project conducted by the Japan Ministry of Education, 
Culture, Sports, Science, and Technology was published. It contains their original experimental 
results and published data extracted from scientific journals. The database is expected to play a 
complementary role to the ALSoD database especially in collecting variations in the Asian region. A 
link to this website allows a wider perspective of mutations available in ALS without geographical bias. 
http://reseq.lifesciencedb.jp/resequence/GeneDetail.do?targetId=1&geneId=EG6647 
 The codes on ASP.NET to generate this link are as shown below: 
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Dim lifesciencedb As String = 
"http://reseq.lifesciencedb.jp/resequence/GeneDetail.do?targetId=1&geneId=EG" 
dv9 = CType(SqlDataSource11.Select(DataSourceSelectArguments.Empty), DataView) 
sequence = CType(dv9.Table.Rows(0)(0), String) 
Label31.Text = lifesciencedb + sequence 
 
'Shows Lifesciencedb (Japan) links available 
If ((geneid = "SOD1") Or (geneid = "TARDBP(TDP43)") Or (geneid = "FUS") Or (geneid = "VAPB") Or 
(geneid = "DCTN1") Or (geneid = "ALS2") Or (geneid = "CNTF") Or (geneid = "DPP6") Or (geneid = 
"SETX") Or (geneid = "CHMP2B") Or (geneid = "ANG") Or (geneid = "HFE") Or (geneid = "APEX1") 
Or (geneid = "APOE") Or (geneid = "ITPR2") Or (geneid = "LIF") Or (geneid = "MAOB") Or (geneid = 
"NEFH") Or (geneid = "PON1") Or (geneid = "PON2") Or (geneid = "PON3") Or (geneid = "FGGY") Or 
(geneid = "PRPH") Or (geneid = "SLC1A2") Or (geneid = "SMN1") Or (geneid = "SMN2") Or (geneid = 
"SPAST") Or (geneid = "VEGFA")) Then 
         
     HyperLink31.Visible = "true" 
        Else 
            HyperLink31.Visible = "false" 
        End If 
 
<asp:HyperLink ID="HyperLink31" runat="server" Target="_blank" ToolTip="An ALS mutation 
database supported by the Ministry of Education, Culture, Sports, Science and Technology in 
Japan">Life Science DB(Japan)</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource11" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ncbi_locuslink_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
  
ALSGene  [539] – “ALSGene freely available on http://www.alsgene.org aims to serve 
as an exhaustive, unbiased, and regularly updated resource of genetic association 
studies in ALS. One of its key features will be up-to-date meta-analyses of all eligible 
genetic polymorphisms that have been investigated for association with ALS risk”. 
http://www.alsgene.org/geneoverview.asp?geneid=1 
The codes on ASP.NET to generate this link are as shown below: 
Dim ALSgene As String = http://www.alsgene.org/geneoverview.asp?geneid= 
Dim dv20 As DataView 
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Dim ALSgene_id As String 
dv20 = CType(SqlDataSource20.Select(DataSourceSelectArguments.Empty), DataView) 
ALSgene_id = CType(dv20.Table.Rows(0)(0), String) 
Label32.Text = ALSgene + ALSgene_id 
 
'Shows ALSgene links available 
        If (ALSgene_id <> 0) Then 
     HyperLink32.Visible = "true" 
        Else 
            HyperLink32.Visible = "false" 
        End If 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource20" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ALSgene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 




The codes on ASP.NET to generate this link are as shown below: 
Dim Gen2Phen As String ="http://www.gen2phen.org/gene/" 
Dim dv6 As DataView 
Dim geneid As Stringdv6 = CType(SqlDataSource8.Select(DataSourceSelectArguments.Empty), 
DataView) 
geneid = CType(dv6.Table.Rows(0)(0), String) 
Label39.Text = Gen2Phen + geneid 
HyperLink39.NavigateUrl = Label39.Text 
 
<asp:HyperLink ID="HyperLink39" runat="server" Target="_blank" ToolTip="GEN2PHEN project is a 
holistic approach to genotype-to-phenotype data.">Gen2Phen</asp:HyperLink>&nbsp;&nbsp; 
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<asp:SqlDataSource ID="SqlDataSource8" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [gene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 




The codes on ASP.NET to generate this link are as shown below: 
Dim Orphanet As String ="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Gene=" 
Dim dv5 As DataView 
      Dim hgnc As String 
dv5 = CType(SqlDataSource7.Select(DataSourceSelectArguments.Empty), DataView) 
hgnc = CType(dv5.Table.Rows(0)(0), String) 
Label41.Text = Orphanet + hgnc 
HyperLink41.NavigateUrl = Label41.Text 
 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
 
<asp:SqlDataSource ID="SqlDataSource7" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [hgnc_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
GeneNetwork  
http://129.125.165.109:8080/Expression/?gene=SOD1 
The codes on ASP.NET to generate this link are as shown below: 
Dim ALSgene As String = http://www.alsgene.org/geneoverview.asp?geneid= 
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Dim dv20 As DataView 
Dim ALSgene_id As String 
dv20 = CType(SqlDataSource20.Select(DataSourceSelectArguments.Empty), DataView) 
ALSgene_id = CType(dv20.Table.Rows(0)(0), String) 
Label32.Text = ALSgene + ALSgene_id 
 
'Shows ALSgene links available 
        If (ALSgene_id <> 0) Then 
     HyperLink32.Visible = "true" 
        Else 
            HyperLink32.Visible = "false" 
        End If 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource20" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ALSgene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 




The codes on ASP.NET to generate this link are as shown below: 
Dim ALSgene As String = http://www.alsgene.org/geneoverview.asp?geneid= 
Dim dv20 As DataView 
Dim ALSgene_id As String 
dv20 = CType(SqlDataSource20.Select(DataSourceSelectArguments.Empty), DataView) 
ALSgene_id = CType(dv20.Table.Rows(0)(0), String) 
Label32.Text = ALSgene + ALSgene_id 
 
'Shows ALSgene links available 
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        If (ALSgene_id <> 0) Then 
     HyperLink32.Visible = "true" 
        Else 
            HyperLink32.Visible = "false" 
        End If 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
<asp:SqlDataSource ID="SqlDataSource20" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ALSgene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 




The codes on ASP.NET to generate this link are as shown below: 
Dim ALSgene As String = http://www.alsgene.org/geneoverview.asp?geneid= 
Dim dv20 As DataView 
Dim ALSgene_id As String 
dv20 = CType(SqlDataSource20.Select(DataSourceSelectArguments.Empty), DataView) 
ALSgene_id = CType(dv20.Table.Rows(0)(0), String) 
Label32.Text = ALSgene + ALSgene_id 
 
'Shows ALSgene links available 
        If (ALSgene_id <> 0) Then 
     HyperLink32.Visible = "true" 
        Else 
            HyperLink32.Visible = "false" 
        End If 
<asp:HyperLink ID="HyperLink32" runat="server" Target="_blank" ToolTip="The ALSGene database 
will provide a comprehensive, unbiased and regularly updated field synopsis of genetic association 
studies performed in ALS.">ALSGene</asp:HyperLink>&nbsp;&nbsp; 
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<asp:SqlDataSource ID="SqlDataSource20" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
        SelectCommand="SELECT [ALSgene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
            <asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
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Appendix 18 - Claustalw and Jalview codes 
Dim dv6 As DataView 
Dim geneid As String 
dv6 = CType(SqlDataSource8.Select(DataSourceSelectArguments.Empty), 
DataView) 
geneid = CType(dv6.Table.Rows(0)(0), String) 
Dim specie1 As String = "~/Applets/" 
Dim specie2 As String = "species.aspx" 
Label23.Text = specie1 + geneid + specie2 




<asp:SqlDataSource ID="SqlDataSource8" runat="server" ConnectionString="<%$ 
ConnectionStrings:alsodConnectionString1 %>" 
SelectCommand="SELECT [gene_id] FROM [gene] WHERE ([gene_id] = @gene_id)"> 
    <SelectParameters> 
<asp:QueryStringParameter Name="gene_id" QueryStringField="gene_id" 
Type="String" /> 
        </SelectParameters> 
    </asp:SqlDataSource> 
The hyperlink redirects to an applet code on different species: 
<applet code="jalview.bin.JalviewLite" 
           archive="jalviewApplet.jar" style="width: 
735px; height: 242px; margin-top: 0px;"> 
                        <param name="embedded" value="true"> 
                        <param name="sequence1" 





                        <param name="sequence2" 





                        <param name="sequence3" 





                        <param name="sequence4" 





                        <param name="sequence5" 





                        <param name="sequence6" 
value="Q7YXM6|Q7YXM6_APILI(Common_honeybee)         ---------





                        <param name="sequence7" 





                        <param name="sequence8" 





                        <param name="sequence9" 





                        <param name="sequence10" 





                        <param name="sequence11" 





                        <param name="sequence12" 





                        <param name="sequence13" 





                        <param name="sequence14" 





                        <param name="sequence15" 





                        <param name="sequence16" 
value="Q9C0T2|Q9C0T2_CRYNE(Cryptococcus_neoformans_var_neoformans)     ----
------------MVKAVAVLK-GDSHVYGTITFTQD-SEGAP-VCVSGEIKNLDADAKRGF-HVHEFGDNTNG--
-CTSAGPHYNPFHKNHGGPTAAERHVGDLGNVQTNGCGVAMVDISDKVISLFGPH---
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SIIGRSMVVHAGTDDLGKGGNE---ESLKTGNAGARLACGVIGIAA-----------------------------
-"> 
                        <param name="sequence17" 





                        <param name="sequence18" 





                        <param name="sequence19" 





                        <param name="sequence20" 





                        <param name="sequence21" 





                        <param name="sequence22" 




                        <param name="defaultColour" value="Zappo"> 
                        <param name="showAnnotation" value="false"> 
                        <param name="windowHeight" value="515"> 
                        <param name="windowWidth" value="650"> 
                        <param name="showConservation" value="false"> 
                        <param name="showQuality" value="false"> 
                        <param name="showConsensus" value="false"> 
 
                        <param name="showFullId" value="false"> 
                        <param name="RGB"  value="F2F2FF"> 
                        <param name="linkLabel_1" value="SRS"> 
                        <param name="linkUrl_1" 
value="http://srs.ebi.ac.uk/srs7bin/cgi-bin/wgetz?-e+[uniprot-
all:$SEQUENCE_ID$]+-vn+2"> 
                        <param name="linkLabel_2" value="Uniprot"> 
                        <param name="linkUrl_2" 
value="http://us.expasy.org/cgi-bin/niceprot.pl?$SEQUENCE_ID$"> 
                         
                      </applet> 
The second section  is an applet code on the variants of a selected gene: 
<applet code="jalview.bin.JalviewLite" 
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           archive="jalviewApplet.jar" class="style1" 
style="width: 734px; height: 168px"> 
                        <param name="embedded" value="true"> 








                        <param name="sequence3" value="ALSOD_LEVEL2 ---T-G-
V-R---M-S----K----------------V--S-----FR----------S------------S---Y------
-VSIM-VV--C-VVM--KH----V-----TT----------V--------------NGE--STRRI--T--" > 
                        <param name="sequence4" value="ALSOD_LEVEL3 ---V-S-
--V------------------------------------------------------------------------
---K------D-------N----------------------------------------------------" > 
                        <param name="sequence5" value="ALSOD_LEVEL4 -------
---------------------------------------------------------------------------
---S------R-------Y----------------------------------------------------" > 
                        <param name="sequence6" value="ALSOD_LEVEL5 -------
---------------------------------------------------------------------------
----------S------------------------------------------------------------"> 
                        <param name="sequence7" value="ALSOD_LEVEL6 -------
---------------------------------------------------------------------------
----------V------------------------------------------------------------"> 
                        <param name="defaultColour" value="Zappo"> 
                        <param name="showAnnotation" value="false"> 
                        <param name="windowHeight" value="515"> 
                        <param name="windowWidth" value="650"> 
                        <param name="showConservation" value="false"> 
                        <param name="showQuality" value="false"> 
                        <param name="showConsensus" value="false"> 
 
                        <param name="showFullId" value="false"> 
                        <param name="RGB"  value="F2F2FF"> 
                        <param name="linkLabel_1" value="SRS"> 
                        <param name="linkUrl_1" 
value="http://srs.ebi.ac.uk/srs7bin/cgi-bin/wgetz?-e+[uniprot-
all:$SEQUENCE_ID$]+-vn+2"> 
                        <param name="linkLabel_2" value="Uniprot"> 
                        <param name="linkUrl_2" 
value="http://us.expasy.org/cgi-bin/niceprot.pl?$SEQUENCE_ID$"> 
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Appendix 19 – GeneMANIA 
//where n is the current total of genes 
For i= 1 to n 
Executebutton.visible = True 
If checkbox[i].item.selected > 3 
 checkbox.visible = "Disable" 
 clearbutton.visible = True 




 iframe.visible = True 
 Dim urlgenemania = "http://genemania.org&o=9606&g=" 
checkbox.select.count = j 
For k=1 to j 
message.txt = label(k) + '/' 
End 
 
This is translated into ASP.NET code as follows: 
Private Sub Page_Load(ByVal sender As System.Object, ByVal e As 
System.EventArgs) Handles MyBase.Load 
         
            Dim index1 As Integer 
            Label1.Text = "<p> Selected gene(s):</p>" 
            Label2.Text = "" 
            For index1 = 0 To CheckBoxList1.Items.Count - 1 
                If (CheckBoxList1.Items(index1).Selected = "True") Then 
                Label1.Text = Label1.Text + 
CheckBoxList1.Items(index1).Text + "&nbsp;&nbsp;&nbsp;" 
                    'If (CheckBoxList1.Items.Count > 5) Then  
                    'CheckBoxList1.Visible = "False" 
                    'End If 
                Label2.Text= Label2.Text + CheckBoxList1.Items(index1).Text 
+ "|" 
                End If 
            Next index1 
         
            Dim geneBaseUrl1 As String = 
"http://genemania.org/link?o=9606&g=" 
             
            'Dim dv1 As DataView 
            'Dim genedetails As String 
            'Label2.Text = geneBaseUrl1 + genedetails 
        HyperLink1.NavigateUrl = geneBaseUrl1 + Label2.Text 
        HyperLink2.NavigateUrl = "~/overview/interaction.aspx" 
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        'HyperLink1.Target= 
         'End If 
    End Sub   
The javascript used to embed the iframe code into the webpage is as shown: 
<iframe name="Iframe1" runat="server"                                                
style="width: 800px; height: 550px;"> 
<p>Your browser does not support iframes.</p>                                           
</iframe> 
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      var xmlDoc = null; 
      if (window.ActiveXObject) { 
// code for IE 
          xmlDoc = new ActiveXObject("Microsoft.XMLDOM"); 
          xmlDoc.async = false; 
          xmlDoc.load("countrylatlong.xml"); 
          var x = xmlDoc.getElementsByTagName('Alsod'); 
      } 
      else if (document.implementation.createDocument) { 
// code for Mozilla, Firefox, Opera, etc. 
          xmlDoc = document.implementation.createDocument("", "", null); 
          xmlDoc.async = false; 
          xmlDoc.load("countrylatlong.xml"); 
      //xmlDoc.onload = createPlacemark1; 
      //var x = xmlDoc.getElementsByTagName("Alsod"); 
          var x = xmlDoc.documentElement; 
           
      } 
      else { 
          alert('Your browser cannot handle this script'); 
      } 
           
          var ge = null; 
          var placemark = new Array(); 
          var point = new Array(); 
          var la = new Array(); 
          var counter = 0; 
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          google.load("earth", "1"); 
       
       
 
      function init() {     
 google.earth.createInstance('map3d', initCB,failureCB); 
  // google.earth.createInstance("map3d", loadNetworkLink,failureCallback); 
      } 
 
      function initCB(instance) {     
 ge = instance;     
 ge.getWindow().setVisibility(true);  // required! 
          ge.getNavigationControl().setVisibility(ge.VISIBILITY_AUTO); 
          ge.getOptions().setOverviewMapVisibility(true); 
          createPlacemark2(); 
      } 
 
 
      function createPlacemark2() { 
 
 
          var mutation = new Array(); 
          var latitude = new Array(); 
          var longitude = new Array(); 
          var country = new Array(); 
          
    // create arrays of placemarks,points etc 
 
          for (i = 0; i < x.length; i++) { 
 
              mutation[i] = 
(x[i].getElementsByTagName('mutation_mnemonic')[0].childNodes[0].nodeValue); 
              latitude[i] = (x[i].getElementsByTagName('latitude')[0].childNodes[0].nodeValue); 
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              longitude[i] = (x[i].getElementsByTagName('longitude')[0].childNodes[0].nodeValue); 
              country[i] = (x[i].getElementsByTagName('country')[0].childNodes[0].nodeValue); 
 
               
              placemark[i] = ge.createPlacemark(''); 
 
   // create the point 
              point[i] = ge.createPoint(''); 
              point[i].setLatitude(latitude[i]); 
              point[i].setLongitude(longitude[i]); 
              placemark[i].setGeometry(point[i]); 
 
   // add the placemark to the earth DOM 
              ge.getFeatures().appendChild(placemark[i]); 
 
   // look at the placemark we created 
              la[i] = ge.createLookAt(''); 
              la[i].set(latitude[i], longitude[i], 
                0, // altitude 
                ge.ALTITUDE_RELATIVE_TO_GROUND, 
                 0, // heading 
                 0, // straight-down tilt 
                 4521188 // range (inverse of zoom) 
                 ); 
 
              ge.getView().setAbstractView(la[i]); 
 
   // give the placemark a name and a description (a balloon will 
   // automatically show on click) 
              placemark[i].setName(mutation[i]); 
              placemark[i].setDescription('Found in ' + country[i]); 
          } 
      } 
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      function failureCB(errorCode) { 
          alert("Failure loading the Google Earth Plugin: " + errorCode); 
      } 
         
          google.setOnLoadCallback(init);          
      </script> 
<body onload="initialize()"> 
<div id="map3d_container" style="border: 1px solid silver; height: 500px;"> 
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    ''' if the string is like '21:123455' or 'X:123' etc ''' 
    parts=pos_str.split(':') 
    if len(parts) != 2: 
        return False 
    if parts[0] not in ('1','2','3','4','5','6','7','8','9','10','11','12','13', '14','15','16','17','18','19','20','21','22','X'): 
        return False  
    if parts[1].isdigit(): 
        return True 
    return False 
 
################################################################################ 





for line in ifile: 
    cols=line.split('\t') 
    if is_pos(cols[6]): 
        snp_pos.add(cols[6]) 
    else:  
        continue 
 
ifile.close() 
# the input table is a bit missformatted on some lines (447,480) 
# for example: line 480 
# one extra tab after 'NP_001136.1:p.Phe100Ile'.  
# The position string is now in column 8, instead of column 7. 
# Removed it manually.  
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################################################################################ 
# for all files in directory 1kg  






for pos in snp_pos: 
    snp_lines[pos]='' 
 
for filename in os.listdir('.'): 
    ifile=open(filename) 
    for line in ifile: 
        cols=line.split('\t') 
        pos_str=cols[0] 
        if pos_str in snp_pos: 
            if len(cols[1])==1 and len(cols[2])==1: # SNP  
                snp_lines[pos_str]=snp_lines[pos_str]+'\t'+line[:-1] 
            else: # indels 
                continue 





# re-open the input table, appending the lines from 1kg 
ifile=open('population_frequency.txt') 
for line in ifile: 
    cols=line.split('\t') 
    if cols[6] not in snp_pos: 
        print(line[:-1]) 
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    else: 
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Appendix 22 – Perl Scripts to transpose, break, replace and join 
columns of a sequence 
Transpose sequence 
#!/usr/bin/perl 
# Transpose lineS <-> 1 column 
# OLUBUNMI ABEL 
# 17/06/2011 
 
$infile = "TDP43_codon.txt"; 
$outfile = ""; 
 
###  READ ARGUMENTS  ################################################## 
 
foreach my $a (0..$#ARGV) { 
 
   ### input directory  
   if ($ARGV[$a] eq "-i") { 
      $infile = $ARGV[$a+1]; 
   } 
 
   ### output file  
   elsif ($ARGV[$a] eq "-o") { 
      $outfile = $ARGV[$a+1]; 
   } 
   ### help 
   elsif ($ARGV[$a] eq "-h") { 
      die "Syntax: transpose_seq.pl -i inputfilename -o outputfilename (default 
output=inputfilename.tr)\n"; 
   } 
} 
 
if ($infile eq ""){die "STOP! You have to specify the input file name";} 
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if ($outfile eq ""){$outfile="$infile".".tr"} 
 
 
###  READ AND WRITE DATA  ################################################## 
 
open inf, $infile or die "STOP! File $infile not found"; 




foreach $line (<inf>){ 
 chomp $line; 
  @line=split //,$line; 
  for ($j=0;$j<=$#line;$j++){ 
    print ouf "$line[$j]\n"; 
  } 
  $i++; 
} 
 



















### Read arguments from the command line 
 










foreach my $a (0..$#ARGV) { 
 
 ### help 
 if ($ARGV[0] eq "-h") { 
  &PrintHelp; 
        } 
 
 ### input file 1 
 elsif ($ARGV[$a] eq "-i1") { 
  $infile1 = $ARGV[$a+1]; 
 } 
 
 ### input file 2 
 elsif ($ARGV[$a] eq "-i2") { 
  $infile2 = $ARGV[$a+1]; 
 } 
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 ### shift 
 elsif ($ARGV[$a] eq "-shift") { 
  $shift = $ARGV[$a+1]; 
 } 
 
 ### threshold 
 elsif ($ARGV[$a] eq "-threshold") { 
    if ($ARGV[$a+1] =~ /^-?\d+\.?\d*$/) { 
       $th1 = $ARGV[$a+1]; 
       if ($ARGV[$a+2] =~ /^-?\d+\.?\d*$/) { 
          $th2=$ARGV[$a+2]; 
              } 
       else {$th2=$th1; 
       } 
    } 
 } 
 
 ### output file  
 elsif ($ARGV[$a] eq "-o") { 
  $outfile = $ARGV[$a+1]; 
 } 
 
 ### verbosity  
 elsif ($ARGV[$a] eq "-v") { 
  $verbo=1; 
    } 
} 
 
if ($infile1 eq "" or $infile2 eq "" ) { 
 die "STOP! You have to give the name of to input file.\n"; 
} 
if ($outfile eq "") { 
 $outfile="$infile1_$infile2.out"; 
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} 
 
}  # End of ReadArguments 
 
################################################################ 
### Print help 
 
 
sub PrintHelp { 
  open HELP, "| more"; 
  print <<EndHelp; 
NAME 
        join-cols.pl 
 
DESCRIPTION 
        Build one table (in one output file) from 2 separated  
        tables (in 2 separated files). 
 
AUTHORS 
        Didier Gonze (dgonze\@ulb.ac.be)   
 
OPTIONS 
        -i1 in_file_name_1 
        -i2 in_file_name_2 
                Specify the input files name. 
  Two files must be specified. 
 
       -shift # 
               Specify the shift between file1 and file2 (default: shift=0). 
        The shift can be negative. 
 
 -threshold # [#] 
  Define a threshold below which the data are not printed. 
 - 449 - 
  If only one value is given, the threshold will be the same for 
  both files. If two values are given, the first one corresponds 
  to the first file, while the second corresponds to the second. 
 
        -o out_file_name 
                Specify the output file. If no data in file 2 correspond  
                to data in file 1 or vice versa (because of shift for example),  
  "NA" will be indicated. 
                 
        -v  
                Verbosity: print detailed informations during the process.            
             
        -h 
                Give help (print this message). This argument must be  
                the first one. 
 
EXAMPLE 
        perl join-cols.pl -i1 mylist1 -i2 mylist2 -shift 2 -threshold 0 -o mydoublelist 
 
EndHelp 






### Create the new table joining the two tables 
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open inf1, $infile1 or die "STOP! File $infile1 not found"; 
open inf2, $infile2 or die "STOP! File $infile2 not found"; 
open ouf, ">$outfile"; 
 
if ($shift > 0 ){ 
  for ($i=1; $i<=$shift; $i++){ 
    $line2=<inf2>;   # skip lines in inf2 
    chomp $line2; 
    if ("$th2" eq "" or $line2 >= $th2){ 
       print ouf "NA\t$line2\n"; 
    } 
    $nbnull++; 
  } 
} 
if ($shift < 0 ){ 
  for ($i=1; $i<=-$shift; $i++){ 
    $line1=<inf1>;   # skip lines in inf1 
    chomp $line1; 
    if ("$th1" eq "" or $line1 >= $th1){ 
       print ouf "$line1\tNA\n"; 
    } 
    $nbnull++; 
  } 
} 
 
foreach $line1 (<inf1>) { 
    $nblines++; 
    chomp $line1; 
    $line2=<inf2>; 
    if ($line2 ne ""){ 
      chomp $line2; 
      if (("$th1" eq "" or $line1 >= $th1) and ("$th2" eq "" or $line2 >= $th2)){ 
         print ouf "$line1\t$line2\n"; 
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      } 
    } 
    else{ 
      if ("$th1" eq "" or $line1 >= $th1) { 
         print ouf "$line1\tNA\n";  # add last lines from inf1 
      } 
      $nbnull++; 
    } 
} 
 
if ($shift < 0 ){ 
  for ($i=1; $i<=-$shift; $i++){ 
    $line2=<inf2>;   # add last lines from inf2 
    chomp $line2; 
    if ("$th2" eq "" or $line2 >= $th2){ 
       print ouf "NA\t$line2\n"; 
    } 
    $nbnull++; 
  } 
} 
 





if ($verbo==1) {print "File $outfile created.\n";} 
if ($verbo==1) {print "There are $nblines OK lines.\n";} 
if ($verbo==1) {print "There are $nbnull NULL lines.\n";} 
if ($verbo==1) {print "Shift=$shift.\n";} 
 
}  # End of CreateNewTable 
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Repeat amino acids 20 times 
#!/usr/bin/perl 
 
# Transpose lineS <-> 1 column 
# oLUBUNMI ABEL 
# 05/06/2009 
 
$outfile = "DCTN1_possibilities.txt"; 
 
 
###  READ AND WRITE DATA  ################################################## 
 
open ouf, ">$outfile"; 
 
#### Let i be numberof codons (with M is different from without M) 
for ($i = 1; $i <=1253; ($i=$i+1)) { 
$j="A R N D C Q E G H I L K M
 F P S T W Y V"; 
 
print ouf $j; 
print ouf "\n"; 
     
} 




Break and replace columns 
#!/usr/bin/perl 
 
# READ COLUMNS, REPLACE SPACE WITH TAB AND ADD PRINT 
# Olubunmi Abel 
# 12/07/2011 
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$infile = "VCP_NETPHOS.txt"; 
$outfile = ""; 
###  READ ARGUMENTS  ################################################## 
foreach my $a (0..$#ARGV) { 
   ### input directory  
   if ($ARGV[$a] eq "-i") { 
      $infile = $ARGV[$a+1]; 
   } 
   ### output file  
   elsif ($ARGV[$a] eq "-o") { 
      $outfile = $ARGV[$a+1]; 
   } 
   ### help 
   elsif ($ARGV[$a] eq "-h") { 
      die "Syntax: transpose.pl -i inputfilename -o outputfilename (default output=inputfilename.tr)\n"; 
   } 
} 
if ($infile eq ""){die "STOP! You have to specify the input file name"; 
} 
if ($outfile eq ""){$outfile="file_"."$infile"} 
###  READ DATA  ################################################## 
open inf, $infile or die "STOP! File $infile not found"; 
open ouf, ">$outfile"; 
 
 
foreach $line (<inf>){ 
chomp $line; 
@data=split / /,$line; 
  
print ouf "VCP"."\t".@data[1]."\t".@data[2]."\t".@data[3]."\t".@data[4]."\n"; 
}print "Output file $outfile created\n"; 
close inf; 
close ouf; 





# READ COLUMNS, REPLACE SPACE WITH TAB AND ADD PRINT 
# Olubunmi Abel 
# 12/07/2011 
$infile = "VCP_NETPHOS.txt"; 
$outfile = ""; 
###  READ ARGUMENTS  ################################################## 
foreach my $a (0..$#ARGV) { 
   ### input directory  
   if ($ARGV[$a] eq "-i") { 
      $infile = $ARGV[$a+1]; 
   } 
   ### output file  
   elsif ($ARGV[$a] eq "-o") { 
      $outfile = $ARGV[$a+1]; 
   } 
   ### help 
   elsif ($ARGV[$a] eq "-h") { 
      die "Syntax: transpose.pl -i inputfilename -o outputfilename (default output=inputfilename.tr)\n"; 
   } 
} 
if ($infile eq ""){die "STOP! You have to specify the input file name"; 
} 
if ($outfile eq ""){$outfile="file_"."$infile"} 
###  READ DATA  ################################################## 
open inf, $infile or die "STOP! File $infile not found"; 
open ouf, ">$outfile"; 
 
 
foreach $line (<inf>){ 
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chomp $line; 
@data=split / /,$line; 
  
print ouf "VCP"."\t".@data[1]."\t".@data[2]."\t".@data[3]."\t".@data[4]."\n"; 
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Appendix 23 – SQL Script for testing and verifying ranking 
system 
SELECT Rank_Mutations, Rank_Patients, Rank_Cases, Rank_Controls, 
Rank_Codon, Rank_FALS, Rank_SALS, Rank_Replications, Rank_Pathogenicity, 
Rank_Populations, Gene ,SUM( Rank_Mutations + Rank_Patients + Rank_Cases + 
Rank_Controls + Rank_Codon + Rank_FALS + Rank_SALS + Rank_Replications + 
Rank_Pathogenicity + Rank_Populations + 0) As Rank_Sum, DENSE_RANK() OVER 
(ORDER BY SUM( Rank_Mutations + Rank_Patients + Rank_Cases + Rank_Controls 
+ Rank_Codon + Rank_FALS + Rank_SALS + Rank_Replications + 
Rank_Pathogenicity + Rank_Populations + 0) ASC) AS Final_Rank FROM (SELECT 
[KCLAD\spngoka].Number_of_mutations_per_gene.Rank As 
Rank_Mutations,[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Rank AS 
Rank_Patients, [KCLAD\spngoka].[Number_of_cases_recorded].Rank As 
Rank_Cases, [KCLAD\spngoka].[Number_of_controls_recorded].Rank As 
Rank_Controls, [KCLAD\spngoka].[Number_of_mutations_in 









Rank_Populations, [KCLAD\spngoka].[Number_of_mutations_per_gene].Gene FROM 
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD INNER JOIN 
[KCLAD\spngoka].Number_of_mutations_per_gene ON 
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Gene = 
[KCLAD\spngoka].Number_of_mutations_per_gene.Gene INNER JOIN 
[KCLAD\spngoka].[Number_of_cases_recorded] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_cases_recorded].Gene INNER JOIN 
[KCLAD\spngoka].[Number_of_controls_recorded] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_controls_recorded].Gene INNER JOIN 
[KCLAD\spngoka].[Number_of_mutations_in _same_codon_by_rank] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_mutations_in _same_codon_by_rank].Gene INNER 
JOIN [KCLAD\spngoka].[Number_of_patients_with_family_history_FALS] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_patients_with_family_history_FALS].Gene INNER 
JOIN [KCLAD\spngoka].[Number_of_patients_without_family_history_SALS] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_patients_without_family_history_SALS].Gene INNER 
JOIN [KCLAD\spngoka].[Number_of_times_mutation_is_replicated] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_times_mutation_is_replicated].Gene INNER JOIN 
[KCLAD\spngoka].[Number_of_pathogenic_mutations_by_rank] ON 
[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_pathogenic_mutations_by_rank].Gene INNER JOIN 
[KCLAD\spngoka].[Number_of_unique_countries_on_genes] ON 
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[KCLAD\spngoka].[Number_of_mutations_per_gene].Gene = 
[KCLAD\spngoka].[Number_of_unique_countries_on_genes].Gene) As table1 GROUP 
BY Rank_Mutations, Rank_Patients, Rank_Cases, Rank_Controls, Rank_Codon, 
Rank_FALS, Rank_SALS, Rank_Replications, Rank_Pathogenicity, 
Rank_Populations, Gene  
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Appendix 24 – Columns/Field list in each SQL table 
Gene 
SELECT [gene_id] 
      ,[hgnc_id] 
      ,[ensembl_id] 
      ,[swissport_id] 
      ,[ncbi_locuslink_id] 
      ,[ncbi_refseq_id] 
      ,[structure_id] 
      ,[omim_id] 
      ,[genecards_id] 
      ,[gene_name] 
      ,[keywords] 
      ,[chromosome_name] 
      ,[chromosome_position] 
      ,[chromosome_band] 
      ,[chromosome_bp] 
      ,[chromosome] 
      ,[protein_name] 
      ,[protein_function] 
      ,[phenotype] 
      ,[gene_certification] 
      ,[gene_comment] 
      ,[other_names] 
      ,[sequence_tran] 
      ,[sequence] 
      ,[ucsc_id] 
      ,[accession_no] 
      ,[reason_for_investigation] 
      ,[result] 
      ,[category] 
      ,[graph] 
      ,[gene_effect] 
      ,[ihop] 
      ,[pdb_id] 
      ,[dbSNP] 
      ,[pubmed_id1] 
      ,[pubmed_id2] 
      ,[ALSgene_id] 
      ,[inheritance_pattern] 
      ,[syndrome_id] 
      ,[causative_id] 
      ,[FALS_only] 
      ,[DB_no] 
      ,[snp] 
      ,[basepair] 
      ,[pvalue] 
      ,[snp_pubmed_id] 
      ,[snp_paperlink] 
      ,[lifesciencedb] 
  FROM [Alsod].[dbo].[gene] 
Mutation 
SELECT [mutation_id] 
      ,[mutation_alias] 
      ,[mutation_name] 
      ,[mutation_mnemonic] 
      ,[gene_id] 
      ,[institution_code] 
      ,[mutation_type] 
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      ,[seq_location_id] 
      ,[position] 
      ,[sequence_position_relative] 
      ,[codon] 
      ,[codon_id] 
      ,[sequence_original] 
      ,[sequence_mutated] 
      ,[sequence_location_type] 
      ,[sequence_location_number] 
      ,[aa_original] 
      ,[aa_mutated] 
      ,[restriction_site] 
      ,[enzyme] 
      ,[mutation_approved_status] 
      ,[mutation_approved_date] 
      ,[mutation_approved_by] 
      ,[mutation_submitted_date] 
      ,[mutation_documentation] 
      ,[mutation_comment] 
      ,[first_author] 
      ,[year] 
      ,[journal] 
      ,[mutation_documentation_type] 
      ,[link] 
      ,[phenotype] 
      ,[zygosity] 
      ,[reference_id] 
      ,[countryiso1] 
      ,[countryiso2] 
      ,[countryiso3] 
      ,[countryiso4] 
      ,[countryiso5] 
      ,[countryiso6] 
      ,[countryiso7] 
      ,[countryiso8] 
      ,[countryiso9] 
      ,[countryiso10] 
      ,[countryiso11] 
      ,[countryiso12] 
      ,[countryiso13] 
      ,[countryiso14] 
      ,[countryiso15] 
      ,[countryiso16] 
      ,[countryiso17] 
      ,[countryiso18] 
      ,[countryiso19] 
      ,[countryiso20] 
      ,[swissprot_id] 
      ,[pubmed_id] 
      ,[title] 
      ,[doi] 
      ,[dbSNP] 
      ,[frequency] 
      ,[frequency_references] 
      ,[data_from] 
      ,[HGVS_Nucleotide] 
      ,[HGVS_protein] 
      ,[Location] 
      ,[dbSNP_id] 
  FROM [Alsod].[dbo].[mutation] 
Patient_clinical_record 
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SELECT [patient_id] 
      ,[sensory_symptom] 
      ,[sensory_sign] 
      ,[autonomic_dysfunction_symptom] 
      ,[autonomic_dysfunction_sign] 
      ,[parkinsonism_symptom] 
      ,[parkinsonism_sign] 
      ,[dementia] 
      ,[dementia_description] 
      ,[other_atypical_exists] 
      ,[other_atypical_description] 
      ,[neuropathology_available] 
      ,[s_path_mcx] 
      ,[s_path_cort_spin_tract] 
      ,[s_path_ahmn] 
      ,[s_path_post_column] 
      ,[s_path_spin_cerebell_tra] 
      ,[s_path_oculomot_nucl] 
      ,[s_path_onuf_nucl] 
      ,[s_path_clarke_column] 
      ,[s_path_other_description] 
      ,[m_path_mcx_bunina_body] 
      ,[m_path_mcx_LBI] 
      ,[m_path_mcx_UbIRI] 
      ,[m_path_mcx_vacuola] 
      ,[m_path_mcx_nf_acc_inn_p] 
      ,[m_path_mcx_nf_acc_inn_nonp] 
      ,[m_path_mcx_nf_acc_axon] 
      ,[m_path_mcx_sod1_IR] 
      ,[m_path_sc_bunina_body] 
      ,[m_path_sc_LBI] 
      ,[m_path_sc_UbIRI] 
      ,[m_path_sc_vacuola] 
      ,[m_path_sc_nf_acc_inn_p] 
      ,[m_path_sc_nf_acc_inn_nonp] 
      ,[m_path_sc_nf_acc_axon] 
      ,[m_path_sc_sod1_ir] 
      ,[m_path_prfront_bunina_body] 
      ,[m_path_prfront_lbi] 
      ,[m_path_prfront_ubiri] 
      ,[m_path_prfront_vacuola] 
      ,[m_path_prfront_nf_acc_inn_p] 
      ,[m_path_prfront_nf_acc_inn_nonp] 
      ,[m_path_prfront_nf_acc_axon] 
      ,[m_path_prfront_sod1_ir] 
      ,[m_path_hippocamp_ubiri] 
      ,[s_path_other_desc_short] 
      ,[genetics_pub_exists] 
      ,[genetics_pub_desc_short] 
      ,[genetics_pub_desc_long] 
      ,[clinical_pub_exists] 
      ,[clinical_pub_desc_long] 
      ,[clinical_pub_desc_short] 
      ,[neuropath_pub_exists] 
      ,[neuropath_pub_desc_long] 
      ,[neuropath_pub_desc_short] 
      ,[experimental_pub_exists] 
      ,[experimental_pub_desc_long] 
      ,[experimental_pub_desc_short] 
      ,[activity_rbc_method_id] 
      ,[activity_rbc_method] 
      ,[activity_rbc_value] 
 - 461 - 
      ,[activity_lymphoblast_method_id] 
      ,[activity_lymphoblast_method] 
      ,[activity_lymphoblast_value] 
      ,[activity_fibroblast_method_id] 
      ,[activity_fibroblast_method] 
      ,[activity_fibroblast_value] 
      ,[activity_brain_method_id] 
      ,[activity_brain_method] 
      ,[activity_brain_value] 
      ,[activity_cervical_method_id] 
      ,[activity_cervical_method] 
      ,[activity_cervical_value] 
      ,[activity_thoracic_method_id] 
      ,[activity_thoracic_method] 
      ,[activity_thoracic_value] 
      ,[activity_lumbar_method_id] 
      ,[activity_lumbar_method] 
      ,[activity_lumbar_value] 
      ,[activity_other_method_id] 
      ,[activity_other_method] 
      ,[activity_other_method_value] 
      ,[presenting_symptom] 
      ,[cra_emotional] 
      ,[cra_jaw_jerk] 
      ,[cra_facial_reflexes] 
      ,[cra_tongue_fasc] 
      ,[cra_tongue_wast] 
      ,[cra_tongue_spast] 
      ,[ul_left_wasting] 
      ,[ul_left_fasciculation] 
      ,[ul_left_weakness] 
      ,[ul_left_tone] 
      ,[ul_left_triceps_reflex] 
      ,[ul_left_biceps_reflex] 
      ,[ul_left_brachiorad_reflex] 
      ,[ul_left_fingerHS] 
      ,[ul_right_wasting] 
      ,[ul_right_fasciculation] 
      ,[ul_right_weakness] 
      ,[ul_right_tone] 
      ,[ul_right_triceps_reflex] 
      ,[ul_right_biceps_reflex] 
      ,[ul_right_brachiorad_reflex] 
      ,[ul_right_fingerHS] 
      ,[thor_trunk_wasting] 
      ,[thor_trunk_fasciculation] 
      ,[thor_trunk_weakness] 
      ,[thor_trunk_tone] 
      ,[ll_left_wasting] 
      ,[ll_left_fasciculation] 
      ,[ll_left_weakness] 
      ,[ll_left_tone] 
      ,[ll_left_clonus] 
      ,[ll_left_knee_reflex] 
      ,[ll_left_ankle_reflex] 
      ,[ll_left_plantar] 
      ,[ll_right_wasting] 
      ,[ll_right_fasciculation] 
      ,[ll_right_weakness] 
      ,[ll_right_tone] 
      ,[ll_right_clonus] 
      ,[ll_right_knee_reflex] 
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      ,[ll_right_ankle_reflex] 
      ,[ll_right_plantar] 
      ,[umn_rostral_lmn] 
      ,[mr_imaging_head] 
      ,[mr_imaging_cerv_spine] 
      ,[mr_imaging_tl_spine] 
      ,[evid_lmn_involve_cra_emg] 
      ,[evid_lmn_involve_ul_left_emg] 
      ,[evid_lmn_involve_ul_right_emg] 
      ,[evid_lmn_involve_thortrunk_emg] 
      ,[evid_lmn_involve_ll_left_emg] 
      ,[evid_lmn_involve_ll_right_emg] 
      ,[if_umn_abs_were_they_ever_pr] 
      ,[el_escorial_criteria] 
      ,[pat_nonneuro_disease_descr] 
      ,[fam_nonneuro_disease_exists] 
      ,[fam_nonneuro_disease_descr] 
      ,[pat_nonneuro_disease_short] 
      ,[fam_nonneuro_disease_short] 
      ,[material_dna] 
      ,[material_lymphoblast] 
      ,[material_fibroblast] 
      ,[material_brain] 
      ,[material_spinal_cord_cervical] 
      ,[material_spinal_cord_thoracic] 
      ,[material_spinal_cord_lumbar] 
      ,[material_other] 
  FROM [Alsod].[dbo].[patient_clinical_record] 
Patient_genetic_record 
SELECT [patient_id] 
      ,[gene_id] 
      ,[family_id] 
      ,[screened] 
      ,[mutation_id] 
      ,[mutation_found] 
      ,[zygosity] 
      ,[status] 
      ,[family_history] 
      ,[affected] 
  FROM [Alsod].[dbo].[patient_genetic_record] 
Patient_record 
SELECT [patient_id] 
      ,[institution_code] 
      ,[patient_mnemonic] 
      ,[patient_first_name] 
      ,[patient_middle_init] 
      ,[patient_last_name] 
      ,[family_id] 
      ,[father_id] 
      ,[mother_id] 
      ,[family_history_old] 
      ,[sex] 
      ,[birth_date] 
      ,[country_iso_code] 
      ,[ethnic_origin] 
      ,[status_old] 
      ,[screened_for_sod1_old] 
      ,[mutation_found_old] 
      ,[mutation_id_old] 
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      ,[zygosity] 
      ,[last_accessed] 
      ,[date_of_onset] 
      ,[date_of_death] 
      ,[date_of_diagnosis] 
      ,[alive] 
      ,[age_of_onset] 
      ,[diagnosis_age] 
      ,[death_age] 
      ,[site_of_onset] 
      ,[site_of_onset_lr] 
      ,[site_of_onset_pd] 
      ,[death_diagnosis] 
      ,[weight] 
      ,[fvc] 
      ,[disease_duration] 
      ,[comments] 
      ,[UMN_signs] 
      ,[LMN_signs] 
      ,[cognitive_signs] 
      ,[phenotype] 
  FROM [Alsod].[dbo].[patient_record] 
Replicated mutation table 
SELECT [gene] 
      ,[mutation] 
      ,[codon] 
      ,[exons] 
      ,[families] 
      ,[generations] 
      ,[affected_patients] 
      ,[affected_controls] 
      ,[sporadic] 
      ,[familial] 
      ,[family_history] 
      ,[cases] 
      ,[controls] 
      ,[LODscore] 
      ,[linkage_shown] 
      ,[country1] 
      ,[country2] 
      ,[country3] 
      ,[country4] 
      ,[country5] 
      ,[ethnicity] 
      ,[snp] 
      ,[pathogenic] 
      ,[author] 
      ,[year] 
      ,[pubmed_id] 
      ,[PANTHER_Value] 
      ,[PANTHER_Prediction] 
      ,[SIFT_Value] 
      ,[SIFT_Prediction] 
      ,[PolyPhen_Value] 
      ,[PolyPhen_Prediction] 
      ,[controversies] 
      ,[comment] 
      ,[S_No] 
      ,[title] 
      ,[link] 
      ,[country6] 
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      ,[country7] 
      ,[country8] 
      ,[country9] 
      ,[country10] 
  FROM [Alsod].[dbo].[mutation_replication] 
Animal models 
SELECT [HomoloGeneID] 
      ,[Organism_Name] 
      ,[Biological_Name] 
      ,[Kegg_id] 
      ,[ncbi_locuslink_id] 
      ,[gene_id] 
      ,[EntrezGene_id] 
      ,[MGI_id] 
      ,[hgnc_id] 
      ,[omim_id] 
      ,[chromosome] 
      ,[genomic_coordinates_strand] 
      ,[genomic_chromosome] 
      ,[genomic_location] 
      ,[chromosome_split] 
      ,[genomic_range] 
      ,[strand] 
      ,[gene_name] 
      ,[Synonyms] 
      ,[ID] 
  FROM [Alsod].[dbo].[AnimalModels] 
Codons 
SELECT [gene_id] 
      ,[trinucleotide] 
      ,[codon_id] 
      ,[sequence_position_list] 
      ,[sequence_location_number] 
  FROM [Alsod].[dbo].[codons] 
Continents 
SELECT [continent_id] 
      ,[continent_name] 
  FROM [Alsod].[dbo].[Continent] 
Counter 
SELECT [count] 
  FROM [Alsod].[dbo].[counter] 
Country 
SELECT [country_iso_code] 
      ,[country_name] 
      ,[continent_id] 
  FROM [Alsod].[dbo].[Country] 
Country details 
SELECT [country_iso_code] 
      ,[country] 
      ,[fips104] 
      ,[iso2] 
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      ,[iso3] 
      ,[isono] 
      ,[capital] 
      ,[region] 
      ,[currency] 
      ,[currency_code] 
      ,[population] 
      ,[t_lag] 
      ,[t_type] 
      ,[comments] 
      ,[language] 
      ,[city_info] 
      ,[dialing_code] 
      ,[latitude] 
      ,[longitude] 
  FROM [Alsod].[dbo].[countrydetails] 
Country information 
SELECT [country_iso_code] 
      ,[country] 
      ,[fips104] 
      ,[iso2] 
      ,[iso3] 
      ,[isono] 
      ,[capital] 
      ,[region] 
      ,[currency] 
      ,[currency_code] 
      ,[population] 
      ,[t_lag] 
      ,[t_type] 
      ,[comments] 
      ,[language] 
      ,[city_info] 
      ,[dialing_code] 
  FROM [Alsod].[dbo].[countryinfo] 
Country latitude and longitude 
SELECT [country_iso_code] 
      ,[latitude] 
      ,[longitude] 
  FROM [Alsod].[dbo].[countrylatlong]  
Credibility_survey 
SELECT [S_No] 
      ,[Expert] 
      ,[ALS2] 
      ,[ANG] 
      ,[DAO] 
      ,[DCTN1] 
      ,[FIG4] 
      ,[FUS] 
      ,[NEFH] 
      ,[OPTN] 
      ,[SETX] 
      ,[SOD1] 
      ,[SPG11] 
      ,[TARDBP] 
      ,[VAPB] 
      ,[VCP] 
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  FROM [Alsod].[dbo].[credibility_survey] 
Gene authors 
SELECT [AuthorID] 
      ,[Lastname] 
      ,[Firstname] 
      ,[Initials] 
      ,[Address] 
      ,[Email] 
  FROM [Alsod].[dbo].[gene_authors] 
Gene study 
SELECT [Lastname] 
      ,[AuthorID] 
      ,[Month] 
      ,[Year] 
      ,[Others] 
      ,[Title] 
      ,[Volume] 
      ,[Paperlink] 
      ,[gene_id] 
      ,[PMID] 
      ,[Comment] 
      ,[doi_key] 
      ,[StudyID] 
  FROM [Alsod].[dbo].[gene_study] 
Gene_sequence 
SELECT [gene_id] 
      ,[sequence_position] 
      ,[sequence_position_relative] 
      ,[sequence_location_type] 
      ,[sequence_location_number] 
      ,[sequence_location_order] 
      ,[nucleotide] 
  FROM [Alsod].[dbo].[gene_sequence] 
Epidemiology 
SELECT [Gene] 
      ,[country] 
      ,[country_iso_code] 
      ,[set] 
      ,[controls] 
      ,[cases] 
      ,[Male-cases] 
      ,[Female-cases] 
      ,[bulbar] 
      ,[limb] 
      ,[others] 
      ,[dead] 
      ,[alive] 
      ,[unknown] 
      ,[FALS] 
      ,[SALS] 
      ,[first_author] 
      ,[year] 
      ,[title] 
      ,[pubmed_id] 
      ,[phenotype] 
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  FROM [Alsod].[dbo].[Epidemiology] 
Gene frequency 
SELECT [s_no] 
      ,[gene] 
      ,[country_iso_code] 
      ,[replication_id] 
      ,[Total_cases] 
      ,[Total_FALS_screened] 
      ,[Total_SALS_screened] 
      ,[Total_affected] 
      ,[FALS_number] 
      ,[FALS_percentage] 
      ,[SALS_number] 
      ,[SALS_percentage] 
      ,[Total_controls] 
      ,[Total_controls_affected] 
      ,[phenotype] 
      ,[comment] 
  FROM [Alsod].[dbo].[gene_frequency] 
Gene snps 
SELECT [gene_id] 
      ,[snp] 
      ,[basepair] 
      ,[pvalue] 
      ,[pubmed_id] 
      ,[paperlink] 
      ,[term] 
      ,[S_No] 
      ,[First_Author] 
      ,[Year] 
  FROM [Alsod].[dbo].[gene_SNP] 
Gene snps ALSGene website 
SELECT [chromosome_name] 
      ,[gene_id] 
      ,[ncbi_locuslink_id] 
      ,[gene_name] 
      ,[First_Author] 
      ,[Year] 
      ,[pubmed_id] 
      ,[snp1] 
      ,[snp2] 
      ,[mutation_mnemonic] 
      ,[codon] 
      ,[paperlink] 
      ,[basepair] 
      ,[term] 
      ,[pvalue] 
      ,[S_No] 
  FROM [Alsod].[dbo].[gene_SNP_ALSGene] 
Gene snps Lifeseq website 
SELECT [gene_id] 
      ,[DNA_change_original_from] 
      ,[DNA_change_original_to] 
      ,[chromosome_name] 
      ,[position] 
 - 468 - 
      ,[basepair] 
      ,[exon] 
      ,[snp2] 
      ,[mutation_mnemonic] 
      ,[codon] 
      ,[mRNA_accession_no] 
      ,[amino_acid_accession_no] 
      ,[amino_acid_change_as_seen] 
      ,[zygosity] 
      ,[ethnicity] 
      ,[country] 
      ,[families] 
      ,[number_patients_with_mutations] 
      ,[rate_patients_with_mutation] 
      ,[rate_patients] 
      ,[rate_patients_mutation_found] 
      ,[rate_patients_mutation_not_found] 
      ,[rate_controls] 
      ,[rate_controls_mutation_found] 
      ,[rate_controls_mutation_not found] 
      ,[odd_ratio] 
      ,[CI(95%)] 
      ,[Chi-Square_p_value] 
      ,[clinical_characteristics] 
      ,[family_history] 
      ,[gender] 
      ,[age_onset] 
      ,[duration_in_text] 
      ,[duration_months] 
      ,[UMN] 
      ,[LMN] 
      ,[Site_onset] 
      ,[years_until_initiation_respirator] 
      ,[pubmed_id] 
      ,[paper_title] 
      ,[First_Author] 
      ,[Year] 
      ,[comment] 
      ,[journal] 
  FROM [Alsod].[dbo].[gene_SNP_lifeseq] 
Gene snps updated 
SELECT [gene_id] 
      ,[snp] 
      ,[basepair] 
      ,[pvalue] 
      ,[pubmed_id] 
      ,[paperlink] 
      ,[term] 
      ,[First_Author] 
      ,[Year] 
      ,[link] 
      ,[Amino_acid] 
      ,[S_No] 
  FROM [Alsod].[dbo].[gene_SNP_updated] 
Guestbook 
SELECT [LastName] 
      ,[FirstName] 
      ,[Email] 
      ,[Comment] 
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      ,[SentDateTime] 
  FROM [Alsod].[dbo].[guestbook] 
GWA_BOS 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_BOS] 
GWA_FRA 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_FRA] 
GWA_HOL 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_HOL] 
GWA_NIH 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
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      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_NIH] 
GWA_NOKEY 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[ID] 
      ,[POP] 
  FROM [Alsod].[dbo].[GWA_NOKEY] 
GWA_UK 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_UK] 
GWA_USA 
SELECT [CHROMOSOME] 
      ,[SNP] 
      ,[BP] 
      ,[A1] 
      ,[F_A] 
      ,[F_U] 
      ,[A2] 
      ,[CHISQ] 
      ,[PVALUE] 
      ,[ODDRATIO] 
      ,[L95] 
      ,[U95] 
      ,[neglogpval] 
  FROM [Alsod].[dbo].[GWA_USA] 
GWA_UK_BOS 
SELECT [chr] 
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      ,[snp] 
      ,[bp] 
      ,[pvalbos] 
      ,[pvaluk] 
      ,[newpvalueukbos] 
      ,[id] 
      ,[log_ukbos] 
  FROM [Alsod].[dbo].[GWA_UK_BOS] 
GWA_UK_BOS_FRA 
SELECT [chr] 
      ,[snp] 
      ,[bp] 
      ,[pvalfra] 
      ,[pvalbos] 
      ,[newpvaluebosfra] 
      ,[pvaluk] 
      ,[newpvalueukbosfra] 
      ,[id] 
      ,[log_bosfra] 
      ,[log_ukbosfra] 
  FROM [Alsod].[dbo].[GWA_UK_BOS_FRA] 
GWA_UK_BOS_FRA_NIH 
SELECT [chr] 
      ,[snp] 
      ,[bp] 
      ,[pvalusa] 
      ,[pvalfra] 
      ,[newpvaluefrausa] 
      ,[pvalbos] 
      ,[newpvaluebosfrausa] 
      ,[pvaluk] 
      ,[newpvalueukbosfrausa] 
      ,[newpvalueukfrausa] 
      ,[newpvalueukfra] 
      ,[newpvaluebosusa] 
      ,[newpvalueukusa] 
      ,[id] 
      ,[log_frausa] 
      ,[log_bosfrausa] 
      ,[log_ukbosfrausa] 
      ,[log_ukfrausa] 
      ,[log_ukfra] 
      ,[log_bosusa] 
      ,[log_ukusa] 
  FROM [Alsod].[dbo].[GWA_UK_BOS_FRA_NIH] 
GWA_UK_BOS_FRA_USA 
SELECT [chr] 
      ,[snp] 
      ,[bp] 
      ,[pvalusa] 
      ,[pvalfra] 
      ,[newpvaluefrausa] 
      ,[pvalbos] 
      ,[newpvaluebosfrausa] 
      ,[pvaluk] 
      ,[newpvalueukbosfrausa] 
      ,[newpvalueukfrausa] 
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      ,[newpvalueukfra] 
      ,[newpvaluebosusa] 
      ,[newpvalueukusa] 
      ,[id] 
      ,[log_frausa] 
      ,[log_bosfrausa] 
      ,[log_ukbosfrausa] 
      ,[log_ukfrausa] 
      ,[log_ukfra] 
      ,[log_bosusa] 
      ,[log_ukusa] 
  FROM [Alsod].[dbo].[GWA_UK_BOS_FRA_USA] 
GWA_UK_BOS_HOL_FRA_NIH 
SELECT [chr] 
      ,[snp] 
      ,[bp] 
      ,[pvalhol] 
      ,[pvalusa] 
      ,[newpvalueholusa] 
      ,[pvalfra] 
      ,[newpvalueholfrausa] 
      ,[pvalbos] 
      ,[newpvaluebosholfrausa] 
      ,[pvaluk] 
      ,[newpvalueukbosholfrausa] 
      ,[newpvalueholfra] 
      ,[newpvalueboshol] 
      ,[newpvalueukhol] 
      ,[newpvaluebosholusa] 
      ,[newpvaluebosholfra] 
      ,[newpvalueukholusa] 
      ,[newpvalueukholfra] 
      ,[newpvalueukbosusa] 
      ,[newpvalueukboshol] 
      ,[newpvalueukbosholfra] 
      ,[newpvalueukbosholusa] 
      ,[newpvalueukholfrausa] 
      ,[id] 
      ,[log_holusa] 
      ,[log_holfrausa] 
      ,[log_bosholfrausa] 
      ,[log_ukbosholfrausa] 
      ,[log_holfra] 
      ,[log_boshol] 
      ,[log_ukhol] 
      ,[log_bosholusa] 
      ,[log_bosholfra] 
      ,[log_ukholusa] 
      ,[log_ukholfra] 
      ,[log_ukbosusa] 
      ,[log_ukboshol] 
      ,[log_ukbosholfra] 
      ,[log_ukbosholusa] 
      ,[log_ukholfrausa] 
  FROM [Alsod].[dbo].[GWA_UK_BOS_HOL_FRA_NIH] 
GWA_UK_BOS_HOL_FRA_USA 
SELECT [chr] 
      ,[snp] 
      ,[bp] 
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      ,[pvalhol] 
      ,[pvalusa] 
      ,[newpvalueholusa] 
      ,[pvalfra] 
      ,[newpvalueholfrausa] 
      ,[pvalbos] 
      ,[newpvaluebosholfrausa] 
      ,[pvaluk] 
      ,[newpvalueukbosholfrausa] 
      ,[newpvalueholfra] 
      ,[newpvalueboshol] 
      ,[newpvalueukhol] 
      ,[newpvaluebosholusa] 
      ,[newpvaluebosholfra] 
      ,[newpvalueukholusa] 
      ,[newpvalueukholfra] 
      ,[newpvalueukbosusa] 
      ,[newpvalueukboshol] 
      ,[newpvalueukbosholfra] 
      ,[newpvalueukbosholusa] 
      ,[newpvalueukholfrausa] 
      ,[id] 
      ,[log_holusa] 
      ,[log_holfrausa] 
      ,[log_bosholfrausa] 
      ,[log_ukbosholfrausa] 
      ,[log_holfra] 
      ,[log_boshol] 
      ,[log_ukhol] 
      ,[log_bosholusa] 
      ,[log_bosholfra] 
      ,[log_ukholusa] 
      ,[log_ukholfra] 
      ,[log_ukbosusa] 
      ,[log_ukboshol] 
      ,[log_ukbosholfra] 
      ,[log_ukbosholusa] 
      ,[log_ukholfrausa] 
      ,[neg2logpvalhol] 
      ,[neg2logpvalusa] 
      ,[neg2logpvalfra] 
      ,[neg2logpvalbos] 
      ,[neg2logpvaluk] 
  FROM [Alsod].[dbo].[GWA_UK_BOS_HOL_FRA_USA] 
GWA_CATALOGUE 
SELECT [Added_date] 
      ,[Pubmed_id] 
      ,[First_author] 
      ,[Submission_date] 
      ,[Journal] 
      ,[Link] 
      ,[Study] 
      ,[Disease_trait] 
      ,[Initial_sample_size] 
      ,[Replication_sample_size] 
      ,[Region] 
      ,[Reported_genes] 
      ,[Strongest_snps_risk_allele] 
      ,[Snps] 
      ,[Risk_allele_frequency] 
      ,[P_value] 
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      ,[P_value_text] 
      ,[Odd_ratio_beta] 
      ,[CI_95_percent_text] 
      ,[Platform_snp_passing_QC] 
      ,[CNV] 
      ,[S_No] 
  FROM [Alsod].[dbo].[GWA_CATALOGUE] 
GWA_ALL_COMMON_DATA 
SELECT [id] 
      ,[chr] 
      ,[snp] 
      ,[bp] 
      ,[pvalbos] 
      ,[pvalhol] 
      ,[pvaluk] 
      ,[new_pvalue_bos] 
      ,[new_pvalue_hol] 
      ,[new_pvalue_uk] 
      ,[new_pvalue_sum] 
  FROM [Alsod].[KCLAD\spngoka].[GWA_ALL_COMMON_DATA] 
GWA_CHIDIST_ALL_COMMON 
SELECT [id] 
      ,[newpvalue] 
      ,[chidist] 
      ,[pvalue_plot] 
  FROM [Alsod].[KCLAD\spngoka].[GWA_CHIDIST_ALL_COMMON] 
GWASTUDY 
SELECT [ID] 
      ,[POP] 
      ,[POPCODE] 
      ,[STUDY] 
      ,[YEAR] 
      ,[FROMNUM] 
      ,[TONUM] 
      ,[LINKID] 
  FROM [Alsod].[KCLAD\spngoka].[GWASTUDY] 
GWA_FOGH 
SELECT [SNP] 
      ,[CHROMOSOME] 
      ,[BP] 
      ,[PVALUE] 
  FROM [Alsod].[dbo].[GWA_FOGH] 
Institution 
SELECT [institution_code] 
      ,[institution_name] 
      ,[department] 
      ,[institution_address1] 
      ,[institution_address2] 
      ,[institution_address3] 
      ,[city] 
      ,[state] 
      ,[postcode] 
      ,[country_iso_code] 
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      ,[contact_title] 
      ,[contact_first_name] 
      ,[contact_middle_init] 
      ,[contact_last_name] 
      ,[telephone] 
      ,[extension] 
      ,[facsimile] 
      ,[e_mail_address] 
  FROM [Alsod].[dbo].[institution] 
IPAddress of countries 
SELECT [ip1] 
      ,[ip2] 
      ,[registry] 
      ,[assigned] 
      ,[iso2] 
      ,[iso3] 
      ,[country] 




      ,[contact_title] 
      ,[contact_first_name] 
      ,[contact_middle_init] 
      ,[contact_last_name] 
      ,[institution_name] 
      ,[department] 
      ,[institution_address1] 
      ,[institution_address2] 
      ,[institution_address3] 
      ,[city] 
      ,[postcode] 
      ,[country_iso_code] 
      ,[telephone] 
      ,[extension] 
      ,[facsimile] 
      ,[e_mail_address] 




      ,[codon] 
      ,[sequence] 
      ,[score] 
      ,[phosphorylated] 
      ,[message] 




      ,[Pathogenic] 




      ,[Total_no_family_history] 
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      ,[P_deletrious] 
      ,[gene] 
      ,[mutation] 
      ,[codon] 
      ,[name] 
      ,[Accession] 
      ,[score] 
      ,[position] 
      ,[Pwt] 
      ,[Psubstituted] 
      ,[NIC] 
      ,[message] 




      ,[mutation] 
      ,[codon] 
      ,[position] 
      ,[PSIC_score] 
      ,[prediction] 
      ,[PSIC_score_new] 




      ,[codon] 
      ,[gene] 
      ,[mutation_from] 
      ,[mutation_to] 
      ,[message] 
      ,[subPSEC] 




      ,[gene_id] 
      ,[sequence_original_mutated] 
      ,[sequence_original] 
      ,[sequence_mutated] 
      ,[Location] 
      ,[Ref_Allele] 
      ,[Var_Allele] 
      ,[Global_Count] 
      ,[Global_Freq] 
      ,[South_American_Count] 
      ,[South_American_Freq] 
      ,[Asian_Count] 
      ,[Asian_Freq] 
      ,[African_Count] 
      ,[African_Freq] 
      ,[European_Count] 
      ,[European_Freq] 




      ,[gene_id] 
      ,[sequence_original_mutated] 
      ,[sequence_original] 
      ,[sequence_mutated] 
      ,[Location] 
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      ,[Ref_Allele] 
      ,[Var_Allele] 
      ,[Global_Count] 
      ,[Global_Freq] 
      ,[European_American_Count] 
      ,[European_American_Freq] 
      ,[African_American_Count] 
      ,[African_American_Freq] 




      ,[mutation_mnemonic] 
      ,[mutated_from_to] 
      ,[exon_number] 
      ,[codon_id] 
      ,[subpsec_score] 




      ,[gene_id] 
      ,[pubmed_id] 
      ,[ID] 




      ,[pubmed_id] 
      ,[year] 
      ,[first_author] 
      ,[ID] 




      ,[reference_pubmed_id] 
      ,[reference_medline_id] 
      ,[reference] 
      ,[reference_title] 
      ,[reference_authors] 
      ,[reference_year] 
      ,[reference_type] 
      ,[reference_subtype] 
      ,[reference_comment1] 
      ,[reference_comment2] 
      ,[reference_comment3] 




      ,[mutation_id] 
      ,[gene_id] 
      ,[patient_id] 




      ,[age] 
      ,[gender] 
      ,[country] 
      ,[status] 
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      ,[q211] 
      ,[q212] 
      ,[q220] 
      ,[q230] 
      ,[q240] 
      ,[q250] 
      ,[q310] 
      ,[q320] 
      ,[q330] 
      ,[q340] 
      ,[q350] 
      ,[q360] 
      ,[q371] 
      ,[q372] 
      ,[q373] 
      ,[q374] 
      ,[q375] 
      ,[q410] 
      ,[q420] 
      ,[q430] 
      ,[q510] 
      ,[q520] 
      ,[q530] 
      ,[q540] 
      ,[q550] 
      ,[referrer] 
      ,[other_referrer] 




      ,[amino_acid] 
      ,[code] 




      ,[ORIGINAL] 
      ,[POSITION] 
      ,[VARIATION] 
      ,[MUTATION] 
      ,[ID] 
      ,[TYPE] 
      ,[DESCRIPTION] 
      ,[DATA_FROM] 




      ,[institution_code] 
      ,[username] 
      ,[password] 
      ,[superuser] 
      ,[user_email] 
      ,[contact_title] 
      ,[contact_first_name] 
      ,[contact_middle_init] 
      ,[contact_last_name] 
      ,[institution_name] 
      ,[department] 
      ,[institution_address1] 
      ,[institution_address2] 
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      ,[institution_address3] 
      ,[state] 
      ,[city] 
      ,[postcode] 
      ,[country_iso_code] 
      ,[telephone] 
      ,[facsimile] 
      ,[contact_person] 
      ,[extension] 




      ,[minor] 
      ,[langid] 
      ,[sublangid] 
      ,[sortid] 




      ,[IPAddress] 
      ,[Host] 
      ,[Country] 
      ,[Page] 
      ,[summaryhttp] 
      ,[summaryraw] 
      ,[ID] 
      ,[CountryCode] 




      ,[chrom] 
      ,[strand] 
      ,[txtStart] 
      ,[txtEnd] 
      ,[cdsStart] 
      ,[cdsEnd] 
      ,[exonCount] 
      ,[exonStarts] 
      ,[exonEnds] 
      ,[proteinID] 
      ,[alignID] 
      ,[id] 
  FROM [Alsod].[KCLAD\spngoka].[genome] 
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Appendix 25 – T-SQL scripts in each SQL view 
ANALYZE_JOINTDATA_VIEW 
SELECT     dbo.ANALYZE_THEIRDATA.CHROMOSOME, dbo.ANALYZE_THEIRDATA.SNP, 
dbo.ANALYZE_THEIRDATA.BP, dbo.ANALYZE_THEIRDATA.PVALUE,  
                      dbo.ANALYZE_OURDATA.PVALHOL, 
dbo.ANALYZE_OURDATA.PVALUSA, dbo.ANALYZE_OURDATA.PVALFRA, 
dbo.ANALYZE_OURDATA.PVALBOS,  
                      dbo.ANALYZE_OURDATA.PVALUK, 
dbo.ANALYZE_THEIRDATA.neg2logpval, dbo.ANALYZE_OURDATA.neg2logpvalhol,  
                      dbo.ANALYZE_OURDATA.neg2logpvalusa, 
dbo.ANALYZE_OURDATA.neg2logpvalfra, dbo.ANALYZE_OURDATA.neg2logpvalbos,  
                      dbo.ANALYZE_OURDATA.neg2logpvaluk 
FROM         dbo.ANALYZE_THEIRDATA INNER JOIN 




SELECT     dbo.countryinfo.country_iso_code, dbo.countryinfo.country, 
dbo.countryinfo.fips104, dbo.countryinfo.iso2, dbo.countryinfo.iso3, 
dbo.countryinfo.isono,  
                      dbo.countryinfo.capital, dbo.countryinfo.region, 
dbo.countryinfo.currency, dbo.countryinfo.currency_code, 
dbo.countryinfo.population,  
                      dbo.countryinfo.t_lag, dbo.countryinfo.t_type, 
dbo.countryinfo.comments, dbo.countryinfo.language, 
dbo.countryinfo.city_info,  
                      dbo.countryinfo.dialing_code, 
dbo.countrylatlong.latitude, dbo.countrylatlong.longitude 
FROM         dbo.countryinfo INNER JOIN 
                      dbo.countrylatlong ON 
dbo.countryinfo.country_iso_code = dbo.countrylatlong.country_iso_code 
 
gender_report 
SELECT     dbo.patient_genetic_record.gene_id AS Gene, COUNT(CASE [sex] 
WHEN 'female' THEN 'Others' ELSE NULL END) AS Male,  
                      COUNT(CASE [sex] WHEN 'male' THEN 'Others' ELSE NULL 
END) AS Female, COUNT(CASE [sex] WHEN 'Others' THEN 'Others' ELSE NULL END)  
                      AS Others, COUNT(dbo.patient_record.sex) AS Total 
FROM         dbo.patient_genetic_record INNER JOIN 
                      dbo.patient_record ON 
dbo.patient_genetic_record.patient_id = dbo.patient_record.patient_id 
GROUP BY dbo.patient_genetic_record.gene_id 
 
mutationtype_report 
SELECT     dbo.patient_genetic_record.gene_id AS Gene, COUNT(CASE 
[mutation_type] WHEN 'Compound' THEN 'Others' ELSE NULL END) AS Compound,  
                      COUNT(CASE [mutation_type] WHEN 'Substitution' THEN 
'Others' ELSE NULL END) AS Substitution,  
                      COUNT(CASE [mutation_type] WHEN 'Deletion' THEN 
'Others' ELSE NULL END) AS Deletion,  
                      COUNT(CASE [mutation_type] WHEN 'Polymorphism' THEN 
'Others' ELSE NULL END) AS Polymorphism,  
                      COUNT(CASE [mutation_type] WHEN 'Insertion' THEN 
'Others' ELSE NULL END) AS Insertion,  
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                      COUNT(CASE [mutation_type] WHEN 'Others' THEN 
'Others' ELSE NULL END) AS Others, COUNT(dbo.mutation.mutation_type) AS 
Total 
FROM         dbo.patient_genetic_record INNER JOIN 
                      dbo.mutation ON 
dbo.patient_genetic_record.mutation_id = dbo.mutation.mutation_id AND  




SELECT     COUNT(dbo.patient_genetic_record.gene_id) AS SODCOMPOUND 
FROM         dbo.patient_record INNER JOIN 
                      dbo.patient_genetic_record ON 
dbo.patient_record.patient_id = dbo.patient_genetic_record.patient_id INNER 
JOIN 
                      dbo.mutation ON 
dbo.patient_genetic_record.mutation_id = dbo.mutation.mutation_id AND  
                      dbo.patient_genetic_record.mutation_id = 
dbo.mutation.mutation_id 
WHERE     (dbo.patient_genetic_record.gene_id = 'sod1') AND 
(dbo.mutation.mutation_type = 'compound') 
 
site_of_onset_report 
SELECT     dbo.patient_genetic_record.gene_id AS Gene, COUNT(CASE 
[site_of_onset] WHEN 'leg' THEN 'Others' ELSE NULL END) AS Leg,  
                      COUNT(CASE [site_of_onset] WHEN 'arm' THEN 'Others' 
ELSE NULL END) AS Arm,  
                      COUNT(CASE [site_of_onset] WHEN 'bulbar' THEN 
'Others' ELSE NULL END) AS Bulbar,  
                      COUNT(CASE [site_of_onset] WHEN 'Others' THEN 
'Others' ELSE NULL END) AS Others, COUNT(dbo.patient_record.site_of_onset) 
AS Total 
FROM         dbo.patient_genetic_record INNER JOIN 
                      dbo.patient_record ON 
dbo.patient_genetic_record.patient_id = dbo.patient_record.patient_id 
GROUP BY dbo.patient_genetic_record.gene_id 
 
SOD1_MUTATIONS 
SELECT     TOP (100) PERCENT mutation_mnemonic, gene_id, mutation_type, 
codon, sequence_location_number 
FROM         dbo.mutation 
WHERE     (gene_id = 'SOD1') AND (codon <> 0) 
 
statistics_country 
SELECT     TOP (100) PERCENT Country, COUNT(*) AS Frequency 
FROM         dbo.visitors 
GROUP BY Country 
ORDER BY Frequency 
 
study_expression 
SELECT     TOP (100) PERCENT dbo.gene_study.Lastname + ',' + 
dbo.gene_study.Year + ' [' + dbo.gene_study.gene_id + ']' AS expression,  
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                      dbo.gene_study.Lastname, dbo.gene_study.Month, 
dbo.gene_study.Year, dbo.gene_study.Title, dbo.gene_study.PMID, 
dbo.gene.gene_id,  
                      dbo.gene_study.StudyID, dbo.gene.ucsc_id, 
dbo.gene.protein_name, dbo.gene.other_names, 
dbo.gene.reason_for_investigation, dbo.gene.result,  
                      dbo.gene_study.Others, dbo.gene_study.Volume, 
dbo.gene.ncbi_locuslink_id, dbo.gene.structure_id, dbo.gene.omim_id, 
dbo.gene.chromosome,  
                      dbo.gene.category, dbo.gene.hgnc_id, 
dbo.gene_study.Comment, dbo.gene_study.doi_key, dbo.gene_study.Paperlink, 
dbo.gene.keywords,  
                      dbo.gene.swissport_id, dbo.gene.ihop, 
dbo.gene.gene_effect 
FROM         dbo.gene_study INNER JOIN 
                      dbo.gene ON dbo.gene_study.gene_id = dbo.gene.gene_id 
 
AllGenes_Trinuc_Codes 
SELECT     dbo.codons.gene_id, dbo.codons.codon_id AS codon, 
dbo.codons.trinucleotide, dbo.trinucleotides.code 
FROM         dbo.codons INNER JOIN 




SELECT DISTINCT  
                      TOP (100) PERCENT dbo.mutation.gene_id, 
dbo.mutation.aa_mutated, dbo.mutation.aa_original, dbo.mutation.codon, 
dbo.trinucleotides.code,  
                      dbo.mutation.mutation_type 
FROM         dbo.mutation INNER JOIN 
                      dbo.trinucleotides ON dbo.mutation.aa_mutated = 
dbo.trinucleotides.amino_acid 
ORDER BY dbo.mutation.codon 
 
Credibility_score_analysis 
SELECT     [KCLAD\spngoka].Number_of_mutations_per_gene.Rank AS 
Rank_Mutations,  
                      
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Rank AS Rank_Patients,  
                      [KCLAD\spngoka].Number_of_cases_affected.Rank AS 
Rank_Affected_Cases,  
                      [KCLAD\spngoka].Number_of_cases_tested.Rank AS 
Rank_Tested_Cases,  
                      [KCLAD\spngoka].Number_of_controls_affected.Rank AS 
Rank_Affected_Controls,  
                      [KCLAD\spngoka].Number_of_controls_tested.Rank AS 
Rank_Tested_Controls,  
                      [KCLAD\spngoka].[Number_of_mutations_in 
_same_codon_by_rank].Rank AS Rank_Codon,  
                      
[KCLAD\spngoka].Number_of_patients_with_family_history_FALS.Rank AS 
Rank_FALS,  
                      
[KCLAD\spngoka].Number_of_patients_without_family_history_SALS.Rank AS 
Rank_SALS,  
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[KCLAD\spngoka].Number_of_times_mutation_is_replicated.Rank AS 
Rank_Replications,  
                      
[KCLAD\spngoka].Number_of_unique_countries_on_genes.Rank AS 
Rank_Populations,  
                      [KCLAD\spngoka].Ranking_LOD_score.Rank AS 
Rank_LOD_Score, [KCLAD\spngoka].Number_of_mutations_per_gene.Gene 
FROM         [KCLAD\spngoka].Number_of_affected_patients_in_ALSoD INNER 
JOIN 
                      [KCLAD\spngoka].Number_of_mutations_per_gene ON  
                      
[KCLAD\spngoka].Number_of_affected_patients_in_ALSoD.Gene = 
[KCLAD\spngoka].Number_of_mutations_per_gene.Gene INNER JOIN 
                      [KCLAD\spngoka].Number_of_cases_affected ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_cases_affected.Gene INNER JOIN 
                      [KCLAD\spngoka].Number_of_cases_tested ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_cases_tested.Gene INNER JOIN 
                      [KCLAD\spngoka].Number_of_controls_affected ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_controls_affected.Gene INNER JOIN 
                      [KCLAD\spngoka].Number_of_controls_tested ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_controls_tested.Gene INNER JOIN 
                      [KCLAD\spngoka].[Number_of_mutations_in 
_same_codon_by_rank] ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].[Number_of_mutations_in _same_codon_by_rank].Gene INNER 
JOIN 
                      
[KCLAD\spngoka].Number_of_patients_with_family_history_FALS ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_patients_with_family_history_FALS.Gene INNER JOIN 
                      
[KCLAD\spngoka].Number_of_patients_without_family_history_SALS ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_patients_without_family_history_SALS.Gene INNER 
JOIN 
                      
[KCLAD\spngoka].Number_of_times_mutation_is_replicated ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_times_mutation_is_replicated.Gene INNER JOIN 
                      [KCLAD\spngoka].Number_of_unique_countries_on_genes 
ON  
                      [KCLAD\spngoka].Number_of_mutations_per_gene.Gene = 
[KCLAD\spngoka].Number_of_unique_countries_on_genes.Gene INNER JOIN 





SELECT     TOP (100) PERCENT LEFT(DateTime, 12) AS Daily, ID 
FROM         dbo.visitors 
ORDER BY ID 
 
Gridview_Replicated_mutations 
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SELECT     Gene, mutation_mnemonic AS Mutation, COUNT(mutation_mnemonic) AS 
Frequency, DENSE_RANK() OVER (ORDER BY COUNT(mutation_mnemonic) DESC) 
 AS Rank_Mutation 
FROM         (SELECT     [KCLAD\spngoka].patient_record_view.Gene, 
dbo.mutation.mutation_mnemonic, 
[KCLAD\spngoka].patient_record_view.first_author,  
                                              
[KCLAD\spngoka].patient_record_view.year, 
[KCLAD\spngoka].patient_record_view.pubmed_id 
                       FROM          [KCLAD\spngoka].patient_record_view 
INNER JOIN 
                                              dbo.mutation ON 
[KCLAD\spngoka].patient_record_view.mid = dbo.mutation.mutation_id 
                       UNION 
                       SELECT DISTINCT gene_id, mutation_mnemonic, 
First_Author, Year, pubmed_id 
                       FROM         dbo.gene_SNP_lifeseq 
                       WHERE     (mutation_mnemonic IS NOT NULL) AND 
(mutation_mnemonic <> 'NA') 
                       UNION 
                       SELECT DISTINCT gene, mutation, author, year, 
pubmed_id 
                       FROM         dbo.mutation_replication 
                       UNION 
                       SELECT DISTINCT gene_id, mutation_mnemonic, 
First_Author, Year, pubmed_id 
                       FROM         dbo.gene_SNP_ALSGene 
                       WHERE     (mutation_mnemonic IS NOT NULL) AND 
(mutation_mnemonic <> 'NA')) AS derivedtbl_1 
 
Gridview_total_cases 
SELECT DISTINCT TOP (100) PERCENT gene, cases, author, year, pubmed_id 
FROM         dbo.mutation_replication 
WHERE     (cases IS NOT NULL) 
ORDER BY gene 
 
Gridview_total_controls 
SELECT DISTINCT gene, cases, controls, author, year, pubmed_id 
FROM         dbo.mutation_replication 
WHERE     (controls IS NOT NULL) 
 
Gridview_unique_countries 
SELECT DISTINCT gene_id, country 
FROM         dbo.gene_SNP_lifeseq 
WHERE     (family_history IS NOT NULL) AND (gender IS NOT NULL) AND 
(mutation_mnemonic IS NOT NULL) AND (country IS NOT NULL) 
UNION 
SELECT DISTINCT Gene, Country 
FROM         [KCLAD\spngoka].patient_record_view 
GROUP BY Gene, Country 
 
GWA_ALL 
SELECT     [KCLAD\spngoka].GWA_BOS.S_No AS snbos, 
[KCLAD\spngoka].GWA_HOL.S_No AS snhol, [KCLAD\spngoka].GWA_UK.S_No AS snuk,  
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                      [KCLAD\spngoka].GWA_BOS.CHROMOSOME AS chr, 
[KCLAD\spngoka].GWA_BOS.SNP AS snpbos, [KCLAD\spngoka].GWA_HOL.SNP AS 
snphol,  
                      [KCLAD\spngoka].GWA_UK.SNP AS snpuk, 
[KCLAD\spngoka].GWA_BOS.BP AS bpbos, [KCLAD\spngoka].GWA_HOL.BP AS bphol,  
                      [KCLAD\spngoka].GWA_UK.BP AS bpuk, 
[KCLAD\spngoka].GWA_BOS.PVALUE AS pvalbos, [KCLAD\spngoka].GWA_HOL.PVALUE 
AS pvalhol,  
                      [KCLAD\spngoka].GWA_UK.PVALUE AS pvaluk 
FROM         [KCLAD\spngoka].GWA_BOS INNER JOIN 
                      [KCLAD\spngoka].GWA_HOL ON 
[KCLAD\spngoka].GWA_BOS.SNP = [KCLAD\spngoka].GWA_HOL.SNP INNER JOIN 




SELECT     [KCLAD\spngoka].GWA_ALL_COMMON_DATA.id, 
[KCLAD\spngoka].GWA_CHIDIST_ALL_COMMON.id AS id2,  
                      [KCLAD\spngoka].GWA_ALL_COMMON_DATA.chr, 
[KCLAD\spngoka].GWA_ALL_COMMON_DATA.snp, 
[KCLAD\spngoka].GWA_ALL_COMMON_DATA.bp,  
                      [KCLAD\spngoka].GWA_ALL_COMMON_DATA.pvalbos, 
[KCLAD\spngoka].GWA_ALL_COMMON_DATA.pvalhol,  
                      [KCLAD\spngoka].GWA_ALL_COMMON_DATA.pvaluk, 
[KCLAD\spngoka].GWA_CHIDIST_ALL_COMMON.newpvalue,  
                      [KCLAD\spngoka].GWA_CHIDIST_ALL_COMMON.chidist, 
[KCLAD\spngoka].GWA_CHIDIST_ALL_COMMON.pvalue_plot 
FROM         [KCLAD\spngoka].GWA_ALL_COMMON_DATA INNER JOIN 
                      [KCLAD\spngoka].GWA_CHIDIST_ALL_COMMON ON  




SELECT     TOP (100) PERCENT dbo.mutation.mutation_mnemonic, 
dbo.countrydetails.latitude, dbo.countrydetails.longitude, 
dbo.countrydetails.country 
FROM         dbo.mutation INNER JOIN 
                      dbo.countrydetails ON dbo.mutation.countryiso1 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso2 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso3 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso4 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso5 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso6 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso7 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso8 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso9 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso10 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso11 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso12 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso13 = 
dbo.countrydetails.country_iso_code OR  
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                      dbo.mutation.countryiso14 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso15 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso16 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso17 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso18 = 
dbo.countrydetails.country_iso_code OR dbo.mutation.countryiso19 = 
dbo.countrydetails.country_iso_code OR  
                      dbo.mutation.countryiso20 = 
dbo.countrydetails.country_iso_code 
WHERE     (dbo.mutation.gene_id = 'SOD1') AND 
(dbo.mutation.sequence_location_type = 'exon') 
ORDER BY dbo.mutation.codon 
 
mutation update 
SELECT     mutation_alias, mutation_name, mutation_mnemonic, gene_id, 
mutation_type, codon, first_author, year, countryiso1, pubmed_id, doi 
FROM         dbo.mutation 
WHERE     (gene_id = 'ALS2') 
 
No_SALS_view 
SELECT     Gene, COUNT([family History]) AS Total_no_family_history 
FROM         (SELECT     [KCLAD\spngoka].patient_record_view.sex, 
[KCLAD\spngoka].patient_record_view.Country,  
                                              
[KCLAD\spngoka].patient_record_view.[family History], 
[KCLAD\spngoka].patient_record_view.Gene, dbo.mutation.mutation_mnemonic,  
                                              
[KCLAD\spngoka].patient_record_view.first_author, 
[KCLAD\spngoka].patient_record_view.year,  
                                              
[KCLAD\spngoka].patient_record_view.pubmed_id, 
[KCLAD\spngoka].patient_record_view.[Site of Onset] 
                       FROM          [KCLAD\spngoka].patient_record_view 
INNER JOIN 
                                              dbo.mutation ON 
[KCLAD\spngoka].patient_record_view.Mutation = dbo.mutation.mutation_name 
                       WHERE      
([KCLAD\spngoka].patient_record_view.[family History] = 'No') 
                       UNION 
                       SELECT     gender, country, family_history, gene_id, 
mutation_mnemonic, First_Author, Year, pubmed_id, Site_onset 
                       FROM         dbo.gene_SNP_lifeseq 
                       WHERE     (family_history IS NOT NULL) AND (gender 
IS NOT NULL) AND (mutation_mnemonic IS NOT NULL) AND (family_history = 
'No'))  
                      AS table1 
GROUP BY Gene 
 
Number_of_affected_patients_in_ALSoD 
SELECT     gene_id AS Gene, COUNT(*) AS Frequency, DENSE_RANK() OVER (ORDER 
BY COUNT(gene_id) DESC) AS Rank 
FROM         dbo.patient_genetic_record 
WHERE     (gene_id <> 'LUM') AND (gene_id <> 'CRYM') 
GROUP BY gene_id 
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Number_of_cases_affected 
SELECT     gene_id AS Gene, SUM(rate_patients_mutation_found) AS 
Total_cases_affected, DENSE_RANK() OVER (ORDER BY 
SUM(rate_patients_mutation_found) 
                       DESC) AS Rank 
FROM         (SELECT DISTINCT gene_id, rate_patients_mutation_found, 
First_Author, Year 
                       FROM          dbo.gene_SNP_lifeseq 
                       WHERE      (rate_patients_mutation_found IS NOT 
NULL)) AS table1 
GROUP BY gene_id 
 
Number_of_cases_recorded 
SELECT     gene AS Gene, SUM(cases) AS Total_cases_recorded, DENSE_RANK() 
OVER (ORDER BY SUM(cases) DESC) AS Rank 
FROM         (SELECT DISTINCT gene, cases, controls, author, year, 
pubmed_id 
                       FROM          dbo.mutation_replication 
                       WHERE      (cases IS NOT NULL)) AS table1 
GROUP BY gene 
 
Number_of_cases_tested 
SELECT     gene_id AS Gene, SUM(rate_patients_mutation_not_found) AS 
Total_cases_tested, DENSE_RANK() OVER (ORDER BY 
SUM(rate_patients_mutation_not_found) 
                       DESC) AS Rank 
FROM         (SELECT DISTINCT gene_id, First_Author, Year, 
rate_patients_mutation_not_found 
                       FROM          dbo.gene_SNP_lifeseq 
                       WHERE      (rate_patients_mutation_not_found IS NOT 
NULL)) AS table1 
GROUP BY gene_id 
 
Number_of_controls_affected 
SELECT     gene_id AS Gene, SUM(rate_controls_mutation_found) AS 
Total_controls_affected, DENSE_RANK() OVER (ORDER BY 
SUM(rate_controls_mutation_found) 
                       ASC) AS Rank 
FROM         (SELECT DISTINCT gene_id, First_Author, Year, 
rate_controls_mutation_found 
                       FROM          dbo.gene_SNP_lifeseq 
                       WHERE      (rate_controls_mutation_found IS NOT 
NULL)) AS table1 
GROUP BY gene_id 
 
Number_of_controls_recorded 
SELECT     gene AS Gene, SUM(controls) AS Total_controls_recorded, 
DENSE_RANK() OVER (ORDER BY SUM(controls) DESC) AS Rank 
FROM         (SELECT DISTINCT gene, cases, controls, author, year, 
pubmed_id 
                       FROM          dbo.mutation_replication 
                       WHERE      (controls IS NOT NULL)) AS table1 
GROUP BY gene 
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Number_of_controls_tested 
SELECT     gene_id AS Gene, SUM([rate_controls_mutation_not found]) AS 
Total_controls_tested, DENSE_RANK() OVER (ORDER BY 
SUM([rate_controls_mutation_not found]) 
                       DESC) AS Rank 
FROM         (SELECT DISTINCT gene_id, [rate_controls_mutation_not found] 
                       FROM          dbo.gene_SNP_lifeseq 
                       WHERE      ([rate_controls_mutation_not found] IS 
NOT NULL)) AS table1 
GROUP BY gene_id 
 
Number_of_families_with_generations 
SELECT DISTINCT gene, mutation, codon, score, families, generations, 
author, year, pubmed_id, DENSE_RANK() OVER (ORDER BY families DESC)  
AS Rank 
FROM         dbo.mutation_replication 
WHERE     (families IS NOT NULL) AND (generations IS NOT NULL) AND 
(families <> '0') 
 
Number_of_mutations_in _same_codon_by_rank 
SELECT     Gene, Sum(Rank) AS Rank_Summation, DENSE_RANK() OVER (ORDER BY 
Sum(Rank) DESC) AS Rank 
FROM         (SELECT     TOP (100) PERCENT gene_id AS Gene, codon AS Codon, 
COUNT(codon) AS Frequency, DENSE_RANK() OVER (ORDER BY COUNT(codon) DESC) 
                       AS Rank 
FROM         (SELECT     TOP (100) PERCENT gene_id, mutation_mnemonic, 
codon 
                       FROM          dbo.mutation 
                       WHERE      (codon IS NOT NULL) AND (codon <> 0) 
                       ORDER BY codon) AS table1 
GROUP BY gene_id, codon 
ORDER BY codon) AS table2 
GROUP BY Gene 
 
Number_of_mutations_per_gene 
SELECT     gene_id AS Gene, COUNT(gene_id) AS Frequency, DENSE_RANK() OVER 
(ORDER BY COUNT(gene_id) DESC) AS Rank 
FROM         (SELECT     gene_id, mutation_mnemonic 
                       FROM          dbo.mutation 
                       WHERE      (mutation_mnemonic IS NOT NULL AND 
mutation_mnemonic <> 'NA')) AS derivedtbl_1 
GROUP BY gene_id 
 
Number_of_pathogenic_mutations_by_rank 
SELECT     Gene, Pathogenic, DENSE_RANK() OVER (ORDER BY ([Pathogenic]) 
DESC) AS Rank 
FROM         (SELECT     Gene, Pathogenic 
                       FROM          dbo.No_PATHOGENICITY 
                       UNION 
                       SELECT     Gene, Pathogenic 
                       FROM         [KCLAD\spngoka].PATHOGENICITY_VIEW) AS 
table1 
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Number_of_patients_with_family_history_FALS 
SELECT     Gene, Count([family History]) AS Total_family_history, 
DENSE_RANK() OVER (ORDER BY Count([family History]) DESC) AS Rank 
FROM         (SELECT     [KCLAD\spngoka].patient_record_view.Sex, 
[KCLAD\spngoka].patient_record_view.Country,  
                                              
[KCLAD\spngoka].patient_record_view.[family History], 
[KCLAD\spngoka].patient_record_view.Gene, dbo.mutation.mutation_mnemonic,  
                                              
[KCLAD\spngoka].patient_record_view.first_author, 
[KCLAD\spngoka].patient_record_view.year,  
                                              
[KCLAD\spngoka].patient_record_view.pubmed_id, 
[KCLAD\spngoka].patient_record_view.[Site of Onset] 
                       FROM          [KCLAD\spngoka].patient_record_view 
INNER JOIN 
                                              dbo.mutation ON 
[KCLAD\spngoka].patient_record_view.Mutation = dbo.mutation.mutation_name 
                       WHERE      
([KCLAD\spngoka].patient_record_view.[family History] = 'Yes') 
                       UNION 
                       SELECT     gender, country, family_history, gene_id, 
mutation_mnemonic, First_Author, Year, pubmed_id, Site_onset 
                       FROM         dbo.gene_SNP_lifeseq 
                       WHERE     (family_history IS NOT NULL) AND (gender 
IS NOT NULL) AND (mutation_mnemonic IS NOT NULL) AND (family_history = 
'Yes'))  
                      AS table1 
 
Number_of_patients_without_family_history_SALS 
SELECT     Gene, Total_no_family_history, DENSE_RANK() OVER (ORDER BY 
[Total_no_family_history] DESC) AS Rank 
FROM         (SELECT     Gene, Total_no_family_history 
                       FROM          dbo.No_SALS 
                       UNION 
                       SELECT     Gene, Total_no_family_history 
                       FROM         [KCLAD\spngoka].No_SALS_view) AS table1 
 
Number_of_publications 
SELECT     gene_id AS Gene, Count(gene_id) AS Total_Publication, 
DENSE_RANK() OVER (ORDER BY COUNT(gene_id) DESC) AS Rank 
FROM         (SELECT     [Lastname], [Year], [gene_id], [Title], [PMID], 
[Paperlink] 
                       FROM          dbo.gene_study 
                       UNION 
                       SELECT DISTINCT first_author, year, gene_id, title, 
pubmed_id, link 
                       FROM         dbo.mutation 
                       WHERE     (first_author <> 'NULL') 
                       UNION 
                       SELECT DISTINCT First_Author, Year, gene_id, 
paperlink, pubmed_id, link 
                       FROM         dbo.gene_SNP_updated 
                       WHERE     (First_Author <> 'NULL') AND (paperlink <> 
'NULL')) AS table1 
GROUP BY gene_id 
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Number_of_times_mutation_is_replicated 
SELECT     Gene, Sum(Rank_Mutation) AS Rank_Summation, DENSE_RANK() OVER 
(ORDER BY Sum(Rank_Mutation) DESC) AS Rank 
FROM         (SELECT     Gene, mutation_mnemonic AS Mutation, 
COUNT(mutation_mnemonic) AS Frequency, DENSE_RANK() OVER (ORDER BY 
COUNT(mutation_mnemonic) 
                                               DESC) AS Rank_Mutation 
FROM         (SELECT     [KCLAD\spngoka].patient_record_view.Gene, 
dbo.mutation.mutation_mnemonic, 
[KCLAD\spngoka].patient_record_view.first_author,  
                                              
[KCLAD\spngoka].patient_record_view.year, 
[KCLAD\spngoka].patient_record_view.pubmed_id 
                       FROM          [KCLAD\spngoka].patient_record_view 
INNER JOIN 
                                              dbo.mutation ON 
[KCLAD\spngoka].patient_record_view.mid = dbo.mutation.mutation_id 
                       UNION 
                       SELECT DISTINCT gene_id, mutation_mnemonic, 
First_Author, Year, pubmed_id 
                       FROM         dbo.gene_SNP_lifeseq 
                       WHERE     (mutation_mnemonic IS NOT NULL) AND 
(mutation_mnemonic <> 'NA') 
                       UNION 
                       SELECT DISTINCT gene, mutation, author, year, 
pubmed_id 
                       FROM         dbo.mutation_replication 
                       UNION 
                       SELECT DISTINCT gene_id, mutation_mnemonic, 
First_Author, Year, pubmed_id 
                       FROM         dbo.gene_SNP_ALSGene 
                       WHERE     (mutation_mnemonic IS NOT NULL) AND 
(mutation_mnemonic <> 'NA')) AS derivedtbl_1 
GROUP BY mutation_mnemonic, Gene) AS table2 
GROUP BY Gene 
 
Number_of_unique_countries_on_genes 
SELECT     gene_id AS Gene, Count(gene_id) AS Total_Countries, DENSE_RANK() 
OVER (ORDER BY COUNT(gene_id) DESC) AS Rank 
FROM         (SELECT DISTINCT gene_id, country 
                       FROM          dbo.gene_SNP_lifeseq 
                       WHERE      (family_history IS NOT NULL) AND (gender 
IS NOT NULL) AND (mutation_mnemonic IS NOT NULL) AND (country IS NOT NULL) 
                       UNION 
                       SELECT DISTINCT Gene, Country 
                       FROM         [KCLAD\spngoka].patient_record_view 
                       GROUP BY Gene, Country) AS table1 
GROUP BY gene_id 
 
Pathogenicity_Check 
SELECT     TOP (100) PERCENT dbo.PANTHER_scores.gene, 
dbo.PANTHER_scores.mutation, dbo.PANTHER_scores.codon,  
                      dbo.PANTHER_scores.subPSEC AS PANTHER, 
dbo.PANTHER_scores.message AS Prediction1,  
                      dbo.POLYPHEN_scores.PSIC_score_new AS POLYPHEN, 
dbo.POLYPHEN_scores.prediction AS Prediction2, dbo.SIFT_scores.subPSEC AS 
SIFT,  
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                      dbo.SIFT_scores.message AS Prediction3, CASE WHEN 
dbo.PANTHER_scores.message = 'Deletrious' THEN '1' ELSE '0' END AS 
Panther_rate,  
                      CASE WHEN (dbo.POLYPHEN_scores.prediction = 'Benign' 
OR 
                      dbo.POLYPHEN_scores.prediction = 'NA') THEN '0' ELSE 
'1' END AS Polyphen_rate,  
                      CASE WHEN dbo.SIFT_scores.message = 'AFFECT PROTEIN 
FUNCTION ' THEN '1' ELSE '0' END AS Sift_rate 
FROM         dbo.PANTHER_scores INNER JOIN 
                      dbo.POLYPHEN_scores ON dbo.PANTHER_scores.mutation = 
dbo.POLYPHEN_scores.mutation AND  
                      dbo.PANTHER_scores.gene = dbo.POLYPHEN_scores.gene 
INNER JOIN 
                      dbo.SIFT_scores ON dbo.POLYPHEN_scores.codon = 
dbo.SIFT_scores.codon AND dbo.POLYPHEN_scores.gene = dbo.SIFT_scores.gene 
 
Pathogenicity_Check_Summary 
SELECT     gene, mutation, codon, PANTHER, Prediction1, POLYPHEN, 
Prediction2, SIFT, Prediction3, Panther_rate, Polyphen_rate, Sift_rate,  
                      CAST(Panther_rate AS int) + CAST(Sift_rate AS int) + 
CAST(Polyphen_rate AS int) AS Result, CASE WHEN (CAST(Panther_rate AS int)  
                      + CAST(Sift_rate AS int) + CAST(Polyphen_rate AS 
int)) >= '1' THEN 'Yes' ELSE 'No' END AS Pathogenic 
FROM         [KCLAD\spngoka].Pathogenicity_Check 
 
pathogenicity_specific_mutation_stats 
SELECT     Gene, mutation_mnemonic, COUNT(Gene) AS No_Patients, SUM(CASE 
WHEN [family_History] = 'Yes' THEN 1 ELSE 0 END) AS FALS,  
                      SUM(CASE WHEN [family_History] = 'No' THEN 1 ELSE 0 
END) AS SALS, SUM(CASE WHEN Sex = 'male' THEN 1 ELSE 0 END) AS Male,  
                      SUM(CASE WHEN Sex = 'female' THEN 1 ELSE 0 END) AS 
Female, SUM(CASE WHEN [Site_of_Onset] = 'leg' THEN 1 ELSE 0 END) AS Leg,  
                      SUM(CASE WHEN [Site_of_Onset] = 'arm' THEN 1 ELSE 0 
END) AS Arm, SUM(CASE WHEN [Site_of_Onset] = 'limb' THEN 1 ELSE 0 END) AS 
Limbs,  
                      SUM(CASE WHEN [Site_of_Onset] = 'spinal' THEN 1 ELSE 
0 END) AS Spinal, SUM(CASE WHEN [Site_of_Onset] = 'unknown' THEN 1 ELSE 0 
END)  
                      AS Unknown, SUM(CASE WHEN [Site_of_Onset] = 'bulbar' 
THEN 1 ELSE 0 END) AS Bulbar,  
                      SUM(CASE WHEN [Site_of_Onset] <> 'bulbar' THEN 1 ELSE 
0 END) AS Limb 
FROM         (SELECT     Gene, sex, Country, Ethnicity, [Age of Onset] AS 
Age_of_Onset, [Site of Onset] AS Site_of_Onset, [family History] AS 
family_History,  
                                              Mutation, mutation_mnemonic, 
first_author, year, pubmed_id, disease_duration 
                       FROM          [KCLAD\spngoka].patient_record_view 
                       WHERE      (Gene = 'SOD1') AND (mutation_mnemonic = 
'I113T')) AS derivedtbl_1 
GROUP BY Gene, mutation_mnemonic 
 
PATHOGENICITY_VIEW 
SELECT     gene, COUNT(gene) AS Pathogenic 
FROM         (SELECT     gene, mutation, Panther_rate, Sift_rate, 
Polyphen_rate, Result, Pathogenic 
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                       FROM          
[KCLAD\spngoka].Pathogenicity_Check_Summary 
                       WHERE      (Pathogenic = 'Yes')) AS derivedtbl_1 
GROUP BY gene 
 
patient_mutation_country 
SELECT DISTINCT TOP (100) PERCENT dbo.mutation.mutation_mnemonic, 
dbo.Country.country_name, dbo.mutation.codon 
FROM         dbo.patient_genetic_record INNER JOIN 
                      dbo.patient_record ON 
dbo.patient_genetic_record.patient_id = dbo.patient_record.patient_id INNER 
JOIN 
                      dbo.mutation ON 
dbo.patient_genetic_record.mutation_id = dbo.mutation.mutation_id INNER 
JOIN 
                      dbo.Country ON dbo.patient_record.country_iso_code = 
dbo.Country.country_iso_code 
WHERE     (dbo.mutation.gene_id = 'SOD1') AND 
(dbo.mutation.sequence_location_type = 'exon') 
ORDER BY dbo.mutation.codon 
 
patient_record_analysis 
SELECT     Gene, COUNT(mid) AS No_Patients, SUM(CASE WHEN [family History] 
= 'Yes' THEN 1 ELSE 0 END) AS FALS,  
                      SUM(CASE WHEN [family History] = 'No' THEN 1 ELSE 0 
END) AS SALS, SUM(CASE WHEN [family History] = 'Unk' THEN 1 ELSE 0 END) AS 
NotKnown,  
                      SUM(CASE WHEN Sex = 'male' THEN 1 ELSE 0 END) AS 
Male, SUM(CASE WHEN Sex = 'female' THEN 1 ELSE 0 END) AS Female,  
                      SUM(CASE WHEN Sex = 'Anonymou' THEN 1 ELSE 0 END) AS 
Anonymous, SUM(CASE WHEN [Site of Onset] = 'leg' THEN 1 ELSE 0 END) AS Leg,  
                      SUM(CASE WHEN [Site of Onset] = 'arm' THEN 1 ELSE 0 
END) AS Arm, SUM(CASE WHEN [Site of Onset] = 'limb' THEN 1 ELSE 0 END) AS 
Limb,  
                      SUM(CASE WHEN [Site of Onset] = 'spinal' THEN 1 ELSE 
0 END) AS Spinal, SUM(CASE WHEN [Site of Onset] = 'unknown' THEN 1 ELSE 0 
END)  
                      AS Unknown, SUM(CASE WHEN [Site of Onset] = 'bulbar' 
THEN 1 ELSE 0 END) AS Bulbar,  
                      SUM(CASE WHEN [Site of Onset] <> 'bulbar' THEN 1 ELSE 
0 END) AS Non_Bulbar, AVG([Age of Onset]) AS Mean_Age_Onset 
FROM         [KCLAD\spngoka].patient_record_view 
GROUP BY Gene 
 
patient_record_analysis_summary 
SELECT     SUM(No_Patients) AS Total, SUM(FALS) AS Fals, SUM(SALS) AS Sals, 
SUM(NotKnown) AS NotKnown, SUM(Male) AS Male, SUM(Female) AS Female,  
                      SUM(Anonymous) AS Anonymous, SUM(Leg) AS Leg, 
SUM(Arm) AS Arm, SUM(Limb) AS Limb, SUM(Spinal) AS Spinal, SUM(Unknown) AS 
Unknown,  
                      SUM(Bulbar) AS Bulbar, SUM(Non_Bulbar) AS Non_Bulbar, 
AVG(Mean_Age_Onset) AS [Mean Age] 
FROM         [KCLAD\spngoka].patient_record_analysis 
 
patient_record_mutation_frequency 
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SELECT     TOP (100) PERCENT Mutation, COUNT(*) AS Frequency, Gene 
FROM         [KCLAD\spngoka].patient_record_view 
GROUP BY Mutation, Gene 
HAVING      (COUNT(*) > 0) 
ORDER BY Gene, Frequency DESC 
 
patient_record_view 
SELECT     TOP (100) PERCENT p.sex, c.country_name AS Country, 
p.ethnic_origin AS Ethnicity, p.age_of_onset AS [Age of Onset],  
                      p.site_of_onset AS [Site of Onset], p.date_of_onset 
AS dof, p.alive, g.screened, g.family_history AS [family History], 
g.gene_id AS Gene,  
                      m.mutation_type, m.mutation_name AS Mutation, 
m.codon_id, m.mutation_id AS mid, m.first_author, m.year, m.pubmed_id, 
p.disease_duration,  
                      m.mutation_mnemonic, g.family_id, CHARINDEX(' ', 
g.family_id) AS Space, SUBSTRING(g.family_id, 1, NULLIF (CHARINDEX(' ', 
g.family_id) - 1, - 1))  
                      AS first_author2, SUBSTRING(g.family_id, CHARINDEX(' 
', g.family_id) + 1, LEN(g.family_id)) AS year2 
FROM         dbo.mutation AS m INNER JOIN 
                      dbo.patient_genetic_record AS g ON m.mutation_id = 
g.mutation_id INNER JOIN 
                      dbo.patient_record AS p ON g.patient_id = 
p.patient_id INNER JOIN 
                      dbo.Country AS c ON p.country_iso_code = 
c.country_iso_code 
WHERE     (m.mutation_id NOT LIKE '%none%') AND (p.age_of_onset <> ' ') 
ORDER BY 'Gene', m.codon_id 
 
Polyphen_Sift 
SELECT     dbo.POLYPHEN_scores.gene, dbo.POLYPHEN_scores.mutation, 
dbo.POLYPHEN_scores.codon, dbo.POLYPHEN_scores.PSIC_score AS POLYPHEN,  
                      dbo.POLYPHEN_scores.prediction AS Prediction2, 
dbo.SIFT_scores.subPSEC AS SIFT, dbo.SIFT_scores.message AS Prediction3 
FROM         dbo.POLYPHEN_scores INNER JOIN 
                      dbo.SIFT_scores ON dbo.POLYPHEN_scores.gene = 
dbo.SIFT_scores.gene AND dbo.POLYPHEN_scores.codon = dbo.SIFT_scores.codon 
WHERE     (dbo.POLYPHEN_scores.PSIC_score IS NOT NULL) AND 
(dbo.SIFT_scores.subPSEC IS NOT NULL) 
 
Ranking_LOD_score 
SELECT DISTINCT gene, LODscore, author, year, DENSE_RANK() OVER (ORDER BY 
LODscore DESC) AS Rank FROM dbo.mutation_replication WHERE  (LODscore IS 
NOT NULL) OR (LODscore <> '0')  
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Appendix 26 – Disk Usage by Table in ALSoD 
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Table Name # Records Data (KB) Indexes (KB)
dbo.amino_acid 22 8 16
dbo.ANALYZE_JOINTDATA 4 8 8
dbo.ANALYZE_NOKEY 1,420,354 68,752 24
dbo.ANALYZE_OURDATA 288,136 40,072 144
dbo.ANALYZE_OURDATA_OLD 281,907 23,280 160
dbo.ANALYZE_THEIRDATA 4 8 8
dbo.Animal_Pubmed 2,404 384 8
dbo.AnimalModels 4,404 1,440 8
dbo.aspnet_Applications 2 8 56
dbo.aspnet_Membership 111 72 56
dbo.aspnet_Paths 0 0 0
dbo.aspnet_PersonalizationAllUsers 0 0 0
dbo.aspnet_PersonalizationPerUser 0 0 0
dbo.aspnet_Profile 0 0 0
dbo.aspnet_Roles 0 0 0
dbo.aspnet_SchemaVersions 6 8 8
dbo.aspnet_Users 111 16 48
dbo.aspnet_UsersInRoles 0 0 0
dbo.aspnet_WebEvent_Events 0 0 0
dbo.codons 7,414 456 200
dbo.codons1 414 32 8
dbo.codons2 147 8 8
dbo.codons3 526 32 8
dbo.codons4 2,677 152 8
dbo.codons5 577 32 8
dbo.Continent 7 8 16
dbo.counter 1 8 8
dbo.Country 234 8 32
dbo.countrydetails 236 40 16
dbo.countryinfo 244 40 8
dbo.countrylatlong 241 8 8
dbo.credibility_survey 5 8 8
dbo.dtproperties 35 256 16
dbo.Epidemiology 21 8 8
dbo.gene 112 384 16
dbo.gene_authors 201 80 16
dbo.gene_frequency 1 8 8
dbo.gene_sequence 325,001 15,456 5,128
dbo.gene_sequence1 13,871 984 8
dbo.gene_sequence2 11,010 672 8
dbo.gene_sequence3 12,647 776 8
dbo.gene_sequence4 94,546 5,848 8
dbo.gene_sequence5 39,195 2,432 8
dbo.gene_SNP 47 32 8
dbo.gene_SNP_ALSGene 413 96 8
dbo.gene_SNP_lifeseq 2,752 1,216 8
dbo.gene_SNP_updated 1,422 352 8
dbo.gene_study 286 304 24
dbo.guestbook 26 88 8
dbo.GWA_BOS 282,448 52,056 184
dbo.GWA_CATALOGUE 4,811 2,336 16
dbo.GWA_CATALOGUE_1 4,239 2,072 32
dbo.GWA_CATALOGUE2 0 0 0
dbo.GWA_FOGH 6,138,741 234,688 1,456
dbo.GWA_FRA 286,507 52,808 192
dbo.GWA_HOL 288,136 53,104 192
dbo.GWA_NIH 287,640 53,016 192
dbo.GWA_NOKEY 1,420,350 150,760 16
dbo.GWA_UK 275,619 50,792 184
dbo.GWA_UK_BOS 423,672 41,744 128
dbo.GWA_UK_BOS_FRA 286,507 42,712 112
dbo.GWA_UK_BOS_FRA_NIH 287,640 70,760 192
dbo.GWA_UK_BOS_FRA_USA 0 0 0
dbo.GWA_UK_BOS_HOL_FRA_NIH 288,136 118,216 248
dbo.GWA_UK_BOS_HOL_FRA_USA 288,136 118,216 320
dbo.GWA_USA 287,640 33,680 200
dbo.GWA3_BEL 224,629 45,048 160
dbo.GWA3_FRA 224,629 45,048 176
dbo.GWA3_HOL 224,629 45,048 160
dbo.GWA3_IRE 224,629 22,528 144
dbo.GWA3_ITA 224,629 45,048 160
dbo.GWA3_NOKEY 1,797,032 206,232 24
dbo.GWA3_POPULATIONS 255 16 8
dbo.GWA3_SWE 224,629 45,048 160
dbo.GWA3_UK 224,629 45,048 160
dbo.GWA3_USA 224,629 45,048 176
dbo.institution 91 32 16
dbo.institution1 57 32 32
dbo.ipcountry 95,296 5,952 8
dbo.ipcountry2 0 0 0
dbo.ipcountry3 65,536 3,232 16
dbo.members 0 0 0
dbo.mutation 531 864 16
dbo.mutation_new 0 24 8
dbo.mutation_replication 811 312 8
dbo.mutation_replication2 860 112 8
dbo.mutation_replication3 541 88 8
dbo.mutation1 137 96 32
dbo.NETPHOS_scores 1,295 72 8
dbo.No_PATHOGENICITY 1 16 8
dbo.No_SALS 4 8 8
dbo.PANTHER_scores 146,866 20,360 8
dbo.patient_clinical_record 853 120 16
dbo.patient_genetic_record 929 344 16
dbo.patient_genetic_record1 303 104 16
dbo.patient_genetic_record2 168 64 16
dbo.patient_record 958 392 24
dbo.POLYPHEN_scores 428 48 8
dbo.population_frequency_1000genome 56 8 8
dbo.population_frequency_EVS 89 16 8
dbo.random_subpsec 1,008 40 16
dbo.Reference_MGI 557,280 22,672 56
dbo.Reference_Pubmed 27,894 3,760 16
dbo.refs 71 32 32
dbo.refs_lookup 176 16 8
dbo.SIFT_scores 12,276 704 8
dbo.smadmin4 1 8 32
dbo.smagent_agentgroup4 0 0 0
dbo.smagent4 1 8 48
dbo.smagentcommand4 0 0 0
dbo.smagentgroup4 0 0 0
dbo.smagentkey4 4 8 16
dbo.smagenttype4 14 8 80
dbo.smagenttypeactions4 22 8 16
dbo.smagenttypeattribute4 158 40 64
dbo.smagenttypeattrvalues4 172 32 16
dbo.smauthazmap4 0 0 0
dbo.smcertmap4 0 0 0
dbo.smdomain_admin4 0 0 0
dbo.smdomain_userdirect4 0 0 0
dbo.smdomain4 0 0 0
dbo.smkeymanagement4 1 8 16
dbo.smodbcquery4 0 8 32
dbo.smpasswordpolicy4 0 0 0
dbo.smpolicy4 0 0 0
dbo.smpolicylink4 0 0 0
dbo.smrealm4 0 0 0
dbo.smresponse_responseg4 0 0 0
dbo.smresponse4 0 0 0
dbo.smresponseattr4 0 0 0
dbo.smresponsegroup4 0 0 0
dbo.smrootconfig4 1 8 16
dbo.smrule_rulegroup4 0 0 0
dbo.smrulegroup4 0 0 0
dbo.smrules4 0 0 0
dbo.smscheme4 15 8 96
dbo.smselfreg4 0 0 0
dbo.smservercommand4 200 40 48
dbo.smuserdirectory4 0 8 64
dbo.smuserpolicy4 0 0 0
dbo.sod1_methods 4 8 16
dbo.survey 135 24 16
dbo.sysdiagrams 6 248 24
dbo.trinucleotides 64 8 16
dbo.UNIPROT_MUTATION 26 8 8
dbo.users 112 40 16
dbo.users1 55 64 32
dbo.version 0 0 0
dbo.visitors 778,435 123,248 24
KCLAD\spngoka.genome 66,803 31,400 40
KCLAD\spngoka.GWA_ALL_COMMON_DATA 281,907 32,456 88
KCLAD\spngoka.GWA_BOS 287,142 46,120 160
KCLAD\spngoka.GWA_CHIDIST_ALL_COMMON 281,907 10,352 56
KCLAD\spngoka.GWA_HOL 287,935 46,248 168
KCLAD\spngoka.GWA_NOKEY 858,323 85,192 16
KCLAD\spngoka.GWA_UK 283,246 45,496 168
KCLAD\spngoka.GWA_UK_BOS 569,590 51,544 168
KCLAD\spngoka.GWA_UK_BOS_HOL 287,935 47,488 144
KCLAD\spngoka.GWASTUDY 3 8 8
KCLAD\spngoka.mutationCountry 0 0 0
Disk Usage by Table
[Alsod]
on VM3 at 13/02/2014 16:27:25
This report provides detailed data on the utilization of disk space by tables within the Database.


































































































































































 - 496 - 
Appendix 27 – Label visibility on credibility analysis webpage 
<asp:Label ID="Label1" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label3" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label4" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label5" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label6" runat="server" Visible="false"></asp:Label><br /> 
     
  <asp:Label ID="Labela" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Labelb" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Labelc" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Labeld" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Labele" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Labelf" runat="server" Visible="false"></asp:Label><br /> 
     
  <asp:Label ID="Label2a" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2b" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2c" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2d" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2e" runat="server" Visible="false"></asp:Label><br /> 
  <asp:Label ID="Label2f" runat="server" Visible="false"></asp:Label><br /> 
To cross check the scripts generated from the formula during execution and debugging, the label 
visibility was set to ‘true’. 
 
 
<asp:Label ID="Label1" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Label2" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Label3" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Label4" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Label5" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Label6" runat="server" Visible="true"></asp:Label><br /> 
     
    <asp:Label ID="Labela" runat="server" Visible="true"></asp:Label><br /> 
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    <asp:Label ID="Labelb" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Labelc" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Labeld" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Labele" runat="server" Visible="true"></asp:Label><br /> 
    <asp:Label ID="Labelf" runat="server" Visible="true"></asp:Label><br /> 
     
   <asp:Label ID="Label2a" runat="server" Visible="true"></asp:Label><br /> 
   <asp:Label ID="Label2b" runat="server" Visible="true"></asp:Label><br /> 
   <asp:Label ID="Label2c" runat="server" Visible="true"></asp:Label><br /> 
   <asp:Label ID="Label2d" runat="server" Visible="true"></asp:Label><br /> 
   <asp:Label ID="Label2e" runat="server" Visible="true"></asp:Label><br /> 
   <asp:Label ID="Label2f" runat="server" Visible="true"></asp:Label><br /> 
  
 - 498 - 
Appendix 28 – User interface ASP.NET code 
<asp:CheckBoxList ID="tables" runat="server" AutoPostBack ="false"  
                        ToolTip="Select checkbox if desired as one of the criteria for analysing credibility 
score" RepeatColumns="3"  
                        RepeatDirection="Horizontal"> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_affected_patients_in_ALSoD]" 
Text="Rank_Patients" Enabled="false" ></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_mutations_per_gene]" 
Text="Rank_Mutations" Enabled="false"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_cases_recorded]" 
Text="Rank_Cases"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_controls_recorded]" 
Text="Rank_Controls"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_mutations_in 
_same_codon_by_rank]" Text="Rank_Codon"></asp:ListItem> 
                     <asp:ListItem 
Value="[KCLAD\spngoka].[Number_of_patients_with_family_history_FALS]" 
Text="Rank_FALS"></asp:ListItem> 
                     <asp:ListItem 
Value="[KCLAD\spngoka].[Number_of_patients_without_family_history_SALS]" 
Text="Rank_SALS"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_times_mutation_is_replicated]" 
Text="Rank_Replications"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_pathogenic_mutations_by_rank]" 
Text="Rank_Pathogenicity"></asp:ListItem> 
                     <asp:ListItem Value="[KCLAD\spngoka].[Number_of_unique_countries_on_genes]" 
Text="Rank_Populations"></asp:ListItem> 
                      
                    </asp:CheckBoxList> 
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public class MainActivity extends Activity { 
 WebView browser; 
 
    @SuppressLint("SetJavaScriptEnabled") 
 @Override 
    public void onCreate(Bundle savedInstanceState) { 
        super.onCreate(savedInstanceState); 
        setContentView(R.layout.activity_main); 
         
     // find the WebView by name in the main.xml of step 2 
        browser=(WebView)findViewById(R.id.wvwMain); 
         
        // Enable javascript 
        browser.getSettings().setJavaScriptEnabled(true);   
         
        // load a webpage 
        browser.loadUrl("http://alsod.iop.kcl.ac.uk/Mobile/index.aspx"); 
 
    } 
    @Override 
    public boolean onCreateOptionsMenu(Menu menu) { 
        getMenuInflater().inflate(R.menu.activity_main, menu); 
        return true; 
    } 
} 
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Appendix 30 – Possible graphs of 31 combinations for 5 
populations 
If Label1.Text = "UK" Then 
            Image4.ImageUrl = "~/PlotGraphs/Uk.png" 
        ElseIf Label1.Text = "BOSTON" Then 
            Image4.ImageUrl = "~/PlotGraphs/Bos.png" 
        ElseIf Label1.Text = "HOLLAND" Then 
            Image4.ImageUrl = "~/PlotGraphs/Hol.png" 
        ElseIf Label1.Text = "FRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/Fra.png" 
        ElseIf Label1.Text = "NIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/Usa.png" 
        ElseIf Label1.Text = "UKBOSTON" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBos.png" 
        ElseIf Label1.Text = "UKHOLLAND" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkHol.png" 
        ElseIf Label1.Text = "UKFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkFra.png" 
        ElseIf Label1.Text = "UKNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkUsa.png" 
        ElseIf Label1.Text = "UKBOSTONHOLLAND" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosHol.png" 
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        ElseIf Label1.Text = "UKBOSTONFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosFra.png" 
        ElseIf Label1.Text = "UKBOSTONNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosUsa.png" 
        ElseIf Label1.Text = "UKHOLLANDFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkHolFra.png" 
        ElseIf Label1.Text = "UKHOLLANDNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkHolUsa.png" 
        ElseIf Label1.Text = "UKFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkFraUsa.png" 
        ElseIf Label1.Text = "UKBOSTONHOLLANDFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosHolFra.png" 
        ElseIf Label1.Text = "UKBOSTONHOLLANDNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosHolUsa.png" 
        ElseIf Label1.Text = "UKBOSTONFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosFraUsa.png" 
        ElseIf Label1.Text = "UKHOLLANDFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkHolFraUsa.png" 
        ElseIf Label1.Text = "BOSTONHOLLAND" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosHol.png" 
        ElseIf Label1.Text = "BOSTONFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosFra.png" 
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        ElseIf Label1.Text = "BOSTONNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosUsa.png" 
        ElseIf Label1.Text = "BOSTONHOLLANDFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosHolFra.png" 
        ElseIf Label1.Text = "BOSTONHOLLANDNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosHolUsa.png" 
        ElseIf Label1.Text = "BOSTONFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosFraUsa.png" 
        ElseIf Label1.Text = "BOSTONHOLLANDFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/BosHolFraUsa.png" 
        ElseIf Label1.Text = "HOLLANDFRANCE" Then 
            Image4.ImageUrl = "~/PlotGraphs/HolFra.png" 
        ElseIf Label1.Text = "HOLLANDNIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/HolUsa.png" 
        ElseIf Label1.Text = "HOLLANDFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/HolFraUsa.png" 
        ElseIf Label1.Text = "FRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/FraUsa.png" 
        ElseIf Label1.Text = "UKBOSTONHOLLANDFRANCENIH" Then 
            Image4.ImageUrl = "~/PlotGraphs/UkBosHolFraUsa.png" 
        Else : table3.Visible = "False" 
            table2.Visible = "True" 
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Appendix 31 – UCSC Genome Browser 
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN"> 
<HTML><HEAD> 
<TITLE>Human chrX:151,073,054-151,383,976 - UCSC Genome Browser v187</TITLE> 
 <META http-equiv="Content-Script-Type" content="text/javascript"> 




<FORM ACTION="../cgi-bin/hgTracks" NAME="TrackHeaderForm" METHOD=GET> 
 
<INPUT TYPE=HIDDEN NAME="hgsid" VALUE="109992416"><CENTER> 
<DIV STYLE="white-space:nowrap;"> 
<TABLE WIDTH="100%" BGCOLOR="#000000" BORDER="0" CELLSPACING="0" 
CELLPADDING="1"><TR><TD> 
<TABLE WIDTH="100%" BGCOLOR="#2636D1" BORDER="0" CELLSPACING="0" 
CELLPADDING="2"><TR> 
<TD ALIGN=CENTER><A HREF="../index.html?org=Human&db=hg18&hgsid=109992416" 
class="topbar">Home</A></TD><TD ALIGN=CENTER><A HREF="../cgi-
bin/hgGateway?org=Human&db=hg18&hgsid=109992416" class="topbar">Genomes</A></TD><TD 
ALIGN=CENTER><A HREF="../cgi-bin/hgBlat?hgsid=109992416" class="topbar">Blat</A></TD><TD 
ALIGN=CENTER><A HREF="../cgi-bin/hgTables?db=hg18&position=chrX:151073054-
151383976&hgsid=109992416" class="topbar">Tables</A></TD><TD ALIGN=CENTER><A 









6" TARGET=_blank class="topbar">Ensembl</A></TD><TD ALIGN=CENTER><A 
HREF="http://www.ncbi.nlm.nih.gov/mapview/maps.cgi?taxid=9606&CHR=X&BEG=151073054&END
=151383976" TARGET=_blank class="topbar">NCBI</A></TD><TD ALIGN=CENTER><A 
HREF="../cgi-bin/hgTracks?hgsid=109992416&hgt.psOutput=on" class="topbar">PDF/PS</A></TD> 
<TD ALIGN=CENTER><A HREF="../cgi-bin/hgSession?hgsid=109992416&hgS_doMainPage=1" 
class="topbar">Session</A></TD><TD ALIGN=CENTER><A 
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<FONT SIZE=5><B>UCSC Genome Browser on Human Mar. 2006 Assembly</B></FONT><BR> 
<INPUT TYPE=IMAGE BORDER=0 NAME="hgt.dummyEnterButton" src="../images/DOT.gif">move 
<INPUT TYPE=SUBMIT NAME="hgt.left3" VALUE="<<<" ><INPUT TYPE=SUBMIT 
NAME="hgt.left2" VALUE=" <<" ><INPUT TYPE=SUBMIT NAME="hgt.left1" VALUE=" < " ><INPUT 
TYPE=SUBMIT NAME="hgt.right1" VALUE=" > " ><INPUT TYPE=SUBMIT NAME="hgt.right2" 
VALUE=">> " ><INPUT TYPE=SUBMIT NAME="hgt.right3" VALUE=">>>" > zoom in <INPUT 
TYPE=SUBMIT NAME="hgt.in1" VALUE="1.5x" ><INPUT TYPE=SUBMIT NAME="hgt.in2" VALUE=" 
3x " ><INPUT TYPE=SUBMIT NAME="hgt.in3" VALUE="10x" ><INPUT TYPE=SUBMIT 
NAME="hgt.inBase" VALUE="base" > zoom out <INPUT TYPE=SUBMIT NAME="hgt.out1" 
VALUE="1.5x" ><INPUT TYPE=SUBMIT NAME="hgt.out2" VALUE=" 3x " ><INPUT TYPE=SUBMIT 
NAME="hgt.out3" VALUE="10x" ><BR> 
<INPUT TYPE=HIDDEN NAME="position" VALUE="chrX:151073054-151383976"> 
<input type='hidden' name="hgtgroup_map_close" id="hgtgroup_map_close_1" value="0"> 
<input type='hidden' name="hgtgroup_phenDis_close" id="hgtgroup_phenDis_close_1" value="0"> 
<input type='hidden' name="hgtgroup_genes_close" id="hgtgroup_genes_close_1" value="0"> 
<input type='hidden' name="hgtgroup_rna_close" id="hgtgroup_rna_close_1" value="0"> 
<input type='hidden' name="hgtgroup_regulation_close" id="hgtgroup_regulation_close_1" value="0"> 
<input type='hidden' name="hgtgroup_compGeno_close" id="hgtgroup_compGeno_close_1" 
value="0"> 
<input type='hidden' name="hgtgroup_varRep_close" id="hgtgroup_varRep_close_1" value="0"> 
<input type='hidden' name="hgtgroup_encodeGenes_close" id="hgtgroup_encodeGenes_close_1" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeTxLevels_close" 
id="hgtgroup_encodeTxLevels_close_1" value="0"> 
<input type='hidden' name="hgtgroup_encodeChip_close" id="hgtgroup_encodeChip_close_1" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeChrom_close" id="hgtgroup_encodeChrom_close_1" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeCompAndVar_close" 
id="hgtgroup_encodeCompAndVar_close_1" value="0"> 
</CENTER></FORM> 
<FORM ACTION="../cgi-bin/hgTracks" NAME="TrackForm" METHOD=POST> 
 
<input type='hidden' name="hgtgroup_map_close" id="hgtgroup_map_close_2" value="0"> 
<input type='hidden' name="hgtgroup_phenDis_close" id="hgtgroup_phenDis_close_2" value="0"> 
<input type='hidden' name="hgtgroup_genes_close" id="hgtgroup_genes_close_2" value="0"> 
<input type='hidden' name="hgtgroup_rna_close" id="hgtgroup_rna_close_2" value="0"> 
<input type='hidden' name="hgtgroup_regulation_close" id="hgtgroup_regulation_close_2" value="0"> 
<input type='hidden' name="hgtgroup_compGeno_close" id="hgtgroup_compGeno_close_2" 
value="0"> 
<input type='hidden' name="hgtgroup_varRep_close" id="hgtgroup_varRep_close_2" value="0"> 
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<input type='hidden' name="hgtgroup_encodeGenes_close" id="hgtgroup_encodeGenes_close_2" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeTxLevels_close" 
id="hgtgroup_encodeTxLevels_close_2" value="0"> 
<input type='hidden' name="hgtgroup_encodeChip_close" id="hgtgroup_encodeChip_close_2" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeChrom_close" id="hgtgroup_encodeChrom_close_2" 
value="0"> 
<input type='hidden' name="hgtgroup_encodeCompAndVar_close" 
id="hgtgroup_encodeCompAndVar_close_2" value="0"> 
<INPUT TYPE=HIDDEN NAME="hgsid" VALUE="109992416"><CENTER>position/search <INPUT 
TYPE=TEXT NAME="position" SIZE=30 VALUE="chrX:151,073,054-151,383,976"> 
 <INPUT TYPE=SUBMIT NAME="submit" VALUE="jump" ><INPUT TYPE="button" VALUE="clear" 
onClick="document.TrackForm.position.value=''"> size 310,923 bp. <INPUT TYPE=SUBMIT 
NAME="hgTracksConfigPage" VALUE="configure" > 
<MAP Name=ideoMap> 
<AREA SHAPE=RECT COORDS="68,6,80,15" HREF="../cgi-bin/hgTracks?position=chrX:1-
4300000&hgsid=109992416" TITLE="p22.33"> 
<AREA SHAPE=RECT COORDS="80,6,84,15" HREF="../cgi-bin/hgTracks?position=chrX:4300001-
6000000&hgsid=109992416" TITLE="p22.32"> 
<AREA SHAPE=RECT COORDS="84,6,94,15" HREF="../cgi-bin/hgTracks?position=chrX:6000001-
9500000&hgsid=109992416" TITLE="p22.31"> 
<AREA SHAPE=RECT COORDS="94,6,115,15" HREF="../cgi-bin/hgTracks?position=chrX:9500001-
17100000&hgsid=109992416" TITLE="p22.2"> 
<AREA SHAPE=RECT COORDS="115,6,121,15" HREF="../cgi-
bin/hgTracks?position=chrX:17100001-19200000&hgsid=109992416" TITLE="p22.13"> 
<AREA SHAPE=RECT COORDS="121,6,128,15" HREF="../cgi-
bin/hgTracks?position=chrX:19200001-21800000&hgsid=109992416" TITLE="p22.12"> 
<AREA SHAPE=RECT COORDS="128,6,136,15" HREF="../cgi-
bin/hgTracks?position=chrX:21800001-24900000&hgsid=109992416" TITLE="p22.11"> 
<AREA SHAPE=RECT COORDS="136,6,148,15" HREF="../cgi-
bin/hgTracks?position=chrX:24900001-29400000&hgsid=109992416" TITLE="p21.3"> 
<AREA SHAPE=RECT COORDS="148,6,154,15" HREF="../cgi-
bin/hgTracks?position=chrX:29400001-31500000&hgsid=109992416" TITLE="p21.2"> 
<AREA SHAPE=RECT COORDS="154,6,171,15" HREF="../cgi-
bin/hgTracks?position=chrX:31500001-37500000&hgsid=109992416" TITLE="p21.1"> 
<AREA SHAPE=RECT COORDS="171,6,184,15" HREF="../cgi-
bin/hgTracks?position=chrX:37500001-42300000&hgsid=109992416" TITLE="p11.4"> 
<AREA SHAPE=RECT COORDS="184,6,197,15" HREF="../cgi-
bin/hgTracks?position=chrX:42300001-47300000&hgsid=109992416" TITLE="p11.3"> 
<AREA SHAPE=RECT COORDS="197,6,204,15" HREF="../cgi-
bin/hgTracks?position=chrX:47300001-49700000&hgsid=109992416" TITLE="p11.23"> 
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<AREA SHAPE=RECT COORDS="204,6,218,15" HREF="../cgi-
bin/hgTracks?position=chrX:49700001-54700000&hgsid=109992416" TITLE="p11.22"> 
<AREA SHAPE=RECT COORDS="218,6,223,15" HREF="../cgi-
bin/hgTracks?position=chrX:54700001-56600000&hgsid=109992416" TITLE="p11.21"> 
<AREA SHAPE=RECT COORDS="223,6,231,15" HREF="../cgi-
bin/hgTracks?position=chrX:56600001-59500000&hgsid=109992416" TITLE="p11.1"> 
<AREA SHAPE=RECT COORDS="231,6,246,15" HREF="../cgi-
bin/hgTracks?position=chrX:59500001-65000000&hgsid=109992416" TITLE="q11.1"> 
<AREA SHAPE=RECT COORDS="246,6,247,15" HREF="../cgi-
bin/hgTracks?position=chrX:65000001-65100000&hgsid=109992416" TITLE="q11.2"> 
<AREA SHAPE=RECT COORDS="246,6,253,15" HREF="../cgi-
bin/hgTracks?position=chrX:65100001-67700000&hgsid=109992416" TITLE="q12"> 
<AREA SHAPE=RECT COORDS="253,6,266,15" HREF="../cgi-
bin/hgTracks?position=chrX:67700001-72200000&hgsid=109992416" TITLE="q13.1"> 
<AREA SHAPE=RECT COORDS="266,6,270,15" HREF="../cgi-
bin/hgTracks?position=chrX:72200001-73800000&hgsid=109992416" TITLE="q13.2"> 
<AREA SHAPE=RECT COORDS="270,6,276,15" HREF="../cgi-
bin/hgTracks?position=chrX:73800001-76000000&hgsid=109992416" TITLE="q13.3"> 
<AREA SHAPE=RECT COORDS="276,6,299,15" HREF="../cgi-
bin/hgTracks?position=chrX:76000001-84500000&hgsid=109992416" TITLE="q21.1"> 
<AREA SHAPE=RECT COORDS="299,6,304,15" HREF="../cgi-
bin/hgTracks?position=chrX:84500001-86200000&hgsid=109992416" TITLE="q21.2"> 
<AREA SHAPE=RECT COORDS="304,6,320,15" HREF="../cgi-
bin/hgTracks?position=chrX:86200001-91900000&hgsid=109992416" TITLE="q21.31"> 
<AREA SHAPE=RECT COORDS="320,6,324,15" HREF="../cgi-
bin/hgTracks?position=chrX:91900001-93500000&hgsid=109992416" TITLE="q21.32"> 
<AREA SHAPE=RECT COORDS="324,6,337,15" HREF="../cgi-
bin/hgTracks?position=chrX:93500001-98200000&hgsid=109992416" TITLE="q21.33"> 
<AREA SHAPE=RECT COORDS="337,6,349,15" HREF="../cgi-
bin/hgTracks?position=chrX:98200001-102500000&hgsid=109992416" TITLE="q22.1"> 
<AREA SHAPE=RECT COORDS="349,6,352,15" HREF="../cgi-
bin/hgTracks?position=chrX:102500001-103600000&hgsid=109992416" TITLE="q22.2"> 
<AREA SHAPE=RECT COORDS="352,6,370,15" HREF="../cgi-
bin/hgTracks?position=chrX:103600001-110500000&hgsid=109992416" TITLE="q22.3"> 
<AREA SHAPE=RECT COORDS="370,6,388,15" HREF="../cgi-
bin/hgTracks?position=chrX:110500001-116800000&hgsid=109992416" TITLE="q23"> 
<AREA SHAPE=RECT COORDS="388,6,398,15" HREF="../cgi-
bin/hgTracks?position=chrX:116800001-120700000&hgsid=109992416" TITLE="q24"> 
<AREA SHAPE=RECT COORDS="398,6,423,15" HREF="../cgi-
bin/hgTracks?position=chrX:120700001-129800000&hgsid=109992416" TITLE="q25"> 
<AREA SHAPE=RECT COORDS="423,6,425,15" HREF="../cgi-
bin/hgTracks?position=chrX:129800001-130300000&hgsid=109992416" TITLE="q26.1"> 
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<AREA SHAPE=RECT COORDS="425,6,433,15" HREF="../cgi-
bin/hgTracks?position=chrX:130300001-133500000&hgsid=109992416" TITLE="q26.2"> 
<AREA SHAPE=RECT COORDS="433,6,445,15" HREF="../cgi-
bin/hgTracks?position=chrX:133500001-137800000&hgsid=109992416" TITLE="q26.3"> 
<AREA SHAPE=RECT COORDS="445,6,451,15" HREF="../cgi-
bin/hgTracks?position=chrX:137800001-140100000&hgsid=109992416" TITLE="q27.1"> 
<AREA SHAPE=RECT COORDS="451,6,456,15" HREF="../cgi-
bin/hgTracks?position=chrX:140100001-141900000&hgsid=109992416" TITLE="q27.2"> 
<AREA SHAPE=RECT COORDS="456,6,470,15" HREF="../cgi-
bin/hgTracks?position=chrX:141900001-146900000&hgsid=109992416" TITLE="q27.3"> 
<AREA SHAPE=RECT COORDS="470,6,492,15" HREF="../cgi-
bin/hgTracks?position=chrX:146900001-154913754&hgsid=109992416" TITLE="q28"> 
</MAP> 
<TABLE BORDER=0 CELLPADDING=0><TR><TD HEIGHT=5></TD></TR><TR><TD><IMG SRC = 
"../trash/hgtIdeo/hgtIdeo_genome_5c4e_4392c0.gif" BORDER=1 WIDTH=496 HEIGHT=21 
USEMAP=#ideoMap ></TD></TR><TR><TD HEIGHT=5></TD></TR></TABLE><MAP Name=map> 
<AREA SHAPE=RECT COORDS="1,1,12,10" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=ruler" TITLE="Base Position controls"> 
<AREA SHAPE=RECT COORDS="1,11,12,29" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=knownGene" TITLE="UCSC Genes controls"> 
<AREA SHAPE=RECT COORDS="1,30,12,48" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=refGene" TITLE="RefSeq Genes controls"> 
<AREA SHAPE=RECT COORDS="1,49,12,67" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=mgcGenes" TITLE="MGC Genes controls"> 
<AREA SHAPE=RECT COORDS="1,68,12,86" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=mrna" TITLE="Human mRNAs controls"> 
<AREA SHAPE=RECT COORDS="1,87,12,105" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=intronEst" TITLE="Spliced ESTs controls"> 
<AREA SHAPE=RECT COORDS="1,106,12,254" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=multiz28way" TITLE="Conservation controls"> 
<AREA SHAPE=RECT COORDS="1,255,12,273" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=snp129" TITLE="SNPs (129) controls"> 
<AREA SHAPE=RECT COORDS="1,274,12,292" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=snp128" TITLE="SNPs (128) controls"> 
<AREA SHAPE=RECT COORDS="1,293,12,311" HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=rmsk" TITLE="RepeatMasker controls"> 
<AREA SHAPE=RECT COORDS="115,0,132,9" HREF="../cgi-
bin/hgTracks?position=chrX:151026416-151130056&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="132,0,149,9" HREF="../cgi-
bin/hgTracks?position=chrX:151036780-151140420&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="149,0,165,9" HREF="../cgi-
bin/hgTracks?position=chrX:151047144-151150784&hgsid=109992416" TITLE="3x zoom"> 
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<AREA SHAPE=RECT COORDS="165,0,182,9" HREF="../cgi-
bin/hgTracks?position=chrX:151057508-151161148&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="182,0,199,9" HREF="../cgi-
bin/hgTracks?position=chrX:151067872-151171512&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="199,0,216,9" HREF="../cgi-
bin/hgTracks?position=chrX:151078237-151181877&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="216,0,233,9" HREF="../cgi-
bin/hgTracks?position=chrX:151088601-151192241&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="233,0,249,9" HREF="../cgi-
bin/hgTracks?position=chrX:151098965-151202605&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="249,0,266,9" HREF="../cgi-
bin/hgTracks?position=chrX:151109329-151212969&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="266,0,283,9" HREF="../cgi-
bin/hgTracks?position=chrX:151119693-151223333&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="283,0,300,9" HREF="../cgi-
bin/hgTracks?position=chrX:151130057-151233697&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="300,0,317,9" HREF="../cgi-
bin/hgTracks?position=chrX:151140421-151244061&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="317,0,333,9" HREF="../cgi-
bin/hgTracks?position=chrX:151150785-151254425&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="333,0,350,9" HREF="../cgi-
bin/hgTracks?position=chrX:151161149-151264789&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="350,0,367,9" HREF="../cgi-
bin/hgTracks?position=chrX:151171513-151275153&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="367,0,384,9" HREF="../cgi-
bin/hgTracks?position=chrX:151181878-151285518&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="384,0,401,9" HREF="../cgi-
bin/hgTracks?position=chrX:151192242-151295882&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="401,0,417,9" HREF="../cgi-
bin/hgTracks?position=chrX:151202606-151306246&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="417,0,434,9" HREF="../cgi-
bin/hgTracks?position=chrX:151212970-151316610&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="434,0,451,9" HREF="../cgi-
bin/hgTracks?position=chrX:151223334-151326974&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="451,0,468,9" HREF="../cgi-
bin/hgTracks?position=chrX:151233698-151337338&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="468,0,485,9" HREF="../cgi-
bin/hgTracks?position=chrX:151244062-151347702&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="485,0,501,9" HREF="../cgi-
bin/hgTracks?position=chrX:151254426-151358066&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="501,0,518,9" HREF="../cgi-
bin/hgTracks?position=chrX:151264790-151368430&hgsid=109992416" TITLE="3x zoom"> 
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<AREA SHAPE=RECT COORDS="518,0,535,9" HREF="../cgi-
bin/hgTracks?position=chrX:151275154-151378794&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="535,0,552,9" HREF="../cgi-
bin/hgTracks?position=chrX:151285519-151389159&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="552,0,569,9" HREF="../cgi-
bin/hgTracks?position=chrX:151295883-151399523&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="569,0,585,9" HREF="../cgi-
bin/hgTracks?position=chrX:151306247-151409887&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="585,0,602,9" HREF="../cgi-
bin/hgTracks?position=chrX:151316611-151420251&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="602,0,619,9" HREF="../cgi-
bin/hgTracks?position=chrX:151326975-151430615&hgsid=109992416" TITLE="3x zoom"> 
<AREA SHAPE=RECT COORDS="11,11,620,19" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&knownGene=pack" 
TITLE="Toggle the display density of UCSC Genes"> 
<AREA SHAPE=RECT COORDS="11,11,620,19" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&knownGene=pack" 
TITLE="Toggle the display density of UCSC Genes"> 
<AREA SHAPE=RECT COORDS="11,30,620,38" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&refGene=pack" 
TITLE="Toggle the display density of RefSeq Genes"> 
<AREA SHAPE=RECT COORDS="11,30,620,38" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&refGene=pack" 
TITLE="Toggle the display density of RefSeq Genes"> 
<AREA SHAPE=RECT COORDS="11,49,620,57" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&mgcGenes=dense" 
TITLE="Toggle the display density of MGC Genes"> 
<AREA SHAPE=RECT COORDS="11,49,620,57" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&mgcGenes=dense" 
TITLE="Toggle the display density of MGC Genes"> 
<AREA SHAPE=RECT COORDS="11,68,620,76" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&mrna=pack" TITLE="Toggle 
the display density of Human mRNAs"> 
<AREA SHAPE=RECT COORDS="11,68,620,76" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&mrna=pack" TITLE="Toggle 
the display density of Human mRNAs"> 
<AREA SHAPE=RECT COORDS="11,87,620,95" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&intronEst=pack" 
TITLE="Toggle the display density of Spliced ESTs"> 
<AREA SHAPE=RECT COORDS="11,87,620,95" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&intronEst=pack" 
TITLE="Toggle the display density of Spliced ESTs"> 
<AREA SHAPE=RECT COORDS="11,106,620,114" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&multiz28way=dense" 
TITLE="Toggle the display density of Conservation"> 
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<AREA SHAPE=RECT COORDS="11,106,620,114" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&multiz28way=dense" 
TITLE="Toggle the display density of Conservation"> 
<AREA SHAPE=RECT COORDS="11,255,620,263" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp129=pack" 
TITLE="Toggle the display density of SNPs (129)"> 
<AREA SHAPE=RECT COORDS="11,255,620,263" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp129=pack" 
TITLE="Toggle the display density of SNPs (129)"> 
<AREA SHAPE=RECT COORDS="11,274,620,282" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp128=pack" 
TITLE="Toggle the display density of SNPs (128)"> 
<AREA SHAPE=RECT COORDS="11,274,620,282" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp128=pack" 
TITLE="Toggle the display density of SNPs (128)"> 
<AREA SHAPE=RECT COORDS="11,293,620,301" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&rmsk=full" TITLE="Toggle 
the display density of RepeatMasker"> 
<AREA SHAPE=RECT COORDS="11,293,620,301" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&rmsk=full" TITLE="Toggle 
the display density of RepeatMasker"> 
<AREA SHAPE=RECT COORDS="13,57,597,66" HREF="../cgi-
bin/hgc?hgsid=109992416&o=151087187&t=151370481&g=mgcGenes&i=BC028629&c=chrX&l=151
073053&r=151383976&db=hg18&pix=620"  TITLE="BC028629"> 
<AREA SHAPE=RECT COORDS="115,114,619,254" HREF="../cgi-
bin/hgc?hgsid=109992416&o=151073053&t=151383976&g=multiz28way&i=multiz28way&c=chrX&l=
151073053&r=151383976&db=hg18&pix=620" > 
<AREA SHAPE=RECT COORDS="11,19,620,29" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&knownGene=pack" 
TITLE="Toggle the display density of UCSC Genes"> 
<AREA SHAPE=RECT COORDS="11,38,620,48" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&refGene=pack" 
TITLE="Toggle the display density of RefSeq Genes"> 
<AREA SHAPE=RECT COORDS="11,76,620,86" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&mrna=pack" TITLE="Toggle 
the display density of Human mRNAs"> 
<AREA SHAPE=RECT COORDS="11,95,620,105" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&intronEst=pack" 
TITLE="Toggle the display density of Spliced ESTs"> 
<AREA SHAPE=RECT COORDS="11,263,620,273" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp129=pack" 
TITLE="Toggle the display density of SNPs (129)"> 
<AREA SHAPE=RECT COORDS="11,282,620,292" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&snp128=pack" 
TITLE="Toggle the display density of SNPs (128)"> 
<AREA SHAPE=RECT COORDS="11,301,620,311" HREF="../cgi-
bin/hgTracks?position=chrX:151073054-151383976&hgsid=109992416&rmsk=full" TITLE="Toggle 
the display density of RepeatMasker"> 
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</MAP> 
<IMG SRC = "../trash/hgt/hgt_genome_5c4e_4392c0.gif" BORDER=1 WIDTH=620 HEIGHT=311 
USEMAP=#map ><BR> 
<TABLE BORDER=0 CELLSPACING=1 CELLPADDING=1 WIDTH=620 COLS=27><TR> 
<TD COLSPAN=6 ALIGN=CENTER NOWRAP>move start<BR><INPUT TYPE=SUBMIT 
NAME="hgt.dinkLL" VALUE=" < " ><INPUT TYPE=TEXT NAME="dinkL" SIZE=3 VALUE="2.0"> 
<INPUT TYPE=SUBMIT NAME="hgt.dinkLR" VALUE=" > " ></TD><TD COLSPAN=15 style="white-
space:normal">Click on a feature for details. Click on base position to zoom in around cursor. Click 
gray/blue bars on left for track options and descriptions.</TD><TD COLSPAN=6 ALIGN=CENTER 
NOWRAP>move end<BR><INPUT TYPE=SUBMIT NAME="hgt.dinkRL" VALUE=" < " ><INPUT 
TYPE=TEXT NAME="dinkR" SIZE=3 VALUE="2.0"> 
<INPUT TYPE=SUBMIT NAME="hgt.dinkRR" VALUE=" > " ></TD></TR></TABLE> 
<INPUT TYPE=SUBMIT NAME="hgt.reset" VALUE="default tracks" >&nbsp;<INPUT TYPE=SUBMIT 
NAME="hgt.hideAll" VALUE="hide all" > <INPUT TYPE="button" VALUE="add custom tracks" 
onClick="document.customTrackForm.submit();return false;"> <INPUT TYPE=SUBMIT 
NAME="hgTracksConfigPage" VALUE="configure" > <INPUT TYPE=SUBMIT 
NAME="hgt.toggleRevCmplDisp" VALUE="reverse" > <INPUT TYPE=SUBMIT NAME="submit" 
VALUE="refresh" ><BR> 
<script type='text/javascript' src='../js/hgTracks.js'></script> 
<noscript><b>Your browser does not support JavaScript so some functionality may be 
missing!</b></noscript> 
<table border=0 cellspacing=1 cellpadding=1 width=610> 
<tr><td colspan='5' align='CENTER' nowrap>Use drop-down controls below and press refresh to alter 
tracks displayed.<BR>Tracks with lots of items will automatically be displayed in more compact 
modes.</td></tr> 
<TR><th align="left" colspan=5 BGCOLOR=#536ED3><table width='100%'><tr><td align='left'> 
<A NAME="mapGroup"></A><A HREF="../cgi-
bin/hgTracks?hgsid=109992416&hgtgroup_map_close=1#mapGroup" class='bigBlue'><IMG 
height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 'map');" id="map_button" 
src="../images/remove_sm.gif" alt="-" class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' 
width='100%'> 
<B><FONT COLOR="#FFFFFF">Mapping and Sequencing Tracks</FONT></B></td><td 
align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='map-1'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=ruler"> Base Position<BR> </A><SELECT 





 - 513 - 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=cytoBand"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=stsMap"> STS 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=fishClones"> FISH 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=recombRate"> 







</td></tr><tr style='display: ' id='map-2'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=ctgPos"> Map Contigs<BR> </A><SELECT 
NAME="ctgPos" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 




</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=gold"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=gap"> Gap<BR> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=clonePos"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=bacEndPairs"> 







</td></tr><tr style='display: ' id='map-3'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=fosEndPairs"> Fosmid End Pairs<BR> </A><SELECT 
NAME="fosEndPairs" class=hiddenText style="width: 70px" > 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=gc5Base"> GC 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=oligoMatch"> Short 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=cutters"> Restr 











height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 'phenDis');" id="phenDis_button" 
src="../images/remove_sm.gif" alt="-" class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' 
width='100%'> 
<B><FONT COLOR="#FFFFFF">Phenotype and Disease Associations</FONT></B></td><td 
align='right'> 
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<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='phenDis-4'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=gad"> GAD View<BR> </A><SELECT NAME="gad" 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=caseControl"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=nimhBipolar"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=rgdQtl"> RGD 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=rgdRatQtl"> RGD 








</td></tr><tr style='display: ' id='phenDis-5'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=jaxQtlMapped"> MGI Mouse QTL<BR> </A><SELECT 











height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 'genes');" id="genes_button" 
src="../images/remove_sm.gif" alt="-" class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' 
width='100%'> 
<B><FONT COLOR="#FFFFFF">Genes and Gene Prediction Tracks</FONT></B></td><td 
align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='genes-6'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=knownGene"> UCSC Genes<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=knownGeneOld2"> 
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<OPTION>full</OPTION> 
</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=knownAlt"> Alt 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=ccdsGene"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=refGene"> RefSeq 







</td></tr><tr style='display: ' id='genes-7'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=xenoRefGene"> Other RefSeq<BR> </A><SELECT 







 - 519 - 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=mgcGenes"> MGC 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=orfeomeGenes"> 








</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=transMap"> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=vegaGeneComposite"> Vega Genes<BR> 







</td></tr><tr style='display: ' id='genes-8'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=ensGene"> Ensembl Genes<BR> </A><SELECT 








</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=acembly"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=sibGene"> SIB 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=nscan"> N-







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=contrastGene"> 
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</td></tr><tr style='display: ' id='genes-9'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=sgpGene"> SGP Genes<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=geneid"> Geneid 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=genscan"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=exoniphy"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=augustus"> 
Augustus<BR> </A><SELECT NAME="augustus" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 






</td></tr><tr style='display: ' id='genes-10'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=rnaGene"> RNA Genes<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=acescan"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=evofold"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=wgRna"> 








</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=mammalPsg"> Pos 







</td></tr><TR><th align="left" colspan=5 BGCOLOR=#536ED3><table width='100%'><tr><td 
align='left'> 
<A NAME="rnaGroup"></A><A HREF="../cgi-
bin/hgTracks?hgsid=109992416&hgtgroup_rna_close=1#rnaGroup" class='bigBlue'><IMG height='18' 
width='18' onclick="return toggleTrackGroupVisibility(this, 'rna');" id="rna_button" 
src="../images/remove_sm.gif" alt="-" class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' 
width='100%'> 
<B><FONT COLOR="#FFFFFF">mRNA and EST Tracks</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='rna-11'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=mrna"> Human mRNAs<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=intronEst"> Spliced 
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</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=est"> Human 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=xenoMrna"> Other 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=xenoEst"> Other 







</td></tr><tr style='display: ' id='rna-12'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=HInvGeneMrna"> H-Inv<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=uniGene_3"> 
UniGene<BR> </A><SELECT NAME="uniGene_3" class=hiddenText style="width: 70px" > 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=rnaCluster"> Gene 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=sibTxGraph"> SIB 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=polyA"> 







</td></tr><tr style='display: ' id='rna-13'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=cgapSage"> CGAP SAGE<BR> </A><SELECT 
NAME="cgapSage" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 
<OPTION>dense</OPTION> 









class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'regulation');" id="regulation_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">Expression and Regulation</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='regulation-14'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyHumanExon"> Affy All Exon<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyHuEx1"> Affy 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=agilentCgh"> 
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<OPTION>full</OPTION> 
</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=allenBrainAli"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=gnfAtlas2"> GNF 







</td></tr><tr style='display: ' id='regulation-15'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyRatio"> GNF Ratio<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=yaleBertoneTars"> 








 - 528 - 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyU133"> Affy 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyGnf1h"> Affy 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyU133Plus2"> 







</td></tr><tr style='display: ' id='regulation-16'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyU95"> Affy U95<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=cpgIslandExt"> 
CpG Islands<BR> </A><SELECT NAME="cpgIslandExt" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 






</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=firstEF"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=switchDbTss"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=eponine"> Eponine 







</td></tr><tr style='display: ' id='regulation-17'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=vistaEnhancers"> Vista Enhancers<BR> </A><SELECT 








</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=tfbsConsSites"> 









bin/hgTrackUi?hgsid=109992416&c=chrX&g=wgEncodeGisSuper"> GIS PET...<BR> </A><SELECT 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=wgEncodeUcsdNgTaf1Super"> LI/UCSD TAF1...<BR> 




</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=oreganno"> 







</td></tr><tr style='display: ' id='regulation-18'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=affyTxnPhase3Super"> Affy Txn...<BR> </A><SELECT 
NAME="affyTxnPhase3Super" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 
<OPTION>show</OPTION> 
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</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=regPotential7X"> 






</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=targetScanS"> TS 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=uppsalaChipSuper"> Uppsala ChIP...<BR> 




</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=laminB1Super"> 









class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'compGeno');" id="compGeno_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">Comparative Genomics</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
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</tr><tr style='display: ' id='compGeno-19'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=multiz28way"> Conservation<BR> </A><SELECT 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=mostConserved28way"> Most Conserved<BR> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=multiz17way"> 17-








bin/hgTrackUi?hgsid=109992416&c=chrX&g=phastConsElements17way"> 17-Way Most Cons<BR> 







 - 533 - 
</td><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=consIndelsHgMmCanFam"> Cons Indels MmCf<BR> 







</td></tr><tr style='display: ' id='compGeno-20'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainStrPur2"> S. purpuratus Chain<BR> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netStrPur2"> S. 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainBraFlo1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netBraFlo1"> 
Lancelet Net<BR> </A><SELECT NAME="netBraFlo1" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 
<OPTION>dense</OPTION> 
 - 534 - 
<OPTION>full</OPTION> 
</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainPetMar1"> 







</td></tr><tr style='display: ' id='compGeno-21'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=netPetMar1"> Lamprey Net<BR> </A><SELECT 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainOryLat1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netOryLat1"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainGasAcu1"> 









</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netGasAcu1"> 





</td></tr><tr style='display: ' id='compGeno-22'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainFr2"> Fugu Chain<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netFr2"> Fugu 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainTetNig1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netTetNig1"> 
Tetraodon Net<BR> </A><SELECT NAME="netTetNig1" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 




</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=ecoresTetNig1"> 








</td></tr><tr style='display: ' id='compGeno-23'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainDanRer5"> Zebrafish Chain<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netDanRer5"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainXenTro2"> X. 







 - 537 - 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netXenTro2"> X. 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainGalGal3"> 







</td></tr><tr style='display: ' id='compGeno-24'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=netGalGal3"> Chicken Net<BR> </A><SELECT 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainAnoCar1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netAnoCar1"> 
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</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainOrnAna1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netOrnAna1"> 





</td></tr><tr style='display: ' id='compGeno-25'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainMonDom4"> Opossum Chain<BR> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netMonDom4"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainCanFam2"> 






 - 539 - 
</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netCanFam2"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainFelCat3"> 







</td></tr><tr style='display: ' id='compGeno-26'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=netFelCat3"> Cat Net<BR> </A><SELECT 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainEquCab1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netEquCab1"> 





 - 540 - 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainBosTau4"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netBosTau4"> 





</td></tr><tr style='display: ' id='compGeno-27'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainCavPor3"> Guinea Pig Chain<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netCavPor3"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainRn4"> Rat 
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</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netRn4"> Rat 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainMm9"> 







</td></tr><tr style='display: ' id='compGeno-28'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=netMm9"> Mouse Net<BR> </A><SELECT 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainCalJac1"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netCalJac1"> 
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</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainRheMac2"> 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netRheMac2"> 





</td></tr><tr style='display: ' id='compGeno-29'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainPonAbe2"> Orangutan Chain<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netPonAbe2"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainPanTro2"> 
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</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=netPanTro2"> 









height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 'varRep');" id="varRep_button" 
src="../images/remove_sm.gif" alt="-" class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' 
width='100%'> 
<B><FONT COLOR="#FFFFFF">Variation and Repeats</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='varRep-30'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=snp129"> SNPs (129)<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=snp128"> SNPs 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=snp126"> SNPs 
(126)<BR> </A><SELECT NAME="snp126" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 
<OPTION>dense</OPTION> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=snpArray"> SNP 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=hapmapSnps"> 







</td></tr><tr style='display: ' id='varRep-31'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=hapmapLdPh"> HapMap LD Phased<BR> </A>[No 
data-chrX]</td><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=tajdSnp"> Tajima's D SNPs<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=tajD"> Tajima's 
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</SELECT> 
</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=dgv"> DGV Struct 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=genomicSuperDups"> Segmental Dups<BR> 







</td></tr><tr style='display: ' id='varRep-32'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=cnp"> Structural Var<BR> </A><SELECT NAME="cnp" 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=exaptedRepeats"> 
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</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=rmsk"> 





</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=nestedRepeats"> 








</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=simpleRepeat"> 







</td></tr><tr style='display: ' id='varRep-33'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=microsat"> Microsatellite<BR> </A><SELECT 







</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=chainSelf"> Self 
Chain<BR> </A><SELECT NAME="chainSelf" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 
<OPTION>dense</OPTION> 









class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'encodeGenes');" id="encodeGenes_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">ENCODE Regions and Genes</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='encodeGenes-34'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeRegions"> ENCODE Regions<BR> 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeGencodeSuper"> Gencode Genes...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeEgaspSuper"> EGASP...<BR> </A><SELECT 






</A><SELECT NAME="encodePseudogene" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 






</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeRna"> 







</td></tr><tr style='display: ' id='encodeGenes-35'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUViennaRnaz"> Vienna RNAz<BR> 











class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'encodeTxLevels');" id="encodeTxLevels_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">ENCODE Transcript Levels</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='encodeTxLevels-36'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeAffyRnaSuper"> Affy RNA...<BR> 
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</td><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeBuFirstExon"> BU First Exon<BR> 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeRikenCage"> Riken CAGE<BR> </A><SELECT 






bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeStanfordPromoters"> Stanf Promoter<BR> 








bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeStanfordRtPcr"> Stanf RTPCR<BR> 







</td></tr><tr style='display: ' id='encodeTxLevels-37'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeYaleRnaSuper"> Yale RNA...<BR> 
</A><SELECT NAME="encodeYaleRnaSuper" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 




bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeAffyEcSuper"> Affy EC...<BR> </A>[No data-




class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'encodeChip');" id="encodeChip_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">ENCODE Chromatin Immunoprecipitation</FONT></B></td><td 
align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='encodeChip-38'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeAffyChipSuper"> Affy ChIP...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUcsdChipSuper"> LI/UCSD ChIP...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeSangerChipSuper"> Sanger ChIP-chip...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeStanfordChipSuper"> Stanf ChIP...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUcDavisChipSuper"> UC Davis ChIP...<BR> 
</A><SELECT NAME="encodeUcDavisChipSuper" class=hiddenText style="width: 70px" > 




</td></tr><tr style='display: ' id='encodeChip-39'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUtexChipSuper"> UT-Austin ChIP...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUppsalaChipSuper"> Uppsala ChIP...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeYaleChipSuper"> Yale ChIP...<BR> 








class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'encodeChrom');" id="encodeChrom_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">ENCODE Chromosome, Chromatin and DNA 
Structure</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='encodeChrom-40'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeBUORChID"> BU ORChID<BR> </A><SELECT 
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</td><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeNhgriDukeDnaseHs"> Duke/NHGRI 






</td><td align=left><A HREF="../cgi-bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUncFaire"> 






bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUvaDnaRepSuper"> UVa DNA Rep...<BR> 





bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeUwDnaseSuper"> UW DNase...<BR> 








p" class='bigBlue'><IMG height='18' width='18' onclick="return toggleTrackGroupVisibility(this, 
'encodeCompAndVar');" id="encodeCompAndVar_button" src="../images/remove_sm.gif" alt="-" 
class='bigBlue'></A>&nbsp;&nbsp;</td><td align='center' width='100%'> 
<B><FONT COLOR="#FFFFFF">ENCODE Comparative Genomics and 
Variation</FONT></B></td><td align='right'> 
<input type='submit' name='submit' value='refresh'> 
</td></tr></table></th> 
</tr><tr style='display: ' id='encodeCompAndVar-41'><td align=left><A HREF="../cgi-
bin/hgTrackUi?hgsid=109992416&c=chrX&g=encodeIndels"> NHGRI DIPs<BR> </A><SELECT 
NAME="encodeIndels" class=hiddenText style="width: 70px" > 
<OPTION SELECTED>hide</OPTION> 








<INPUT TYPE=SUBMIT NAME="submit" VALUE="refresh" ></CENTER> 
</FORM> 
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Appendix 32 – UCSC Track for chromosome 9 
browser position chr9:27357278-27579657 
track name=Fin_Hap description="ALS Finland HAP" color=0,0,255, 
chr9 27357278 27357278 rs1330921 
chr9 27375002 27375002 rs1110264 
chr9 27376505 27376505 rs1110155 
chr9 27392961 27392961 rs2150336 
chr9 27399264 27399264 rs2225389 
chr9 27420232 27420232 rs1161680 
chr9 27428411 27428411 rs2120718 
chr9 27433802 27433802 rs2589054 
chr9 27435104 27435104 rs10812596 
chr9 27437089 27437089 rs1058326 
chr9 27440211 27440211 rs944404 
chr9 27442240 27442240 rs1316679 
chr9 27448939 27448939 rs725804 
chr9 27458461 27458461 rs10511816 
chr9 27467874 27467874 rs1444533 
chr9 27468052 27468052 rs1822723 
chr9 27472235 27472235 rs4879515 
chr9 27473959 27473959 rs895023 
chr9 27480967 27480967 rs7046653 
chr9 27485418 27485418 rs2440622 
chr9 27492986 27492986 rs1977661 
chr9 27519316 27519316 rs903603 
chr9 27526397 27526397 rs2814707 
chr9 27533281 27533281 rs3849942 
chr9 27546780 27546780 rs10122902 
chr9 27547919 27547919 rs10757665 
chr9 27551049 27551049 rs774359 
chr9 27562255 27562255 rs2282241 
chr9 27565785 27565785 rs1948522 
chr9 27569560 27569560 rs1982915 
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chr9 27578731 27578731 rs702231 
chr9 27579657 27579657 rs696826 
track name=Common_Hap description="ALS UK_FRA_HOL_US HAP" color=255,0,0, 
chr9 27357278 27357278 rs1330921 
chr9 27375002 27375002 rs1110264 
chr9 27376505 27376505 rs1110155 
chr9 27392961 27392961 rs2150336 
chr9 27399264 27399264 rs2225389 
chr9 27420232 27420232 rs1161680 
chr9 27428411 27428411 rs2120718 
chr9 27433802 27433802 rs2589054 
chr9 27435104 27435104 rs10812596 
chr9 27437089 27437089 rs1058326 
chr9 27440211 27440211 rs944404 
chr9 27442240 27442240 rs1316679 
chr9 27448939 27448939 rs725804 
chr9 27458461 27458461 rs10511816 
chr9 27467874 27467874 rs1444533 
chr9 27468052 27468052 rs1822723 
chr9 27472235 27472235 rs4879515 
chr9 27473959 27473959 rs895023 
chr9 27480967 27480967 rs7046653 
chr9 27485418 27485418 rs2440622 
chr9 27492986 27492986 rs1977661 
chr9 27519316 27519316 rs903603 
chr9 27526397 27526397 rs2814707 
chr9 27533281 27533281 rs3849942 
chr9 27546780 27546780 rs10122902 
chr9 27547919 27547919 rs10757665 
chr9 27551049 27551049 rs774359 
chr9 27562255 27562255 rs2282241 
chr9 27565785 27565785 rs1948522 
chr9 27569560 27569560 rs1982915 
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chr9 27578731 27578731 rs702231 
chr9 27579657 27579657 rs696826 
track name=BE_Hap description="ALS BE HAP" color=55,0,0, 
chr9 27357278 27357278 rs1330921 
chr9 27375002 27375002 rs1110264 
chr9 27376505 27376505 rs1110155 
chr9 27392961 27392961 rs2150336 
chr9 27399264 27399264 rs2225389 
chr9 27420232 27420232 rs1161680 
chr9 27428411 27428411 rs2120718 
chr9 27433802 27433802 rs2589054 
chr9 27435104 27435104 rs10812596 
chr9 27437089 27437089 rs1058326 
chr9 27440211 27440211 rs944404 
chr9 27442240 27442240 rs1316679 
chr9 27448939 27448939 rs725804 
track name=SWE_Hap description="ALS SWE HAP" color=55,0,0, 
chr9 27458461 27458461 rs10511816 
chr9 27467874 27467874 rs1444533 
chr9 27468052 27468052 rs1822723 
chr9 27472235 27472235 rs4879515 
chr9 27473959 27473959 rs895023 
chr9 27480967 27480967 rs7046653 
chr9 27485418 27485418 rs2440622 
chr9 27492986 27492986 rs1977661 
chr9 27519316 27519316 rs903603 
chr9 27526397 27526397 rs2814707 
chr9 27533281 27533281 rs3849942 
chr9 27546780 27546780 rs10122902 
chr9 27547919 27547919 rs10757665 
chr9 27551049 27551049 rs774359 
chr9 27562255 27562255 rs2282241 
chr9 27565785 27565785 rs1948522 
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chr9 27569560 27569560 rs1982915 
chr9 27578731 27578731 rs702231 
chr9 27579657 27579657 rs696826 
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Protected Sub Search_Click(ByVal sender As Object, ByVal e As 
System.EventArgs) 
        Label1.Visible= "False" 
        If TextBox1.Text = "" Then 
     Response.Redirect("~/GWA2/gwas_fogh.aspx") 
        ElseIf TextBox1.Text <> "" Then 
  Dim dv1 As DataView 
  dv1 = 
CType(SqlDataSource1.Select(DataSourceSelectArguments.Empty), DataView) 
         If (dv1.Table.Rows.Count = 0) Then  
  Label1.Visible= "True" 
  ElseIf  (dv1.Table.Rows.Count > 0) Then  
  Dim SNP As String = TextBox1.Text      
  GridView1.Visible = "True" 
  End If 
                    
        End If 





SqlDataSource1 = SELECT DISTINCT [SNP] FROM dbo.[GWA_FOGH] WHERE ([SNP] = 
@SNP) 
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Appendix 35 – Populating Animal model table using T-SQL 
CREATE TABLE [dbo].[AnimalModels]( 
 [HomoloGeneID] [varchar](50) NULL, 
 [Organism_Name] [varchar](30) NOT NULL, 
 [Biological_Name] [varchar](100) NOT NULL, 
 [Kegg_id] [varchar](30) NULL, 
 [ncbi_locuslink_id] [varchar](50) NULL, 
 [gene_id] [varchar](24) NOT NULL, 
 [EntrezGene_id] [varchar](30) NOT NULL, 
 [MGI_id] [varchar](50) NULL, 
 [hgnc_id] [varchar](24) NULL, 
 [omim_id] [varchar](124) NULL, 
 [chromosome] [varchar](50) NULL, 
 [genomic_coordinates_strand] [varchar](150) NULL, 
 [genomic_chromosome] [varchar](50) NULL, 
 [genomic_location] [varchar](50) NULL, 
 [chromosome_split] [varchar](100) NULL, 
 [genomic_range] [varchar](50) NULL, 
 [strand] [text] NULL, 
 [gene_name] [varchar](1024) NULL, 
 [Synonyms] [text] NULL) 
GO 
 
BULK INSERT dbo.[AnimalModels] 
FROM '\\vm3\Alsod\DataSets\Animalmodels\animals.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[AnimalModels] 
ADD [ID] [int] IDENTITY(1,1) NOT NULL; 
GO 




--Importing reference data from MGI 
CREATE TABLE dbo.[Reference_MGI]( 
 [MGI_id] [varchar](50) NULL, 
 [gene_id] [varchar](64) NOT NULL, 
 [pubmed_id] [varchar](20) NOT NULL) 
GO 
 
BULK INSERT dbo.[Reference_MGI] 
FROM '\\vm3\Alsod\DataSets\Animalmodels\MRK_Reference_uploadversion.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[Reference_MGI] 
ADD [ID] [int] IDENTITY(1,1) PRIMARY KEY; 
GO 
 
--Importing reference data from pubmed 
CREATE TABLE dbo.[Reference_Pubmed]( 
 [title] [varchar](1024) NULL, 
 [pubmed_id] [varchar](20) NOT NULL, 
 [year] [varchar](5) NOT NULL, 
 [first_author] [varchar](24) NOT NULL)  
GO 
 
BULK INSERT dbo.[Reference_Pubmed] 
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FROM '\\vm3\Alsod\DataSets\Animalmodels\pubmed_references_oct13.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[Reference_Pubmed] 
ADD [ID] [int] IDENTITY(1,1) PRIMARY KEY; 
GO 
 
CREATE TABLE dbo.[Animal_Pubmed]( 
 [title] [varchar](1024) NOT NULL, 
 [pubmed_id] [varchar](20) NOT NULL, 
 [year] [varchar](5) NOT NULL, 
 [first_author] [varchar](24) NOT NULL, 
 [EntrezGene_id] [varchar](30) NOT NULL, 
 [gene_id] [varchar](64) NOT NULL) 
GO 
 
BULK INSERT dbo.[Animal_Pubmed] 
FROM '\\vm3\Alsod\DataSets\Animalmodels\animal_spast.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




--After importing all, then: 
ALTER TABLE dbo.[Animal_Pubmed] 
ADD [ID] [int] IDENTITY(1,1) PRIMARY KEY; 
GO 
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---Data for UK 
CREATE TABLE dbo.[GWA_UK]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
 
BULK INSERT dbo.[GWA_UK] 
FROM '\\vm3\Alsod\DataSets\uk\uk_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




---Data for BOSTON 
CREATE TABLE dbo.[GWA_BOS]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
 
BULK INSERT dbo.[GWA_BOS] 
FROM '\\vm3\Alsod\DataSets\bos\bos_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




--Data for HOLLAND 
CREATE TABLE dbo.[GWA_HOL]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
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 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
BULK INSERT dbo.[GWA_HOL] 
FROM '\\vm3\Alsod\DataSets\hol\hol_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




---Data for FRANCE 
CREATE TABLE dbo.[GWA_FRA]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
BULK INSERT dbo.[GWA_FRA] 
FROM '\\vm3\Alsod\DataSets\fra\fra_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




--Data for USA 
CREATE TABLE dbo.[GWA_USA]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
BULK INSERT dbo.[GWA_USA] 
FROM '\\vm3\Alsod\DataSets\usa\usa_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 
ROWTERMINATOR = '\n'    




--------neglogpvalue for single tables 
ALTER TABLE dbo.GWA_UK 
ADD neglogpval AS (-1 * log10(PVALUE)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_BOS 
ADD neglogpval AS (-1 * log10(PVALUE)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_HOL 
ADD neglogpval AS (-1 * log10(PVALUE)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_FRA 
ADD neglogpval AS (-1 * log10(PVALUE)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_USA 
ADD neglogpval AS (-1 * log10(PVALUE)) PERSISTED; 
GO 
 
--Create table to insert all data 
CREATE TABLE dbo.[GWA_NOKEY] 
([CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) NULL, 
 [BP] [int] NULL, 
 [A1] [varchar](1) NULL, 
 [F_A] [float] NULL, 
 [F_U] [float] NULL, 
 [A2] [varchar](1) NULL, 
 [CHISQ] [float] NULL, 
 [PVALUE] [float] NULL, 
 [ODDRATIO] [float] NULL, 
 [L95] [float] NULL, 
 [U95] [float] NULL) 
GO 
 
---Bulk Insert the data from space delimited file 
BULK INSERT dbo.[GWA_NOKEY] 
FROM '\\vm3\Alsod\DataSets\uk\uk_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 





BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\bos\bos_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\hol\hol_result_assoc.txt'             
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WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\fra\fra_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




BULK INSERT dbo.GWA_NOKEY 
FROM '\\vm3\Alsod\DataSets\usa\usa_result_assoc.txt'             
WITH     
(                 
FIELDTERMINATOR = ' ',                 




---Insert ID and Population column 
ALTER TABLE dbo.GWA_NOKEY 
ADD ID INT IDENTITY(1,1); 
GO 
 
ALTER TABLE dbo.GWA_NOKEY 
ADD POP VARCHAR(50); 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'UK' 
WHERE ID BETWEEN 1 AND 275619 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'BOSTON' 
WHERE ID BETWEEN 275620 AND 558067 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'HOLLAND' 
WHERE ID BETWEEN 558068 AND 846203 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'FRANCE' 
WHERE ID BETWEEN 846204 AND 1132710 
GO 
 
UPDATE dbo.GWA_NOKEY SET POP = 'USA' 
WHERE ID BETWEEN 1132711 AND 1420350 
GO 
 






create table dbo.GWA_UK_BOS 
(chr int NOT NULL, 
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snp varchar(30) NOT NULL, 
bp int NOT NULL, 
pvalbos float NULL, 
pvaluk float NULL, 




BULK INSERT dbo.GWA_UK_BOS 
FROM '\\vm3\Alsod\DataSets\DataPlots\uk_bos.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.GWA_UK_BOS 




create table dbo.GWA_UK_BOS_FRA 
(chr int NOT NULL, 
snp varchar(30) NOT NULL, 
bp int NOT NULL, 
pvalfra float NULL, 
pvalbos float NULL, 
newpvaluebosfra float NULL, 
pvaluk float NULL, 




BULK INSERT dbo.GWA_UK_BOS_FRA 
FROM '\\vm3\Alsod\DataSets\DataPlots\uk_bos_fra.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.GWA_UK_BOS_FRA 




create table dbo.GWA_UK_BOS_FRA_USA 
(chr int NOT NULL, 
snp varchar(30) NOT NULL, 
bp int NOT NULL, 
pvalusa float NULL, 
pvalfra float NULL, 
newpvaluefrausa float NULL, 
pvalbos float NULL, 
newpvaluebosfrausa float NULL, 
pvaluk float NULL, 
newpvalueukbosfrausa float NULL, 
newpvalueukfrausa float NULL, 
newpvalueukfra float NULL, 
newpvaluebosusa float NULL, 
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BULK INSERT dbo.GWA_UK_BOS_FRA_USA 
FROM '\\vm3\Alsod\DataSets\DataPlots\uk_bos_fra_usa.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 




create table dbo.GWA_UK_BOS_HOL_FRA_USA 
(chr int NOT NULL, 
snp varchar(30) NOT NULL, 
bp int NOT NULL, 
pvalhol float NULL, 
pvalusa float NULL, 
newpvalueholusa float NULL, 
pvalfra float NULL, 
newpvalueholfrausa float NULL, 
pvalbos float NULL, 
newpvaluebosholfrausa float NULL, 
pvaluk float NULL, 
newpvalueukbosholfrausa float NULL, 
newpvalueholfra float NULL, 
newpvalueboshol float NULL, 
newpvalueukhol float NULL, 
newpvaluebosholusa float NULL, 
newpvaluebosholfra float NULL, 
newpvalueukholusa float NULL, 
newpvalueukholfra float NULL, 
newpvalueukbosusa float NULL, 
newpvalueukboshol float NULL, 
newpvalueukbosholfra float NULL, 
newpvalueukbosholusa float NULL, 




BULK INSERT dbo.GWA_UK_BOS_HOL_FRA_USA 
FROM '\\vm3\Alsod\DataSets\DataPlots\uk_bos_hol_fra_usa.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD id INT IDENTITY(1,1) PRIMARY KEY; 
GO 
 
---Add log of pvalue column to plot graph 
ALTER TABLE dbo.GWA_UK_BOS 
ADD log_ukbos AS (-1 * log10(newpvalueukbos)) PERSISTED; 
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GO 
-- 
ALTER TABLE dbo.GWA_UK_BOS_FRA 
ADD log_bosfra AS (-1 * log10(newpvaluebosfra)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA 
ADD log_ukbosfra AS (-1 * log10(newpvalueukbosfra)) PERSISTED; 
GO 
-- 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_frausa AS (-1 * log10(newpvaluefrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_bosfrausa AS (-1 * log10(newpvaluebosfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_ukbosfrausa AS (-1 * log10(newpvalueukbosfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_ukfrausa AS (-1 * log10(newpvalueukfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_ukfra AS (-1 * log10(newpvalueukfra)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_bosusa AS (-1 * log10(newpvaluebosusa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_FRA_USA 
ADD log_ukusa AS (-1 * log10(newpvalueukusa)) PERSISTED; 
GO 
---- 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_holusa AS (-1 * log10(newpvalueholusa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_holfrausa AS (-1 * log10(newpvalueholfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_bosholfrausa AS (-1 * log10(newpvaluebosholfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukbosholfrausa AS (-1 * log10(newpvalueukbosholfrausa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_holfra AS (-1 * log10(newpvalueholfra)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_boshol AS (-1 * log10(newpvalueboshol)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
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ADD log_ukhol AS (-1 * log10(newpvalueukhol)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_bosholusa AS (-1 * log10(newpvaluebosholusa)) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_bosholfra AS (-1 * log10(newpvaluebosholfra)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukholusa AS (-1 * log10(newpvalueukholusa)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukholfra AS (-1 * log10(newpvalueukholfra)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukbosusa AS (-1 * log10(newpvalueukbosusa)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukboshol AS (-1 * log10(newpvalueukboshol)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukbosholfra AS (-1 * log10(newpvalueukbosholfra)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukbosholusa AS (-1 * log10(newpvalueukbosholusa)) PERSISTED; 
GO 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD log_ukholfrausa AS (-1 * log10(newpvalueukholfrausa)) PERSISTED; 
GO 
 
---negative 2 log of each p-value 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD neg2logpvalhol AS -2 * log(pvalhol) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD neg2logpvalusa AS -2 * log(pvalusa) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD neg2logpvalfra AS -2 * log(pvalfra) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD neg2logpvalbos AS -2 * log(pvalbos) PERSISTED; 
GO 
 
ALTER TABLE dbo.GWA_UK_BOS_HOL_FRA_USA 
ADD neg2logpvaluk AS -2 * log(pvaluk) PERSISTED; 
GO 
 
ALTER TABLE dbo.ANALYZE_THEIRDATA 




CREATE TABLE [dbo].[ANALYZE_OURDATA]( 
 [CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) PRIMARY KEY, 
 [BP] [int] NULL, 
 [PVALHOL] [float] NULL, 
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 [PVALUSA] [float] NULL, 
 [PVALFRA] [float] NULL, 
 [PVALBOS] [float] NULL, 




INSERT INTO dbo.ANALYZE_OURDATA (CHROMOSOME, SNP, BP, PVALHOL, PVALUSA, 
PVALFRA, PVALBOS, PVALUK)  




--calculate -2ln(p) on ourdata 
ALTER TABLE dbo.ANALYZE_OURDATA 
ADD neg2logpvalhol AS -2 * log(pvalhol) PERSISTED; 
GO 
 
ALTER TABLE dbo.ANALYZE_OURDATA 
ADD neg2logpvalusa AS -2 * log(pvalusa) PERSISTED; 
GO 
 
ALTER TABLE dbo.ANALYZE_OURDATA 
ADD neg2logpvalfra AS -2 * log(pvalfra) PERSISTED; 
GO 
 
ALTER TABLE dbo.ANALYZE_OURDATA 
ADD neg2logpvalbos AS -2 * log(pvalbos) PERSISTED; 
GO 
 
ALTER TABLE dbo.ANALYZE_OURDATA 




---create no key table 
CREATE TABLE dbo.[ANALYZE_NOKEY] 
([CHROMOSOME] [int] NULL, 
 [SNP] [varchar](30) NULL, 
 [BP] [int] NULL, 
 [PVALUE] [float] NULL, 




----Previously before haploview method, logs are calculated (no more 
necessary) 
ALTER TABLE GWA_UK_BOS_HOL 
ADD id INT IDENTITY(1,1) PRIMARY KEY; 
GO 
 
ALTER TABLE GWA_UK_BOS_HOL 
ADD log_holbos_plot AS (-1 * log10(newpvalueholbos)) PERSISTED; 
GO 
 
ALTER TABLE GWA_UK_BOS_HOL 
ADD log_holbosuk_plot AS (-1 * log10(newpvalueholbosuk)) PERSISTED; 
GO 
 
ALTER TABLE GWA_UK_BOS_HOL 
ADD log_holuk_plot AS (-1 * log10(newpvalueholuk)) PERSISTED; 
GO 
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BULK INSERT GWA_UK_BOS 
FROM '\\vm3\Alsod\DataSets\DataPlots\uk_bos.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE GWA_UK_BOS 
ADD id INT IDENTITY(1,1) PRIMARY KEY; 
GO 
 
ALTER TABLE GWA_UK_BOS 
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Appendix 37 – Updating database using T-SQL 
 
----TO DELETE  
delete from dbo.visitors where 
[Page]='http://alsod.iop.kcl.ac.uk/Als/charts/hitcountstatistics.aspx' 
go 




SELECT DATEADD(d,DATEDIFF(d,1,GETDATE()),0) As 'Yesterday' 
go 
 
----pages accessed from yesterday 
SELECT * 
FROM visitors 
WHERE DateTime >= DATEADD(d,DATEDIFF(d,1,GETDATE()),0) 
AND DateTime < DATEADD(d,DATEDIFF(d,0,GETDATE()),0) 
go 
 
---pages by frequency for yesterday 
SELECT Country, COUNT(*) AS 'Frequency' 
FROM visitors  
WHERE [DateTime] BETWEEN DATEADD(d,DATEDIFF(d,1,GETDATE()),0) 
AND DATEADD(d,DATEDIFF(d,0,GETDATE()),0) 
GROUP BY Country ORDER BY Country 
 
SELECT TOP 1 [BP] FROM [GWA_UK] WHERE ([CHROMOSOME] = 6) ORDER BY [BP] 
 
--- Daily data on visitors 
select  top (100) [DateTime] as [Date],COUNT(*) AS 'Frequency' from 
dbo.visitors group by [DateTime] order by [DateTime] 
 
SELECT    TOP (100) LEFT(DateTime, 12) AS Date, COUNT(*) AS 'Frequency' 
FROM         dbo.visitors 
GROUP BY DateTime 
 
SELECT     TOP (100) PERCENT LEFT(DateTime, 12) AS Daily, COUNT(*) AS 
'Frequency' 
FROM         dbo.visitors 
GROUP BY DateTime 
ORDER BY DateTime 
 
select distinct [Date], COUNT(*) AS 'Frequency' from 
[Alsod].[KCLAD\spngoka].[daily_visitors_report] 
GROUP BY [Date] 
ORDER BY [Date] 
 
--Chosen query. works fine but too long. 
select distinct [Daily], COUNT(*) AS 'Frequency' from 
[Alsod].[KCLAD\spngoka].[daily_visit3] 
GROUP BY [Daily] 
ORDER BY [Daily] 
 
SELECT DATENAME(mm-yyyy, DateTime) AS Daily FROM dbo.visitors GROUP BY 
DATENAME(mm-yyyy, DateTime) 
 
SELECT CONVERT (SMALLDATETIME, CONVERT (VARCHAR, [DateTime],103),103) As 
Daily FROM dbo.visitors order by Daily 
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SELECT [DateTime](Month,getDate()) + ' ' + [DateTime](Year,getDate()) AS 
Daily FROM dbo.visitors GROUP BY Daily 
 
SELECT   
    DATENAME(mm, DateTime) AS Month,   
    DATENAME(yyyy, DateTime) AS Year,   
    COUNT(*) AS Frequency   
FROM dbo.visitors AS article   
GROUP BY   
    DATENAME(mm, DateTime),   
    DATENAME(yyyy, DateTime)   
ORDER BY Year 
 
--Not quite. unordered! 
SELECT   
    DATENAME(mm, Daily) AS Month,   
    DATENAME(yyyy, Daily) AS Year,   
    COUNT(*) AS Frequency   
FROM [Alsod].[KCLAD\spngoka].[daily_visit3] AS article   
GROUP BY   
    DATENAME(mm, Daily),   
    DATENAME(yyyy, Daily) 
 
Select Distinct DateName(mm, [DateTime]) as 'Month', 
year([DateTime])  
as 'Year'from dbo.visitors 




select CONVERT(datetime, [DateTime], 103) as [Date]from dbo.visitors 
GROUP BY [DateTime] 
 
SELECT     TOP (100) LEFT(DateTime, 12) AS Date, COUNT(*) AS 'Frequency' 
FROM         dbo.visitors 
GROUP BY DateTime 
 
SELECT     TOP (100) LEFT([DateTime], 12) AS [Date], COUNT(distinct 
[DateTime]) AS 'Frequency', ID 
FROM         dbo.visitors 
GROUP BY [DateTime], ID 
ORDER BY ID 
 
 
SELECT     TOP (100) Country, COUNT(*) AS 'Frequency' 
FROM         dbo.visitors 
GROUP BY Country 
ORDER BY Country 
 




CREATE TABLE [genome]( 
 [structure_id] [varchar](50) NOT NULL, 
 [chrom] [varchar](15) NOT NULL, 
 [strand] [varchar](1) NULL, 
 [txtStart] [int] NULL, 
 [txtEnd] [int] NULL, 
 [cdsStart] [int] NULL, 
 [cdsEnd] [int] NULL, 
 [exonCount] [int] NULL, 
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 [exonStarts] [text] NULL, 
 [exonEnds] [text] NULL, 
 [proteinID] [varchar](50) NULL, 
 [alignID] [varchar](50) NULL) 
GO 
 
BULK INSERT [genome] 
FROM '\\vm3\Alsod\DataSets\genome.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE [genome] 




CREATE TABLE [gene_sequence_new]( 
 [gene_id] [varchar](64) NOT NULL, 
 [ncbi_refseq_id] [varchar](50) NULL, 
 [strand] [varchar](1) NULL, 
 [genomic_size] [int] NULL, 
 [exon_count] [int] NULL, 
 [coding_exon_count] [int] NULL, 
 [structure_id] [varchar](50) NOT NULL, 
 [chrom] [int] NOT NULL, 
 [rangefrom] [int] NOT NULL, 
 [rangeto] [int] NOT NULL, 
 [sequence_location_type] [varchar](24) NULL, 




BULK INSERT [gene_sequence_new] 
FROM '\\vm3\Alsod\DataSets\GeneSequence1.txt'             
WITH     
(                 
FIELDTERMINATOR = ',',                 




drop table [gene_sequence_new] 
go 
 




Select * From Information_Schema.Tables 
go 
 
--adds user to bulkadmin role 





GRANT CONTROL ON SCHEMA::dbo TO public 
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GO 
 
--To truncate tables 
TRUNCATE TABLE dbo.GWA_UK_BOS_FRA_USA 
go 
 
--Create table for gene SNPs 
CREATE TABLE dbo.[gene_SNP]( 
 [gene_id] [varchar](64) PRIMARY KEY, 
 [snp] [varchar](50) NOT NULL, 
 [basepair] [int] NOT NULL, 
 [pvalue] [float] NULL, 




ALTER TABLE dbo.[gene_SNP] 
ADD [term] [varchar](10) NULL; 
GO 
ALTER TABLE dbo.[gene_SNP] 
ADD S_No int IDENTITY(1,1); 
GO 
ALTER TABLE dbo.[gene_SNP] 
ADD [First_Author] [varchar](50) NULL; 
GO 
ALTER TABLE dbo.[gene_SNP] 
ADD [Year] [varchar](50) NULL; 
GO 
 
---An updated gene SNPlist 
CREATE TABLE dbo.[gene_SNP_updated]( 
 [gene_id] [varchar](64) NULL, 
 [snp] [varchar](50) NULL, 
 [basepair] [int] NULL, 
 [pvalue] [float] NULL, 
 [pubmed_id] [varchar](20) NULL, 
 [paperlink] [varchar](1024)NULL, 
 [term] [varchar](10) NULL, 
 [First_Author] [varchar](50) NULL, 
 [Year] [varchar](50) NULL, 
 [link] [varchar](1024) NULL, 
 [Amino_acid] [varchar](50) NULL) 
GO 
 
BULK INSERT dbo.[gene_SNP_updated] 
FROM '\\vm3\Alsod\SNP\updated_snps.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[gene_SNP_updated] 





---Create table for gene SNPs from ALSGene site 
 
CREATE TABLE dbo.[gene_SNP_ALSGene]( 
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 [chromosome_name] [varchar](4) NOT NULL, 
 [gene_id] [varchar](64) NOT NULL, 
 [ncbi_locuslink_id] int NULL, 
 [gene_name] [varchar](1024) NULL, 
 [First_Author] [varchar](50) NULL, 
 [Year] [varchar](50) NULL, 
 [pubmed_id] [varchar](20) NULL, 
 [snp1] [varchar](50) NULL, 
 [snp2] [varchar](50) NULL, 
 [mutation_mnemonic] [varchar](1024) NULL, 
 [codon] int NULL, 
 [paperlink] [varchar](1024)NULL, 
 [basepair] [int] NULL, 
 [term] [varchar](10) NULL, 




BULK INSERT dbo.[gene_SNP_ALSGene] 
FROM '\\vm3\Alsod\SNP\split_ALSGenesnps.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 









---Extras after bulk insert 
ALTER TABLE dbo.[gene_SNP_ALSGene] 
ADD [S_No] [int] IDENTITY(1,1); 
GO 
 
UPDATE dbo.[gene_SNP_ALSGene] SET [term] = 'GRCh37' 
GO 
 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of 
apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease' 
WHERE [First_Author] = 'Al-Chalabi' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association of 
apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease' 
WHERE [First_Author] = 'Bachus' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'The P413L chromogranin B 
variation in French patients with sporadic amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Blasco' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association between 
divalent metal transport 1 encoding gene (SLC11A2) and disease duration in 
amyotrophic lateral sclerosis' WHERE [First_Author] = 'Blasco' AND [Year] = 
'2011' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Polymorphisms in the GluR2 
gene are not associated with amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Bogaert' 
GO 
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UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Screening of the 
regulatory and coding regions of vascular endothelial growth factor in 
amyotrophic lateral sclerosis' WHERE [First_Author] = 'Brockington' AND 
[Year] = '2005' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Screening of the 
transcriptional regulatory regions of vascular endothelial growth factor 
receptor 2 (VEGFR2) in amyotrophic lateral sclerosis' WHERE [First_Author] 
= 'Brockington' AND [Year] = '2007' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Increased incidence of 
FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral 
sclerosis' WHERE [First_Author] = 'Cereda' AND [Year] = '2006' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'TNF and sTNFR1/2 plasma 
levels in ALS patients' WHERE [First_Author] = 'Cereda' AND [Year] = '2008' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association of 
VEGF promoter polymorphisms with sporadic ALS' WHERE [First_Author] = 
'Chen' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A two-stage genome-wide 
association study of sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Chio' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Sporadic ALS is not 
associated with VAPB gene mutations in Southern Italy' WHERE [First_Author] 
= 'Conforti' AND [Year] = '2006' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A novel Angiogenin gene 
mutation in a sporadic patient with amyotrophic lateral sclerosis from 
southern Italy' WHERE [First_Author] = 'Conforti' AND [Year] = '2008' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of the hOGG1 
Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Coppede' AND [Year] = '2007' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association 
between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral 
sclerosis' WHERE [First_Author] = 'Coppede' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association study between 
XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Coppede' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Variations in the coding 
and regulatory sequences of the angiogenin (ANG) gene are not associated to 
ALS (amyotrophic lateral sclerosis) in the Italian population' WHERE 
[First_Author] = 'Corrado' AND [Year] = '2007' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'VPS54 genetic analysis in 
ALS Italian cohort' WHERE [First_Author] = 'Corrado' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Paraoxonase promoter and 
intronic variants modify risk of sporadic amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Cronin' AND [Year] = '2007' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A genome-wide association 
study of sporadic ALS in a homogenous Irish population' WHERE 
[First_Author] = 'Cronin' AND [Year] = '2008' 
GO 
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UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Analysis of the UNC13A 
gene as a risk factor for sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Daoud' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Absence of angiogenic 
genes modification in Italian ALS patients' WHERE [First_Author] = 'Del Bo' 
AND [Year] = '2008' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'No major progranulin 
genetic variability contribution to disease etiopathogenesis in an ALS 
Italian cohort' WHERE [First_Author] = 'Del Bo' AND [Year] = '2009' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of APOE 
epsilon4 allele with survival in amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Drory' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Whole-genome analysis of 
sporadic amyotrophic lateral sclerosis' WHERE [First_Author] = 'Dunckley' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Ataxin-2 intermediate-
length polyglutamine expansions are associated with increased risk for ALS' 
WHERE [First_Author] = 'Elden' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'No association between DNA 
repair gene XRCC1 and amyotrophic lateral sclerosis' WHERE [First_Author] = 
'Fang' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Possible gender-dependent 
association of vascular endothelial growth factor (VEGF) gene and ALS' 
WHERE [First_Author] = 'Fernandez-Santiago' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Apolipoprotein E and 
multiple sclerosis: a biochemical and genetic investigation' WHERE 
[First_Author] = 'Gaillard' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Androgen receptor gene 
polymorphisms in amyotrophic lateral sclerosis' WHERE [First_Author] = 
'Garofalo' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Identification of new ANG 
gene mutations in a large cohort of Italian patients with amyotrophic 
lateral sclerosis' WHERE [First_Author] = 'Gellera' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Is erythropoietin gene a 
modifier factor in amyotrophic lateral sclerosis?' WHERE [First_Author] = 
'Ghezzi' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association 
between VEGF gene polymorphisms and plasma VEGF levels and sporadic AL' 
WHERE [First_Author] = 'Golenia' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of the H63D 
polymorphism in the hemochromatosis gene with sporadic ALS' WHERE 
[First_Author] = 'Goodall' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A novel candidate region 
for ALS on chromosome 14q11.2' WHERE [First_Author] = 'Greenway' AND [Year] 
= '2004' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'ANG mutations segregate 
with familial and 'sporadic' amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Greenway' AND [Year] = '2006' 
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GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'TDP-43 is not a common 
cause of sporadic amyotrophic lateral sclerosis' WHERE [First_Author] = 
'Guerreiro' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Molecular genetic analysis 
of the APEX nuclease gene in amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Hayward' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'H63D polymorphism in the 
hemochromatosis gene is associated with sporadic amyotrophic lateral 
sclerosis in China' WHERE [First_Author] = 'He' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Replication analysis of 
SNPs on 9p21.2 and 19p13.3 with amyotrophic lateral sclerosis in East 
Asians' WHERE [First_Author] = 'Iida' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Amyotrophic lateral 
sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-
aminolevulinic acid dehydratase and vitamin D receptor genes' WHERE 
[First_Author] = 'Kamel' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Large-scale pathways-based 
association study in amyotrophic lateral sclerosis' WHERE [First_Author] = 
'Kasperaviciute' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'The thermolabile variant 
of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for 
amyotrophic lateral sclerosis' WHERE [First_Author] = 'Kuehnlein' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'APOE: a potential marker 
of disease progression in ALS' WHERE [First_Author] = 'Laaksovirta' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'VEGF is a modifier of 
amyotrophic lateral sclerosis in mice and humans and protects motoneurons 
against ischemic death' WHERE [First_Author] = 'Lacomblez' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A common haplotype within 
the PON1 promoter region is associated with sporadic ALS' WHERE 
[First_Author] = 'Lambrechts' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Reduced expression of the 
Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic 
amyotrophic lateral sclerosis' WHERE [First_Author] = 'Landers' AND [Year] 
= '2008' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Ataxin-2 intermediate-
length polyglutamine expansions in European ALS patients' WHERE 
[First_Author] = 'Landers' AND [Year] = '2009' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Prion protein codon 129 
genotype prevalence is altered in primary progressive aphasia' WHERE 
[First_Author] = 'Lee' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Evaluation of the Golgi 
trafficking protein VPS54 (wobbler) as a candidate for ALS' WHERE 
[First_Author] = 'Li' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Thioredoxin reductase 1 
haplotypes modify familial amyotrophic lateral sclerosis onset' WHERE 
[First_Author] = 'Meisler' 
GO 
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UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A gene-environment study 
of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Mitchell' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Apolipoprotein E 
genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major 
influence on the clinical presentation and prognosis' WHERE [First_Author] 
= 'Morahan' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Apolipoprotein E 
genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major 
influence on the clinical presentation and prognosis' WHERE [First_Author] 
= 'Moulard' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Apolipoprotein E epsilon 4 
allele is not associated with earlier age at onset in amyotrophic lateral 
sclerosis' WHERE [First_Author] = 'Mui' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Motoneuron-specific NR3B 
gene: no association with ALS and evidence for a common null allele' WHERE 
[First_Author] = 'Niemann' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Genotyping of presenilin-1 
polymorphism in amyotrophic lateral sclerosis' WHERE [First_Author] = 
'Panas' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Spinobulbar muscular 
atrophy can mimic ALS: the importance of genetic testing in male patients 
with atypical ALS' WHERE [First_Author] = 'Parboosingh' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Mutations of the ANG gene 
in French patients with sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Paubel' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'New application of 
intelligent agents in sporadic amyotrophic lateral sclerosis identifies 
unexpected specific genetic background' WHERE [First_Author] = 'Penco' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'HFE H63D polymorphism is 
increased in patients with amyotrophic lateral sclerosis of Italian origin' 
WHERE [First_Author] = 'Restagno' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association of PON 
polymorphisms with sporadic ALS in an Italian population' WHERE 
[First_Author] = 'Ricci' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Paraoxonase cluster 
polymorphisms are associated with sporadic ALS' WHERE [First_Author] = 
'Saeed' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'A polymorphism in the 
poliovirus receptor gene differs in motor neuron disease' WHERE 
[First_Author] = 'Saunderson' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of ALS with 
head injury, cigarette smoking and APOE genotypes' WHERE [First_Author] = 
'Schmidt' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'No association of DYNC1H1 
with sporadic ALS in a case-control study of a northern European derived 
population: a tagging SNP approach' WHERE [First_Author] = 'Shah' 
GO 
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UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Chromosome 9p21 in 
sporadic amyotrophic lateral sclerosis in the UK and seven other countries: 
a genome-wide association study' WHERE [First_Author] = 'Shatunov' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association 
between apolipoprotein E genotype and sporadic amyotrophic lateral 
sclerosis' WHERE [First_Author] = 'Siddique' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Analysis of heavy 
neurofilament subunit gene polymorphism in Russian patients with sporadic 
motor neuron disease (MND)' WHERE [First_Author] = 'Skvortsova' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Paraoxonase gene 
polymorphisms and sporadic ALS' WHERE [First_Author] = 'Slowik' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'The association between 
H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch 
population' WHERE [First_Author] = 'Sutedja' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Development of a high-
throughput microarray-based resequencing system for neurological disorders 
and its application to molecular genetics of amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Takahashi' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'VEGF promoter haplotype 
and amyotrophic lateral sclerosis (ALS)' WHERE [First_Author] = 'Terry' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Distribution of MnSOD 
polymorphisms in sporadic ALS patients' WHERE [First_Author] = 'Tomblyn' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Screening of AP 
endonuclease as a candidate gene for amyotrophic lateral sclerosis (ALS)' 
WHERE [First_Author] = 'Tomkins' AND [Year] = '2000' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Mutation screening of 
manganese superoxide dismutase in amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Tomkins' AND [Year] = '2001' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of paraoxonase 
gene cluster polymorphisms with ALS in France, Quebec, and Sweden' WHERE 
[First_Author] = 'Valdmanis' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'ITPR2 as a susceptibility 
gene in sporadic amyotrophic lateral sclerosis: a genome-wide association 
study' WHERE [First_Author] = 'van Es' AND [Year] = '2007' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Genetic variation in DPP6 
is associated with susceptibility to amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'van Es' AND [Year] = '2008' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Genome-wide association 
study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for 
sporadic amyotrophic lateral sclerosis' WHERE [First_Author] = 'van Es' AND 
[Year] = '2009' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Manganese-containing 
superoxide dismutase signal sequence polymorphism associated with sporadic 
motor neuron disease' WHERE [First_Author] = 'Van Lendeghem' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Lack of association 
between VEGF polymorphisms and ALS in a Dutch population' WHERE 
[First_Author] = 'Van Vught' AND [Year] = '2005' 
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GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'P413L CHGB is not 
associated with ALS susceptibility or age at onset in a Dutch population' 
WHERE [First_Author] = 'van Vught' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Risk genotypes at TMEM106B 
are associated with cognitive impairment in amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Vass' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Increased incidence of the 
Hfe mutation in amyotrophic lateral sclerosis and related cellular 
consequences' WHERE [First_Author] = 'Wang' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Genetic analysis of the 
cystatin C gene in familial and sporadic ALS patients' WHERE [First_Author] 
= 'Watanabe' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Paraoxonase 1 (PON1) 
organophosphate hydrolysis is not reduced in ALS' WHERE [First_Author] = 
'Wills' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Quantification of cystatin 
C in cerebrospinal fluid from various neurological disorders and 
correlation with G73A polymorphism in CST3' WHERE [First_Author] = 
'Yamamoto-Watanabe' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'HFE mutations are not 
strongly associated with sporadic ALS' WHERE [First_Author] = 'Yen' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'The C(-1562)T polymorphism 
of the MMP-9 gene and the risk of sporadic amyotrophic lateral sclerosis' 
WHERE [First_Author] = 'Zawislak' AND [Year] = '2009' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'The -A162G polymorphism of 
the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Zawislak' AND [Year] = '2010' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'Association of APOE with 
age at onset of sporadic amyotrophic lateral sclerosis' WHERE 
[First_Author] = 'Zetterberg' 
GO 
UPDATE dbo.[gene_SNP_ALSGene] SET [paperlink] = 'VEGF C2578A polymorphism 
does not contribute to amyotrophic lateral sclerosis susceptibility in 
sporadic Chinese patients' WHERE [First_Author] = 'Zhang' 
GO 
 
---Create table for gene SNPs from lifeseq site 
 
CREATE TABLE dbo.[gene_SNP_lifeseq]( 
 [gene_id] [varchar](500) NOT NULL, 
 [DNA_change_original_from] [varchar](200) NULL, 
 [DNA_change_original_to] [varchar](200) NULL, 
 [chromosome_name] [varchar](4) NULL, 
 [position] [varchar](100) NULL, 
 [basepair] [int] NULL, 
 [exon] [varchar](100) NULL, 
 [snp2] [varchar](500) NULL, 
 [mutation_mnemonic] [varchar](1024) NULL, 
 [codon] int NULL, 
 [mRNA_accession_no] [varchar](200) NULL, 
 [amino_acid_accession_no] [varchar](200) NULL, 
 [amino_acid_change_as_seen] [varchar](1024) NULL, 
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 [zygosity] [varchar](200) NULL, 
 [ethnicity] [varchar](500) NULL, 
 [country] [varchar](500) NULL, 
 [families] [varchar](100) NULL, 
 [number_patients_with_mutations] [varchar](100) NULL, 
 [rate_patients_with_mutation] [varchar](100) NULL, 
 [rate_patients] [varchar](100) NULL, 
 [rate_patients_mutation_found] int NULL, 
 [rate_patients_mutation_not_found] int NULL, 
 [rate_controls] [varchar](100) NULL, 
 [rate_controls_mutation_found] int NULL, 
 [rate_controls_mutation_not found] int NULL, 
 [odd_ratio] [varchar](100) NULL, 
 [CI(95%)] [varchar](200) NULL, 
 [Chi-Square_p_value] [varchar](100) NULL, 
 [clinical_characteristics] [text] NULL, 
 [family_history] [varchar](200) NULL, 
 [gender] [varchar](100) NULL, 
 [age_onset] [varchar](100) NULL, 
 [duration_in_text] [varchar](100) NULL, 
 [duration_months] [varchar](100) NULL, 
 [UMN] [varchar](100) NULL, 
 [LMN] [varchar](100) NULL, 
 [Site_onset] [varchar](100) NULL, 
 [years_until_initiation_respirator] [varchar](100) NULL, 
 [pubmed_id] [varchar](20) NULL, 
 [paper_title] [varchar](1024) NULL, 
 [First_Author] [varchar](50) NULL, 
 [Year] [varchar](50) NULL, 
 [comment] [text] NULL, 




BULK INSERT dbo.[gene_SNP_lifeseq] 
FROM '\\vm3\Alsod\SNP\split_lifeseq.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 






---A catalogue of GWAS 
create table dbo.GWA_CATALOGUE( 
Added_date varchar(250) NULL, 
Pubmed_id int NULL, 
First_author varchar(250), 
Submission_date varchar(250) NULL, 
Journal varchar(1024) NULL, 
Link varchar(1024) NULL, 
Study varchar(500) NULL, 
Disease_trait varchar(1024) NULL, 
Initial_sample_size varchar(1024) NULL, 
Replication_sample_size varchar(1024) NULL, 
Region varchar(500) NULL, 
Reported_genes varchar(250) NULL, 
Strongest_snps_risk_allele varchar(250) NULL, 
Snps varchar(250) NULL, 
Risk_allele_frequency varchar(250) NULL, 
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P_value varchar(250) NULL, 
P_value_text varchar(250) NULL, 
Odd_ratio_beta varchar(200) NULL, 
CI_95_percent_text varchar(200) NULL, 
Platform_snp_passing_QC varchar(500) NULL, 
CNV varchar(100) NULL) 
go 
 
--originally from http://www.genome.gov/admin/gwascatalog.txt 
BULK INSERT dbo.GWA_CATALOGUE 
FROM '\\vm3\Alsod\SNP\gwascatalog.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.GWA_CATALOGUE 
ADD S_No int IDENTITY(1,1) PRIMARY KEY; 
GO 
 
--- To search for rows with Amyotrophic Lateral Sclerosis 
SELECT     Added_date, Pubmed_id, First_author, Submission_date, Journal, 
Link, Study, Disease_trait, Initial_sample_size, Replication_sample_size, 
Region,  
                      Reported_genes, Strongest_snps_risk_allele, Snps, 
Risk_allele_frequency, P_value, P_value_text, Odd_ratio_beta, 
CI_95_percent_text,  
                      Platform_snp_passing_QC, CNV, S_No 
FROM         dbo.GWA_CATALOGUE 
WHERE     (Disease_trait = 'Amyotrophic Lateral Sclerosis') 
 
----Update date colmn with trimmed characters 
UPDATE dbo.GWA_CATALOGUE SET Submission_date = RIGHT (Submission_date, 
LEN(Submission_date)-6) 
WHERE  (Disease_trait = 'Amyotrophic Lateral Sclerosis') 
GO  
 
UPDATE dbo.GWA_CATALOGUE SET Strongest_snps_risk_allele = LEFT(REVERSE 
(Strongest_snps_risk_allele),1) 




----Getting count of snp in gwas als 
select count(*) AS 'Total' FROM  dbo.GWA_CATALOGUE WHERE (Disease_trait = 
'Amyotrophic Lateral Sclerosis') 
 
---Remove characters from column 
select RIGHT (Strongest_snps_risk_allele, LEN(Strongest_snps_risk_allele)-
1) as Strongest_snps_risk_allele from dbo.GWA_CATALOGUE WHERE  
(Disease_trait = 'Amyotrophic Lateral Sclerosis') and 
(Strongest_snps_risk_allele <>'NR') 
 
select LEFT(REVERSE (Strongest_snps_risk_allele),1) as 
Strongest_snps_risk_allele from dbo.GWA_CATALOGUE WHERE  (Disease_trait = 
'Amyotrophic Lateral Sclerosis') and (Strongest_snps_risk_allele <>'NR') 
 
----Alter gene table 
ALTER TABLE dbo.gene 
ADD [snp] [varchar](50) NULL; 
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GO 
ALTER TABLE dbo.gene 
ADD [basepair] [int] NULL; 
GO 
ALTER TABLE dbo.gene 
ADD [pvalue] [float] NULL; 
GO 
ALTER TABLE dbo.gene 
ADD [snp_pubmed_id] [varchar](20) NULL; 
GO 
ALTER TABLE dbo.gene 
ADD [ALSgene_id] [varchar](10) NULL; 
GO 
 
ALTER TABLE dbo.gene 




ALTER TABLE dbo.gene 
ADD [lifesciencedb] [varchar](10) NULL; 
GO 
 
UPDATE dbo.gene SET keywords = 'NEFH' 
WHERE gene_id = 'NEFH' 
GO 
 
UPDATE dbo.patient_record SET country_iso_code = 'BR' 
WHERE patient_id = '2215' 
GO 
 
UPDATE dbo.gene SET graph = '1' 
GO 
 
SELECT Pubmed_id, First_author, Submission_date, Journal, 
Initial_sample_size, Replication_sample_size, Region, Reported_genes, 
Strongest_snps_risk_allele, Snps, Risk_allele_frequency, P_value, 
P_value_text, Odd_ratio_beta, CI_95_percent_text, Platform_snp_passing_QC, 
CNV, S_No, Added_date FROM dbo.GWA_CATALOGUE WHERE (Disease_trait = 
'Amyotrophic Lateral Sclerosis') 
GO 
 
UPDATE dbo.gene SET dbSNP = 'rs74315431' 
WHERE gene_id = 'VAPB' 
GO 
 
UPDATE dbo.gene SET pubmed_id1 = '15060112' 
WHERE gene_id = 'VAPB' 
GO 
 
---Get ALSGene id for link to alsgene.org 
UPDATE dbo.gene SET ALSgene_id = '67' WHERE gene_id = 'ALAD' 
GO 
UPDATE dbo.gene SET ALSgene_id = '1' WHERE gene_id = 'ALS2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '7' WHERE gene_id = 'ANG' 
GO 
UPDATE dbo.gene SET ALSgene_id = '2' WHERE gene_id = 'APEX1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '25' WHERE gene_id = 'APOE' 
GO 
UPDATE dbo.gene SET ALSgene_id = '82' WHERE gene_id = 'AR' 
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GO 
UPDATE dbo.gene SET ALSgene_id = '53' WHERE gene_id = 'ATXN2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'B4GALT6' 
GO 
UPDATE dbo.gene SET ALSgene_id = '16' WHERE gene_id = 'C9orf72' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CCS' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CHMP2B' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CNTF' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CNTN4' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CRYM' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CSNK1G3' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'CYP2D6' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'DAO' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'DCTN1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'DISC1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '12' WHERE gene_id = 'DPP6' 
GO 
UPDATE dbo.gene SET ALSgene_id = '88' WHERE gene_id = 'DYNC1H1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'EFEMP1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'ELP3' 
GO 
UPDATE dbo.gene SET ALSgene_id = '10' WHERE gene_id = 'FGGY' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'FIG4' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'FUS' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'GARS' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'HEXA' 
GO 
UPDATE dbo.gene SET ALSgene_id = '8' WHERE gene_id = 'HFE' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'IFNK' 
GO 
UPDATE dbo.gene SET ALSgene_id = '11' WHERE gene_id = 'ITPR2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '14' WHERE gene_id = 'KIFAP3' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'LIF' 
GO 
UPDATE dbo.gene SET ALSgene_id = '37' WHERE gene_id = 'LIPC' 
GO 
UPDATE dbo.gene SET ALSgene_id = '1' WHERE gene_id = 'LOX' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'LUM' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'MAOB' 
 - 588 - 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'MAPT' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'MOBKL2B' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'MT-ND2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'NAIP' 
GO 
UPDATE dbo.gene SET ALSgene_id = '43' WHERE gene_id = 'NEFH' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'NT5C1A' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'OPTN' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'PGRN' 
GO 
UPDATE dbo.gene SET ALSgene_id = '3' WHERE gene_id = 'PON1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '4' WHERE gene_id = 'PON2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '5' WHERE gene_id = 'PON3' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'PRPH' 
GO 
UPDATE dbo.gene SET ALSgene_id = '73' WHERE gene_id = 'PSEN1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '72' WHERE gene_id = 'PVR' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'RBMS1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SCN7A' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SELL' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SEMA6A' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SETX' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SLC1A2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SLC39A11' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SMN1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SMN2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SNCG' 
GO 
UPDATE dbo.gene SET ALSgene_id = '1' WHERE gene_id = 'SOD1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '50' WHERE gene_id = 'SOD2' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SPAST' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SPG7' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'SUSD1' 
GO 
UPDATE dbo.gene SET ALSgene_id = '77' WHERE gene_id = 'TARDBP(TDP43)' 
GO 
UPDATE dbo.gene SET ALSgene_id = '52' WHERE gene_id = 'UNC13A' 
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GO 
UPDATE dbo.gene SET ALSgene_id = '69' WHERE gene_id = 'VAPB' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'VCP' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'VDR' 
GO 
UPDATE dbo.gene SET ALSgene_id = '9' WHERE gene_id = 'VEGFA' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'ZFP64' 
GO 
UPDATE dbo.gene SET ALSgene_id = '0' WHERE gene_id = 'ZNF746' 
GO 
 
----Create table for gene SNPs 
CREATE TABLE dbo.[mutation_replication]( 
 [gene] [varchar](30) NOT NULL, 
 [mutation] [varchar](100) NULL, 
 [codon] [varchar](10) NULL, 
 [families] [varchar](10) NULL, 
 [generations] [varchar](10) NULL, 
 [affected_patients] [varchar](10) NULL, 
 [sporadic] [varchar](10) NULL, 
 [familial] [varchar](10) NULL, 
 [family_history] [varchar](50) NULL, 
 [cases] int NULL, 
 [controls] int NULL, 
 [score] float NULL, 
 [ethnicity] [varchar](500) NULL, 
 [country1] [varchar](500) NULL, 
 [country2] [varchar](500) NULL, 
 [country3] [varchar](500) NULL, 
 [country4] [varchar](500) NULL, 
 [country5] [varchar](500) NULL, 
 [snp] [varchar](500) NULL, 
 [pathogenic] [varchar](10) NULL, 
 [author] [varchar](50) NULL, 
 [year] [varchar](10) NULL, 
 [pubmed_id] int NULL, 
 [google] int NULL, 
 [pubmed] int NULL, 
 [journal] int NULL, 
 [controversies] [varchar](500) NULL, 
 [comment] [varchar](500)NULL) 
GO 
 
BULK INSERT dbo.[mutation_replication] 
FROM '\\vm3\Alsod\SNP\mutation_replication.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




ALTER TABLE dbo.[mutation_replication] 
ADD S_No int IDENTITY(1,1); 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [title] [varchar](1024) NULL; 
GO 
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ALTER TABLE dbo.[mutation_replication] 
ADD [link] [varchar](1024) NULL; 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [country6] [varchar](500) NULL; 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [country7] [varchar](500) NULL; 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [country8] [varchar](500) NULL; 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [country9] [varchar](500) NULL; 
GO 
 
ALTER TABLE dbo.[mutation_replication] 
ADD [country10] [varchar](500) NULL; 
GO 
 
ALTER TABLE dbo.gene 
ADD [inheritance_pattern] [varchar](1024) NULL; 
GO 
 
UPDATE dbo.gene SET inheritance_pattern = 'autosomal dominant' WHERE 
gene_id = 'ANG' 
GO 
UPDATE dbo.gene SET inheritance_pattern = 'dominant and recessive' WHERE 
gene_id = 'SOD1' 
GO 
UPDATE dbo.gene SET inheritance_pattern = 'autosomal recessive' WHERE 
gene_id = 'ALS2' 
GO 
UPDATE dbo.gene SET inheritance_pattern = 'unknown' WHERE gene_id = 'NEFH' 
GO 
UPDATE dbo.gene SET inheritance_pattern = 'classic adult-onset ' WHERE 
gene_id = 'DAO' 
GO 
 
--Hereditary motor syndromes IDs 
ALTER TABLE dbo.[gene] 
ADD [syndrome_id] [varchar](50) NULL; 
GO 
UPDATE dbo.gene SET syndrome_id = 'so' WHERE gene_id = 'SOD1' 
GO 
UPDATE dbo.gene SET syndrome_id = 'als4' WHERE gene_id = 'SETX' 
GO 
UPDATE dbo.gene SET syndrome_id = 'als16q' WHERE gene_id = 'FUS' 
GO 
UPDATE dbo.gene SET syndrome_id = 'als20q' WHERE gene_id = 'VAPB' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alsang' WHERE gene_id = 'ANG' 
GO 
UPDATE dbo.gene SET syndrome_id = 'tdp43als' WHERE gene_id = 
'TARDBP(TDP43)' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alsfig4f' WHERE gene_id = 'FIG4' 
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GO 
UPDATE dbo.gene SET syndrome_id = 'alsoptn' WHERE gene_id = 'OPTN' 
GO 
UPDATE dbo.gene SET syndrome_id = 'sca2' WHERE gene_id = 'ATXN2' 
GO 
UPDATE dbo.gene SET syndrome_id = 'vcpals' WHERE gene_id = 'VCP' 
GO 
UPDATE dbo.gene SET syndrome_id = 'daoals' WHERE gene_id = 'DAO' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alsftd2' WHERE gene_id = 'C9orf72' 
GO 
UPDATE dbo.gene SET syndrome_id = 'vocaldyn' WHERE gene_id = 'DCTN1' 
GO 
UPDATE dbo.gene SET syndrome_id = 'cals' WHERE gene_id = 'ALS2' 
GO 
UPDATE dbo.gene SET syndrome_id = 'als5' WHERE gene_id = 'SPAST' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alssigmar1' WHERE gene_id = 'SIGMAR1' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alsx' WHERE gene_id = 'UBQLN2' 
GO 
UPDATE dbo.gene SET syndrome_id = 'alsftd3' WHERE gene_id = 'CHMP2B' 
GO 
UPDATE dbo.gene SET syndrome_id = 'nf' WHERE gene_id = 'NEFH' 
GO 
UPDATE dbo.gene SET syndrome_id = 'peripherinals' WHERE gene_id = 'PRPH' 
GO 
UPDATE dbo.gene SET syndrome_id = 'taf15als' WHERE gene_id = 'TAF15' 
GO 




ALTER TABLE dbo.[gene] 
ADD [causative_id] [varchar](50) NULL; 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 1' WHERE gene_id = 'SOD1' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 4' WHERE gene_id = 'SETX' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 6' WHERE gene_id = 'FUS' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 8' WHERE gene_id = 'VAPB' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 9' WHERE gene_id = 'ANG' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 10' WHERE gene_id = 'TARDBP(TDP43)' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 11' WHERE gene_id = 'FIG4' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 12' WHERE gene_id = 'OPTN' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 13' WHERE gene_id = 'ATXN2' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 14' WHERE gene_id = 'VCP' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS' WHERE gene_id = 'DAO' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS-FTD 2' WHERE gene_id = 'C9orf72' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS' WHERE gene_id = 'DCTN1' 
GO 
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UPDATE dbo.gene SET causative_id = 'ALS 2' WHERE gene_id = 'ALS2' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 5' WHERE gene_id = 'SPAST' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 16' WHERE gene_id = 'SIGMAR1' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS 15' WHERE gene_id = 'UBQLN2' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS-FTD 3' WHERE gene_id = 'CHMP2B' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS' WHERE gene_id = 'NEFH' 
GO 
UPDATE dbo.gene SET causative_id = 'ALS' WHERE gene_id = 'PRPH' 
GO 




---Create frequency table 
CREATE TABLE dbo.[gene_frequency]( 
 [s_no] [int] IDENTITY(1,1), 
 [gene] [varchar](30)NULL, 
 [country_iso_code] [varchar](2) NULL, 
 [replication_id] [int] NULL, 
 [Total_cases] [int] NULL, 
 [Total_affected] [int] NULL, 
 [FALS_number] [int] NULL, 
 [FALS_percentage] [float] NULL, 
 [SALS_number] [int] NULL, 
 [SALS_percentage] [float] NULL, 
 [phenotype] [varchar] (150) NULL, 
 [comment] [varchar] (1500)) 
GO 
 
SELECT DISTINCT [S_No], [gene],[author]+' ('+ [year]+')' +' - pubmedID:'+ 
[pubmed_id] AS [details] FROM [mutation_replication] 
GO 
 
ALTER TABLE dbo.patient_record 
ADD [phenotype] [varchar](500) NULL; 
GO 
 
UPDATE dbo.patient_record SET phenotype = 'ALS' 
GO 
 
ALTER TABLE dbo.gene 
ADD [FALS_only] [varchar](1) NULL; 
GO 
 
UPDATE dbo.gene SET FALS_only = 'Y' WHERE gene_effect = 'FALS genes' OR 
gene_effect= 'FALS genes found in SALS' 
GO 
UPDATE dbo.gene SET FALS_only = 'N' WHERE gene_effect <> 'FALS genes' 
GO 
 
SELECT [keywords] FROM dbo.gene 
go 
 
---REQUEST BY KARAN LUND (CHRIS SHAW'S LAB 11/04/2013) 
SELECT     TOP (100) PERCENT p.sex, c.country_name, p.ethnic_origin, 
p.age_of_onset, p.site_of_onset, g.gene_id AS 'Gene', p.alive, g.screened,  
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                      g.family_history, g.gene_id, m.mutation_type, 
m.mutation_name AS 'Mutation', m.mutation_mnemonic, 
dbo.institution.institution_name,  
                      dbo.institution.department, 
dbo.institution.contact_first_name, dbo.institution.contact_last_name, 
p.family_id AS 'Author_Year' 
FROM         dbo.mutation AS m INNER JOIN 
                      dbo.patient_genetic_record AS g ON m.mutation_id = 
g.mutation_id INNER JOIN 
                      dbo.patient_record AS p ON g.patient_id = 
p.patient_id INNER JOIN 
                      dbo.Country AS c ON p.country_iso_code = 
c.country_iso_code INNER JOIN 
                      dbo.institution ON m.institution_code = 
dbo.institution.institution_code 
WHERE     (m.mutation_id NOT LIKE '%none%') AND (p.age_of_onset <> ' ') AND 
(g.gene_id = 'SOD1') 
ORDER BY 'Gene', m.codon_id 
 
 
----updated mutation table created and populated with data 06/05/2013 
CREATE TABLE [dbo].[mutation_new]( 
 [mutation_id] [int] NOT NULL, 
 [mutation_alias] [varchar](1024) NULL, 
 [mutation_name] [varchar](1024) NOT NULL, 
 [mutation_mnemonic] [varchar](1024) NULL, 
 [gene_id] [varchar](64) NULL, 
 [institution_code] [varchar](36) NULL, 
 [mutation_type] [varchar](12) NULL, 
 [seq_location_id] [real] NULL, 
 [position] [int] NULL, 
 [sequence_position_relative] [int] NULL, 
 [codon] [int] NULL, 
 [codon_id] [int] NULL, 
 [sequence_original] [varchar](1024) NULL, 
 [sequence_mutated] [varchar](1024) NULL, 
 [sequence_location_type] [varchar](50) NULL, 
 [sequence_location_number] [int] NULL, 
 [aa_original] [varchar](6) NULL, 
 [aa_mutated] [varchar](6) NULL, 
 [restriction_site] [varchar](7) NULL, 
 [enzyme] [varchar](20) NULL, 
 [mutation_approved_status] [varchar](128) NULL, 
 [mutation_approved_date] [datetime] NULL, 
 [mutation_approved_by] [varchar](128) NULL, 
 [mutation_submitted_date] [datetime] NULL, 
 [mutation_documentation] [text] NULL, 
 [mutation_comment] [text] NULL, 
 [first_author] [varchar](24) NULL, 
 [year] [varchar](5) NULL, 
 [journal] [varchar](250) NULL, 
 [mutation_documentation_type] [varchar](18) NULL, 
 [link] [varchar](1024) NULL, 
 [phenotype] [varchar](250) NULL, 
 [zygosity] [varchar](24) NULL, 
 [reference_id] [int] NULL, 
 [countryiso1] [varchar](250) NULL, 
 [countryiso2] [varchar](250) NULL, 
 [countryiso3] [varchar](250) NULL, 
 [countryiso4] [varchar](250) NULL, 
 [countryiso5] [varchar](250) NULL, 
 [countryiso6] [varchar](250) NULL, 
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 [countryiso7] [varchar](250) NULL, 
 [countryiso8] [varchar](250) NULL, 
 [countryiso9] [varchar](250) NULL, 
 [countryiso10] [varchar](250) NULL, 
 [countryiso11] [varchar](250) NULL, 
 [countryiso12] [varchar](250) NULL, 
 [countryiso13] [varchar](250) NULL, 
 [countryiso14] [varchar](250) NULL, 
 [countryiso15] [varchar](250) NULL, 
 [countryiso16] [varchar](250) NULL, 
 [countryiso17] [varchar](250) NULL, 
 [countryiso18] [varchar](250) NULL, 
 [countryiso19] [varchar](250) NULL, 
 [countryiso20] [varchar](250) NULL, 
 [swissprot_id] [varchar](50) NULL, 
 [pubmed_id] [varchar](20) NULL, 
 [title] [varchar](1024) NULL, 
 [doi] [varchar](150) NULL, 
 [HGVS_Nucleotide] [varchar](250) NULL, 
 [HGVS_protein] [varchar](250) NULL, 
 [Location][varchar](250) NULL, 
 [dbSNP] [varchar](20) NULL, 
 [frequency] [int] NULL, 
 [frequency_references] [varchar](250) NULL, 
 [data_from] [varchar](30) NULL) 
GO 
 
BULK INSERT dbo.[mutation_new] 
FROM '\\vm3\Alsod\DataSets\mutation_new.txt'             
WITH     
(                 
FIELDTERMINATOR = '\t',                 




---Insert HGVS_Nucleotide,HGVS_protein, Location columns 
ALTER TABLE dbo.[mutation] 
ADD [HGVS_Nucleotide] [varchar](250) NULL; 
GO 
 
ALTER TABLE dbo.[mutation] 
ADD [HGVS_protein] [varchar](250) NULL; 
GO 
 
ALTER TABLE dbo.[mutation] 
ADD [Location] [varchar](250) NULL; 
GO 
 
ALTER TABLE dbo.[mutation] 
ADD [dbSNP_id] [varchar](250) NULL; 
GO 
 
---Update mutation table with data 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.33C>T', 
HGVS_protein = 'NP_000445.1:p.G11G', Location ='21:33032115', dbSNP_id=''  
WHERE mutation_id = '1' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.180T>C', 
HGVS_protein = 'NP_000445.1:p.S60S', Location ='21:33038772', dbSNP_id=''  
WHERE mutation_id = '2' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.423T>A', 
HGVS_protein = 'NP_000445.1:p.A141A', Location ='21:33040849', 
dbSNP_id='rs143100660'  WHERE mutation_id = '3' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.420C>T', 
HGVS_protein = 'NP_000445.1:p.N140N', Location ='21:33040846', 
dbSNP_id='rs1804449'  WHERE mutation_id = '4' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.462A>G', 
HGVS_protein = 'NP_000445.1:p.Q154Q', Location ='21:33040888', dbSNP_id=''  
WHERE mutation_id = '5' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '6' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '7' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.344G>C', 
HGVS_protein = 'NP_000445.1:p.G115A', Location ='21:33039675', dbSNP_id=''  
WHERE mutation_id = '8' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.269C>T', 
HGVS_protein = 'NP_000445.1:p.A90V', Location ='21:33039600', dbSNP_id=''  
WHERE mutation_id = '9' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.317C>T', 
HGVS_protein = 'NP_000445.1:p.S106L', Location ='21:33039648', dbSNP_id=''  
WHERE mutation_id = '10' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.340A>T', 
HGVS_protein = 'NP_000445.1:p.I114F', Location ='21:33039671', dbSNP_id=''  
WHERE mutation_id = '11' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.422C>G', 
HGVS_protein = 'NP_000445.1:p.A141G', Location ='21:33040848', dbSNP_id=''  
WHERE mutation_id = '12' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.137T>G', 
HGVS_protein = 'NP_000445.1:p.F46C', Location ='21:33036167', 
dbSNP_id='rs121912457'  WHERE mutation_id = '13' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.286G>A', 
HGVS_protein = 'NP_000445.1:p.A96T', Location ='21:33039617', dbSNP_id=''  
WHERE mutation_id = '14' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.25C>G', 
HGVS_protein = 'NP_000445.1:p.L9V', Location ='21:33032107', dbSNP_id=''  
WHERE mutation_id = '15' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.261T>A', 
HGVS_protein = 'NP_000445.1:p.N87K', Location ='21:33039592', dbSNP_id=''  
WHERE mutation_id = '16' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.142G>T', 
HGVS_protein = 'NP_000445.1:p.V48F', Location ='21:33036172', dbSNP_id=''  
WHERE mutation_id = '17' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.230A>T', 
HGVS_protein = 'NP_000445.1:p.D77V', Location ='21:33038822', dbSNP_id=''  
WHERE mutation_id = '18' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '19' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.116T>G', 
HGVS_protein = 'NP_000445.1:p.L39R', Location ='21:33036146', dbSNP_id=''  
WHERE mutation_id = '20' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.115C>G', 
HGVS_protein = 'NP_000445.1:p.L39V', Location ='21:33036145', 
dbSNP_id='rs121912432'  WHERE mutation_id = '21' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.124G>A', 
HGVS_protein = 'NP_000445.1:p.G42S', Location ='21:33036154', 
dbSNP_id='rs121912433'  WHERE mutation_id = '22' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.125G>A', 
HGVS_protein = 'NP_000445.1:p.G42D', Location ='21:33036155', 
dbSNP_id='rs121912434'  WHERE mutation_id = '24' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.131A>G', 
HGVS_protein = 'NP_000445.1:p.H44R', Location ='21:33036161', 
dbSNP_id='rs121912435'  WHERE mutation_id = '25' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.140A>G', 
HGVS_protein = 'NP_000445.1:p.H47R', Location ='21:33036170', 
dbSNP_id='rs121912443'  WHERE mutation_id = '26' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.148G>A', 
HGVS_protein = 'NP_000445.1:p.E50K', Location ='21:33036178', dbSNP_id=''  
WHERE mutation_id = '27' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.203T>G', 
HGVS_protein = 'NP_000445.1:p.L68R', Location ='21:33038795', dbSNP_id=''  
WHERE mutation_id = '28' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '29' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.255G>C', 
HGVS_protein = 'NP_000445.1:p.L85F', Location ='21:33039586', dbSNP_id=''  
WHERE mutation_id = '30' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.259A>G', 
HGVS_protein = 'NP_000445.1:p.N87D', Location ='21:33039590', dbSNP_id=''  
WHERE mutation_id = '31' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.256G>C', 
HGVS_protein = 'NP_000445.1:p.G86R', Location ='21:33039587', 
dbSNP_id='rs121912436'  WHERE mutation_id = '32' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.260A>G', 
HGVS_protein = 'NP_000445.1:p.N87S', Location ='21:33039591', 
dbSNP_id='rs11556620'  WHERE mutation_id = '33' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.272A>T', 
HGVS_protein = 'NP_000445.1:p.D91V', Location ='21:33039603', 
dbSNP_id='rs80265967'  WHERE mutation_id = '34' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.281G>C', 
HGVS_protein = 'NP_000445.1:p.G94A', Location ='21:33039612', 
dbSNP_id='rs121912438'  WHERE mutation_id = '35' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.280G>T', 
HGVS_protein = 'NP_000445.1:p.G94C', Location ='21:33039611', 
dbSNP_id='rs121912437; rs121912460'  WHERE mutation_id = '36' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.280G>C', 
HGVS_protein = 'NP_000445.1:p.G94R', Location ='21:33039611', 
dbSNP_id='rs121912437; rs121912460'  WHERE mutation_id = '37' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.281G>A', 
HGVS_protein = 'NP_000445.1:p.G94D', Location ='21:33039612', 
dbSNP_id='rs121912438'  WHERE mutation_id = '38' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '39' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.304G>C', 
HGVS_protein = 'NP_000445.1:p.D102H', Location ='21:33039635', dbSNP_id=''  
WHERE mutation_id = '40' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.268G>A', 
HGVS_protein = 'NP_000445.1:p.A90T', Location ='21:33039599', dbSNP_id=''  
WHERE mutation_id = '41' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.418A>C', 
HGVS_protein = 'NP_000445.1:p.N140H', Location ='21:33040844', dbSNP_id=''  
WHERE mutation_id = '42' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.164C>G', 
HGVS_protein = 'NP_000445.1:p.T55R', Location ='21:33036194', dbSNP_id=''  
WHERE mutation_id = '43' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.147T>G', 
HGVS_protein = 'NP_000445.1:p.H49Q', Location ='21:33036177', dbSNP_id=''  
WHERE mutation_id = '44' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.376G>C', 
HGVS_protein = 'NP_000445.1:p.D126H', Location ='21:33040802', dbSNP_id=''  
WHERE mutation_id = '45' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.272A>C', 
HGVS_protein = 'NP_000445.1:p.D91A', Location ='21:33039603', 
dbSNP_id='rs80265967'  WHERE mutation_id = '46' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.217G>A', 
HGVS_protein = 'NP_000445.1:p.G73S', Location ='21:33038809', 
dbSNP_id='rs121912455'  WHERE mutation_id = '47' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.263T>C', 
HGVS_protein = 'NP_000445.1:p.V88A', Location ='21:33039594', dbSNP_id=''  
WHERE mutation_id = '48' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.43G>A', 
HGVS_protein = 'NP_000445.1:p.V15M', Location ='21:33032125', dbSNP_id=''  
WHERE mutation_id = '49' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.253T>G', 
HGVS_protein = 'NP_000445.1:p.L85V', Location ='21:33039584', 
dbSNP_id='rs121912452'  WHERE mutation_id = '50' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.44T>G', 
HGVS_protein = 'NP_000445.1:p.V15G', Location ='21:33032126', dbSNP_id=''  
WHERE mutation_id = '51' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.229G>T', 
HGVS_protein = 'NP_000445.1:p.D77Y', Location ='21:33038821', dbSNP_id=''  
WHERE mutation_id = '52' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '53' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '54' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '55' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.374A>T', 
HGVS_protein = 'NP_000445.1:p.D125V', Location ='21:33040800', dbSNP_id=''  
WHERE mutation_id = '56' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.179G>T', 
HGVS_protein = 'NP_000445.1:p.S60I', Location ='21:33038771', dbSNP_id=''  
WHERE mutation_id = '57' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.281G>T', 
HGVS_protein = 'NP_000445.1:p.G94V', Location ='21:33039612', 
dbSNP_id='rs121912438'  WHERE mutation_id = '58' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.425G>A', 
HGVS_protein = 'NP_000445.1:p.G142E', Location ='21:33040851', dbSNP_id=''  
WHERE mutation_id = '59' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.420C>A', 
HGVS_protein = 'NP_000445.1:p.N140K', Location ='21:33040846', 
dbSNP_id='rs1804449'  WHERE mutation_id = '60' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.449T>C', 
HGVS_protein = 'NP_000445.1:p.I150T', Location ='21:33040875', dbSNP_id=''  
WHERE mutation_id = '61' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.455T>C', 
HGVS_protein = 'NP_000445.1:p.I152T', Location ='21:33040881', 
dbSNP_id='rs121912449'  WHERE mutation_id = '62' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '63' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.19T>G', 
HGVS_protein = 'NP_000445.1:p.C7G', Location ='21:33032101', dbSNP_id=''  
WHERE mutation_id = '64' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '65' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.455T>G', 
HGVS_protein = 'NP_000445.1:p.I152S', Location ='21:33040881', 
dbSNP_id='rs121912449'  WHERE mutation_id = '66' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.13G>A', 
HGVS_protein = 'NP_000445.1:p.A5T', Location ='21:33032095', 
dbSNP_id='rs121912444'  WHERE mutation_id = '67' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '68' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.355G>C', 
HGVS_protein = 'NP_000445.1:p.V119L', Location ='21:33039686', dbSNP_id=''  
WHERE mutation_id = '69' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.62T>G', 
HGVS_protein = 'NP_000445.1:p.F21C', Location ='21:33032144', dbSNP_id=''  
WHERE mutation_id = '70' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.424G>T', 
HGVS_protein = 'NP_000445.1:p.G142X', Location ='21:33040850', dbSNP_id=''  
WHERE mutation_id = '71' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '72' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.59A>G', 
HGVS_protein = 'NP_000445.1:p.N20S', Location ='21:33032141', dbSNP_id=''  
WHERE mutation_id = '73' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '74' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.442G>C', 
HGVS_protein = 'NP_000445.1:p.G148R', Location ='21:33040868', dbSNP_id=''  
WHERE mutation_id = '75' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.242A>G', 
HGVS_protein = 'NP_000445.1:p.H81R', Location ='21:33039573', 
dbSNP_id='rs121912458'  WHERE mutation_id = '76' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '77' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.304G>A', 
HGVS_protein = 'NP_000445.1:p.D102N', Location ='21:33039635', dbSNP_id=''  
WHERE mutation_id = '78' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.313A>T', 
HGVS_protein = 'NP_000445.1:p.I105F', Location ='21:33039644', 
dbSNP_id='rs121912445'  WHERE mutation_id = '79' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.319C>G', 
HGVS_protein = 'NP_000445.1:p.L107V', Location ='21:33039650', 
dbSNP_id='rs121912440'  WHERE mutation_id = '80' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.338T>C', 
HGVS_protein = 'NP_000445.1:p.I113T', Location ='21:33039669', 
dbSNP_id='rs74315452'  WHERE mutation_id = '81' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.341T>C', 
HGVS_protein = 'NP_000445.1:p.I114T', Location ='21:33039672', 
dbSNP_id='rs121912441'  WHERE mutation_id = '82' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.404G>A', 
HGVS_protein = 'NP_000445.1:p.S135N', Location ='21:33040830', 
dbSNP_id='rs121912451'  WHERE mutation_id = '83' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.435G>C', 
HGVS_protein = 'NP_000445.1:p.L145F', Location ='21:33040861', dbSNP_id=''  
WHERE mutation_id = '84' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.434T>C', 
HGVS_protein = 'NP_000445.1:p.L145S', Location ='21:33040860', 
dbSNP_id='rs121912446'  WHERE mutation_id = '85' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.436G>A', 
HGVS_protein = 'NP_000445.1:p.A146T', Location ='21:33040862', 
dbSNP_id='rs121912447'  WHERE mutation_id = '86' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.439T>C', 
HGVS_protein = 'NP_000445.1:p.C147R', Location ='21:33040865', dbSNP_id=''  
WHERE mutation_id = '87' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.446T>G', 
HGVS_protein = 'NP_000445.1:p.V149G', Location ='21:33040872', dbSNP_id=''  
WHERE mutation_id = '88' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.197A>G', 
HGVS_protein = 'NP_000445.1:p.N66S', Location ='21:33038789', dbSNP_id=''  
WHERE mutation_id = '89' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.339C>G', 
HGVS_protein = 'NP_000445.1:p.I113M', Location ='21:33039670', dbSNP_id=''  
WHERE mutation_id = '90' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.289G>A', 
HGVS_protein = 'NP_000445.1:p.D97N', Location ='21:33039620', 
dbSNP_id='rs121912459'  WHERE mutation_id = '91' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '92' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.445G>A', 
HGVS_protein = 'NP_000445.1:p.V149I', Location ='21:33040871', dbSNP_id=''  
WHERE mutation_id = '93' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '94' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.380T>A', 
HGVS_protein = 'NP_000445.1:p.L127X', Location ='21:33040806', 
dbSNP_id='rs121912454'  WHERE mutation_id = '95' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.374A>T', 
HGVS_protein = 'NP_000445.1:p.D125V', Location ='21:33040800', dbSNP_id=''  
WHERE mutation_id = '96' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.326G>T', 
HGVS_protein = 'NP_000445.1:p.G109V', Location ='21:33039657', dbSNP_id=''  
WHERE mutation_id = '97' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004738.4:c.166C>T', 
HGVS_protein = 'NP_004729.1:p.P56S', Location ='20:56993374', 
dbSNP_id='rs74315431'  WHERE mutation_id = '98' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.346C>G', 
HGVS_protein = 'NP_000445.1:p.R116G', Location ='21:33039677', 
dbSNP_id='rs74315431'  WHERE mutation_id = '99' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '100' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.14C>T', 
HGVS_protein = 'NP_000445.1:p.A5V', Location ='21:33032096', 
dbSNP_id='rs121912442'  WHERE mutation_id = '101' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.13G>T', 
HGVS_protein = 'NP_000445.1:p.A5S', Location ='21:33032095', 
dbSNP_id='rs121912444'  WHERE mutation_id = '102' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '103' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.23T>A', 
HGVS_protein = 'NP_000445.1:p.V8E', Location ='21:33032105', dbSNP_id=''  
WHERE mutation_id = '104' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.26T>A', 
HGVS_protein = 'NP_000445.1:p.L9Q', Location ='21:33032108', dbSNP_id=''  
WHERE mutation_id = '105' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.37G>C', 
HGVS_protein = 'NP_000445.1:p.G13R', Location ='21:33032119', 
dbSNP_id='rs121912456'  WHERE mutation_id = '106' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.50G>C', 
HGVS_protein = 'NP_000445.1:p.G17A', Location ='21:33032132', dbSNP_id=''  
WHERE mutation_id = '107' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.49G>A', 
HGVS_protein = 'NP_000445.1:p.G17S', Location ='21:33032131', 
dbSNP_id='rs121912453'  WHERE mutation_id = '108' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.64G>A', 
HGVS_protein = 'NP_000445.1:p.E22K', Location ='21:33032146', 
dbSNP_id='rs121912450'  WHERE mutation_id = '109' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.65A>G', 
HGVS_protein = 'NP_000445.1:p.E22G', Location ='21:33032147', dbSNP_id=''  
WHERE mutation_id = '110' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.112G>A', 
HGVS_protein = 'NP_000445.1:p.G38R', Location ='21:33036142', 
dbSNP_id='rs121912431'  WHERE mutation_id = '111' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.280G>A', 
HGVS_protein = 'NP_000445.1:p.G94S', Location ='21:33039611', 
dbSNP_id='rs121912437; rs121912460'  WHERE mutation_id = '112' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.292G>A', 
HGVS_protein = 'NP_000445.1:p.V98M', Location ='21:33039623', dbSNP_id=''  
WHERE mutation_id = '113' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.302A>G', 
HGVS_protein = 'NP_000445.1:p.E101G', Location ='21:33039633', 
dbSNP_id='rs121912439'  WHERE mutation_id = '114' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.301G>A', 
HGVS_protein = 'NP_000445.1:p.E101K', Location ='21:33039632', dbSNP_id=''  
WHERE mutation_id = '115' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.305A>G', 
HGVS_protein = 'NP_000445.1:p.D102G', Location ='21:33039636', dbSNP_id=''  
WHERE mutation_id = '116' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.217G>T', 
HGVS_protein = 'NP_000445.1:p.G73C', Location ='21:33038809', 
dbSNP_id='rs121912455'  WHERE mutation_id = '117' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '118' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.437C>G', 
HGVS_protein = 'NP_000445.1:p.A146G', Location ='21:33040863', dbSNP_id=''  
WHERE mutation_id = '119' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.68A>T', 
HGVS_protein = 'NP_000445.1:p.Q23L', Location ='21:33032150', dbSNP_id=''  
WHERE mutation_id = '120' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.146A>G', 
HGVS_protein = 'NP_000445.1:p.H49R', Location ='21:33036176', dbSNP_id=''  
WHERE mutation_id = '121' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.352C>G', 
HGVS_protein = 'NP_000445.1:p.L118V', Location ='21:33039683', 
dbSNP_id='rs199474723'  WHERE mutation_id = '122' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.31G>C', 
HGVS_protein = 'NP_000445.1:p.G11R', Location ='21:33032113', dbSNP_id=''  
WHERE mutation_id = '123' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.298A>G', 
HGVS_protein = 'NP_000445.1:p.I100V', Location ='21:33039629', dbSNP_id=''  
WHERE mutation_id = '124' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.290A>T', 
HGVS_protein = 'NP_000445.1:p.D97V', Location ='21:33039621', dbSNP_id=''  
WHERE mutation_id = '125' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.287C>T', 
HGVS_protein = 'NP_000445.1:p.A96V', Location ='21:33039618', dbSNP_id=''  
WHERE mutation_id = '126' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.304G>T', 
HGVS_protein = 'NP_000445.1:p.D102Y', Location ='21:33039635', dbSNP_id=''  
WHERE mutation_id = '127' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.355G>T', 
HGVS_protein = 'NP_000445.1:p.V119L', Location ='21:33039686', dbSNP_id=''  
WHERE mutation_id = '129' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.380T>C', 
HGVS_protein = 'NP_000445.1:p.L127S', Location ='21:33040806', 
dbSNP_id='rs121912454'  WHERE mutation_id = '130' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '131' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '134' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '135' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '136' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.89T>C', 
HGVS_protein = 'NP_000445.1:p.V30A', Location ='21:33036119', dbSNP_id=''  
WHERE mutation_id = '137' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.143T>C', 
HGVS_protein = 'NP_000445.1:p.V48A', Location ='21:33036173', dbSNP_id=''  
WHERE mutation_id = '138' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.401A>T', 
HGVS_protein = 'NP_000445.1:p.E134V', Location ='21:33040827', dbSNP_id=''  
WHERE mutation_id = '139' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.260A>T', 
HGVS_protein = 'NP_000445.1:p.N87I', Location ='21:33039591', 
dbSNP_id='rs11556620'  WHERE mutation_id = '140' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.16G>T', 
HGVS_protein = 'NP_000445.1:p.V6L', Location ='21:33032098', dbSNP_id=''  
WHERE mutation_id = '141' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.199C>G', 
HGVS_protein = 'NP_000445.1:p.P67A', Location ='21:33038791', dbSNP_id=''  
WHERE mutation_id = '142' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.262G>A', 
HGVS_protein = 'NP_000445.1:p.V88M', Location ='21:33039593', dbSNP_id=''  
WHERE mutation_id = '145' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.292G>C', 
HGVS_protein = 'NP_000445.1:p.V98L', Location ='21:33039623', dbSNP_id=''  
WHERE mutation_id = '146' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.418A>G', 
HGVS_protein = 'NP_000445.1:p.N140D', Location ='21:33040844', dbSNP_id=''  
WHERE mutation_id = '147' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.443G>A', 
HGVS_protein = 'NP_000445.1:p.G148D', Location ='21:33040869', dbSNP_id=''  
WHERE mutation_id = '148' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.351A>G', 
HGVS_protein = 'NP_000445.1:p.T117T', Location ='21:33039682', dbSNP_id=''  
WHERE mutation_id = '149' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.441T>A', 
HGVS_protein = 'NP_000445.1:p.C147X', Location ='21:33040867', dbSNP_id=''  
WHERE mutation_id = '150' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.256G>A', 
HGVS_protein = 'NP_000445.1:p.G86S', Location ='21:33039587', 
dbSNP_id='rs121912436'  WHERE mutation_id = '151' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.107A>T', 
HGVS_protein = 'NP_001136.1:p.Q36L', Location ='14:21161830', 
dbSNP_id='rs121909535'  WHERE mutation_id = '153' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.122A>T', 
HGVS_protein = 'NP_001136.1:p.K41I', Location ='14:21161845', 
dbSNP_id='rs121909536'  WHERE mutation_id = '154' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.250A>G ', 
HGVS_protein = ' NP_001136.1:p.Lys84Glu', Location ='', dbSNP_id='rs17560'  
WHERE mutation_id = '155' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.164G>A', 
HGVS_protein = 'NP_001136.1:p.R55K', Location ='14:21161887', 
dbSNP_id='rs121909538'  WHERE mutation_id = '157' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
' NP_001136.1:p.Cys39Trp', Location ='', dbSNP_id=''  WHERE mutation_id = 
'160' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.191A>T', 
HGVS_protein = 'NP_001136.1:p.K64I', Location ='14:21161914', 
dbSNP_id='rs121909540'  WHERE mutation_id = '161' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
' NP_001136.1:p.Ile46Val', Location ='', dbSNP_id=''  WHERE mutation_id = 
'162' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.155G>A', 
HGVS_protein = 'NP_001136.1:p.S52N', Location ='14:21161878', 
dbSNP_id='rs121909542'  WHERE mutation_id = '164' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.407C>T', 
HGVS_protein = 'NP_001136.1:p.P136L', Location ='14:21162130', 
dbSNP_id='rs121909543'  WHERE mutation_id = '165' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.409G>A', 
HGVS_protein = 'NP_001136.1:p.V137I', Location ='14:21162132', 
dbSNP_id='rs121909544'  WHERE mutation_id = '166' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1009A>G', 
HGVS_protein = 'NP_031401.1:p.M337V', Location ='1:11082475', 
dbSNP_id='rs80356730'  WHERE mutation_id = '167' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.991C>A', 
HGVS_protein = 'NP_031401.1:p.Q331K', Location ='1:11082457', 
dbSNP_id='rs80356727'  WHERE mutation_id = '168' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.881G>C', 
HGVS_protein = 'NP_031401.1:p.G294A', Location ='1:11082347', 
dbSNP_id='rs80356721'  WHERE mutation_id = '169' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.869G>C', 
HGVS_protein = 'NP_031401.1:p.G290A', Location ='1:11082335', 
dbSNP_id='rs121908395'  WHERE mutation_id = '170' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.892G>A', 
HGVS_protein = 'NP_031401.1:p.G298S', Location ='1:11082358', 
dbSNP_id='rs4884357'  WHERE mutation_id = '171' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.506A>G', 
HGVS_protein = 'NP_031401.1:p.D169G', Location ='1:11078893', 
dbSNP_id='rs80356717'  WHERE mutation_id = '172' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1042G>T', 
HGVS_protein = 'NP_031401.1:p.G348C', Location ='1:11082508', 
dbSNP_id='rs80356733'  WHERE mutation_id = '173' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1028A>G', 
HGVS_protein = 'NP_031401.1:p.Q343R', Location ='1:11082494', 
dbSNP_id='rs80356731'  WHERE mutation_id = '174' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.943G>A', 
HGVS_protein = 'NP_031401.1:p.A315T', Location ='1:11082409', 
dbSNP_id='rs80356726'  WHERE mutation_id = '175' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1562G>A', 
HGVS_protein = 'NP_004951.1:p.R521H', Location ='16:31202740', 
dbSNP_id='rs121909671'  WHERE mutation_id = '176' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1561C>T', 
HGVS_protein = 'NP_004951.1:p.R521C', Location ='16:31202739', 
dbSNP_id='rs121909668; rs121909670'  WHERE mutation_id = '177' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1540A>G', 
HGVS_protein = 'NP_004951.1:p.R514G', Location ='16:31202430', dbSNP_id=''  
WHERE mutation_id = '178' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1551C>G', 
HGVS_protein = 'NP_004951.1:p.H517Q', Location ='16:31202729', 
dbSNP_id='rs121909667'  WHERE mutation_id = '179' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '180' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.730C>T', 
HGVS_protein = 'NP_004951.1:p.R244C', Location ='16:31196466', dbSNP_id=''  
WHERE mutation_id = '181' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1542G>T', 
HGVS_protein = 'NP_004951.1:p.R514S', Location ='16:31202720', dbSNP_id=''  
WHERE mutation_id = '182' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1543G>T', 
HGVS_protein = 'NP_004951.1:p.G515C', Location ='16:31202721', dbSNP_id=''  
WHERE mutation_id = '183' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1553G>A', 
HGVS_protein = 'NP_004951.1:p.R518K', Location ='16:31202731', 
dbSNP_id='rs121909669'  WHERE mutation_id = '184' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1561C>G', 
HGVS_protein = 'NP_004951.1:p.R521G', Location ='16:31202739', 
dbSNP_id='rs121909668; rs121909670'  WHERE mutation_id = '185' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1564A>G', 
HGVS_protein = 'NP_004951.1:p.R522G', Location ='16:31202742', dbSNP_id=''  
WHERE mutation_id = '186' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1571G>C', 
HGVS_protein = 'NP_004951.1:p.R524T', Location ='16:31202749', dbSNP_id=''  
WHERE mutation_id = '187' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1572G>C', 
HGVS_protein = 'NP_004951.1:p.R524S', Location ='16:31202750', dbSNP_id=''  
WHERE mutation_id = '188' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1574C>T', 
HGVS_protein = 'NP_004951.1:p.P525L', Location ='16:31202752', dbSNP_id=''  
WHERE mutation_id = '189' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '190' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '195' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '196' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '197' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '198' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '199' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '200' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '201' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.2992C>T', 
HGVS_protein = 'NP_065970.2:p.R998X', Location ='2:202591577', 
dbSNP_id='rs121908137'  WHERE mutation_id = '202' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.3G>A', HGVS_protein 
= 'NP_001136.1:p.M1I', Location ='14:21161726', dbSNP_id='rs201068740'  
WHERE mutation_id = '204' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.35T>C', 
HGVS_protein = 'NP_001136.1:p.F12S', Location ='14:21161758', dbSNP_id=''  
WHERE mutation_id = '205' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.61C>T', 
HGVS_protein = 'NP_001136.1:p.P21S', Location ='14:21161784', 
dbSNP_id='rs149672657'  WHERE mutation_id = '206' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.413A>G', 
HGVS_protein = 'NP_001136.1:p.H138R', Location ='14:21162136', dbSNP_id=''  
WHERE mutation_id = '207' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.132C>G', 
HGVS_protein = 'NP_001136.1:p.G44G', Location ='14:21161855', 
dbSNP_id='rs147701713'  WHERE mutation_id = '208' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.883G>A', 
HGVS_protein = 'NP_031401.1:p.G295S', Location ='1:11082349', 
dbSNP_id='rs80356723'  WHERE mutation_id = '209' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.269C>T', 
HGVS_protein = 'NP_031401.1:p.A90V', Location ='1:11076931', 
dbSNP_id='rs80356715'  WHERE mutation_id = '210' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.800A>G', 
HGVS_protein = 'NP_031401.1:p.N267S', Location ='1:11082266', 
dbSNP_id='rs80356718'  WHERE mutation_id = '211' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.859G>A', 
HGVS_protein = 'NP_031401.1:p.G287S', Location ='1:11082325', 
dbSNP_id='rs80356719'  WHERE mutation_id = '212' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1083G>T', 
HGVS_protein = 'NP_031401.1:p.R361S', Location ='1:11082549', 
dbSNP_id='rs80356735'  WHERE mutation_id = '213' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1144G>A', 
HGVS_protein = 'NP_031401.1:p.A382T', Location ='1:11082610', 
dbSNP_id='rs11689432'  WHERE mutation_id = '214' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1168A>G', 
HGVS_protein = 'NP_031401.1:p.N390D', Location ='1:11082634', 
dbSNP_id='rs80356741'  WHERE mutation_id = '215' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1169A>G', 
HGVS_protein = 'NP_031401.1:p.N390S', Location ='1:11082635', 
dbSNP_id='rs80356742'  WHERE mutation_id = '216' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.881G>T', 
HGVS_protein = 'NP_031401.1:p.G294V', Location ='1:11082347', 
dbSNP_id='rs80356721'  WHERE mutation_id = '217' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.883G>C', 
HGVS_protein = 'NP_031401.1:p.G295R', Location ='1:11082349', 
dbSNP_id='rs80356723'  WHERE mutation_id = '218' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.995G>A', 
HGVS_protein = 'NP_031401.1:p.S332N', Location ='1:11082461', 
dbSNP_id='rs80356728'  WHERE mutation_id = '219' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1004G>A', 
HGVS_protein = 'NP_031401.1:p.G335D', Location ='1:11082470', 
dbSNP_id='rs80356729'  WHERE mutation_id = '220' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1135T>C', 
HGVS_protein = 'NP_031401.1:p.S379P', Location ='1:11082601', 
dbSNP_id='rs80356738'  WHERE mutation_id = '221' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1136C>G', 
HGVS_protein = 'NP_031401.1:p.S379C', Location ='1:11082602', 
dbSNP_id='rs80356739'  WHERE mutation_id = '222' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1178C>T', 
HGVS_protein = 'NP_031401.1:p.S393L', Location ='1:11082644', 
dbSNP_id='rs80356743'  WHERE mutation_id = '223' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.319C>T', 
HGVS_protein = 'NP_000445.1:p.L107F', Location ='21:33039650', 
dbSNP_id='rs121912440'  WHERE mutation_id = '224' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.280A>G', 
HGVS_protein = 'NP_065970.2:p.I94V', Location ='2:202626437', 
dbSNP_id='rs3219154'  WHERE mutation_id = '225' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.305A>G', 
HGVS_protein = 'NP_065970.2:p.H102R', Location ='2:202626412', dbSNP_id=''  
WHERE mutation_id = '226' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.1166T>C', 
HGVS_protein = 'NP_055861.3:p.L389S', Location ='9:135205819', 
dbSNP_id='rs29001584'  WHERE mutation_id = '227' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.6407G>A', 
HGVS_protein = 'NP_055861.3:p.R2136H', Location ='9:135158790', 
dbSNP_id='rs121434378'  WHERE mutation_id = '228' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.8C>T', HGVS_protein 
= 'NP_055861.3:p.T3I', Location ='9:135224808', dbSNP_id='rs28941475'  
WHERE mutation_id = '229' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1035C>A', 
HGVS_protein = 'NP_031401.1:p.N345K', Location ='1:11082501', 
dbSNP_id='rs80356732'  WHERE mutation_id = '230' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1147A>G', 
HGVS_protein = 'NP_031401.1:p.I383V', Location ='1:11082613', 
dbSNP_id='rs80356740'  WHERE mutation_id = '231' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1055A>G', 
HGVS_protein = 'NP_031401.1:p.N352S', Location ='1:11082521', 
dbSNP_id='rs80356734'  WHERE mutation_id = '232' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1087C>G', 
HGVS_protein = 'NP_031401.1:p.P363A', Location ='1:11082553', dbSNP_id=''  
WHERE mutation_id = '233' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1122T>A', 
HGVS_protein = 'NP_031401.1:p.Y374X', Location ='1:11082588', 
dbSNP_id='rs147795017'  WHERE mutation_id = '234' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1144G>C', 
HGVS_protein = 'NP_031401.1:p.A382P', Location ='1:11082610', 
dbSNP_id='rs11689432'  WHERE mutation_id = '235' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.169_171delTCT', 
HGVS_protein = 'NP_004951.1:p.S57del', Location ='16:31101465', dbSNP_id=''  
WHERE mutation_id = '236' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.467G>A', 
HGVS_protein = 'NP_004951.1:p.G156E', Location ='16:31195661', dbSNP_id=''  
WHERE mutation_id = '237' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.701G>T', 
HGVS_protein = 'NP_004951.1:p.R234L', Location ='16:31196437', dbSNP_id=''  
WHERE mutation_id = '238' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.931A>G', 
HGVS_protein = 'NP_031401.1:p.M311V', Location ='1:11082397', 
dbSNP_id='rs80356725'  WHERE mutation_id = '239' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.382G>C', 
HGVS_protein = 'NP_000445.1:p.G128R', Location ='21:33040808', dbSNP_id=''  
WHERE mutation_id = '240' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.962C>G', 
HGVS_protein = 'NP_031401.1:p.A321G', Location ='1:11082428', dbSNP_id=''  
WHERE mutation_id = '241' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1520G>A', 
HGVS_protein = 'NP_004951.1:p.G507D', Location ='16:31202410', dbSNP_id=''  
WHERE mutation_id = '242' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.413C>G', 
HGVS_protein = 'NP_000445.1:p.T138R', Location ='21:33040839', dbSNP_id=''  
WHERE mutation_id = '243' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.416G>A', 
HGVS_protein = 'NP_000445.1:p.G139E', Location ='21:33040842', dbSNP_id=''  
WHERE mutation_id = '244' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1549C>G', 
HGVS_protein = 'NP_004951.1:p.H517D', Location ='16:31202727', dbSNP_id=''  
WHERE mutation_id = '245' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1132A>G', 
HGVS_protein = 'NP_031401.1:p.N378D', Location ='1:11082598', dbSNP_id=''  
WHERE mutation_id = '246' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.700C>T', 
HGVS_protein = 'NP_004951.1:p.R234C', Location ='16:31196436', dbSNP_id=''  
WHERE mutation_id = '247' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.688G>T', 
HGVS_protein = 'NP_004951.1:p.G230C', Location ='16:31196424', dbSNP_id=''  
WHERE mutation_id = '248' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.674G>T', 
HGVS_protein = 'NP_004951.1:p.G225V', Location ='16:31196410', dbSNP_id=''  
WHERE mutation_id = '249' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.646C>T', 
HGVS_protein = 'NP_004951.1:p.R216C', Location ='16:31196382', dbSNP_id=''  
WHERE mutation_id = '250' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.571G>A', 
HGVS_protein = 'NP_004951.1:p.G191S', Location ='16:31196307', 
dbSNP_id='rs148758737'  WHERE mutation_id = '251' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.875G>A', 
HGVS_protein = 'NP_031401.1:p.S292N', Location ='1:11082341', dbSNP_id=''  
WHERE mutation_id = '252' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.120G>A', 
HGVS_protein = 'NP_031401.1:p.G40G', Location ='1:11073904', dbSNP_id=''  
WHERE mutation_id = '253' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1098C>G', 
HGVS_protein = 'NP_031401.1:p.A366A', Location ='1:11082564', 
dbSNP_id='rs148325203'  WHERE mutation_id = '254' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.3353C>T', 
HGVS_protein = 'NP_055861.3:p.T1118I', Location ='9:135203632', dbSNP_id=''  
WHERE mutation_id = '255' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1561C>A', 
HGVS_protein = 'NP_004951.1:p.R521S', Location ='16:31202739', 
dbSNP_id='rs121909668; rs121909670'  WHERE mutation_id = '256' 
GO 
 - 610 - 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1562G>T', 
HGVS_protein = 'NP_004951.1:p.R521L', Location ='16:31202740', 
dbSNP_id='rs121909671'  WHERE mutation_id = '257' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.335G>A', 
HGVS_protein = 'NP_000445.1:p.C112Y', Location ='21:33039666', dbSNP_id=''  
WHERE mutation_id = '258' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.19T>A', 
HGVS_protein = 'NP_000445.1:p.C7S', Location ='21:33032101', dbSNP_id=''  
WHERE mutation_id = '259' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1192C>T', 
HGVS_protein = 'NP_068815.2:p.Q398X', Location ='10:13167989', dbSNP_id=''  
WHERE mutation_id = '260' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1433A>G', 
HGVS_protein = 'NP_068815.2:p.E478G', Location ='10:13174098', dbSNP_id=''  
WHERE mutation_id = '261' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.287C>G', 
HGVS_protein = 'NP_000445.1:p.A96G', Location ='21:33039618', dbSNP_id=''  
WHERE mutation_id = '263' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.68A>G', 
HGVS_protein = 'NP_000445.1:p.Q23R', Location ='21:33032150', dbSNP_id=''  
WHERE mutation_id = '264' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.199C>T', 
HGVS_protein = 'NP_000445.1:p.P67S', Location ='21:33038791', dbSNP_id=''  
WHERE mutation_id = '265' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.184G>C', 
HGVS_protein = 'NP_000445.1:p.G62R', Location ='21:33038776', dbSNP_id=''  
WHERE mutation_id = '266' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '267' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '268' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1540A>C', 
HGVS_protein = 'NP_004951.1:p.R514R', Location ='16:31202430', dbSNP_id=''  
WHERE mutation_id = '270' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.2143C>T', 
HGVS_protein = 'NP_065970.2:p.Q715X', Location ='2:202609008', 
dbSNP_id='rs121908139'  WHERE mutation_id = '271' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.1102G>A', 
HGVS_protein = 'NP_065970.2:p.V368M', Location ='2:202625615', 
dbSNP_id='rs3219156'  WHERE mutation_id = '272' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.4217G>A', 
HGVS_protein = 'NP_065970.2:p.R1406K', Location ='2:202574667', dbSNP_id=''  
WHERE mutation_id = '273' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.4015C>T', 
HGVS_protein = 'NP_065970.2:p.L1339L', Location ='2:202575821', 
dbSNP_id='rs3219168'  WHERE mutation_id = '274' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '276' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1150G>C', 
HGVS_protein = 'NP_031401.1:p.G384R', Location ='1:11082616', dbSNP_id=''  
WHERE mutation_id = '284' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1153T>G', 
HGVS_protein = 'NP_031401.1:p.W385G', Location ='1:11082619', dbSNP_id=''  
WHERE mutation_id = '285' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.139C>G', 
HGVS_protein = 'NP_000445.1:p.H47D', Location ='21:33036169', dbSNP_id=''  
WHERE mutation_id = '286' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.200C>G', 
HGVS_protein = 'NP_000445.1:p.P67R', Location ='21:33038792', dbSNP_id=''  
WHERE mutation_id = '287' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.251A>G', 
HGVS_protein = 'NP_000445.1:p.D84G', Location ='21:33039582', dbSNP_id=''  
WHERE mutation_id = '288' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007126.3:c.572G>A', 
HGVS_protein = 'NP_009057.1:p.R191Q', Location ='9:35065252', 
dbSNP_id='rs121909334'  WHERE mutation_id = '294' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007126.3:c.475C>G', 
HGVS_protein = 'NP_009057.1:p.R159G', Location ='9:35065349', dbSNP_id=''  
WHERE mutation_id = '295' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007126.3:c.1774G>A', 
HGVS_protein = 'NP_009057.1:p.D592N', Location ='9:35059720', dbSNP_id=''  
WHERE mutation_id = '296' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007126.3:c.464G>A', 
HGVS_protein = 'NP_009057.1:p.R155H', Location ='9:35065360', 
dbSNP_id='rs121909329; rs121909333'  WHERE mutation_id = '299' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '300' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001917.4:c.595C>T', 
HGVS_protein = 'NP_001908.3:p.R199W', Location ='12:109288126', 
dbSNP_id='rs3825251'  WHERE mutation_id = '301' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '302' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '303' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '304' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014845.5:c.157G>T', 
HGVS_protein = 'NP_055660.1:p.D53Y', Location ='6:110036371', 
dbSNP_id='rs121908290'  WHERE mutation_id = '306' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014845.5:c.143A>G', 
HGVS_protein = 'NP_055660.1:p.D48G', Location ='6:110036357', dbSNP_id=''  
WHERE mutation_id = '307' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014845.5:c.1162A>G', 
HGVS_protein = 'NP_055660.1:p.R388G', Location ='6:110081477', dbSNP_id=''  
WHERE mutation_id = '308' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014845.5:c.1231A>G', 
HGVS_protein = 'NP_055660.1:p.I411V', Location ='6:110081546', dbSNP_id=''  
WHERE mutation_id = '309' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '310' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014845.5:c.2705T>C', 
HGVS_protein = 'NP_055660.1:p.I902T', Location ='6:110146449', dbSNP_id=''  
WHERE mutation_id = '311' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '312' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '313' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.232A>G', 
HGVS_protein = 'NP_001136.1:p.K78E', Location ='14:21161955', 
dbSNP_id='rs141055235'  WHERE mutation_id = '314' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.36C>T', 
HGVS_protein = 'NP_001136.1:p.F(-13)L', Location ='14:21161759', 
dbSNP_id=''  WHERE mutation_id = '315' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.434G>A', 
HGVS_protein = 'NP_001136.1:p.R145H', Location ='14:21162157', dbSNP_id=''  
WHERE mutation_id = '317' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.203T>C', 
HGVS_protein = 'NP_000445.1:p.L68P', Location ='21:33038795', dbSNP_id=''  
WHERE mutation_id = '318' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.2464G>A', 
HGVS_protein = 'NP_065970.2:p.V822M', Location ='2:202598115', 
dbSNP_id='rs2276615'  WHERE mutation_id = '319' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_020919.3:c.1619G>A', 
HGVS_protein = 'NP_065970.2:p.G540E', Location ='2:202619247', dbSNP_id=''  
WHERE mutation_id = '320' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004738.4:c.137C>T', 
HGVS_protein = 'NP_004729.1:p.T46I', Location ='20:56993345', dbSNP_id=''  
WHERE mutation_id = '321' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '325' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_002345.3:c.596T>C', 
HGVS_protein = 'NP_002336.1:p.L199P', Location ='12:91502161', 
dbSNP_id='rs147975710'  WHERE mutation_id = '326' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001888.3:c.505C>T', 
HGVS_protein = 'NP_001879.1:p.R169C', Location ='16:21279043', 
dbSNP_id='rs148349291'  WHERE mutation_id = '327' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004082.4:c.3746C>T', 
HGVS_protein = 'NP_004073.2:p.T1249I', Location ='2:74588717', 
dbSNP_id='rs72466496'  WHERE mutation_id = '328' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.198T>C', 
HGVS_protein = 'NP_031401.1:p.A66A', Location ='1:11073982', 
dbSNP_id='rs61730366'  WHERE mutation_id = '329' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004082.4:c.1712T>C', 
HGVS_protein = 'NP_004073.2:p.M571T', Location ='2:74595997', 
dbSNP_id='rs121909343'  WHERE mutation_id = '330' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004082.4:c.2353C>T', 
HGVS_protein = 'NP_004073.2:p.R785W', Location ='2:74594023', 
dbSNP_id='rs121909344'  WHERE mutation_id = '331' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004082.4:c.3302G>A', 
HGVS_protein = 'NP_004073.2:p.R1101K', Location ='2:74590464', 
dbSNP_id='rs121909345'  WHERE mutation_id = '332' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.34G>T', 
HGVS_protein = 'NP_000445.1:p.D12Y', Location ='21:33032116', dbSNP_id=''  
WHERE mutation_id = '333' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.328G>T', 
HGVS_protein = 'NP_000445.1:p.D110Y', Location ='21:33039659', dbSNP_id=''  
WHERE mutation_id = '334' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '335' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.4660T>G', 
HGVS_protein = 'NP_055861.3:p.C1554G', Location ='9:135202325', 
dbSNP_id='rs112089123'  WHERE mutation_id = '336' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_015046.5:c.7640T>C', 
HGVS_protein = 'NP_055861.3:p.I2547T', Location ='9:135140020', 
dbSNP_id='rs151117904'  WHERE mutation_id = '337' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.13_14delinsTT', 
HGVS_protein = 'NP_000445.1:p.A4F', Location ='21:33032095 - 21:33032096', 
dbSNP_id=''  WHERE mutation_id = '338' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_018008.3:c.563G>A', 
HGVS_protein = 'NP_060478.3:p.G188D', Location ='3:62357981', 
dbSNP_id='rs199850439'  WHERE mutation_id = '339' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003585.3:c.626G>T', 
HGVS_protein = 'NP_003576.2:p.R209L', Location ='17:11884', dbSNP_id=''  
WHERE mutation_id = '340' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014461.2:c.940T>G', 
HGVS_protein = 'NP_055276.1:p.F314V', Location ='3:1363512', 
dbSNP_id='rs144474590'  WHERE mutation_id = '341' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_014461.2:c.2861A>T', 
HGVS_protein = 'NP_055276.1:p.E954V', Location ='3:1444045', dbSNP_id=''  
WHERE mutation_id = '342' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001257.4:c.193C>T', 
HGVS_protein = 'NP_001248.1:p.R65C', Location ='16:83065650', dbSNP_id=''  
WHERE mutation_id = '343' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001257.4:c.308C>T', 
HGVS_protein = 'NP_001248.1:p.A103V', Location ='16:83065765', 
dbSNP_id='rs199539898'  WHERE mutation_id = '344' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001257.4:c.337G>C', 
HGVS_protein = 'NP_001248.1:p.G113R', Location ='16:83065794', 
dbSNP_id='rs183971768'  WHERE mutation_id = '345' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001257.4:c.736C>T', 
HGVS_protein = 'NP_001248.1:p.R246W', Location ='16:83378566', dbSNP_id=''  
WHERE mutation_id = '346' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001257.4:c.1099G>C', 
HGVS_protein = 'NP_001248.1:p.E367Q', Location ='16:83636197', 
dbSNP_id='rs200000145'  WHERE mutation_id = '347' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004490.2:c.1519C>T', 
HGVS_protein = 'NP_004481.2:p.H507Y', Location ='2:165349650', 
dbSNP_id='rs144301087'  WHERE mutation_id = '348' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_022898.1:c.95A>T', 
HGVS_protein = 'NP_075049.1:p.E32V', Location ='14:99724140', dbSNP_id=''  
WHERE mutation_id = '351' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '352' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_145243.3:c.205C>T', 
HGVS_protein = 'NP_660286.1:p.H69Y', Location ='1:59004762', 
dbSNP_id='rs75220198'  WHERE mutation_id = '353' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_145243.3:c.815A>G', 
HGVS_protein = 'NP_660286.1:p.E272G', Location ='1:58999918', 
dbSNP_id='rs139938730'  WHERE mutation_id = '354' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_145243.3:c.1093G>T', 
HGVS_protein = 'NP_660286.1:p.D365Y', Location ='1:58996320', 
dbSNP_id='rs77980955'  WHERE mutation_id = '355' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_175733.3:c.460G>A', 
HGVS_protein = 'NP_783860.1:p.V154M', Location ='11:7324584', 
dbSNP_id='rs78477754'  WHERE mutation_id = '356' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_175733.3:c.712A>G', 
HGVS_protein = 'NP_783860.1:p.I238V', Location ='11:7334840', dbSNP_id=''  
WHERE mutation_id = '357' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_175733.3:c.1057C>G', 
HGVS_protein = 'NP_783860.1:p.L353V', Location ='11:7437285', 
dbSNP_id='rs117876446'  WHERE mutation_id = '358' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021076.3:c.2601G>T', 
HGVS_protein = 'NP_066554.2:p.K867N', Location ='22:29886230', 
dbSNP_id='rs138156220'  WHERE mutation_id = '359' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021076.3:c.2753A>G', 
HGVS_protein = 'NP_066554.2:p.E918G', Location ='22:29886382', 
dbSNP_id='rs189881592'  WHERE mutation_id = '360' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021076.3:c.1037G>A', 
HGVS_protein = 'NP_066554.2:p.R346H', Location ='22:29879517', dbSNP_id=''  
WHERE mutation_id = '361' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021076.3:c.119C>T', 
HGVS_protein = 'NP_066554.2:p.A40V', Location ='22:29876370', dbSNP_id=''  
WHERE mutation_id = '362' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_138966.3:c.1204G>A', 
HGVS_protein = 'NP_620416.1:p.G401R', Location ='', dbSNP_id='rs149193005 '  
WHERE mutation_id = '363' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_016441.2:c.1217A>G', 
HGVS_protein = 'NP_057525.1:p.N406S', Location ='2:36706682', 
dbSNP_id='rs139895660'  WHERE mutation_id = '364' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001706.4:c.218A>G', 
HGVS_protein = 'NP_001697.2:p.N73S', Location ='3:187449662', dbSNP_id=''  
WHERE mutation_id = '365' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021248.2:c.274G>A', 
HGVS_protein = 'NP_067071.1:p.E92K', Location ='', dbSNP_id=''  WHERE 
mutation_id = '366' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021248.2:c.401C>T', 
HGVS_protein = 'NP_067071.1:p.T134M', Location ='', dbSNP_id=''  WHERE 
mutation_id = '367' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021248.2:c.1598G>A', 
HGVS_protein = 'NP_067071.1:p.R533H', Location ='', dbSNP_id=''  WHERE 
mutation_id = '368' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '369' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '370' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_005856.2:c.349G>A', 
HGVS_protein = 'NP_005847.1:p.E117K', Location ='7:45222913', dbSNP_id=''  
WHERE mutation_id = '371' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_030932.3:c.701T>C', 
HGVS_protein = 'NP_112194.2:p.I234T', Location ='13:60554984', dbSNP_id=''  
WHERE mutation_id = '372' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_030932.3:c.944 C>T', 
HGVS_protein = '', Location ='', dbSNP_id='rs76366906'  WHERE mutation_id = 
'373' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '374' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '375' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '376' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '377' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_006940.4:c.1085A>C', 
HGVS_protein = 'NP_008871.3:p.Q362P', Location ='12:23757400', 
dbSNP_id='rs144670919'  WHERE mutation_id = '378' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.67G>T', 
HGVS_protein = 'NP_068815.2:p.G23X', Location ='10:13151189', dbSNP_id=''  
WHERE mutation_id = '379' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.844A>C', 
HGVS_protein = 'NP_068815.2:p.T282P', Location ='10:13164449', dbSNP_id=''  
WHERE mutation_id = '380' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.941A>T', 
HGVS_protein = 'NP_068815.2:p.Q314L', Location ='10:13166053', 
dbSNP_id='rs142812715'  WHERE mutation_id = '381' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.552+1delG', 
HGVS_protein = '', Location ='10:13154636', dbSNP_id=''  WHERE mutation_id 
= '382' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1401+4A>G', 
HGVS_protein = '', Location ='10:13169907', dbSNP_id=''  WHERE mutation_id 
= '383' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1670A>C', 
HGVS_protein = 'NP_068815.2:p.K557T', Location ='10:13178802', dbSNP_id=''  
WHERE mutation_id = '384' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003487.3:c.91G>A', 
HGVS_protein = 'NP_003478.1:p.A31T', Location ='17:34147071', dbSNP_id=''  
WHERE mutation_id = '385' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
'NP_003478.1:p.D386N', Location ='', dbSNP_id=''  WHERE mutation_id = '386' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
'NP_003478.1:p.R388H', Location ='', dbSNP_id=''  WHERE mutation_id = '387' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
'NP_003478.1:p.R395Q', Location ='', dbSNP_id=''  WHERE mutation_id = '388' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003487.3:c.1392_1415del24', 
HGVS_protein = 'NP_003478.1:p.Arg464_Arg472delinsArg', Location 
='17:34171704 - 17:34171727', dbSNP_id=''  WHERE mutation_id = '389' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003487.3:c.1422_1445del', 
HGVS_protein = 'NP_003478.1:p.R474_D481del', Location ='17:34171734 - 
17:34171757', dbSNP_id=''  WHERE mutation_id = '390' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003487.3:c.717G>A', 
HGVS_protein = 'NP_003478.1:p.G239G', Location ='17:34163188', 
dbSNP_id='rs144851351'  WHERE mutation_id = '391' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '392' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.654T>C', 
HGVS_protein = 'NP_068815.2:p.S218S', Location ='10:13160915', dbSNP_id=''  
WHERE mutation_id = '393' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.287G>T', 
HGVS_protein = 'NP_068815.2:p.R96L', Location ='10:13152394', 
dbSNP_id='rs184561087'  WHERE mutation_id = '394' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.691_692insAG', 
HGVS_protein = 'NP_068815.2:p.Leu231delinsTerTerfs', Location ='10:13160952 
- 10:13160953', dbSNP_id=''  WHERE mutation_id = '395' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.277G>C', 
HGVS_protein = 'NP_068815.2:p.A93P', Location ='10:13152384', dbSNP_id=''  
WHERE mutation_id = '396' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.811C>T', 
HGVS_protein = 'NP_068815.2:p.R271C', Location ='10:13164416', dbSNP_id=''  
WHERE mutation_id = '397' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.118C>T', 
HGVS_protein = 'NP_079413.3:p.Q40X', Location ='15:44955728', dbSNP_id=''  
WHERE mutation_id = '398' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '399' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '400' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.5974C>T', 
HGVS_protein = 'NP_079413.3:p.R1992X', Location ='15:44867132', 
dbSNP_id='rs200793464'  WHERE mutation_id = '401' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.2198T>G', 
HGVS_protein = 'NP_079413.3:p.L733X', Location ='15:44918575', dbSNP_id=''  
WHERE mutation_id = '403' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.2608A>G', 
HGVS_protein = 'NP_079413.3:p.I870V', Location ='15:44913969', dbSNP_id=''  
WHERE mutation_id = '404' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '405' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '406' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '407' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.5970C>G', 
HGVS_protein = 'NP_079413.3:p.Y1990X', Location ='15:44867136', dbSNP_id=''  
WHERE mutation_id = '408' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_025137.3:c.6157G>A', 
HGVS_protein = 'NP_079413.3:p.V2053M', Location ='15:44865793', 
dbSNP_id='rs149003934'  WHERE mutation_id = '409' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '410' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1529A>G', 
HGVS_protein = 'NP_004951.1:p.K510R', Location ='16:31202419', dbSNP_id=''  
WHERE mutation_id = '411' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1483C>T', 
HGVS_protein = 'NP_004951.1:p.R495X', Location ='16:31202373', dbSNP_id=''  
WHERE mutation_id = '412' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.760A>G', 
HGVS_protein = 'NP_004951.1:p.M254V', Location ='16:31196496', dbSNP_id=''  
WHERE mutation_id = '413' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_005866.2:c.304G>C', 
HGVS_protein = 'NP_005857.1:p.E102Q', Location ='9:34637265', dbSNP_id=''  
WHERE mutation_id = '414' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_013444.3:c.1516C>A', 
HGVS_protein = 'NP_038472.2:p.P506T', Location ='X:56591822', dbSNP_id=''  
WHERE mutation_id = '415' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_013444.3:c.1490C>A', 
HGVS_protein = 'NP_038472.2:p.P497H', Location ='X:56591796', dbSNP_id=''  
WHERE mutation_id = '417' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_013444.3:c.1489C>T', 
HGVS_protein = 'NP_038472.2:p.P497S', Location ='X:56591795', dbSNP_id=''  
WHERE mutation_id = '418' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_013444.3:c.1525C>T', 
HGVS_protein = 'NP_038472.2:p.P509S', Location ='X:56591831', dbSNP_id=''  
WHERE mutation_id = '419' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_013444.3:c.1573C>T', 
HGVS_protein = 'NP_038472.2:p.P525S', Location ='X:56591879', dbSNP_id=''  
WHERE mutation_id = '420' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '421' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.476G>T', 
HGVS_protein = 'NP_068815.2:p.G159V', Location ='10:13154559', dbSNP_id=''  
WHERE mutation_id = '422' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.495C>T', 
HGVS_protein = 'NP_068815.2:Q165X', Location ='', dbSNP_id=''  WHERE 
mutation_id = '423' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1360C>G', 
HGVS_protein = 'NP_068815.2:p.Q454E', Location ='10:13169862', dbSNP_id=''  
WHERE mutation_id = '425' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '426' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '427' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '428' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1442C>T', 
HGVS_protein = 'NP_068815.2:p.A481V', Location ='10:13174107', dbSNP_id=''  
WHERE mutation_id = '429' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.177G>C', 
HGVS_protein = 'NP_068815.2:p.K59N', Location ='10:13152284', dbSNP_id=''  
WHERE mutation_id = '430' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '432' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.35A>C', 
HGVS_protein = 'NP_000445.1:p.D12A', Location ='21:33032117', dbSNP_id=''  
WHERE mutation_id = '433' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001917.4:c.113G>A', 
HGVS_protein = 'NP_001908.3:p.R38H', Location ='12:109278895', 
dbSNP_id='rs3825251'  WHERE mutation_id = '434' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '435' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '436' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '437' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '438' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.284T>C', 
HGVS_protein = 'NP_000445.1:p.V95A', Location ='21:33039615', 
dbSNP_id='rs202198235'  WHERE mutation_id = '439' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.362A>T', 
HGVS_protein = 'NP_000445.1:p.H121L', Location ='21:33040788', dbSNP_id=''  
WHERE mutation_id = '440' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.425G>C', 
HGVS_protein = 'NP_000445.1:p.G142A', Location ='21:33040851', dbSNP_id=''  
WHERE mutation_id = '441' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.112T>C', 
HGVS_protein = 'NP_001136.1:p.Y38H', Location ='14:21161835', dbSNP_id=''  
WHERE mutation_id = '442' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.137A>G', 
HGVS_protein = 'NP_001136.1:p.D46G', Location ='14:21161860', dbSNP_id=''  
WHERE mutation_id = '443' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.2:c.1080C>T', 
HGVS_protein = 'NP_004951.1:p.S439S', Location ='16:31201374', 
dbSNP_id='rs190724342 '  WHERE mutation_id = '444' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.98C>T', 
HGVS_protein = 'NP_003891.1:p.A33V', Location ='5:179248034', 
dbSNP_id='rs200396166'  WHERE mutation_id = '445' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.457G>A', 
HGVS_protein = 'NP_003891.1:p.V153I', Location ='5:179251013', 
dbSNP_id='rs145056421'  WHERE mutation_id = '446' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.683C>T', 
HGVS_protein = 'NP_003891.1:p.P228L', Location ='5:179252155', 
dbSNP_id='rs151191977'  WHERE mutation_id = '447' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.702G>A', 
HGVS_protein = 'NP_003891.1:p.V234V', Location ='5:179252174', dbSNP_id=''  
WHERE mutation_id = '448' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '449' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.783C>T', 
HGVS_protein = 'NP_003891.1:p.H261H', Location ='5:179260060', 
dbSNP_id='rs145001811'  WHERE mutation_id = '450' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '451' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.961C>T', 
HGVS_protein = 'NP_003891.1:p.R321C', Location ='5:179260238', 
dbSNP_id='rs140226523'  WHERE mutation_id = '452' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '453' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.1175C>T', 
HGVS_protein = 'NP_003891.1:p.P392L', Location ='5:179263445', 
dbSNP_id='rs104893941'  WHERE mutation_id = '454' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.1231G>A', 
HGVS_protein = 'NP_003891.1:p.G411S', Location ='5:179263501', 
dbSNP_id='rs143511494'  WHERE mutation_id = '455' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_003900.4:c.1273G>A', 
HGVS_protein = 'NP_003891.1:p.G425R', Location ='5:179263543', dbSNP_id=''  
WHERE mutation_id = '456' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '457' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '458' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide 
='NM_004960.3:c.287291delCCTACinsAT', HGVS_protein = 
'NP_004951.1:p.Ser96del', Location ='16:31488469', dbSNP_id=''  WHERE 
mutation_id = '459' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.667-
678delGGCGGCGGCGGC', HGVS_protein = 'NP_004951.1:p.G223-G226del', Location 
='', dbSNP_id=''  WHERE mutation_id = '460' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1449-
1488delCTACCGGGGCCGCGGCGGGGACCGTGGAGGCTTCCGAGGG', HGVS_protein = 
'NP_004951.1:p.Y485AfsX514', Location ='', dbSNP_id=''  WHERE mutation_id = 
'463' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1483delC', 
HGVS_protein = 'NP_004951.1:p.Arg495Glufs', Location ='16:31202373', 
dbSNP_id=''  WHERE mutation_id = '464' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1485delA', 
HGVS_protein = 'NP_004951.1:p.Arg495Arg=fs', Location ='16:31202375', 
dbSNP_id=''  WHERE mutation_id = '465' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1527insTGGC', 
HGVS_protein = 'NP_004951.1:p.K510WfsX517', Location ='', dbSNP_id=''  
WHERE mutation_id = '466' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.412A>G', 
HGVS_protein = 'NP_000445.1:p.T138A', Location ='21:33040838', dbSNP_id=''  
WHERE mutation_id = '468' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '469' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.442G>A', 
HGVS_protein = 'NP_000445.1:p.G148S', Location ='21:33040868', dbSNP_id=''  
WHERE mutation_id = '470' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.433C>T', 
HGVS_protein = 'NP_001136.1:p.R145C', Location ='14:21162156', dbSNP_id=''  
WHERE mutation_id = '471' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1484delG', 
HGVS_protein = 'NP_004951.1:p.Arg495Glnfs', Location ='16:31202374', 
dbSNP_id=''  WHERE mutation_id = '472' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '476' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '477' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.176T>C', 
HGVS_protein = 'NP_001136.1:p.L59P', Location ='14:21161899', 
dbSNP_id='rs11541242'  WHERE mutation_id = '478' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.250A>G', 
HGVS_protein = 'NP_001136.1:p.K84E', Location ='14:21161973', 
dbSNP_id='rs17560'  WHERE mutation_id = '480' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_002934.2:c.300C>A', 
HGVS_protein = ' NP_002925.1:p.His100Gln', Location ='', 
dbSNP_id='rs8012891'  WHERE mutation_id = '482' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_005022.3:c.211T>G', 
HGVS_protein = 'NP_005013.1:p.C71G', Location ='17:4850037', dbSNP_id=''  
WHERE mutation_id = '484' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_005022.3:c.341T>C', 
HGVS_protein = 'NP_005013.1:p.M114T', Location ='17:4849277', dbSNP_id=''  
WHERE mutation_id = '485' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '486' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_005022.3:c.353G>T', 
HGVS_protein = 'NP_005013.1:p.G118V', Location ='17:4849265', dbSNP_id=''  
WHERE mutation_id = '487' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.355G>A', 
HGVS_protein = 'NP_000445.1:p.V119M', Location ='21:33039686', dbSNP_id=''  
WHERE mutation_id = '488' 
GO 
 - 622 - 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.346C>T', 
HGVS_protein = 'NP_000445.1:p.R116C', Location ='21:33039677', dbSNP_id=''  
WHERE mutation_id = '489' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_000454.4:c.113G>T', 
HGVS_protein = 'NP_000445.1:p.G38V', Location ='21:33036143', dbSNP_id=''  
WHERE mutation_id = '490' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.1043G>T', 
HGVS_protein = 'NP_031401.1:p.G348V', Location ='1:11082509', dbSNP_id=''  
WHERE mutation_id = '492' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.962C>T', 
HGVS_protein = 'NP_031401.1:p.A321V', Location ='1:11082428', dbSNP_id=''  
WHERE mutation_id = '493' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.-69C>T', 
HGVS_protein = '', Location ='1:11072744', dbSNP_id=''  WHERE mutation_id = 
'498' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.-66G>T', 
HGVS_protein = '', Location ='1:11072747', dbSNP_id=''  WHERE mutation_id = 
'500' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.81G>A', 
HGVS_protein = 'NP_031401.1:p.Leu27Leu=', Location ='1:11073865', 
dbSNP_id=''  WHERE mutation_id = '501' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.-12-54G>A', 
HGVS_protein = '', Location ='1:11073719', dbSNP_id=''  WHERE mutation_id = 
'502' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.198T>C', 
HGVS_protein = 'NP_031401.1:p.Ala66Ala=', Location ='1:11073982', 
dbSNP_id='rs61730366'  WHERE mutation_id = '503' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.312C>T', 
HGVS_protein = 'NP_031401.1:p.Ser104Ser=', Location ='1:11076974', 
dbSNP_id=''  WHERE mutation_id = '504' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.411A>G', 
HGVS_protein = 'NP_031401.1:p.Lys137', Location ='', dbSNP_id='14:11078798'  
WHERE mutation_id = '505' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.403-80G>A', 
HGVS_protein = '', Location ='1:11078710', dbSNP_id=''  WHERE mutation_id = 
'506' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_007375.3:c.543+112C>A', 
HGVS_protein = '', Location ='1:11079042', dbSNP_id=''  WHERE mutation_id = 
'507' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.379G>A', 
HGVS_protein = 'NP_001136.1:p.V103I', Location ='14:21162102', dbSNP_id=''  
WHERE mutation_id = '508' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.323A>G', 
HGVS_protein = 'NP_001136.1:p.H84R', Location ='14:21162046', dbSNP_id=''  
WHERE mutation_id = '509' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1392G>T', 
HGVS_protein = 'NP_004951.1:p.M464I', Location ='16:31202162', dbSNP_id=''  
WHERE mutation_id = '510' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.52C>T', 
HGVS_protein = 'NP_004951.1:p.P18S', Location ='16:31193847', 
dbSNP_id='rs144888138'  WHERE mutation_id = '511' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.188A>G', 
HGVS_protein = 'NP_004951.1:p.N63S', Location ='16:31193983', 
dbSNP_id='rs140883211'  WHERE mutation_id = '512' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.475 A>T', 
HGVS_protein = 'NP_004951.1:p.N159Y', Location ='16:31195669', dbSNP_id=''  
WHERE mutation_id = '513' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.491_495 + 
1delGAGGTgc', HGVS_protein = 'NP_004951.1:p.G174_G175del', Location ='', 
dbSNP_id=''  WHERE mutation_id = '515' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide 
='NM_004960.3:c.430_447delGGACAGCAGCAAAGCTAT', HGVS_protein = 
'NP_004951.1:p.G144_Y149del', Location ='16:31195624 - 16:31195641', 
dbSNP_id=''  WHERE mutation_id = '517' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '519' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.666_667insGGC', 
HGVS_protein = 'NP_004951.1:p.G222_G223insG', Location ='', 
dbSNP_id='rs72550890'  WHERE mutation_id = '521' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.667_669delGGC', 
HGVS_protein = 'NP_004951.1:p.G223del', Location ='', dbSNP_id='rs72550890'  
WHERE mutation_id = '523' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.676G>A', 
HGVS_protein = 'NP_004951.1:p.G226S', Location ='16:31196412', dbSNP_id=''  
WHERE mutation_id = '524' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1147C>T', 
HGVS_protein = 'NP_004951.1:p.R383C', Location ='16:31201441', dbSNP_id=''  
WHERE mutation_id = '525' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1506dupA', 
HGVS_protein = 'NP_004951.1:p.R502fsX15', Location ='', dbSNP_id=''  WHERE 
mutation_id = '526' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1555C>T', 
HGVS_protein = 'NP_004951.1:p.Q519X', Location ='16:31202733', dbSNP_id=''  
WHERE mutation_id = '527' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.6C>T', HGVS_protein 
= 'NP_004951.1:p.Ala2Ala=', Location ='16:31191541', dbSNP_id=''  WHERE 
mutation_id = '528' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.147C>A', 
HGVS_protein = 'NP_004951.1:p.G49G', Location ='', dbSNP_id='rs741810'  
WHERE mutation_id = '529' 
GO 
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UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.153 C>T', 
HGVS_protein = 'NP_004951.1:p.G51G', Location ='', dbSNP_id='rs61733962'  
WHERE mutation_id = '533' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.222A>G', 
HGVS_protein = 'NP_004951.1:p.Gly74Gly=', Location ='16:31195210', 
dbSNP_id=''  WHERE mutation_id = '534' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.269C>T', 
HGVS_protein = 'NP_004951.1:p.Y91Y', Location ='', dbSNP_id='rs73530286'  
WHERE mutation_id = '535' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.287C>T', 
HGVS_protein = 'NP_004951.1:p.Y97Y', Location ='', dbSNP_id='rs1052352'  
WHERE mutation_id = '536' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.504A>T', 
HGVS_protein = 'NP_004951.1:p.Gly168Gly=', Location ='16:31195698', 
dbSNP_id=''  WHERE mutation_id = '537' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.510A>T', 
HGVS_protein = 'NP_004951.1:p.Gly170Gly=', Location ='16:31195704', 
dbSNP_id=''  WHERE mutation_id = '538' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.684C>T', 
HGVS_protein = 'NP_004951.1:p.G228G', Location ='16:31196420', 
dbSNP_id='rs151073460 '  WHERE mutation_id = '539' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1156C>A', 
HGVS_protein = 'NP_004951.1:p.R386R', Location ='', dbSNP_id='rs61733965'  
WHERE mutation_id = '540' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1173C>A', 
HGVS_protein = 'NP_004951.1:p.P391P', Location ='16:31201600', dbSNP_id=''  
WHERE mutation_id = '541' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1464C>T', 
HGVS_protein = 'NP_004951.1:p.G488G', Location ='16:31202354', 
dbSNP_id='rs150529460'  WHERE mutation_id = '542' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_004960.3:c.1566G>A', 
HGVS_protein = 'NP_004951.1:p.R522R', Location ='16:31202744', 
dbSNP_id='rs138901914 '  WHERE mutation_id = '543' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
'NP_001136.1:p.Q(-10)D', Location ='', dbSNP_id=''  WHERE mutation_id = 
'544' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
' NP_001136.1:p.Thr80Ser', Location ='', dbSNP_id=''  WHERE mutation_id = 
'546' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001145.4:c.298T>A', 
HGVS_protein = ' NP_001136.1:p.Phe100Ile', Location ='', 
dbSNP_id='14:21162021'  WHERE mutation_id = '548' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = 
' NP_001136.1:p.Asn49Ser', Location ='', dbSNP_id=''  WHERE mutation_id = 
'550' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '553' 
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GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '554' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '555' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '556' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '557' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='', HGVS_protein = '', Location 
='', dbSNP_id=''  WHERE mutation_id = '558' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001008211.1:c.1107A>G', 
HGVS_protein = 'NP_001008212.1:p.L369L', Location ='10:13167526', 
dbSNP_id='rs149806984 '  WHERE mutation_id = '559' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_001008211.1:c.1704A>G', 
HGVS_protein = 'NP_001008212.1:p.L568L', Location ='10:13178836', 
dbSNP_id=''  WHERE mutation_id = '560' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.412G>A', 
HGVS_protein = 'NP_068815.2:p.T34T', Location ='', dbSNP_id='rs2234968'  
WHERE mutation_id = '561' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.433G>A', 
HGVS_protein = 'NP_068815.2:p.L41L', Location ='', dbSNP_id='rs11591687'  
WHERE mutation_id = '562' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.603T>A', 
HGVS_protein = 'NP_068815.2:p.M98K', Location ='', dbSNP_id='rs11258194'  
WHERE mutation_id = '563' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.799A>G', 
HGVS_protein = 'NP_068815.2:p.E163E', Location ='10:13154572', 
dbSNP_id='rs113811959 '  WHERE mutation_id = '564' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1273C>T', 
HGVS_protein = 'NP_068815.2:p.S321S', Location ='10:13166075', 
dbSNP_id='rs150381274'  WHERE mutation_id = '565' 
GO 
UPDATE dbo.mutation SET HGVS_Nucleotide ='NM_021980.4:c.1274G>A', 
HGVS_protein = 'NP_068815.2:p.E322K', Location ='', dbSNP_id='rs523747'  
WHERE mutation_id = '566' 
GO 
 
ALTER TABLE dbo.[gene] 
ADD [DB_no] int NULL; 
GO 
 
UPDATE dbo.gene SET DB_no='1'  WHERE gene_id = 'SOD1' 
GO 
UPDATE dbo.gene SET DB_no='2'  WHERE gene_id = 'ALS2' 
GO 
--UPDATE dbo.gene SET DB_no='3'  WHERE gene_id = 'SOD1' 
--GO 
UPDATE dbo.gene SET DB_no='4'  WHERE gene_id = 'SETX' 
GO 
UPDATE dbo.gene SET DB_no='5'  WHERE gene_id = 'SPAST' 
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GO 
UPDATE dbo.gene SET DB_no='6'  WHERE gene_id = 'FUS' 
GO 
--UPDATE dbo.gene SET DB_no='7'  WHERE gene_id = 'SOD1' 
--GO 
UPDATE dbo.gene SET DB_no='8'  WHERE gene_id = 'VAPB' 
GO 
UPDATE dbo.gene SET DB_no='9'  WHERE gene_id = 'ANG' 
GO 
UPDATE dbo.gene SET DB_no='10'  WHERE gene_id = 'TARDBP' 
GO 
UPDATE dbo.gene SET DB_no='11'  WHERE gene_id = 'FIG4' 
GO 
UPDATE dbo.gene SET DB_no='12'  WHERE gene_id = 'OPTN' 
GO 
UPDATE dbo.gene SET DB_no='13'  WHERE gene_id = 'ATXN2' 
GO 
UPDATE dbo.gene SET DB_no='14'  WHERE gene_id = 'VCP' 
GO 
UPDATE dbo.gene SET DB_no='15'  WHERE gene_id = 'UBQLN2' 
GO 
UPDATE dbo.gene SET DB_no='16'  WHERE gene_id = 'SIGMAR1' 
GO 
--UPDATE dbo.gene SET DB_no='17'  WHERE gene_id = 'SOD1' 
--GO 
UPDATE dbo.gene SET DB_no='18'  WHERE gene_id = 'PFN1' 
GO 
--UPDATE dbo.gene SET DB_no='19'  WHERE gene_id = 'SOD1' 
--GO 
UPDATE dbo.gene SET DB_no='20'  WHERE gene_id = 'C9orf72' 
GO 
UPDATE dbo.gene SET DB_no='21'  WHERE gene_id = 'CHMP2B' 
GO 
UPDATE dbo.gene SET DB_no='22'  WHERE gene_id = 'UNC13A' 
GO 
UPDATE dbo.gene SET DB_no='23'  WHERE gene_id = 'DAO' 
GO 
UPDATE dbo.gene SET DB_no='24'  WHERE gene_id = 'DCTN1' 
GO 
UPDATE dbo.gene SET DB_no='25'  WHERE gene_id = 'NEFH' 
GO 
UPDATE dbo.gene SET DB_no='26'  WHERE gene_id = 'PRPH' 
GO 
UPDATE dbo.gene SET DB_no='27'  WHERE gene_id = 'SQSTM1' 
GO 
UPDATE dbo.gene SET DB_no='28'  WHERE gene_id = 'TAF15' 
GO 
UPDATE dbo.gene SET DB_no='29'  WHERE gene_id = 'SPG11' 
GO 
UPDATE dbo.gene SET DB_no='30'  WHERE gene_id = 'ELP3' 
GO 
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 ANG_sequence_twenties.txt.tr  +   ANG_codon.txt.tr = result3.txt 
 result3.txt  +  possiblilities.txt.tr = result4.txt 
Example of gene codon AA and NT tranformations using perl script e.g.  ANG 



























































































































































































































































































































1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 
6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 
7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 
9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 
10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 
11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 11 
12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 
13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 
14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 14 
15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 
16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 
17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 17 
18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18 
19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 19 
20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 
21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 21 
22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 
23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 23 
24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 
25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 25 
26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 26 
27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 27 
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28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 
29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 29 
30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 
31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 31 
32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 32 
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 
34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 34 
35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 35 
36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 
37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 37 
38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 38 
39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 39 
40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 
41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 
42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 42 
43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 43 
44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 44 
45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 
46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 46 
47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 47 
48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 48 
49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 49 
50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 
51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 51 
52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 52 
53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 
54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 
55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 55 
56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 56 
57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 57 
58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 58 
59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 59 
60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 60 
61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 61 
62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 62 
63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 63 
64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 
65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 65 
66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 66 
67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 67 
68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 68 
69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 69 
70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 70 
71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 71 
72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 72 
73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 73 
74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 74 
75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 
76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 76 
77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 77 
78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 78 
79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 79 
80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 80 
81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 
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82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 
83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 83 
84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 84 
85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 85 
86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 86 
87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 87 
88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 88 
89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 89 
90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 90 
91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 91 
92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 92 
93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 93 
94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 94 
95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 95 
96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 96 
97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 97 
98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 98 
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ANG codon transformed 
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Appendix 39 – Sample of letter sent to ALS Experts  
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Appendix 40 – Database Schema  
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Appendix 41 – List of Files 
ALSoD Files on KCL Server screen dump taken on 27
th
 January 2014 
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 animalmodels.xls – To update animal model table 
 ALSoD_update_july_2013.xls – To update mutation and patient data 
 Survey_ranking_credibility_genes.xls 
Poster Presentations 
 ALSOD_Advert.xls     19
th
 August 2009 
 ALSOD_MNDA_Poster     13
th
 October 2009 
 ALSOD_MNDA_Poster(ammended)   22
nd
 March 2010 
 ALSOD_ABN_Poster(ammended)   15
th
 April 2010 
 ALSOD_Advert2010     11
th
 September 2010 
 ALSOD_WELLCOMETRUST_Poster_ammended 6
th
 December 2010 
 ALSOD_MNDA_2010_Poster    8
th
 December 2010 
 ALSOD_MRC_Poster25082011    30
th
 August 2011 
 ALSOD_MNDA_Poster2012    26
th
 November 2012 
 ALSOD_Advert2013     4
th
 September 2013 
Oral Presentations 
 ALSOD PRESENTATION2008. ppt 
 Presentation231110.ppt     November 2010 
 Showcase_Credibility. ppt    Novemeber 2011 
 - 660 - 
 Showcase     November 2012 
 Departmental talk on ALS database  January 2013 
 ALSoD_MNDA2013. ppt     December 2013 
 Departmental talk on ALS database  February 2014 
Abstracts submitted and approved for presentations 
 Showcase_mobile_friendly.doc  words  November 2012 
 Showcase_abstract_and_form_2011.doc words November 2011 
 Showcase_Abstract proforma.doc 
 ALSoD_abstract_MNDA_Italy2013.doc    
 
List of Python script on population frequency 
snp_match.py 
List of textfiles imported into database  
countries, gwas,1000genome,EVS  
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Appendix 42 - Recaptcha 
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Solution 1:  
Database diagram support objects cannot be installed because this database does not have a 
valid owner. To continue, first use the Files page of the Database Properties dialog box or the 
ALTER AUTHORIZATION statement to set the database owner to a valid login, then add the 
database diagram support objects. 
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Solution 3:  
If google map does not appear immediately but requests the user to download the plug-in, then 
the user can click on the download button. This is because the user has not got the java plugin 











 <customErrors mode="Off"  
defaultRedirect="GenericErrorPage.htm"> 
<customErrors mode="RemoteOnly"  
defaultRedirect="GenericErrorPage.htm"> 
      <error  statusCode="403" redirect="NoAccess.htm"/> 
     <error statusCode="404" edirect="FileNotFound.htm"/> 
    </customErrors> 
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any error does not show the error encountered but 




1. Msg 4861, Level 16, State 1, Line 2 
Cannot bulk load because the file "C:\Documents and Settings\spngoka\Desktop\Alsod 
stuff\DataSets\uk\uk_result_assoc.txt" could not be opened. Operating system error code 
3(error not found). 
 
Solution 5: 
   
Check to ensure ‘C:\Documents and Settings\spngoka\Desktop\Alsod 
stuff\DataSets\uk\uk_result_assoc.txt ‘ exists at the specified location on the SQL Server.  Note 
that the path is accessed from the server rather than the client.  If the file resides on the client 
machine, you'll   
need to create a share and assign file/share permissions to the SQL Server service in order to 
BULK INSERT from a network location. The best option was to copy the file to the webserver 
\\vmw\Alsod\ so it could be accessed directly while bulk inserting. 
 
Solution blog  website: 
http://www.eggheadcafe.com/forumarchives/SQLServerprogramming/Jan2006/post26056833.asp 
I finally, copied C:\Documents and Settings\spngoka\Desktop\Alsod 





2. The statement has been terminated. 
Msg 9002, Level 17, State 2, Line 1 
 - 668 - 
The transaction log for database 'Alsod' is full.  
 
Soulution 6: 




“The temp directory in chart handler configuration is not accessible” in Microsoft Chart Control 
while creating charts. 
Solution 7 
And what it is when you look in to your web.config you will find this TAG in the appSettings: 
 
<add key="ChartImageHandler" value="Storage=file;Timeout=20;Url=~/tempImages/;"/> 
 
When you drag the Chart control into design mode it adds the tag above to the web.config and 
you shoud have a folder called TempImages. You get the error when its trying to right or modify 
that folder and all you need is to give the folder the right access. 
 
On my Vista machine i just gave  COMPNAME\Users write and modify access. 




If a website is down ater an upgrade, it could be an App_Offline.htm problem 
Solution blog website: http://weblogs.asp.net/scottgu/archive/2005/10/06/426755.aspx 
Solution 8: Once you remove the app_offline.htm file, the next request into the application will 
cause ASP.NET to load the application and thewebsite will continue working as expected. 
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Appendix 44 – Gantt Chart of Project 
METHODOLOGY AND TIMELINE 
 
      

























  Tasks                         
1 Acquire skills from library & internet                         
2 Study architecture of database & webpage                          
3 
Restructure and cleanup database and 
website                         
4 Update database                          
5 Create gene overview  page and hyperlinks                         
6 Create graphical pages summarizing data                         
7 Design webpage for monitoring visitors                         
8 
Import and process data for association 
studies                         
9 Design webpage to view GWA studies                         
10 Import and process data for linkage studies                         
11 
Design webpage to link groups working on 
ALS                         
12 
Combination of Linkage and Association 
studies                         
13 
Extend database and webpage to include 
other species                         
14 Write other operational codes                     
15 Tidying up database and webpages                         
16 ALSOD Documentation                         
17 Writing thesis                         
18 Testing                         
19 Delays                         
20 Keep log book                         
21 Communicating progress to supervisors                         
22 Consultations                         
23 
Learning bioinformatic tools like R, Plink, 
Perl etc                         
24 
Attending meetings, seminars, lectures, 
conferences                         
25  MILESTONES   M1   M2       M3       M4 
  Detailed tasks                         
  Background tasks                         
 
M1- Completion of database restructure and updates  M3 - Completion of database extension  
M2 - Completion of association and linkage studies  M4 - Completion of report writing 
Detailed tasks Background tasks 
1     Literature review 
2 – 4    Creating Database structure and checking data 
quality 
5 -7    Design user interface 
8 – 12       Writing and testing codes for Data Analysis 
13 – 15     Extension of database 
16 – 17     Documentation 
18 - 20 Write-ups and tests 
21 - 24 Consultations 
25  Milestones 
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Appendix 45 – Glossary 
Amino acids Amino acids are the building blocks used by cells, including motor 
neurons, to create proteins. Just as the letters of the alphabet can 
be combined to form an almost endless variety of words, amino 
acids can be linked together to form a vast variety of proteins. 
Atrophy It is wasting and shrinkage of tissue. 
Axon It is the long, hairlike extension of a nerve cell that carries a 
message to the next nerve cell. 
Biomarker A biomarker is a substance that can be used to diagnose or monitor 
disease. Currently, there is no biomarker available to diagnose or 
monitor ALS. To learn about efforts to identify biomarkers for ALS 
Bulbar onset This refers to the type of ALS where initial symptoms appear in the 
face and neck, such as difficulty swallowing or forming words. 
Cerebellum It is a large, two-halved structure (hemispheres) located in the lower 
part of the brain that's responsible for the coordination of movement 
and balance. 
Clinical onset Clinical onset refers to the time at which signs or symptoms of a 
disease first appears. 
Definite ALS If loss of upper and lower motor neurons is detected in three or more 
regions of the body, the disease is diagnosed as definite ALS. 
Dementia The progressive decline in cognitive function due to damage or 
disease in the brain. Memory, attention, language, and problem 
solving ability may be impaired. Dementia can also result in 
confusion. Dementia occurs due to the degeneration of the cortex of 
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the brain. Some people with ALS also experience dementia. 
Dysarthria Dysarthria is impaired speech and language due to weakness or 
stiffness in the muscles used for speaking 
Dysphagia Dysphagia is difficulty in swallowing 
Fasciculation A localized, uncontrolled, uncoordinated involuntary twitching of a 
single muscle group. Fasciculations could be benign or indicative of 
disease. Fasciculations are often described as one of the first 
symptoms of ALS. 
Frontotemporal 
Dementia 
Also called frontotemporal lobular degeneration (FTLD), 
frontotemporal dementia (FTD) is a term that refers to a number of 
disorders that occur due to shrinkage of the frontal and temporal 
lobes of the brain. Symptoms include executive dysfunction 
(difficulties in critical thinking and problem solving), language/speech 
deficits and behavioral problems. Certain people with ALS also have 
FTD. 
HumVar HumVar is preferred model for diagnostics of Mendelian diseases which 
requires distinguishing mutations with drastic effects from all the remaining 
human variation, including abundant mildly deleterious alleles 
HumDiv HumDiv is preferred model for evaluating rare alleles, dense mapping of 
regions identified by genome-wide association studies, and analysis of 
natural selection. 
Hyperreflexia hyperreflexia is excessive response of muscle reflexes when a 
normal stimulus is applied. 
Hyporeflexia hyporeflexia is weak or absent muscle response when a normal 
stimulus is applied. 
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in vivo In vivo refers to laboratory studies performed within a whole, living 
organism. 
Incidence The occurrence of new cases of a condition. Incidence is commonly 
measured in new cases per 1,000 (or 100,000) of population at risk, 
per year. The incidence of ALS typically varies between 1 and 4 
diagnoses per 100,000 of populations per year in the U.S. 
Limb Onset Refers to the type of ALS where initial symptoms appear in the 




These are the motor neurons connecting the brainstem and spinal 
cord to muscle fibers, bringing the nerve impulses from the upper 
motor neurons out to the muscles. In ALS, the motor neurons 
degenerate or die, ceasing to send messages to muscles. Unable to 




MRI is a medical imaging technique used to visualize the integrity of 
specific structures and tissues in the body. It has much greater soft 
tissue contrast than computed tomography (CT) making it especially 
useful in neurological, musculoskeletal, cardiovascular, and 




Multiple Sclerosis (MS) - a disease of the central nervous system 
that is unpredictable. MS can be relatively benign, disabling, or 
devastating, leaving the patient unable to speak, walk, or write. 
Neuron Neuron is a cell specialized to conduct and generate electrical 
impulses and to carry information from one part of the brain to 




Parkinson's disease (PD) is a neurodegenerative brain disease that 
results in shaking (tremors) and muscle stiffness. Other symptoms 
include trouble walking or maintaining balance.The disease is 
thought to occur due to loss of dopamine-producing neurons in the 
brain. 
Phenotype A phenotype refers to everything observable about a living 
organism. ALS is often a described as a disease with variable 
phenotypes because the symptoms of the disease can differ 





A computer-based imaging technique that provides a picture of the 
brain's activity rather than its structure. The technique detects levels 
of injected glucose labeled with a radioactive tracer. 
primary lateral 
sclerosis (PLS) 
A progressive neurological disease in which the upper motor nerve 
cells (neurons) deteriorate. If the lower motor neurons are not 
affected within two years, the disease usually remains a pure upper 




A condition that begins with difficulties in speaking, chewing and 
swallowing due to lower motor nerve cell (neuron) deterioration. This 




A progressive neurological disease in which the lower motor nerve 
cells (neurons) deteriorate. If the upper motor neurons are 
unaffected within two years, the disease usually remains a pure 
lower motor neuron disease. 
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Spinal cord The spinal cord is the part of the central nervous system that 
extends from the base of the skull through the lower back. It is 
continuous with the brain stem and encased in a triple sheath of 
membranes. The spinal cord is typically 15 to 17 inches long and 
contains 33 vertebrae and 31 pairs of nerves. The spinal cord 
enables the brain to communicate with the rest of the body. 
spinal muscular 
atrophy (SMA) 
A hereditary neurological disease in which only the lower motor 
nerve cells are affected. 
Upper motor 
neurons 
Upper motor neurons (UMNs) originate in the motor cortex of the 
brain. Upper motor neurons enable certain movements including 
walking and chewing food. 
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Appendix 46 - Acronyms 
PC - Personal Computer 
NIH - National Institutes of Health 
CODASYL – Conference on Data System Language 
DBMS DataBase Management System 
IMS - Information Management System  
ORDBMS – Object Relational Database Management System 
XML - Extensible Markup Language 
API – Application Programming Interfaces 
KDD - Knowledge Discovery in Databases  
OMIM – Online Mendelian Inheritance in Man 
MND – Motor Neuron Disease 
ALSA – Amyotrophic Lateral Sclerosis Association 
UMN – Upper Motor Neuron 
LMN – Lower Motor Neuron 
NCBI - National Center for Biotechnology Information 
UCSC – University of California Santa Cruz 
KEGG – Kyoto Encyclopedia of Genes and Genomes 
UNIPROT - Universal Protein 
GWAS – Genome Wide Association Study 
RSS – Rich Site Summary or Really Simple Syndication 
BOAA - β-N-Oxalylamino-l-alanine  
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Appendix 47 - Resources 
Scientific websites 
1000 Genomes project - www.1000genomes.org/  
Exome Variant Server database - http://evs.gs.washington.edu/EVS/ 
Database of single-nucleotide polymorphisms (dbSNP) -  http://www.ncbi.nlm.nih.gov/SNP/ 
ExonPrimer - http://ihg.gsf.de/ihg/ExonPrimer.html 
NCBI37/hg19 assembly -  http://genome.ucsc.edu/ 
NHLBI GO Exome Sequencing Project (NHLBI-ESP) - https://esp.gs.washington.edu/drupal 
Online Mendelian Inheritance in Man (OMIM) - http://www.omim.org/ 
Personal genome databases -  http://www.sequenceontology.org/resources/10Gen.html 
PLINK algorithm -  http://pngu.mgh.harvard.edu/purcell/plink/ 
PolyPhen-2 - http://genetics.bwh.harvard.edu/pph2/ 
Refseq -  http://www.ncbi.nlm.nih.gov/projects/RefSeq/ 
UCSC Human Genome Browser -  http://genome.ucsc.edu/ 
NCBI - http://www.ncbi.nlm.nih.gov/gene 
Gene cards - http://www.genecards.org/ 
ExPASy Bioinformatics Resource Portal - http://www.expasy.org/ 
UniProt - http://www.uniprot.org/ 
iHop - http://www.ihop-net.org/UniPub/iHOP/ 
KEGG ALS pathway - http://www.genome.jp/kegg-bin/show_pathway?hsa05014 
Genetic Testing Registry - http://www.ncbi.nlm.nih.gov/gtr/ 
NCBI Gene Review - http://www.ncbi.nlm.nih.gov/books/NBK1450/ 
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Neuromuscular Disease Center - http://neuromuscular.wustl.edu/index.html 
Mouse Genome Informatics - http://www.informatics.jax.org/ 
Gene Ontology - http://www.geneontology.org/ 
Ensembl - http://www.ensembl.org/index.html 
WikiGenes - http://www.wikigenes.org/ 
ALSmutationDatabase https://reseq.biosciencedbc.jp/resequence/SearchDisease.do?targetId=1 
GWAS Phenomap Project – http://www.gwascentral.org/gwasphenomap 
ALSGene – http://www.alsgene.org  
 
Bioinformatics tools 
GeneMANIA - http://genemania.org/ 
NetPhos 2.0 Server - http://www.cbs.dtu.dk/services/NetPhos/ 
Bioinformatics resource portal - http://bioinformaticsweb.net/ 
Displaying your own Annotations in the Genome Browser - 
http://genome.cse.ucsc.edu/goldenPath/help/customTrack.html 
Human Variation SNP ids - http://www.ncbi.nlm.nih.gov/projects/SNP/tranSNP/tranSNP.cgi 
PANTHER – http://www.pantherdb.org/tools/csnpScoreForm.jsp 
SIFT - http://sift.jcvi.org/www/SIFT_BLink_submit.html 
POLYPHEN - http://genetics.bwh.harvard.edu/pph2/index.shtml 
 
Tutorial websites 
Introduction to ASP.Net Tutorial - http://asp.net-tutorials.com/basics/introduction/ 
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Android Development Tutorial - http://www.vogella.com/tutorials/Android/article.html 
Learn C++ - http://www.learncpp.com/ 
Information about genetics - http://www.info.co.uk/genetics?cb=28&cmp=2036 
How to track a website - 
https://developers.google.com/analytics/devguides/collection/gajs/asyncTracking?csw=1 
How to make a widget for a website - http://www.ehow.com/how_2059724_make-widget-
website.html 
Using Microsoft’s Chart Controls - http://www.4guysfromrolla.com/articles/111809-1.aspx 
The Chi Square Statistics - http://math.hws.edu/javamath/ryan/ChiSquare.html 
Using R - http://rdotnet.codeplex.com/ 
Available R packages - http://cran.r-project.org/ 
The R Statistical Language and C#.NET - http://www.codeproject.com/Articles/25819/The-R-
Statistical-Language-and-C-NET-Foundations 
Redirecting to an ASP.NET Mobile Web Page - http://msdn.microsoft.com/en-
US/library/fhhycabe(v=vs.80) 
Blackberry Developer - https://developer.blackberry.com/ 
ASP.NET MVC 4 Mobile Features - http://www.asp.net/mvc/tutorials/mvc-4/aspnet-mvc-4-
mobile-features 
Introduction of Mobile Controls - http://www.codeproject.com/Articles/17842/Introduction-of-
Mobile-Controls-Available-in-ASP-N 
Mobile Apps & Sites with ASP.NET - http://www.asp.net/mobile 
ASP.NET IsMobileDevice and how it works - http://ngeor.net/2011/03/asp-net-ismobiledevice-
and-how-it-works/ 
How to develop Android apps - http://reviews.cnet.co.uk/mobile-apps/how-to-develop-android-
apps-50008626/ 
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Expanding/Collapsing GridView Rows - http://www.codeproject.com/Articles/25858/Expanding-
Collapsing-GridView-Rows 
Server 2005 – Populating the Database - http://www.exforsys.com/tutorials/sql-server-
2005/populating-the-sql-server-database.html 
ORDER BY statement - http://www.1keydata.com/sql/sqlorderby.html 
Ajax Control Toolkit Tutorials - http://www.asp.net/ajaxlibrary/act_tutorials.ashx 
Ajax, IE and Firefox! - http://powerdream5.wordpress.com/2007/10/11/ajax-ie-and-firefox/ 
Digging More intoSQL Server 2000 Using Client-side Javascript - 
http://www.devarticles.com/c/a/JavaScript/Digging-More-into-SQL-Server-2000-Using-
Clientside-JavaScript/ 
Google Developers - https://developers.google.com/maps/?csw=1 
Google Maps via ASP.NET/SQL Server Tutorial - http://forums.asp.net/t/1286639.aspx 
How to embed almost anything in your website - http://www.labnol.org/internet/how-to-embed-
in-html-webpages/6365/ 
Google Geomap Visualization API in ASP.Net - http://www.aspsnippets.com/Articles/Google-
Geomap-Visualization-API-in-ASP.Net.aspx 
Google Maps and ASP.NET - http://be.sys-con.com/node/171162?page=0%2C1 
Upgrading Your Google Maps JavascriptApplication to v3 - 
https://developers.google.com/maps/documentation/javascript/v2/v2tov3?csw=1 
Google Maps API Tutorial - http://econym.org.uk/gmap/ 
Chart Gallery – Google Charts - 
https://developers.google.com/chart/interactive/docs/gallery?csw=1 
SQL Programming - 
http://publib.boulder.ibm.com/infocenter/iseries/v5r3/index.jsp?topic=%2Fsqlp%2Frbafydelete.ht
m 
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Non Scientific websites 
Google Earth API - https://developers.google.com/earth/ 
Java for Window - http://java.com/en/download/win8.jsp 
Wikipedia - http://en.wikipedia.org/wiki/Main_Page 
WolframAlpha - http://www.wolframalpha.com/ 
Blogs on Web development 
How to create a mobile version of a website 
http://forums.asp.net/t/1470188.aspx?how+to+create+a+mobile+version+of+a+website+ 
Fix: Facebook Like Button Not Working - http://www.allwebmaster.com/fix-facebook-like-button-
not-working/ 
Insert Records using TextBox to SQL Database - http://www.bigresource.com/MS_SQL--Insert-
Records-Using-from-Text-box-to-SQL-database--P5dXIRD8.html 
How to insert data in database using Textboxes - 
http://www.querycat.com/question/d01e1d84babbb71c2b2385f7a8bde242 
Call a perl script using ASP.NET - http://www.asp.net/ajaxlibrary/act_tutorials.ashx 
TSQL Text File Output - http://www.dbforums.com/microsoft-sql-server/1607213-tsql-text-file-
output.html 
How do I send a database query to a text file - http://databases.aspfaq.com/database/how-do-i-
send-a-database-query-to-a-text-file.html 
Social Media Accounts 
Facebook – https://www.facebook.com/pages/ALSoD/307667685943735 
Twitter - https://twitter.com/ALSoD_Database 
  
